0001193125-22-275831.txt : 20221102 0001193125-22-275831.hdr.sgml : 20221102 20221102161229 ACCESSION NUMBER: 0001193125-22-275831 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 86 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221102 DATE AS OF CHANGE: 20221102 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SLR Investment Corp. CENTRAL INDEX KEY: 0001418076 IRS NUMBER: 261381340 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 814-00754 FILM NUMBER: 221354196 BUSINESS ADDRESS: STREET 1: 500 PARK AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: (212) 993-1670 MAIL ADDRESS: STREET 1: 500 PARK AVENUE STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: Solar Capital Ltd. DATE OF NAME CHANGE: 20071109 10-Q 1 d375653d10q.htm 10-Q 10-Q
falseQ30001418076--12-31NYInvestment is on non-accrual status.Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 22.7% of the total assets of the Company.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2022 in these controlled investments are as follows:Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis, non-qualifying assets in the portfolio represented 23.1% of the total assets of the Company.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows:Indicates an investment that is wholly held by the Company through NEFPASS LLC.Denotes a subsidiary of SLR Equipment Finance.SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.Non-income producing security.OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor.Interest is paid in kind (“PIK”).Spread is 5.50% Cash / 0.50% PIK.AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.See note 14 to the consolidated financial statements.See note 9 to the consolidated financial statements.See note 15 to the consolidated financial statements.Denotes a Level 1 investment.See note 13 to the consolidated financial statements.The Company’s investment in SOINT, LLC include a one dollar investment in common shares.See note 11 to the consolidated financial statements.The Company’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively.Spread is 6.00% Cash / 2.00% PIK.Spread is 2.50% Cash / 12.50% PIK.Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of September 30, 2022.Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2021.On April 1, 2022, in connection with the Merger (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. For further details, refer to Note 16 “Merger with SUNS”.Aggregate net unrealized appreciation for U.S. federal income tax purposes is $19,495; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $82,598 and $63,103, respectively, based on a tax cost of $1,651,087. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2022, asset coverage was 187.0%.Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014, 2013 and 2012 periods was $100,175, $98,196, $94,301, $93,392, and $92,302, respectively.Based on the market price at closing of $18.13, adjusted for transaction costs. 0001418076 2022-09-30 0001418076 2021-12-31 0001418076 2022-07-01 2022-09-30 0001418076 2021-07-01 2021-09-30 0001418076 2022-01-01 2022-09-30 0001418076 2021-01-01 2021-09-30 0001418076 2022-10-31 0001418076 2022-09-30 2022-09-30 0001418076 2022-04-01 2022-04-01 0001418076 2022-05-03 0001418076 2022-05-23 2022-05-23 0001418076 2021-01-01 2021-12-31 0001418076 2021-09-30 0001418076 2020-12-31 0001418076 2015-01-01 2015-12-31 0001418076 2016-01-01 2016-12-31 0001418076 2017-01-01 2017-12-31 0001418076 2014-01-01 2014-12-31 0001418076 2018-01-01 2018-12-31 0001418076 2019-01-01 2019-12-31 0001418076 2020-01-01 2020-12-31 0001418076 2012-01-01 2012-12-31 0001418076 2013-01-01 2013-12-31 0001418076 2021-06-30 0001418076 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SenseonicsHoldingsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:VenusConceptLtdMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:DelphinusMedicalTechnologiesIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:ConventusOrthopaedicsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CentrexionTherapeuticsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CardioFocusIncMember 2021-12-31 0001418076 slrc:SlrEquipmentFinanceEquityInterestsMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:SointLlcMember slrc:PreferredEquityZeroPointSevenPercentMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:AtyrPharmaIncMember 2021-12-31 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AlteonHealthLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:BasicFunInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:CommunityBrandsParentcoLlcFkaMinistryBrandsMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:InszoneMidLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:EnhancedPermanentCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:KoreWirelessGroupInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OneTouchDirectLlcMember 2021-12-31 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:MmitHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:PptManagementHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SunmedGroupHoldingsLlcMember 2021-12-31 0001418076 slrc:StrytenEnergyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RqmCorp.Member 2021-12-31 0001418076 slrc:PhymedManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:VarileaseFinanceInc.Member 2021-12-31 0001418076 slrc:AcresCommercialMortgageLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:UsrParentInc.StaplesMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:RugDoctorLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:BridgebioPharmaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AxcellaHealthIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArdelyxInc.Member 2021-12-31 0001418076 slrc:ArcutisBiotherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlimeraSciencesInc.Member 2021-12-31 0001418076 slrc:OmniguideHoldingsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:NeuroneticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:GlookoInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:DelphinusMedicalTechnologiesInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CerapedicsInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-12-31 0001418076 slrc:RezoluteIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:SocTelemedInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:ScpharmaceuticalsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:RubiusTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:ChampionAirLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:EasyPakLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GeorgiaJetIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstNationalCapitalLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstAmericanCommercialBancorpIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GmtCorporationMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HawkeyeContractingCompanyLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HaljoeCoachesUsaLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:KoolPakLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalExpressIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalCoachLinesIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RosscoCraneRiggingIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RaneLightMetalCastingsIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:MountainAirHelicoptersIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StaffordLogisticsIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SidelinesTreeServiceLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StarCoachesIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SturgeonServicesInternationalIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WombleCompanyIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:UpTruckingServicesLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrolleysIncMember 2021-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtThirtyEightPointZeroMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:TotalInvestmentMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MinimumMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MaximumMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:WeightedAverageMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:WeightedAverageMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MaximumMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MinimumMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2021-12-31 0001418076 slrc:CreditFacilityOneMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:KbhtMember 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2021-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SocTelemedInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2021-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:RezoluteIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RqmCorp.Member 2021-12-31 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2021-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2021-12-31 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2021-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2021-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:RscAcquisitionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BridgebioPharmaInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2021-12-31 0001418076 slrc:OisManagementServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2021-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2021-12-31 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2021-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:InszoneMidLlcMember 2021-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MmitHoldingsLlcMember 2021-12-31 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2021-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2021-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2021-12-31 0001418076 slrc:CapitalMarketsMember 2021-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2021-12-31 0001418076 slrc:InsuranceMember 2021-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2021-12-31 0001418076 slrc:ItServicesMember 2021-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2021-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2021-12-31 0001418076 slrc:MetalsAndMiningMember 2021-12-31 0001418076 slrc:AerospaceAndDefenseMember 2021-12-31 0001418076 slrc:MachineryMember 2021-12-31 0001418076 slrc:HealthCareTechnologyMember 2021-12-31 0001418076 slrc:AirlinesMember 2021-12-31 0001418076 slrc:AutoComponentsMember 2021-12-31 0001418076 slrc:SpecialtyRetailMember 2021-12-31 0001418076 slrc:CommunicationsEquipmentMember 2021-12-31 0001418076 slrc:ContainersAndPackagingMember 2021-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2021-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2021-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2021-12-31 0001418076 slrc:AirFreightAndLogisticsMember 2021-12-31 0001418076 slrc:ConsumerFinanceMember 2021-12-31 0001418076 slrc:MultiSectorHoldingsMember 2021-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2021-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2021-12-31 0001418076 slrc:PharmaceuticalsMember 2021-12-31 0001418076 slrc:SoftwareMember 2021-12-31 0001418076 slrc:PersonalProductsMember 2021-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2021-12-31 0001418076 slrc:BiotechnologyMember 2021-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2021-12-31 0001418076 slrc:RoadAndRailMember 2021-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:DelphinusMedicalTechnologiesIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:KbhTopcoLlcKingsbridgeMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:CardioFocusIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:CentrexionTherapeuticsIncMember 2022-09-30 0001418076 slrc:AtyrPharmaIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-09-30 0001418076 slrc:SointLlcMember slrc:PreferredEquityzeroPointFourPercentMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:ConventusOrthopaedicsIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrCreditSolutionsMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncClassBMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncWarrantsMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrBusinessCreditMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SenseonicsHoldingsIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:VapothermIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:TwentyeightyInvestorsLlcMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:VenusConceptLtdMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxVendingLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:MountainAirHelicoptersIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SuperiorTransportationIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:StarCoachesIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:StCoachesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SlrEquipmentFinanceMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SidelinesTreeServiceLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WombleCompanyIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:UpTruckingServicesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WarriorCraneServicesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2022-09-30 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtTwentySixPointSevenMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RaneLightMetalCastingsIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RangoIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RoyalCoachLinesIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RoyalExpressIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:HtiLogisticsCorporationMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:KoolPakLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LoyerCapitalLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GmtCorporationMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FreightsolLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GardaClTechnicalServicesIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GeorgiaJetIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EasyPakLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FirstNationalCapitalLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:DongwonAutopartTechnologyIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BoartLongyearCompanyMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:ChampionAirLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CkdHoldingsInc.Member 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AmeraMexInternationalIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AirMethodsCorporationMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BlackhawkMiningLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AfgDallasIiiLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AeroOperatingLlcMember 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-09-30 0001418076 slrc:VapothermInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:CerapedicsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:ScpharmaceuticalsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:GlookoInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:NeuroneticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:OmniguideHoldingsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:RubiusTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AxcellaHealthIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:BridgebioPharmaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:ArdelyxInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:ArcutisBiotherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:ApeelTechnologyIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AlimeraSciencesInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AcresCommercialMortgageLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:VarileaseFinanceInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RdHoldcoInc.Member 2022-09-30 0001418076 slrc:PlasticsManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SparMarketingForceInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:StrytenResourcesLlcMember 2022-09-30 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:TaucManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:TilleyDistributionIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:RqmCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:RscAcquisitionIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:ShoHoldingICorporationShoesForCrewsMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:PptManagementHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:KoreWirelessGroupInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-09-30 0001418076 slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:PhynetDermatologyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:OneTouchDirectLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:MmitHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:MontefioreNyackHospitalMember 2022-09-30 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:NationalSpineAndPainCentersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:MauricesIncorporatedMember 2022-09-30 0001418076 slrc:OisManagementServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:LuxuryAssetCapitalLlcMember 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:InszoneMidLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:IvyFertilityServicesLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:KaseyaIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:HumanInterestIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:GsmAcquisitionCorpMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:HigginbothamInsuranceAgencyIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:HighStreetBuyerIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:CompositeTechnologyAcquisitionCorp.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:CopperRiverSeafoodsInc.Member 2022-09-30 0001418076 slrc:EnhancedPermanentCapitalLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:BasicFunInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:BaymarkHealthServicesIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BdgMediaInc.Member 2022-09-30 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:ApexServicesPartnersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AllStateAgPartsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:TotalInvestmentMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-09-30 0001418076 slrc:PreferredEquityzeroPointFourPercentMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member slrc:InvestmentInSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member slrc:EquipmentFinancingMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member slrc:EquipmentFinancingMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member us-gaap:EquitySecuritiesMember 2022-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:PreferredEquityMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MinimumMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:MaximumMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember srt:WeightedAverageMember 2022-09-30 0001418076 us-gaap:MeasurementInputEbitdaMultipleMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 slrc:BlackScholesPricingModelMember us-gaap:FairValueInputsLevel3Member 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-09-30 0001418076 slrc:CreditFacilityOneMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-09-30 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-09-30 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-09-30 0001418076 slrc:KbhtMember 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2022-09-30 0001418076 slrc:SlrHealthcareAblMember srt:MinimumMember 2022-09-30 0001418076 slrc:SlrHealthcareAblMember srt:MaximumMember 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-09-30 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-09-30 0001418076 slrc:SeniorSecuredCommitmentsMember slrc:SlrHealthcareAblCreditMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember slrc:CitiBankNaMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-09-30 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2022-09-30 0001418076 slrc:RezoluteIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RqmCorp.Member 2022-09-30 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SocTelemedInc.Member 2022-09-30 0001418076 slrc:BasicFunInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:SlrHealthcareAblMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2022-09-30 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2022-09-30 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2022-09-30 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2022-09-30 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2022-09-30 0001418076 slrc:RscAcquisitionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BridgebioPharmaInc.Member 2022-09-30 0001418076 slrc:GlookoInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:OisManagementServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2022-09-30 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2022-09-30 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:InszoneMidLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MmitHoldingsLlcMember 2022-09-30 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:TransportationInfrastructureMember 2022-09-30 0001418076 slrc:FoodProductsMember 2022-09-30 0001418076 slrc:MediaMember 2022-09-30 0001418076 slrc:ThriftsMortgageFinanceMember 2022-09-30 0001418076 slrc:DiversifiedFinancialServicesMember 2022-09-30 0001418076 slrc:MultiSectorHoldingsMember 2022-09-30 0001418076 slrc:PharmaceuticalsMember 2022-09-30 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-09-30 0001418076 slrc:AutoPartsAndEquipmentMember 2022-09-30 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-09-30 0001418076 slrc:CapitalMarketsMember 2022-09-30 0001418076 slrc:RoadAndRailMember 2022-09-30 0001418076 slrc:PersonalProductsMember 2022-09-30 0001418076 slrc:ItServicesMember 2022-09-30 0001418076 slrc:AirlinesMember 2022-09-30 0001418076 slrc:AutoComponentsMember 2022-09-30 0001418076 slrc:LeisureEquipmentAndProductsMember 2022-09-30 0001418076 slrc:SpecialtyRetailMember 2022-09-30 0001418076 slrc:CommunicationsEquipmentMember 2022-09-30 0001418076 slrc:HealthCareTechnologyMember 2022-09-30 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-09-30 0001418076 slrc:InternetSoftwareServicesMember 2022-09-30 0001418076 slrc:TradingCompaniesAndDistributorsMember 2022-09-30 0001418076 slrc:ConstructionAndEngineeringMember 2022-09-30 0001418076 slrc:WaterUtilitiesMember 2022-09-30 0001418076 slrc:ConsumerFinanceMember 2022-09-30 0001418076 slrc:AerospaceAndDefenseMember 2022-09-30 0001418076 slrc:MetalsAndMiningMember 2022-09-30 0001418076 slrc:MachineryMember 2022-09-30 0001418076 slrc:FootwearMember 2022-09-30 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-09-30 0001418076 slrc:ProfessionalServicesMember 2022-09-30 0001418076 slrc:ContainersAndPackagingMember 2022-09-30 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-09-30 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-09-30 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-09-30 0001418076 slrc:DiversifiedConsumerServicesMember 2022-09-30 0001418076 slrc:BiotechnologyMember 2022-09-30 0001418076 slrc:SoftwareMember 2022-09-30 0001418076 slrc:InsuranceMember 2022-09-30 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-09-30 0001418076 slrc:BuildingProductsMember 2022-09-30 0001418076 slrc:InternetAndCatalogRetailMember 2022-09-30 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-09-30 0001418076 slrc:SunsCompanyMergerMember 2022-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-01-01 2021-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-09-30 0001418076 slrc:AdvisoryAgreementMember 2021-01-01 2021-09-30 0001418076 slrc:SlrBusinessCreditMember 2021-01-01 2021-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2021-01-01 2021-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2021-01-01 2021-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2021-01-01 2021-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-01-01 2021-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-07-01 2021-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-07-01 2021-09-30 0001418076 slrc:AdvisoryAgreementMember 2021-07-01 2021-09-30 0001418076 slrc:SlrBusinessCreditMember 2021-07-01 2021-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2021-07-01 2021-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-07-01 2021-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2021-07-01 2021-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2021-07-01 2021-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-07-01 2021-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:ApexServicesPartnersLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BasicFunInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnhancedPermanentCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CopperRiverSeafoodsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ErieConstructionMidwestLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HighStreetBuyerIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FoundationConsumerBrandsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IcimsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KaseyaIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:InszoneMidLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KoreWirelessGroupInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LogixHoldingCompanyLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MauricesIncorporatedMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MmitHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NacHoldingsCorporationJaguarMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:ShoHoldingICorporationShoesForCrewsMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:RxsenseHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:RscAcquisitionIncMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SparMarketingForceInc.Member 2022-01-01 2022-09-30 0001418076 slrc:AcresCommercialMortgageLlcMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:WorldInsuranceAssociatesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:VesscoMidcoHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:VarileaseFinanceInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SecondLienAssetbasedSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:RdHoldcoInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AlimeraSciencesInc.Member 2022-01-01 2022-09-30 0001418076 slrc:ApeelTechnologyIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:ArdelyxInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:AxcellaHealthIncMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:BridgebioPharmaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GlookoInc.Member 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:RubiusTherapeuticsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:ScpharmaceuticalsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtTwentySixPointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:OisManagementServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:OneTouchDirectLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PhynetDermatologyLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PinnacleTreatmentCentersInc.Member 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PlasticsManagementLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:PptManagementHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:RqmCorp.Member 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:StrytenResourcesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SunmedGroupHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TaucManagementLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TilleyDistributionIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CerapedicsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NeuroneticsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OmniguideHoldingsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VapothermInc.Member 2022-01-01 2022-09-30 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:VenusConceptLtdMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:VapothermIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:TwentyeightyInvestorsLlcMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:SpectrumPharmaceuticalsInc.WarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:NationalSpineAndPainCentersLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SlrHealthcareAblMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:SenseonicsHoldingsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:RdHoldcoIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:EssenceGroupHoldingsCorporationLumerisMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:DelphinusMedicalTechnologiesInc.Member slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:ConventusOrthopaedicsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:CentrexionTherapeuticsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:CardioFocusIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:AtyrPharmaIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:SointLlcMember slrc:PreferredEquityzeroPointFourPercentMember 2022-01-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceEquityInterestsMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:WorldwideFlightServicesInc.Member slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:WombleCompanyIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:WindRiverEnvironmentalLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:WarriorCraneServicesLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:UpTruckingServicesLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:SuperiorTransportationIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:StarCoachesIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:StCoachesLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:SmileyLiftingSolutionsLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:SidelinesTreeServiceLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:RoyalExpressIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:RoyalCoachLinesIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:RangoIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:RaneLightMetalCastingsIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:MountainAirHelicoptersIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:LuxVendingLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:LuxCreditConsultantsLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:KoolPakLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:HtiLogisticsCorporationMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:HawkeyeContractingCompanyLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:GmtCorporationMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:GeorgiaJetIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:FirstNationalCapitalLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:FirstAmericanCommercialBancorpIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:EnergyDrillingServicesLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:EasyPakLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:CkdHoldingsInc.Member slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:ChampionAirLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:BowmanEnergySolutionsLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:AfgDallasIiiLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-01-01 2022-09-30 0001418076 slrc:BdgMediaInc.Member slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:MontefioreNyackHospitalMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:LuxuryAssetCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:IvyFertilityServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:HumanInterestIncMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:GsmAcquisitionCorpMember 2022-01-01 2022-09-30 0001418076 slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:BaymarkHealthServicesIncMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:AllStateAgPartsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:AegisToxicologySciencesCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AeroOperatingLlcMember srt:MinimumMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AeroOperatingLlcMember srt:MaximumMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:AirMethodsCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:AirMethodsCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:FreightsolLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:FreightsolLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:LuxVendingLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:LuxVendingLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:RangoIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:RangoIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:StCoachesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:StCoachesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:DelphinusMedicalTechnologiesIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:WarriorCraneServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:WarriorCraneServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MaximumMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember srt:MinimumMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember 2022-01-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember srt:MaximumMember 2022-01-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember srt:MinimumMember 2022-01-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-09-30 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:SpreadOneMember 2022-01-01 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-09-30 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:CreditFacilityOneMember 2022-01-01 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-09-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:SoaggLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember srt:MinimumMember 2022-01-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-09-30 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:CreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-01-01 2022-09-30 0001418076 slrc:CreditFacilityOneMember 2022-01-01 2022-09-30 0001418076 slrc:TermLoansMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember 2022-07-01 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-07-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember 2022-07-01 2022-09-30 0001418076 slrc:PreferredEquityMember 2022-07-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember 2022-07-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-07-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-07-01 2022-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-07-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-07-01 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CitiBankNaMember slrc:SunsSpvLlcMember 2022-07-01 2022-09-30 0001418076 slrc:CreditFacilityOneMember 2022-07-01 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-07-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-07-01 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-07-01 2022-09-30 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtdOneMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BasicFunInc.Member 2021-01-01 2021-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:CommunityBrandsParentcoLlcFkaMinistryBrandsMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:InszoneMidLlcMember 2021-01-01 2021-12-31 0001418076 slrc:IcimsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:EnhancedPermanentCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-01-01 2021-12-31 0001418076 slrc:NacHoldingsCorporationJaguarMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MmitHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:LogixHoldingCompanyLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:KoreWirelessGroupInc.Member 2021-01-01 2021-12-31 0001418076 slrc:UsrParentInc.StaplesMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:ArcutisBiotherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlimeraSciencesInc.Member 2021-01-01 2021-12-31 0001418076 slrc:RugDoctorLlcMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:VarileaseFinanceInc.Member 2021-01-01 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AcresCommercialMortgageLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CentrexionTherapeuticsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:BridgebioPharmaInc.Member 2021-01-01 2021-12-31 0001418076 slrc:ArdelyxInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:AxcellaHealthIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:RezoluteIncMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:GlookoInc.Member 2021-01-01 2021-12-31 0001418076 slrc:ScpharmaceuticalsInc.Member slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:RubiusTherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:AirMethodsCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:ChampionAirLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:DongwonAutopartTechnologyIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GeorgiaJetIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstAmericanCommercialBancorpIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstNationalCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GmtCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RaneLightMetalCastingsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SidelinesTreeServiceLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2021-01-01 2021-12-31 0001418076 slrc:AtyrPharmaIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:CentrexionTherapeuticsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:EssenceGroupHoldingsCorporationLumerisMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtThirtyEightPointZeroMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncWarrantsMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncClassBMember 2021-01-01 2021-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:RdHoldcoIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:VenusConceptLtdMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:SenseonicsHoldingsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:DelphinusMedicalTechnologiesIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:ConventusOrthopaedicsIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:CardioFocusIncMember slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-01-01 2021-12-31 0001418076 slrc:SointLlcMember slrc:PreferredEquityZeroPointSevenPercentMember 2021-01-01 2021-12-31 0001418076 slrc:SoaggLlcMember slrc:PreferredEquityZeroPointSevenPercentMember 2021-01-01 2021-12-31 0001418076 slrc:WombleCompanyIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:WarriorCraneServicesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:UpTruckingServicesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TrolleysIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TailwindsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SuperiorTransportationIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SturgeonServicesInternationalIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StarCoachesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StaffordLogisticsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StCoachesLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SouthTexasOilfieldSolutionsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RoyalExpressIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RoyalCoachLinesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RosscoCraneRiggingIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RangoIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:MountainAirHelicoptersIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LuxCreditConsultantsLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:KoolPakLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:HtiLogisticsCorporationMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:HawkeyeContractingCompanyLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:HaljoeCoachesUsaLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:FreightsolLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EnvironmentalProtectionImprovementCompanyLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EasyPakLlcMember 2021-01-01 2021-12-31 0001418076 slrc:ClubcorpHoldingsIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:BoartLongyearCompanyMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AmeraMexInternationalIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AeroOperatingLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SocTelemedInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:OmniguideHoldingsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:NeuroneticsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:DelphinusMedicalTechnologiesInc.Member 2021-01-01 2021-12-31 0001418076 slrc:CerapedicsInc.Member slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:PhymedManagementLlcMember slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StrytenEnergyLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:RqmCorp.Member slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:PptManagementHoldingsLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:PhynetDermatologyLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:OneTouchDirectLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AmerimarkIntermediateHoldingsLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AlteonHealthLlcMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:AegisToxicologySciencesCorporationMember slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:BlackhawkMiningLlcMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-01-01 2021-12-31 0001418076 slrc:ClubcorpHoldingsIncMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:ClubcorpHoldingsIncMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FreightsolLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:FreightsolLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:GardaClTechnicalServicesIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:LoyerCapitalLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LoyerCapitalLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LuxCreditConsultantsLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LuxCreditConsultantsLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LuxVendingLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:LuxVendingLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-01-01 2021-12-31 0001418076 slrc:SouthTexasOilfieldSolutionsLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SouthTexasOilfieldSolutionsLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StCoachesLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:StCoachesLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SuperiorTransportationIncMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:SuperiorTransportationIncMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TailwindsLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TailwindsLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TheSmedleyCompanySmedleyServicesIncMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:TrinityEquipmentRentalsIncMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:WindRiverEnvironmentalLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:WindRiverEnvironmentalLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:WarriorCraneServicesLlcMember srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:WarriorCraneServicesLlcMember srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-01-01 2021-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MaximumMember 2021-01-01 2021-12-31 0001418076 slrc:CapitalCityJetCenterIncMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember srt:MinimumMember 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadTwoMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadThreeMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadOneMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:IncomeApproachValuationTechniqueMember slrc:MeasurementInputMarketYieldMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:ValuationApproachMarketMultipleMember slrc:MeasurementInputComparableMultipleMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:MarketApproachValuationTechniqueMember slrc:MeasurementInputReturnOnEquityMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-01-01 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:AviatorcapSiiLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:CreditFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TermLoansMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 us-gaap:CommonStockMember 2022-09-30 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 us-gaap:CommonStockMember slrc:SunsCompanyMergerMember 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-28 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2017-02-15 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2022-06-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2022-06-30 0001418076 slrc:TrancheTwoMember slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2016-11-08 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember srt:MaximumMember 2011-08-26 0001418076 us-gaap:LondonInterbankOfferedRateLIBORMember slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MinimumMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember slrc:CitiBankNaMember srt:MaximumMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember srt:MaximumMember 2021-12-28 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember srt:MaximumMember 2022-01-01 2022-06-30 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalFinancialMember 2012-11-30 2012-11-30 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 2012-12-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalCapitalFinancialHoldingsLlcMember 2016-07-28 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 srt:MaximumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 slrc:SlrHealthcareAblCreditMember srt:MinimumMember 2013-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 slrc:SlrHealthcareAblCreditMember srt:MinimumMember 2014-03-31 0001418076 slrc:SlrHealthcareAblCreditMember srt:MaximumMember 2014-06-27 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 us-gaap:CommonStockMember slrc:SunsCompanyMergerMember 2022-04-01 2022-04-01 0001418076 slrc:AdvisoryAgreementMember srt:MaximumMember 2022-04-01 2022-04-01 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2022-04-01 2022-04-01 0001418076 slrc:SeniorSecuredNotesMember 2012-01-01 2012-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2012-01-01 2012-12-31 0001418076 slrc:CreditFacilityMember 2012-01-01 2012-12-31 0001418076 slrc:TermLoansMember 2012-01-01 2012-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:CreditFacilityMember 2013-01-01 2013-12-31 0001418076 slrc:TermLoansMember 2013-01-01 2013-12-31 0001418076 slrc:CreditFacilityMember 2014-01-01 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TermLoansMember 2014-01-01 2014-12-31 0001418076 slrc:CreditFacilityMember 2015-01-01 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TermLoansMember 2015-01-01 2015-12-31 0001418076 slrc:CreditFacilityMember 2016-01-01 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:TermLoansMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:CreditFacilityMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TermLoansMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:CreditFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-01-01 2018-12-31 0001418076 slrc:TermLoansMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-01-01 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:CreditFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TermLoansMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:CreditFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TermLoansMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2022-11-02 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2022-10-05 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2013-09-30 2013-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2016-05-27 2016-05-27 0001418076 slrc:SlrHealthcareAblCreditMember 2021-04-01 2021-06-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-28 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2016-11-08 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2017-02-15 2017-12-31 0001418076 us-gaap:SubsequentEventMember slrc:SlrSeniorLendingProgramLlcMember slrc:SeniorSecuredCashFlowLoansMember 2022-10-12 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:PreferredEquityMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-09-30 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SoaggLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:SlrBusinessCreditMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:SointLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:SoaggLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:SlrHealthcareAblMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:SlrEquipmentFinanceEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:SlrCreditSolutionsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:KbhTopcoLlcKingsbridgeMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:RdHoldcoIncDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:RdHoldcoIncCommonEquityMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:RdHoldcoIncClassBMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:SlrEquipmentFinanceDebtMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember 2022-06-30 0001418076 slrc:PreferredEquityMember 2022-06-30 0001418076 slrc:EquipmentFinancingMember 2022-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-06-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-06-30 0001418076 us-gaap:EquitySecuritiesMember 2020-12-31 0001418076 slrc:PreferredEquityMember 2020-12-31 0001418076 slrc:EquipmentFinancingMember 2020-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2020-12-31 0001418076 slrc:RdHoldcoIncWarrantsMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2020-12-31 0001418076 slrc:AviatorcapSiiLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2020-12-31 0001418076 slrc:LoyerCapitalLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2021-12-31 0001418076 slrc:AviatorcapSiiLlcMember slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Year iso4217:USD xbrli:shares slrc:basispoints slrc:issuers slrc:loans slrc:fund slrc:Customers
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
 
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the Quarter Ended September 30, 2022
 
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number:
814-00754
 
 
SLR INVESTMENT CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Maryland
 
26-1381340
(State of Incorporation)
 
(I.R.S. Employer
Identification No.)
500 Park Avenue
New York, N.Y.
 
10022
(Address of principal executive offices)
 
(Zip Code)
(212993-1670
(Registrant’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
 
Trading
Symbol(s)
 
Name of Each Exchange
on Which Registered
Common Stock, par value $0.01 per share
 
SLRC
 
The NASDAQ Global Select Market
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T
(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
Non-accelerated
filer
     Smaller Reporting company  
     Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).    Yes  ☐    No  
The number of shares of the registrant’s Common Stock, $.01 par value, outstanding as of October 31, 2022 was 54,772,651.
 
 
 

SLR INVESTMENT CORP.
FORM
10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2022
TABLE OF CONTENTS
 
    
PAGE
 
  
Item 1.
  Financial Statements   
  Consolidated Statements of Assets and Liabilities as of September 30, 2022 (unaudited) and December 31, 2021      3  
       4  
       5  
       6  
  Consolidated Schedule of Investments as of September 30, 2022 (unaudited)      7  
  Consolidated Schedule of Investments as of December 31, 2021      12  
  Notes to Consolidated Financial Statements (unaudited)      17  
  Report of Independent Registered Public Accounting Firm      38  
Item 2.
  Management’s Discussion and Analysis of Financial Condition and Results of Operations      39  
Item 3.
  Quantitative and Qualitative Disclosures About Market Risk      56  
Item 4.
  Controls and Procedures      57  
  
Item 1.
  Legal Proceedings      57  
Item 1A.
  Risk Factors      57  
Item 2.
  Unregistered Sales of Equity Securities and Use of Proceeds      58  
Item 3.
  Defaults Upon Senior Securities      58  
Item 4.
  Mine Safety Disclosures      58  
Item 5.
  Other Information      58  
Item 6.
  Exhibits      58  
  Signatures      60  

PART I. FINANCIAL INFORMATION
In this Quarterly Report, “Company”, “we”, “us”, and “our” refer to SLR Investment Corp. unless the context states otherwise.
 
Item 1.
Financial Statements
SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(in thousands, except share amounts)
 
    
September 30,
2022
(unaudited)
   
December 31,
2021
 
Assets
                
Investments at fair value:
                
Companies less than 5% owned (cost: $1,386,014 and $985,088, respectively)
   $ 1,368,827     $ 964,379  
Companies more than 25% owned (cost: $812,800 and $711,865, respectively)
     786,534       706,203  
Cash
     7,983       2,935  
Cash equivalents (cost: $268,931 and $320,000, respectively)
     268,931       320,000  
Dividends receivable
     11,542       9,028  
Interest receivable
     9,456       6,521  
Receivable for investments sold
     1,276       1,378  
Prepaid expenses and other assets
     886       567  
    
 
 
   
 
 
 
Total assets
   $ 2,455,435     $ 2,011,011  
    
 
 
   
 
 
 
Liabilities
                
Debt ($1,156,200 and $818,500 face amounts, respectively, reported net of unamortized debt issuance costs/market discount of $7,909 and $6,462, respectively. See notes 6 and 7)
   $ 1,148,291     $ 812,038  
Payable for investments and cash equivalents purchased
     268,952       320,041  
Distributions payable
     7,486       17,327  
Management fee payable (see note 3)
     7,890       7,435  
Performance-based incentive fee payable (see note 3)
     4,771       1,864  
Interest payable (see note 7)
     7,083       4,492  
Administrative services payable (see note 3)
     1,293       2,689  
Other liabilities and accrued expenses
     3,444       2,844  
    
 
 
   
 
 
 
Total liabilities
   $ 1,449,210     $ 1,168,730  
    
 
 
   
 
 
 
Commitments and contingencies (see note 10)
                
Net Assets
                
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,772,651 and 42,260,826 shares issued and outstanding, respectively
   $ 548     $ 423  
Paid-in
capital in excess of par
     1,163,713       936,999  
Accumulated distributable net loss
     (158,036     (95,141
    
 
 
   
 
 
 
Total net assets
   $ 1,006,225     $ 842,281  
    
 
 
   
 
 
 
Net Asset Value Per Share
   $ 18.37     $ 19.93  
    
 
 
   
 
 
 
See notes to consolidated financial statements.
 
3

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)
(in thousands, except share amounts)
 
    
Three months ended
   
Nine months ended
 
    
September 30, 2022
   
September 30, 2021
   
September 30, 2022
   
September 30, 2021
 
INVESTMENT INCOME:
                                
Interest:
                                
Companies less than 5% owned
   $ 32,933     $ 19,202     $ 82,450     $ 62,517  
Companies more than 25% owned
     2,431       2,834       6,914       8,605  
Dividends:
                                
Companies less than 5% owned
                                133  
Companies more than 25% owned
     11,969       9,078       32,767       28,485  
Other income:
                                
Companies less than 5% owned
     234       1,044       1,222       3,862  
Companies more than 25% owned
              5                20  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total investment income
     47,567       32,163       123,353       103,622  
    
 
 
   
 
 
   
 
 
   
 
 
 
EXPENSES:
                                
Management fees (see note 3)
   $ 7,890     $ 7,142     $ 22,019     $ 20,842  
Performance-based incentive fees (see note 3)
     4,965       698       9,699       8,444  
Interest and other credit facility expenses (see note 7)
     12,784       7,127       31,464       21,502  
Administrative services expense (see note 3)
     1,132       1,435       3,684       4,170  
Other general and administrative expenses
     935       755       4,212       2,673  
    
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
     27,706       17,157       71,078       57,631  
    
 
 
   
 
 
   
 
 
   
 
 
 
Performance-based incentive fees waived (see note 3)
     (194              (1,552         
    
 
 
   
 
 
   
 
 
   
 
 
 
Net expenses
     27,512       17,157       69,526       57,631  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
   $ 20,055     $ 15,006     $ 53,827     $ 45,991  
    
 
 
   
 
 
   
 
 
   
 
 
 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:
                                
Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned)
   $ (37,326   $ (127   $ (37,401   $ 68  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net change in unrealized gain (loss) on investments and cash equivalents:
                                
Companies less than 5% owned
     28,783       (6,507     3,521       1,284  
Companies more than 25% owned
     2,016       4,999       (20,602     6,105  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net change in unrealized gain (loss) on investments and cash equivalent
s
     30,799       (1,508     (17,081     7,389  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net realized and unrealized gain (loss) on investments and cash equivalents
     (6,527     (1,635     (54,482     7,457  
    
 
 
   
 
 
   
 
 
   
 
 
 
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS
   $ 13,528     $ 13,371     $ (655   $ 53,448  
    
 
 
   
 
 
   
 
 
   
 
 
 
EARNINGS (LOSS) PER SHARE (see note 5)
   $ 0.25     $ 0.32     $ (0.01   $ 1.26  
    
 
 
   
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
4

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS (unaudited)
(in thousands, except share amounts)
 
    
Three months ended
   
Nine months ended
 
    
September 30, 2022
   
September 30, 2021
   
September 30, 2022
   
September 30, 2021
 
Increase (decrease) in net assets resulting from operations:
                                
Net investment income
   $ 20,055     $ 15,006     $ 53,827     $ 45,991  
Net realized gain (loss)
     (37,326     (127     (37,401     68  
Net change in unrealized gain (loss)
     30,799       (1,508     (17,081     7,389  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     13,528       13,371       (655     53,448  
    
 
 
   
 
 
   
 
 
   
 
 
 
Distributions to stockholders:
                                
From net investment income
     (20,055     (17,327     (53,827     (51,981
From return of capital
     (2,401              (8,413         
    
 
 
   
 
 
   
 
 
   
 
 
 
Net distributions to stockholders
     (22,456     (17,327     (62,240     (51,981
    
 
 
   
 
 
   
 
 
   
 
 
 
Capital transactions
(see note 12)
:
                                
Issuance of common stock
                       226,839           
    
 
 
   
 
 
   
 
 
   
 
 
 
Total increase (decrease) in net assets
     (8,928     (3,956     163,944       1,467  
Net assets at beginning of period
     1,015,153       857,446       842,281       852,023  
    
 
 
   
 
 
   
 
 
   
 
 
 
Net assets at end of period
   $ 1,006,225     $ 853,490     $ 1,006,225     $ 853,490  
    
 
 
   
 
 
   
 
 
   
 
 
 
Capital stock activity
(see note 12)
:
                                
Issuance of common stock
                       12,511,825           
    
 
 
   
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
5

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)
(in thousands)
 
    
Nine months ended
 
    
September 30, 2022
   
September 30, 2021
 
Cash Flows from Operating Activities:
                
Net increase (decrease) in net assets resulting from
operations
   $ (655   $ 53,448  
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by operating activities:
                
Net realized (gain) loss on investments and cash equivalents
     37,401       (68
Net change in unrealized (gain) loss on investments
     17,081       (7,389
(Increase) decrease in operating assets:
                
Purchase of investments
     (406,302     (398,349
Proceeds from disposition of investments
     259,784       321,918  
Net accretion of discount on investments
     (7,760     (4,652
Capitalization of
payment-in-kind
income
     (1,753     (5,000
Collections of
payment-in-kind
income
     1,112       942  
Receivable for investments sold
     102       51  
Interest receivable
     (2,935     838  
Dividends receivable
     (2,514     (1,092
Prepaid expenses and other assets
     (319     (40
Cash acquired in merger
     2,313           
Increase (decrease) in operating liabilities:
                
Payable for investments and cash equivalents purchased
     (51,089     116,760  
Management fee payable
     455       607  
Performance-based incentive fee payable
     2,907       (94
Administrative services expense payable
     (1,396     206  
Interest payable
     2,591       3,175  
Other liabilities and accrued expenses
     600       62  
Deferred financing costs/market discount
     1,631       1,169  
    
 
 
   
 
 
 
Net Cash Provided by (Used in) Operating Activities
     (148,746     82,492  
    
 
 
   
 
 
 
Cash Flows from Financing Activities:
                
Cash distributions paid
     (72,081     (51,981
Proceeds from unsecured borrowings
     134,914       49,966  
Repayment of unsecured borrowings
     (150,000         
Proceeds from secured borrowings
     743,892       457,000  
Repayment of secured borrowings
     (554,000     (466,260
    
 
 
   
 
 
 
Net Cash Provided by (Used in) Financing Activities
     102,725       (11,275
    
 
 
   
 
 
 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
     (46,021     71,217  
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD
     322,935       388,776  
    
 
 
   
 
 
 
CASH AND CASH EQUIVALENTS AT END OF PERIOD
   $ 276,914     $ 459,993  
    
 
 
   
 
 
 
Supplemental disclosure of cash flow information:
                
Cash paid for interest
   $ 28,873     $ 18,327  
Issuance of shares in connection with the Merger
(1)
     226,839           
    
 
 
   
 
 
 
 
(1)
On April 1, 2022, in connection with the Merger (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. For further details, refer to Note 16 “Merger with SUNS”.
See notes to consolidated financial statements.
 
6

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited)
September 30, 202
2
(in thousands, except share/unit amount
s
)
 
Description
  
Industry
  
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Senior Secured Loans — 134.4%
                                                                         
First Lien Bank Debt/Senior Secured Loans
                                                                         
Aegis Toxicology Sciences Corporation(16)
   Health Care Providers & Services      L+550       1.00     8.41     5/7/2018        5/9/2025      $ 17,176      $ 16,836      $ 17,176  
All State Ag Parts, LLC(16)
   Trading Companies & Distributors      S+500       1.00     7.84     4/1/2022        9/1/2026        2,681        2,591        2,681  
American Teleconferencing Services, Ltd.**
   Communications Equipment      L+650       1.00              5/5/2016        9/9/2021        36,135        25,926            
American Teleconferencing Services, Ltd.**
   Communications Equipment      L+650       1.00              9/17/2021        12/16/2022        6,581        6,426        1,287  
AmeriMark Intermediate Holdings, LLC(14)
   Internet & Catalog Retail      L+600       1.00     11.09     7/28/2021        10/15/2026        24,633        24,225        24,141  
Apex Services Partners, LLC(16)
   Diversified Consumer Services      S+525       1.00     8.30     8/31/2022        7/31/2025        14,021        13,612        13,601  
Atria Wealth Solutions, Inc.
   Diversified Financial Services      S+600       1.00     8.79     9/14/2018        2/29/2024        10,674        10,617        10,674  
Basic Fun, Inc.
   Specialty Retail      L+550       1.00     8.59     10/30/2020        10/30/2023        2,687        2,675        2,687  
BayMark Health Services, Inc.(16)
   Health Care Providers & Services      L+500       1.00     8.12     4/1/2022        6/11/2027        12,455        11,968        12,455  
BDG Media, Inc.
   Media      L+900       0.25     11.29     7/18/2022        4/27/2023        9,427        9,427        9,427  
CC SAG Holdings Corp. (Spectrum Automotive)(16)
   Diversified Consumer Services      L+575       0.75     9.42     6/29/2021        6/29/2028        16,794        16,468        16,794  
Composite Technology Acquisition Corp.(16)
   Building Products      L+500       1.00     6.50     4/1/2022        2/1/2025        10,759        10,276        10,759  
Copper River Seafoods, Inc.
   Food Products      P+275                9.00     8/31/2022        4/23/2025        9,957        9,957        9,957  
Enhanced Permanent Capital, LLC(3)
   Capital Markets      L+700       1.00     8.72     12/29/2020        12/29/2025        35,205        34,444        35,205  
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16)
   Trading Companies & Distributors      L+475       1.00     8.42     4/1/2022        12/31/2025        6,232        5,997        6,232  
Enverus Holdings, Inc. (fka Drilling Info Holdings)(16)
   IT Services      L+450                7.62     4/1/2022        7/30/2025        11,627        11,119        11,627  
Erie Construction
Mid-west,
LLC(16)
   Building Products      L+475       1.00     7.56     4/1/2022        7/30/2027        9,029        8,674        9,029  
Foundation Consumer Brands, LLC(16)
   Personal Products      L+550       1.00     8.43     2/12/2021        2/12/2027        39,038        38,070        39,038  
GSM Acquisition Corp.(16)
   Leisure Equipment & Products      S+500       1.00     7.32     4/1/2022        11/16/2026        11,468        10,977        11,353  
Higginbotham Insurance Agency, Inc.(16)
   Insurance      L+525       0.75     8.37     4/1/2022        11/25/2026        6,239        5,997        6,239  
High Street Buyer, Inc.(16)
   Insurance      L+600       0.75     8.56     4/1/2022        4/16/2028        7,701        7,257        7,701  
Human Interest Inc.
   Internet Software & Services      S+785       1.00     10.36     6/30/2022        7/1/2027        20,104        19,743        19,702  
iCIMS, Inc.
   Software      S+675       0.75     9.49     8/18/2022        8/18/2028        32,084        31,530        31,522  
Inszone Mid, LLC
   Insurance      L+575       1.00     8.23     9/28/2021        6/30/2026        20,670        20,487        20,670  
Ivy Fertility Services, LLC
   Health Care Providers & Services      L+625       1.00     8.80     12/22/2021        2/25/2026        33,176        32,406        33,176  
Kaseya, Inc.
   Software      S+575       0.75     8.29     6/22/2022        6/23/2029        32,426        31,953        31,939  
Kid Distro Holdings, LLC (Distro Kid)
   Software      L+575       1.00     8.63     9/24/2021        10/1/2027        29,519        29,010        29,519  
Kingsbridge Holdings, LLC(2)
   Multi-Sector Holdings      L+700       1.00     9.29     12/21/2018        12/21/2024        80,000        79,778        80,000  
KORE Wireless Group, Inc.(16)
   Wireless Telecommunication Services      L+550                9.17     12/21/2018        12/21/2024        47,899        47,169        47,899  
Logix Holding Company, LLC(16)
   Communications Equipment      L+575       1.00     8.87     9/14/2018        12/22/2024        14,009        13,159        13,449  
Luxury Asset Capital, LLC
   Thrifts & Mortgage Finance      S+675       1.00     9.38     7/15/2022        7/15/2027        27,500        26,968        27,500  
Maurices, Incorporated(16)
   Specialty Retail      L+675       1.00     9.38     8/27/2021        6/1/2024        8,914        8,746        8,914  
MMIT Holdings, LLC
   IT Services      L+625       1.00     9.50     9/21/2021        9/15/2027        30,909        30,477        30,909  
Montefiore Nyack Hospital
   Health Care Providers & Services      L+495                8.05     8/9/2022        11/15/2024        5,000        5,000        5,000  
NAC Holdings Corporation (Jaguar)(16)
   Insurance      L+525       1.00     8.23     7/30/2021        9/28/2024        28,675        28,234        28,675  
National Spine and Pain Centers, LLC
   Health Care Providers & Services      L+500       1.00     7.31     4/1/2022        6/2/2024        2,486        2,365        2,362  
OIS Management Services, LLC
   Health Care Providers & Services      S+575       1.00     9.45     4/11/2022        7/9/2026        6,262        6,161        6,262  
One Touch Direct, LLC
   Commercial Services & Supplies      P+75                7.00     4/3/2020        3/30/2024        3,487        3,487        3,487  
Orthopedic Care Partners Management, LLC
   Health Care Providers & Services      S+650       1.00     9.36     8/17/2022        5/16/2024        2,843        2,823        2,822  
Pediatric Home Respiratory Services, LLC
   Health Care Providers & Services      S+625       1.00     9.43     8/19/2022        12/4/2024        754        744        743  
Peter C. Foy & Associates Insurance Services, LLC
   Insurance      S+600       0.75     8.96     4/1/2022        11/1/2028        10,006        9,860        10,006  
PhyNet Dermatology LLC
   Health Care Providers & Services      L+600
(15)
 
    1.00     8.85     9/5/2018        8/16/2024        14,498        14,454        14,498  
Pinnacle Treatment Centers, Inc.(16)
   Health Care Providers & Services      L+575       1.00     8.00     1/22/2020        12/31/2022        16,289        16,223        16,289  
Plastics Management, LLC(16)
   Health Care Providers & Services      S+500       1.00     8.13     4/1/2022        8/18/2027        9,515        9,169        9,420  
PPT Management Holdings, LLC(16)
   Health Care Providers & Services      L+850
(11)
 
    1.00     10.78     9/14/2018        12/16/2022        30,515        30,000        24,503  
RQM+ Corp.(16)
   Life Sciences Tools & Services      L+575       1.00     9.31     8/20/2021        8/12/2026        26,890        26,501        26,890  
RSC Acquisition, Inc.(16)
   Insurance      S+550       0.75     7.76     4/1/2022        11/1/2026        5,946        5,776        5,946  
RxSense Holdings LLC(16)
   Diversified Consumer Services      L+500       1.00     8.12     4/1/2022        3/13/2026        11,775        11,328        11,775  
SHO Holding I Corporation (Shoes for Crews)(16)
   Footwear      L+523       1.00     8.04     4/1/2022        4/27/2024        5,719        5,315        5,434  
Southern Orthodontic Partners Management, LLC
   Health Care Providers & Services      S+575       1.00     9.19     6/3/2022        1/27/2026        1,028        1,019        1,028  
SPAR Marketing Force, Inc.
   Media      P+95                7.20     7/18/2022        10/10/2024        9,787        9,787        9,787  
Stryten Resources LLC
   Auto Parts & Equipment      S+800       1.00     11.15     8/11/2021        10/12/2026        25,988        25,548        25,988  
SunMed Group Holdings, LLC(16)
   Health Care Equipment & Supplies      L+575       0.75     8.82     6/16/2021        6/16/2028        25,014        24,487        25,014  
TAUC Management, LLC(16)
   Health Care Providers & Services      L+525       1.00     8.16     4/1/2022        2/12/2027        6,908        6,578        6,874  
Tilley Distribution, Inc.(16)
   Trading Companies & Distributors      L+600       1.00     8.78     4/1/2022        12/31/2026        10,253        9,758        10,253  
Ultimate Baked Goods Midco LLC (Rise Baking)(16)
   Packaged Foods & Meats      L+650       1.00     10.17     8/12/2021        8/13/2027        26,136        25,322        25,874  
Vessco Midco Holdings, LLC(16)
   Water Utilities      L+450       1.00     7.34     4/1/2022        11/2/2026        1,523        1,461        1,508  
World Insurance Associates, LLC(16)
   Insurance      L+575       1.00     8.33     4/1/2022        4/1/2026        23,188        22,463        23,188  
                                                            
 
 
    
 
 
 
Total First Lien Bank Debt/Senior Secured Loans
                                                           $ 958,828      $ 936,888  
                                                            
 
 
    
 
 
 
Second Lien Asset-Based Senior Secured Loans
                                                                         
ACRES Commercial Mortgage, LLC
   Diversified Financial Services      S+705       1.00     9.82     12/24/2021        8/21/2028        29,925      $ 29,380      $ 29,925  
Varilease Finance, Inc.
   Multi-Sector Holdings      L+750       1.00     9.79     8/22/2014        11/15/2025        29,563        29,483        29,563  
                                                            
 
 
    
 
 
 
Total Second Lien Asset-Based Senior Secured Loans
                                                           $ 58,863      $ 59,488  
                                                            
 
 
    
 
 
 
Second Lien Bank Debt/Senior Secured Loans
                                                                         
RD Holdco, Inc.** (2)
   Diversified Consumer Services      S+975
(11)
 
    1.50              12/23/2013        5/16/2023        12,900      $ 11,791      $ 6,450  
                                                            
 
 
    
 
 
 
Total Second Lien Bank Debt/Senior Secured Loans
                                                           $ 11,791      $ 6,450  
                                                            
 
 
    
 
 
 
 
See notes to consolidated financial statements.
 
7

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
September 30, 2022
(in thousands, except share/unit amount
s
)
 
Description
  
Industry
  
Spread
Above
Index
(7)
    
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Senior Secured Loans (continued) —
                                                                     
First Lien Life Science Senior Secured Loans
                                                                          
Alimera Sciences, Inc.(16)
   Pharmaceuticals      L+765        1.78     10.28     12/31/2019        7/1/2024      $ 23,159      $ 23,823      $ 26,280  
Apeel Technology, Inc.
   Biotechnology      S+625        1.00     8.75     6/29/2022        6/1/2027        3,643        3,613        3,606  
Arcutis Biotherapeutics, Inc.(3)
   Pharamceuticals      L+745        0.10     10.08     12/22/2021        1/1/2027        66,849        66,803        67,518  
Ardelyx, Inc.
   Pharmaceuticals      L+795        0.10     10.58     2/23/2022        3/1/2027        9,475        9,407        9,475  
Axcella Health Inc.
   Pharmaceuticals      L+860        0.10     11.23     9/2/2021        9/1/2026        7,137        7,236        7,262  
BridgeBio Pharma, Inc.(3)
   Biotechnology                         9.00     11/17/2021        11/17/2026        39,530        38,954        39,184  
Centrexion Therapeutics, Inc.
   Pharmaceuticals      L+725        2.45     9.88     6/28/2019        1/1/2024        14,578        15,043        15,015  
Cerapedics, Inc.(16)
   Health Care Equipment & Supplies      L+695        2.50     9.58     3/22/2019        3/1/2025        30,982        32,059        33,151  
Glooko, Inc.(16)
   Health Care Technology      L+790        0.10     10.53     9/30/2021        10/1/2026        15,883        15,830        15,903  
Neuronetics, Inc.(16)
   Health Care Equipment & Supplies      L+765        1.66     10.28     3/2/2020        2/28/2025        18,012        18,387        18,463  
OmniGuide Holdings, Inc. (13)
   Health Care Equipment & Supplies      L+1405        0.10     16.68     7/30/2018        7/1/2023        18,879        18,413        19,314  
Rubius Therapeutics, Inc.(16)
   Pharmaceuticals      L+550        2.10     8.13     12/21/2018        6/1/2026        46,473        47,552        46,783  
scPharmaceuticals, Inc.(16)
   Pharmaceuticals      L+795        2.23     10.58     9/17/2019        9/17/2023        2,701        2,787        2,848  
Spectrum Pharmaceuticals, Inc.(16)
   Biotechnology      S+570        2.30     8.72     9/21/2022        9/1/2027        10,525        10,373        10,420  
Vapotherm, Inc.
   Health Care Equipment & Supplies      S+830        1.00     10.93     2/18/2022        2/1/2027        34,455        34,104        34,455  
                                                             
 
 
    
 
 
 
Total First Lien Life Science Senior Secured Loans
                                                            $ 344,384      $ 349,677  
                                                             
 
 
    
 
 
 
Total Senior Secured Loans
                                                           
$
1,373,866
 
  
$
1,352,503
 
                                                             
 
 
    
 
 
 
 
Description
  
Industry
  
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Equipment Financing — 23.7%
                                                    
Aero Operating LLC (10)
   Commercial Services & Supplies     
8.47-9.64%
      2/12/2021       
3/1/2025-12/1/2026
     $ 2,392      $ 2,389      $ 2,389  
AFG Dallas III, LLC (10)
   Diversified Consumer Services      10.00%       8/11/2022       
8/11/2026-8/26/2026
       1,093        1,093        1,093  
Air Methods Corporation (10)
   Airlines     
7.08-7.13%
      11/3/2021       
11/3/2026-11/23/2026
       3,719        3,784        3,719  
AmeraMex International, Inc. (10)
   Commercial Services & Supplies      10.00%       3/29/2019        4/15/2025        1,551        1,551        1,566  
Blackhawk Mining, LLC (10)
   Oil, Gas & Consumable Fuels      11.17%       2/16/2018        11/1/2022        409        409        409  
Boart Longyear Company (10)
   Metals & Mining     
9.06-10.44%
      5/28/2020       
7/1/2024-1/1/2026
       4,231        4,231        4,231  
Bowman Energy Solutions, LLC (10)
   Commercial Services & Supplies      7.42%       7/1/2022        8/1/2026        162        162        162  
Capital City Jet Center, Inc. (10)
   Airlines      10.00%       4/4/2018       
10/4/2023-6/22/26
       2,464        2,464        2,432  
Champion Air, LLC (10)
   Airlines      10.00%       3/19/2018        1/1/2023        1,219        1,219        1,219  
CKD Holdings, Inc. (10)
   Road & Rail     
8.10-8.60%
      9/22/2022       
6/22/26-9/22/27
       3,887        3,887        3,887  
Clubcorp Holdings, Inc. (10)
   Hotels, Restaurants & Leisure     
9.36-13.01%
      5/27/2021       
4/1/2025-10/1/2027
       6,027        6,027        6,027  
Dongwon Autopart Technology Inc. (10)
   Auto Components      7.96%       2/2/2021        1/1/2026        1,962        1,986        1,962  
EasyPak, LLC (10)
   Containers & Packaging      9.01%       1/6/2021        1/1/2024        364        364        364  
Energy Drilling Services, LLC (10)
   Diversified Consumer Services      6.58%       8/26/2022        9/1/2027        1,192        1,192        1,192  
Environmental Protection & Improvement Company, LLC (10)
   Road & Rail      8.25%       9/30/2020        10/1/2027        5,438        5,469        5,438  
Equipment Operating Leases, LLC (2)(12)
   Multi-Sector Holdings      8.37%       4/27/2018        4/27/2025        3,946        3,946        3,847  
First American Commercial Bancorp, Inc. (10)
   Diversified Financial Services     
7.50-9.02%
      10/28/2021       
11/1/2026-4/1/2027
       3,094        3,098        3,094  
First National Capital, LLC (10)
   Diversified Financial Services      9.00%       11/5/2021        8/1/2026        7,533        7,533        7,533  
Freightsol LLC (10)
   Road & Rail     
12.51-12.89%
      4/9/2019        11/1/2023        932        940        932  
Garda CL Technical Services, Inc. (10)
   Commercial Services & Supplies     
8.30-8.77%
      3/22/2018       
6/5/2023-10/5/2023
       669        669        667  
Georgia Jet, Inc. (10)
   Airlines      8.00%       12/4/2017        1/4/2024        520        520        520  
GMT Corporation (10)
   Machinery      10.71%       10/23/2018        1/1/2026        5,032        5,038        5,032  
Hawkeye Contracting Company, LLC (10)
   Construction & Engineering      10.50%       10/8/2021        11/1/2025        1,069        1,069        1,069  
HTI Logistics Corporation (10)
   Commercial Services & Supplies     
9.69-9.94%
      11/15/2018       
5/1/2024-9/1/2025
       322        322        314  
International Automotive Components Group, North America, Inc. (10)
   Auto Components      7.95%       6/23/2021        6/23/2025        6,616        6,659        6,484  
Kool Pak, LLC (10)
   Road & Rail      8.58%       2/5/2018        3/1/2024        233        233        233  
Loyer Capital LLC (2)(12)
   Multi-Sector Holdings     
8.73-11.52%
      5/16/2019       
5/16/24-9/25/24
       7,500        7,500        7,361  
Lux Credit Consultants, LLC (10)
   Road & Rail     
8.28-11.12%
      6/17/2021       
12/1/2024-10/1/2026
       15,930        15,930        15,930  
Lux Vending, LLC (10)
   Consumer Finance     
12.46-13.26%
      8/20/2021       
8/20/2024-10/1/2024
       1,870        1,902        1,870  
Mountain Air Helicopters, Inc. (10)
   Commercial Services & Supplies      10.00%       7/31/2017        2/28/2025        398        396        398  
Rane Light Metal Castings Inc. (10)
   Machinery      10.00%       6/1/2020        7/1/2024        184        184        184  
Rango, Inc. (10)
   Commercial Services & Supplies     
9.33-9.79%
      9/24/2019       
4/1/2023-11/1/2024
       2,374        2,399        2,329  
Royal Coach Lines, Inc.(10)
   Road & Rail      9.56%       11/21/2019        8/1/2025        913        913        833  
Royal Express Inc. (10)
   Road & Rail      9.53%       1/17/2019        2/1/2024        494        497        494  
Sidelines Tree Service LLC (10)
   Diversified Consumer Services      10.25%       7/31/2017        10/1/2022        19        19        19  
SLR Equipment Finance(2)
   Multi-Sector Holdings      8.50%       1/24/2022        1/24/2023        5,000        5,000        5,000  
Smiley Lifting Solutions, LLC(10)
   Commercial Services & Supplies     
7.82-7.95%
      6/30/2022       
9/15/2026-7/1/2029
       2,006        2,006        2,006  
ST Coaches, LLC (10)
   Road & Rail     
8.22-8.58%
      7/31/2017       
10/1/2022-1/25/2025
       1,810        1,810        1,729  
Star Coaches Inc. (10)
   Road & Rail      8.42%       3/9/2018        4/1/2025        3,019        3,019        2,710  
Superior Transportation, Inc. (10)
   Road & Rail     
10.22-10.63%
      7/31/2017        1/1/2026        3,814        3,814        3,814  
The Smedley Company & Smedley Services, Inc. (10)
   Commercial Services & Supplies      4.07%       7/31/2017        1/1/2028        2,706        2,706        2,706  
Trinity Equipment Rentals, Inc. (10)
   Commercial Services & Supplies     
7.94-8.75%
      10/8/2021       
11/1/2024-12/1/2026
       628        628        628  
Up Trucking Services, LLC (10)
   Road & Rail      11.21%       3/23/2018        8/1/2024        510        515        510  
Warrior Crane Services, LLC (10)
   Commercial Services & Supplies      8.95%       7/11/2019       
8/1/2024-8/1/2026
       2,144        2,144        2,104  
Wind River Environmental, LLC (10)
   Diversified Consumer Services     
8.43-10.00%
      7/31/2019       
8/1/2024-10/5/25
       673        675        673  
Womble Company, Inc. (10)
   Energy Equipment & Services      9.11%       12/27/2019        1/1/2025        428        428        411  
Worldwide Flight Services, Inc. (10)
   Transportation Infrastructure      8.32%       9/23/2022        9/23/2027        209        211        209  
               
                             
Shares/Units
               
SLR Equipment Finance Equity Interests (2)(9)(17)*
   Multi-Sector Holdings              7/31/2017                 200        145,000        120,820  
                                            
 
 
    
 
 
 
Total Equipment Financing
                                          
$
263,950
 
  
$
238,553
 
                                            
 
 
    
 
 
 
Preferred Equity – 0.4%
                                                         
SOINT, LLC (2)(3)(4)
   Aerospace & Defense      5.00%
(11)
      6/8/2012        6/30/2023        52,536      $ 5,254      $ 4,176  
                                            
 
 
    
 
 
 
Total Preferred Equity
                                          
$
5,254
 
  
$
4,176
 
                                            
 
 
    
 
 
 
 
See notes to consolidated financial statements.
 
8

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
September 30, 202
2
(in thousands, except share/unit amounts)
 
Description
  
Industry
  
Acquisition
Date
    
Shares/
Units
    
Cost
    
Fair
Value
 
Common Equity/Equity Interests/Warrants—55.7%
                                        
aTyr Pharma, Inc. Warrants *
   Pharmaceuticals      11/18/2016        6,347      $ 106      $     
CardioFocus, Inc. Warrants *
   Health Care Equipment & Supplies      3/31/2017        90        51            
Centrexion Therapeutics, Inc. Warrants *
   Pharmaceuticals      6/28/2019        289,102        136        92  
Conventus Orthopaedics, Inc. Warrants *
   Health Care Equipment & Supplies      6/15/2016        157,500        65            
Delphinus Medical Technologies, Inc. Warrants *
   Health Care Equipment & Supplies      8/18/2017        444,388        74        108  
Essence Group Holdings Corporation (Lumeris) Warrants *
   Health Care Technology      3/22/2017        260,000        129        377  
KBH Topco LLC (Kingsbridge) (2)(5)(18)
   Multi-Sector Holdings      11/3/2020        73,500,000        136,596        147,000  
RD Holdco, Inc. (Rug Doctor) (2)*
   Diversified Consumer Services      12/23/2013        231,177        15,683            
RD Holdco, Inc. (Rug Doctor) Class B (2)*
   Diversified Consumer Services      12/23/2013        522        5,216            
RD Holdco, Inc. (Rug Doctor) Warrants (2)*
   Diversified Consumer Services      12/23/2013        30,370        381            
Senseonics Holdings, Inc. (3)(8)*
   Health Care Equipment & Supplies      7/25/2019        469,353        235        620  
SLR Business Credit (2)(3)(19)
   Diversified Financial Services      4/1/2022        100        81,583        89,370  
SLR Credit Solutions (2)(3)(20)
   Diversified Financial Services      12/28/2012        280,303        280,737        288,760  
SLR Healthcare ABL (2)(3)(21)
   Diversified Financial Services      4/1/2022        32,839        34,335        33,750  
Spectrum Pharmaceuticals, Inc. Warrants *
   Biotechnology      9/21/2022        159,470        50        22  
TwentyEighty Investors, LLC*
   Professional Services      4/1/2022        17,214        5        5  
Vapotherm, Inc. Warrants(3)*
   Health Care Equipment & Supplies      2/18/2022        36,996        210        25  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
   Health Care Equipment & Supplies      5/10/2018        33,430        152            
                           
 
 
    
 
 
 
Total Common Equity/Equity Interests/Warrants
                         
$
555,744
 
  
$
560,129
 
                           
 
 
    
 
 
 
Total Investments (6) — 214.2%
                         
$
2,198,814
 
  
$
2,155,361
 
                           
 
 
    
 
 
 
 
Description
  
Industry
  
Acquisition
Date
    
Maturity

Date
    
Par Amount
        
Cash Equivalents — 26.7%
U.S. Treasury Bill
  
Government
     9/30/2022        11/22/2022      $ 270,000      $ 268,931      $ 268,931  
                                    
 
 
    
 
 
 
Total Investments & Cash Equivalents —240.9%
                                  
$
2,467,745
 
  
$
2,424,292
 
Liabilities in Excess of Other Assets — (140.9%)
                                              (1,418,067
                                             
 
 
 
Net Assets — 100.0%
                                           
$
1,006,225
 
                                             
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of September 30, 2022.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2022 in these controlled investments are as follows:
 
Name of Issuer
  
Fair Value at
December 31, 2021
    
Gross
Additions
    
Gross
Reductions
    
Realized
Gain
(Loss)
    
Change in
Unrealized
Gain (Loss)
   
Interest/Dividend
Income
   
Fair Value at
September 30, 2022
 
Equipment Operating Leases, LLC
   $ 18,939      $         $ 15,725      $         $ 633     $ 668     $ 3,847  
Kingsbridge Holdings, LLC
     80,000                                      (64     5,182       80,000  
KBH Topco, LLC (Kingsbridge)
     145,996                                      1,004       11,288       147,000  
Loyer Capital LLC
     10,725                  3,500                  136       812       7,361  
RD Holdco, Inc. (Rug Doctor, common equity)
                                                                   
RD Holdco, Inc. (Rug Doctor, class B)
     5,216                                      (5,216                  
RD Holdco, Inc. (Rug Doctor, warrants)
                                                                   
RD Holdco, Inc. (debt)
     11,829        685                            (5,351     (18     6,450  
SLR Business Credi
t
               81,583                            7,787       3,400       89,370  
SLR Credit Solutions
     298,766                                      (10,006     15,500       288,760  
SLR Equipment Finance (equity)
     129,102                                      (8,282              120,820  
SLR Equipment Finance (debt)
               5,000                                     270       5,000  
SLR Healthcare ABL
               34,335                            (585     1,730       33,750  
SOAGG LLC
     1,121                  447                  (674     647           
SOINT, LLC
     4,509        203        552                  16       202       4,176  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
     $ 706,203      $ 121,806      $ 20,224      $      $ (20,602   $ 39,681     $ 786,534  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
 
See notes to consolidated financial statements.
 
9

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
September 30, 2022
(in thousands)
 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2022, on a fair value basis,
non-qualifying
assets in the portfolio represented 22.7% of the total assets of the Company.
(4)
The Company’s investment in SOINT, LLC include a one dollar investment in common shares.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $13,274; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $159,987 and $146,713, respectively, based on a tax cost of $2,142,087. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
(15)
Spread is 5.50% Cash / 0.50% PIK.
(16)
Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
(17)
See note 11 to the consolidated financial statements.
(18)
See note 13 to the consolidated financial statements.
(19)
See note 15 to the consolidated financial statements.
(20)
See note 9 to the consolidated financial statements.
(21)
See note 14 to the consolidated financial statements.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
 
See notes to consolidated financial statements.
 
10

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (unaudited) (continued)
September 30, 2022
(in thousands)
 
Industry Classification
  
Percentage of Total
Investments (at fair value) as
of September 30, 2022
 
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)
     21.5
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
     18.3
Pharmaceuticals
     8.1
Health Care Providers & Services
     7.1
Health Care Equipment & Supplies
     6.1
Insurance
     4.8
Software
     4.3
Biotechnology
     2.5
Diversified Consumer Services
     2.4
Wireless Telecommunication Services
     2.2
IT Services
     2.0
Personal Products
     1.8
Road & Rail
     1.7
Capital Markets
     1.6
Thrifts & Mortgage Finance
     1.3
Life Sciences Tools & Services
     1.2
Auto Parts & Equipment
     1.2
Packaged Foods & Meats
     1.2
Internet & Catalog Retail
     1.1
Building Products
     0.9
Internet Software & Services
     0.9
Media
     0.9
Trading Companies & Distributors
     0.9
Commercial Services & Supplies
     0.9
Health Care Technology
     0.8
Communications Equipment
     0.7
Specialty Retail
     0.5
Leisure Equipment & Products
     0.5
Food Products
     0.5
Auto Components
     0.4
Airlines
     0.4
Hotels, Restaurants & Leisure
     0.3
Footwear
     0.2
Machinery
     0.2
Metals & Mining
     0.2
Aerospace & Defense
     0.2
Consumer Finance
     0.1
Water Utilities
     0.1
Construction & Engineering
     0.0
Energy Equipment & Services
     0.0
Oil, Gas & Consumable Fuels
     0.0
Containers & Packaging
     0.0
Transportation Infrastructure
     0.0
Professional Services
     0.0
    
 
 
 
Total Investments
     100.0
    
 
 
 
See notes to consolidated financial statements.
 
11

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2021
(in thousands, except share/unit amounts)
 
Description
  
Industry
  
Spread
Above
Index
(7)
   
LIBOR Floor
   
Interest
Rate
(1)
   
Acquisition
Date
    
Maturity

Date
    
Par Amount
    
Cost
    
Fair
Value
 
Senior Secured Loans — 111.5%
                                                                         
First Lien Bank Debt/Senior Secured Loans
                                                                         
Aegis Toxicology Sciences Corporation
   Health Care Providers & Services      L+550       1.00     6.50     5/7/2018        5/9/2025      $ 12,402      $ 12,283      $ 12,402  
Alteon Health, LLC
   Health Care Providers & Services      L+650       1.00     7.50     9/14/2018        9/1/2023        14,117        14,079        14,117  
American Teleconferencing Services, Ltd.**
   Communications Equipment      L+650       1.00     7.50     5/5/2016        9/9/2021        24,822        24,453        3,345  
American Teleconferencing Services, Ltd.**
   Communications Equipment      L+650       1.00     7.50     9/17/2021        3/31/2022        4,576        4,508        4,576  
AmeriMark Intermediate Holdings, LLC(14)
   Internet & Catalog Retail      L+600       1.00     7.00     7/28/2021        10/15/2026        25,226        24,739        24,721  
Atria Wealth Solutions, Inc
   Diversified Financial Services      L+600       1.00     7.00     9/14/2018        11/30/2022        6,345        6,329        6,345  
Basic Fun, Inc
   Specialty Retail      L+550       1.00     6.50     10/30/2020        10/30/2023        2,902        2,871        2,902  
CC SAG Holdings Corp. (Spectrum Automotive)
   Diversified Consumer Services      L+575       0.75     6.50     6/29/2021        6/29/2028        12,168        11,995        12,168  
Community Brands ParentCo, LLC (f/k/a Ministry Brands)
   Software      L+400       1.00     5.00     7/30/2021        12/2/2022        34,901        34,538        34,901  
Enhanced Permanent Capital, LLC(3)
   Capital Markets      L+700       1.00     8.00     12/29/2020        12/29/2025        26,061        25,418        26,061  
Foundation Consumer Brands, LLC
   Personal Products      L+638       1.00     7.38     2/12/2021        2/12/2027        33,367        32,633        33,367  
iCIMS, Inc.
   Software      L+650       1.00     7.50     9/7/2018        9/12/2024        19,341        19,120        19,341  
Inszone Mid, LLC.
   Insurance      L+575       1.00     6.75     9/28/2021        6/30/2026        11,141        11,035        11,086  
Ivy Fertility Services, LLC
   Health Care Providers & Services      L+625       1.00     7.25     12/22/2021        2/25/2026        21,677        21,299        21,298  
Kid Distro Holdings, LLC (Distro Kid)
   Software      L+600       1.00     7.00     9/24/2021        10/1/2027        29,743        29,168        29,148  
Kingsbridge Holdings, LLC(2) .
   Multi-Sector Holdings      L+700       1.00     8.00     12/21/2018        12/21/2024        80,000        79,713        80,000  
KORE Wireless Group, Inc.(3)
   Wireless Telecommunication Services      L+550                5.72     12/21/2018        12/21/2024        36,470        36,062        36,470  
Logix Holding Company, LLC
   Communications Equipment      L+575       1.00     6.75     9/14/2018        12/22/2024        7,400        7,359        7,178  
Maurices, Incorporated
   Specialty Retail      L+675       1.00     7.75     8/27/2021        6/1/2024        5,135        5,044        5,135  
MMIT Holdings, LLC
   IT Services      L+625       1.00     7.25     9/21/2021        9/15/2027        31,026        30,541        31,026  
NAC Holdings Corporation (Jaguar)
   Insurance      L+525       1.00     6.25     7/30/2021        9/28/2024        15,924        15,730        15,844  
One Touch Direct, LLC
   Commercial Services & Supplies      P+75    
 
  
 
    4.00     4/3/2020        9/30/2022        274        274        274  
PhyNet Dermatology LLC
   Health Care Providers & Services      L+600
(17)
 
    1.00     7.00     9/5/2018        8/16/2024        14,589        14,529        14,589  
Pinnacle Treatment Centers, Inc.
   Health Care Providers & Services      L+575       1.00     6.75     1/22/2020        12/31/2022        11,996        11,953        11,996  
PPT Management Holdings, LLC
   Health Care Providers & Services      L+800
(15)
 
    1.00     9.00     9/14/2018        12/16/2022        21,120        21,086        18,374  
RQM+ Corp
   Life Sciences Tools & Services      L+575       1.00     6.75     8/20/2021        8/12/2026        16,504        16,349        16,462  
Stryten Energy LLC
   Auto Parts & Equipment      L+800       1.00     9.00     8/11/2021        10/12/2026        26,184        25,676        25,923  
SunMed Group Holdings, LLC
   Health Care Equipment & Supplies      L+575       0.75     6.50     6/16/2021        6/16/2028        18,536        18,232        18,351  
Ultimate Baked Goods Midco LLC (Rise Baking)
   Packaged Foods & Meats      L+625       1.00     7.25     8/12/2021        8/13/2027        19,381        18,920        18,896  
USR Parent, Inc. (Staples)
   Specialty Retail      L+884       1.00     9.84     6/3/2020        9/12/2022        3,275        3,275        3,275  
                                                            
 
 
    
 
 
 
Total First Lien Bank Debt/Senior Secured Loans
                                                           $ 579,211      $ 559,571  
      
 
 
    
 
 
 
Second Lien Asset-Based Senior Secured Loans
                                                                         
ACRES Commercial Mortgage, LLC
   Diversified Financial Services      L+705       1.00     8.05     12/24/2021        8/21/2028        29,925      $ 29,328      $ 29,326  
Varilease Finance, Inc.
   Multi-Sector Holdings      L+750       1.00     8.50     8/22/2014        11/15/2025        29,563        29,467        29,563  
                                                            
 
 
    
 
 
 
Total Second Lien Asset-Based Senior Secured Loans
                                                           $ 58,795      $ 58,889  
      
 
 
    
 
 
 
Second Lien Bank Debt/Senior Secured Loans
                                                                         
PhyMed Management LLC
   Health Care Providers & Services      L+1500
(16)
 
    1.00     16.00     12/18/2015        9/30/2022        37,819      $ 37,757      $ 36,874  
Rug Doctor LLC (2)
   Diversified Consumer Services      L+975
(11)
 
    1.50     11.25     12/23/2013        5/16/2023        11,828        11,819        11,829  
                                                            
 
 
    
 
 
 
Total Second Lien Bank Debt/Senior Secured Loans
                                                           $ 49,576      $ 48,703  
      
 
 
    
 
 
 
First Lien Life Science Senior Secured Loans
                                                                         
Alimera Sciences, Inc.
   Pharmaceuticals      L+765       1.78     9.43     12/31/2019        7/1/2024      $ 20,074      $ 20,512      $ 20,475  
Arcutis Biotherapeutics, Inc.(3)
   Pharamceuticals      L+745       0.10     7.55     12/22/2021        1/1/2027        21,735        21,645        21,637  
Ardelyx, Inc.
   Pharmaceuticals      L+745       0.25     7.70     5/10/2018        11/1/2022        14,972        16,198        16,170  
Axcella Health Inc.
   Pharmaceuticals      L+860       0.10     8.70     9/2/2021        9/1/2026        9,278        9,318        9,302  
BridgeBio Pharma, Inc.(3)
   Biotechnology   
 
  
 
 
 
  
 
    9.00     11/17/2021        11/17/2026        34,574        34,082        34,055  
Centrexion Therapeutics, Inc.
   Pharmaceuticals      L+725       2.45     9.70     6/28/2019        1/1/2024        16,400        16,693        16,728  
Cerapedics, Inc.
   Health Care Equipment & Supplies      L+695       2.50     9.45     3/22/2019        3/1/2025        26,861        27,518        27,465  
Delphinus Medical Technologies, Inc.
   Health Care Equipment & Supplies      L+850       1.00     9.50     8/18/2017        6/1/2022        1,089        1,414        1,405  
Glooko, Inc.
   Health Care Technology      L+790       0.10     8.00     9/30/2021        10/1/2026        8,364        8,339        8,322  
Neuronetics, Inc.
   Health Care Equipment & Supplies      L+765       1.66     9.31     3/2/2020        2/28/2025        15,613        15,874        15,878  
OmniGuide Holdings, Inc. (13).
   Health Care Equipment & Supplies      L+1405       0.10     14.15     7/30/2018        7/1/2023        18,879        17,845        18,958  
Rezolute, Inc
   Biotechnology      L+875       0.12     8.87     4/14/2021        4/1/2026        5,675        5,663        5,661  
Rubius Therapeutics, Inc. (3)
   Pharmaceuticals      L+550       2.10     7.60     12/21/2018        6/1/2026        40,291        41,103        41,097  
scPharmaceuticals, Inc.
   Pharmaceuticals      L+795       2.23     10.18     9/17/2019        9/17/2023        4,098        4,165        4,160  
SOC Telemed, Inc.
   Health Care Providers & Services      L+747       0.13     7.60     3/26/2021        4/1/2026        31,137        31,211        31,214  
                                                            
 
 
    
 
 
 
Total First Lien Life Science Senior Secured Loans
                                                           $ 271,580      $ 272,527  
      
 
 
    
 
 
 
Total Senior Secured Loans
                                                          
$
959,162
 
  
$
939,690
 
      
 
 
    
 
 
 
 
See notes to consolidated financial statements.
 
12

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2021
(in thousands, except share/unit amounts)
 
Description
  
Industry
  
Interest Rate
(1)
 
Acquisition
Date
  
Maturity

Date
  
Par Amount
    
Cost
    
Fair
Value
 
Equipment Financing — 32.5%
                                             
Aero Operating LLC (10)
   Commercial Services & Supplies   
8.47-9.64%
  2/12/2021   
3/1/2025-12/1/2026
   $ 3,103      $ 3,100      $ 3,100  
Air Methods Corporation (10)
   Airlines   
7.08-7.13%
  11/3/2021   
11/3/2026-11/23/2026
     4,063        4,145        4,063  
AmeraMex International, Inc. (10)
   Commercial Services & Supplies    10.00%   3/29/2019    3/28/2022      3,149        3,148        3,180  
Blackhawk Mining, LLC (10)
   Oil, Gas & Consumable Fuels   
10.97-11.16%
  2/16/2018   
3/1/2022-11/1/2022
     1,642        1,615        1,636  
Boart Longyear Company (10)
   Metals & Mining   
9.06-10.44%
  5/28/2020   
7/1/2024-1/1/2026
     5,374        5,374        5,374  
Capital City Jet Center, Inc. (10)
   Airlines    10.00%   4/4/2018   
10/4/2023-6/22/26
     3,102        3,102        3,053  
Champion Air, LLC (10)
   Airlines    10.00%   3/19/2018    1/1/2023      1,685        1,685        1,685  
Clubcorp Holdings, Inc. (10)
   Hotels, Restaurants & Leisure   
8.87-9.41%
  5/27/2021   
6/1/2025-1/1/2027
     4,326        4,326        4,326  
Dongwon Autopart Technology Inc. (10)
   Auto Components    7.96%   2/2/2021    1/1/2026      2,347        2,382        2,347  
EasyPak, LLC (10)
   Containers & Packaging    9.01%   1/6/2021    1/1/2024      616        616        616  
Environmental Protection & Improvement Company, LLC (10)
   Road & Rail    8.25%   9/30/2020    10/1/2027      5,921        5,959        5,921  
Equipment Operating Leases, LLC (2)(12)
   Multi-Sector Holdings   
7.53-8.37%
  4/27/2018   
8/1/2022-4/27/2025
     19,671        19,671        18,939  
First American Commercial Bancorp, Inc. (10)
   Diversified Financial Services    7.50%   10/28/2021    11/1/2026      2,487        2,492        2,487  
First National Capital, LLC (10)
   Diversified Financial Services    9.00%   11/5/2021    8/1/2026      8,681        8,681        8,681  
Freightsol LLC (10)
   Road & Rail   
12.51-12.89%
  4/9/2019    11/1/2023      1,364        1,381        1,364  
Garda CL Technical Services, Inc. (10)
   Commercial Services & Supplies   
8.30-8.77%
  3/22/2018   
6/5/2023-10/5/2023
     1,245        1,245        1,242  
Georgia Jet, Inc. (10)
   Airlines    8.00%   12/4/2017    1/4/2024      795        795        795  
GMT Corporation (10)
   Machinery    10.71%   10/23/2018    10/1/2025      5,476        5,484        5,476  
Haljoe Coaches USA, LLC (10)
   Road & Rail    8.53%   7/31/2017    7/1/2024      1,061        1,061        915  
Hawkeye Contracting Company, LLC (10)
   Construction & Engineering    10.50%   10/8/2021    11/1/2025      1,252        1,252        1,252  
HTI Logistics Corporation (10)
   Commercial Services & Supplies   
9.69-9.94%
  11/15/2018   
5/1/2024-9/1/2025
     414        414        404  
International Automotive Components Group, North America, Inc. (10)
   Auto Components    7.95%   6/23/2021    6/23/2025      8,184        8,250        8,184  
Kool Pak, LLC (10)
   Road & Rail    8.58%   2/5/2018    3/1/2024      345        345        345  
Loyer Capital LLC (2)(12)
   Multi-Sector Holdings   
8.73-11.52%
  5/16/2019   
5/16/24-9/25/24
     11,000        11,000        10,725  
Lux Credit Consultants, LLC (10)
   Road & Rail   
8.28-9.65%
  6/17/2021   
12/1/2024-12/1/2025
     9,343        9,343        9,343  
Lux Vending, LLC (10)
   Consumer Finance   
12.46-13.26%
  8/20/2021   
8/20/2024-10/1/2024
     2,526        2,583        2,526  
Mountain Air Helicopters, Inc. (10)
   Commercial Services & Supplies    10.00%   7/31/2017    2/28/2025      479        476        479  
Rane Light Metal Castings Inc. (10)
   Machinery    10.00%   6/1/2020    7/1/2024      253        253        253  
Rango, Inc. (10)
   Commercial Services & Supplies   
9.33-9.79%
  9/24/2019   
4/1/2023-11/1/2024
     3,615        3,656        3,547  
Rossco Crane & Rigging, Inc. (10)
   Commercial Services & Supplies    11.53%   8/25/2017    9/1/2022      126        126        126  
Royal Coach Lines, Inc.(10)
   Road & Rail    9.56%   11/21/2019    8/1/2025      1,041        1,041        950  
Royal Express Inc. (10)
   Road & Rail    9.53%   1/17/2019    2/1/2024      683        690        683  
Sidelines Tree Service LLC (10)
   Diversified Consumer Services    10.25%   7/31/2017    10/1/2022      46        46        45  
South Texas Oilfield Solutions, LLC (10)
   Energy Equipment & Services   
12.52-13.76%
  3/29/2018   
9/1/2022-7/1/2023
     1,363        1,363        1,338  
ST Coaches, LLC (10)
   Road & Rail   
8.22-8.58%
  7/31/2017   
10/1/2022-1/25/2025
     1,951        1,951        1,839  
Stafford Logistics, Inc. (10)
   Commercial Services & Supplies    12.62%   9/11/2019    2/15/2026      7,094        7,094        7,094  
Star Coaches Inc. (10)
   Road & Rail    8.42%   3/9/2018    4/1/2025      3,401        3,401        2,916  
Sturgeon Services International Inc. (10)
   Energy Equipment & Services    18.38%   7/31/2017    2/28/2022      132        132        125  
Superior Transportation, Inc. (10)
   Road & Rail   
10.22-10.62%
  7/31/2017    1/1/2026      4,578        4,578        4,578  
Tailwinds, LLC (10)
   Air Freight & Logistics   
8.50-9.00%
  7/26/2019   
8/1/2024-10/16/2025
     2,267        2,267        2,267  
The Smedley Company & Smedley Services, Inc. (10)
   Commercial Services & Supplies   
10.21-15.36%
  7/31/2017   
10/29/2023-2/10/2024
     3,798        3,800        3,536  
Trinity Equipment Rentals, Inc. (10)
   Commercial Services & Supplies   
7.94-8.75%
  10/8/2021   
11/1/2024-12/1/2026
     777        777        777  
Trolleys, Inc. (10)
   Road & Rail    9.99%   7/18/2018    8/1/2022      1,573        1,573        1,540  
Up Trucking Services, LLC (10)
   Road & Rail    11.21%   3/23/2018    8/1/2024      696        705        696  
Warrior Crane Services, LLC (10)
   Commercial Services & Supplies    8.95%   7/11/2019   
8/1/2024-8/1/2026
     2,567        2,567        2,518  
Wind River Environmental, LLC (10)
   Diversified Consumer Services   
8.43-10.00%
  7/31/2019   
8/1/2024-10/5/25
     870        873        870  
Womble Company, Inc. (10)
   Energy Equipment & Services    9.11%   12/27/2019    1/1/2025      547        547        537  
               
                       
Shares/Units
               
SLR Equipment Finance Equity Interests (2)(9)*
   Multi-Sector Holdings        7/31/2017           200        145,000        129,102  
                                
 
 
    
 
 
 
Total Equipment Financing
                              
$
292,365
 
  
$
273,795
 
                                
 
 
    
 
 
 
Preferred Equity – 0.7%
                                             
SOAGG LLC (2)(3)(4)
   Aerospace & Defense    8.00%   12/14/2010    6/30/2023      446      $ 446      $ 1,121  
SOINT, LLC (2)(3)(4)
   Aerospace & Defense    5.00%
(11)
  6/8/2012    6/30/2023      56,030        5,603        4,509  
                                
 
 
    
 
 
 
Total Preferred Equity
                              
$
6,049
 
  
$
5,630
 
                                
 
 
    
 
 
 
 
See notes to consolidated financial statements.
 
13

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2021
(in thousands, except share/unit amounts)
 
Description
  
Industry
  
Acquisition
Date
    
Shares/Units
    
Cost
    
Fair
Value
 
Common Equity/Equity Interests/Warrants—53.6%
                                        
aTyr Pharma, Inc. Warrants *
   Pharmaceuticals      11/18/2016        6,347      $ 106      $     
CardioFocus, Inc. Warrants *
   Health Care Equipment & Supplies      3/31/2017        90        51            
Centrexion Therapeutics, Inc. Warrants *
   Pharmaceuticals      6/28/2019        289,102        136        65  
Conventus Orthopaedics, Inc. Warrants *
   Health Care Equipment & Supplies      6/15/2016        157,500        65            
Delphinus Medical Technologies, Inc. Warrants *
   Health Care Equipment & Supplies      8/18/2017        444,388        74        80  
Essence Group Holdings Corporation (Lumeris) Warrants *
   Health Care Technology      3/22/2017        208,000        63        258  
KBH Topco LLC (Kingsbridge) (2)(5)
   Multi-Sector Holdings      11/3/2020        73,500,000        136,596        145,996  
RD Holdco Inc. (Rug Doctor) (2)*
   Diversified Consumer Services      12/23/2013        231,177        15,683            
RD Holdco Inc. (Rug Doctor) Class B (2)*
   Diversified Consumer Services      12/23/2013        522        5,216        5,216  
RD Holdco Inc. (Rug Doctor) Warrants (2)*
   Diversified Consumer Services      12/23/2013        30,370        381            
Senseonics Holdings, Inc. (3)(8)*
   Health Care Equipment & Supplies      7/25/2019        406,923        117        1,086  
SLR Credit Solutions (2)(3)
   Diversified Financial Services      12/28/2012        280,303        280,737        298,766  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
   Health Care Equipment & Supplies      5/10/2018        27,352        152            
                           
 
 
    
 
 
 
Total Common Equity/Equity Interests/Warrants
                         
$
439,377
 
  
$
451,467
 
                           
 
 
    
 
 
 
Total Investments (6) — 198.3%
                         
$
1,696,953
 
  
$
1,670,582
 
                           
 
 
    
 
 
 
 
Description
  
Industry
    
Acquisition
Date
    
Maturity

Date
    
Par Amount
               
Cash Equivalents — 38.0%
                                                     
U.S. Treasury Bill
     Government        12/31/2021        1/25/2022      $ 320,000      $ 320,000      $ 320,000  
                                        
 
 
    
 
 
 
Total Investments & Cash Equivalents —236.3%
                                      
$
2,016,953
 
  
$
1,990,582
 
Liabilities in Excess of Other Assets — (136.3%)
                                                  (1,148,301
                                                 
 
 
 
Net Assets — 100.0%
                                               
$
842,281
 
                                                 
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2021.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows:
 
Name of Issuer
  
Fair Value at
December 31, 2020
    
Gross
Additions
    
Gross
Reductions
    
Realized
Gain
(Loss)
    
Change in
Unrealized
Gain
(Loss)
   
Interest/
Dividend
Income
    
Fair Value at
December 31,
2021
 
AviatorCap SII, LLC
   $ 2,941      $         $ 2,941      $          $        $ 92      $     
Equipment Operating Leases, LLC
     25,540                  6,667                  66       1,950        18,939  
Kingsbridge Holdings, LLC
     80,000                                      (79     6,568        80,000  
KBH Topco, LLC (Kingsbridge)
     136,596                                      9,400       13,250        145,996  
Loyer Capital LLC
     14,456                  3,731                           1,426        10,725  
RD Holdco Inc. (Rug Doctor, common equity)
     1,226                                      (1,226                   
RD Holdco Inc. (Rug Doctor, class B)..
     5,216                                                         5,216  
RD Holdco Inc. (Rug Doctor, warrants)..
                                                                    
Rug Doctor LLC
     10,559        1,270                            (6     1,300        11,829  
SLR Credit Solutions
     296,766                                      2,000       22,500        298,766  
SLR Equipment Finance (equity)
     129,102                                                         129,102  
SLR Equipment Finance (debt)
     850                  850                           42            
SOAGG LLC
     2,300                                      (1,179     1,543        1,121  
SOINT, LLC
     4,101        271                            137       271        4,509  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
     $ 709,653      $  1,541      $ 14,189      $         $ 9,113     $  48,942      $ 706,203  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
    
 
 
 
 
See notes to consolidated financial statements.
 
14

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2021
(in thousands)
 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis,
non-qualifying
assets in the portfolio represented 23.1% of the total assets of the Company.
(4)
The Company’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $19,495; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $82,598 and $63,103, respectively, based on a tax cost of $1,651,087. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
(15)
Spread is 6.00% Cash / 2.00% PIK.
(16)
Spread is 2.50% Cash / 12.50% PIK.
(17)
Spread is 5.50% Cash / 0.50% PIK.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
 
See notes to consolidated financial statements.
 
15

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2021
(in thousands)
 
Industry Classification
  
Percentage of Total
Investments (at fair value) as
of December 31, 2021
 
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
     24.8
Diversified Financial Services (includes SLR Credit Solutions)
     20.7
Health Care Providers & Services
     9.6
Pharmaceuticals
     7.8
Software
     5.0
Health Care Equipment & Supplies
     5.0
Biotechnology
     2.4
Wireless Telecommunication Services
     2.2
Personal Products
     2.0
Road & Rail
     1.9
IT Services
     1.9
Diversified Consumer Services
     1.8
Insurance
     1.6
Commercial Services & Supplies
     1.6
Capital Markets
     1.6
Auto Parts & Equipment
     1.5
Internet & Catalog Retail
     1.5
Packaged Foods & Meats
     1.1
Life Sciences Tools & Services
     1.0
Communications Equipment
     0.9
Specialty Retail
     0.7
Auto Components
     0.6
Airlines
     0.6
Health Care Technology
     0.5
Machinery
     0.3
Aerospace & Defense
     0.3
Metals & Mining
     0.3
Hotels, Restaurants & Leisure
     0.3
Consumer Finance
     0.1
Air Freight & Logistics
     0.1
Energy Equipment & Services
     0.1
Oil, Gas & Consumable Fuels
     0.1
Construction & Engineering
     0.1
Containers & Packaging
     0.0
    
 
 
 
Total Investments
     100.0
    
 
 
 
See notes to consolidated financial statements.
 
16

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)
September 30, 2022
(in thousands, except share amounts)
Note 1. Organization
Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1,200,000 of which 47.04% was funded by affiliated parties.
Immediately prior to our initial public offering, through a series of transactions, SLR Investment Corp. (the “Company”, “we”, “us” or “our”), merged with Solar Capital LLC, leaving SLR Investment Corp. as the surviving entity (the
“Pre-IPO
Merger”). SLR Investment Corp. issued an aggregate of approximately 26.65 million shares of common stock and $125,000 in senior unsecured notes to the existing Solar Capital LLC unit holders in connection with the
Pre-IPO
Merger. SLR Investment Corp. had no assets or operations prior to completion of the
Pre-IPO
Merger and as a result, the historical books and records of Solar Capital LLC have become the books and records of the surviving entity. The number of shares used to calculate weighted average shares for use in computations on a per share basis have been decreased retroactively by a factor of approximately 0.4022 for all periods prior to February 9, 2010. This factor represents the effective impact of the reduction in shares resulting from the
Pre-IPO
Merger.
SLR Investment Corp., a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On December 1, 2021, we entered into an Agreement and Plan of Merger (the “Merger Agreement”), with SLR Senior Investment Corp., a Maryland corporation (“SUNS”), Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). The Merger Agreement provided that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger,”) and, immediately thereafter, SUNS will merge with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). The Mergers closed on April 1, 2022. See Note 16 for additional information.
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form
10-Q
and Regulation
S-X,
as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2022.
In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included.
 
17

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
The significant accounting policies consistently followed by the Company are:
 
(a)
Investment transactions are accounted for on the trade date;
 
(b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation]. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
 
18

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the nine months ended September 30, 2022, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
(c)
Gains or losses on investments are calculated by using the specific identification method.
 
(d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
(e)
The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
(f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.
 
(g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
(h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
19

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
 
(i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
(j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
(k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
(l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.
 
(m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
(n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU
2020-04
is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures.
 
20

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Note 3. Agreements
The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser will manage the
day-to-day
operations of, and provide investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and nine months ended September 30, 2022 and 2021.
For the three and nine months ended September 30, 2022, the Company recognized $7,890 and $22,019, respectively, in base management fees and $4,965 and $9,699, respectively, in gross performance-based incentive fees. For the three and nine months ended September 30, 2022, $194 and $1,552 of such performance-based incentive fees were waived. For the three and nine months ended September 30, 2021, the Company recognized $7,142 and $20,842, respectively, in base management fees and $698 and $8,444, respectively, in performance-based incentive fees. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Merger. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser.
The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the three and nine months ended September 30, 2022, the Company recognized expenses under the Administration Agreement of $1,132 and $3,684 respectively. For the three and nine months ended September 30, 2021, the Company recognized expenses under the Administration Agreement of $1,435 and $4,170 respectively. No managerial assistance fees were accrued or collected for the three and nine months ended September 30, 2022 and 2021.
 
21

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Note 4. Net Asset Value Per Share
At September 30, 2022, the Company’s total net assets and net asset value per share were $1,006,225 and $18.37, respectively. This compares to total net assets and net asset value per share at December 31, 2021 of $842,281 and $19.93, respectively.
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and nine months ended September 30, 2022 and 2021:
 
    
Three months ended September 30,
    
Nine months ended September 30,
 
    
2022
    
2021
    
2022
    
2021
 
Earnings (loss) per share (basic & diluted)
                                   
Numerator - net increase (decrease) in net assets resulting from operations:
   $ 13,528      $ 13,371      $ (655    $ 53,448  
Denominator - weighted average shares:
     54,772,651        42,260,826        50,647,874        42,260,826  
Earnings (loss) per share:
   $ 0.25      $ 0.32      ($ 0.01    $ 1.26  
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
 
22

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of September 30, 2022 and December 31, 2021:
Fair Value Measurements
As of September 30, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $         $         $ 1,352,503      $ 1,352,503  
Equipment Financing
                         238,553        238,553  
Preferred Equity
                         4,176        4,176  
Common Equity/Equity Interests/Warrants
     620                  559,509        560,129  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments$
   $ 620      $         $  2,154,741      $ 2,155,361  
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $         $         $ 939,690      $ 939,690  
Equipment Financing
                         273,795        273,795  
Preferred Equity
                         5,630        5,630  
Common Equity/Equity Interests/Warrants
     1,086                  450,381        451,467  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments$
   $ 1,086      $         $  1,669,496      $ 1,670,582  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
                                   
2022 Unsecured Notes
   $         $         $ 150,000      $ 150,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
 
23

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
The following tables provide a summary of the changes in fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at September 30, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, June
 30, 2022
   $  1,178,247     $  255,978     $  4,405     $ 554,597     $ 1,993,227  
Total gains or losses included in earnings:
                                        
Net realized loss
     (37,231                                (37,231
Net change in unrealized gain (loss)
     34,518       (3,849     59       (139     30,589  
Purchase of investment securities
     228,399       15,581       67       5,051       249,098  
Proceeds from dispositions of investment securities
     (51,430     (29,157     (355              (80,942
Transfers in/out of Level 3
                                             
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, September
 30, 2022
   $ 1,352,503     $ 238,553     $ 4,176     $ 559,509     $ 2,154,741  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized gain (loss)
   $ 781     $ (3,849   $ 59     $ (139   $ (3,148
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $  273,795     $  5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
                                        
Net realized loss
     (37,191                                (37,191
Net change in unrealized loss
     (1,890     (6,828     (658     (7,121     (16,497
Purchase of investment securities(1)
     639,306       44,202       202       116,249       799,959  
Proceeds from dispositions of investment securities
     (187,412     (72,616     (998              (261,026
Transfers in/out of Level 3
                                             
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, September
 30, 2022
   $  1,352,503     $ 238,553     $ 4,176     $ 559,509     $ 2,154,741  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized loss
   $ (2,744   $ (6,828   $   (658   $ (7,121   $ (17,351
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Merger.
 
24

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2022:
 
2022 Unsecured Notes
  
For the three months ended
September 30, 2022
 
Beginning fair value
   $      
Net realized (gain) loss
         
Net change in unrealized (gain) loss
         
Borrowings
         
Repayments
         
Transfers in/out of Level 3
         
    
 
 
 
Ending fair value
   $     
    
 
 
 
 
2022 Unsecured Notes
  
For the nine months ended
September 30, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
         
Net change in unrealized (gain) loss
         
Borrowings
         
Repayments
     (150,000
Transfers in/out of Level 3
         
    
 
 
 
Ending fair value
   $     
    
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full.
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2020
   $ 798,052     $  284,846     $ 6,401     $ 440,971     $ 1,530,270  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
              (8              345       337  
Net change in unrealized gain (loss)
     (13,567     1,394       (1,042     9,857       (3,358
Purchase of investment securities
     533,614       76,700       271                610,585  
Proceeds from dispositions of investment securities
     (378,409     (89,137              (675     (468,221
Transfers in/out of Level 3
(1)
                                (117     (117
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized gain (loss)
   $ (12,837   $ 1,394     $ (1,042   $ 9,597     $ (2,888
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset.
 
25

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2021
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
         
Net change in unrealized (gain) loss
         
Borrowings
         
Repayments
         
Transfers in/out of Level 3
         
    
 
 
 
Ending fair value
   $ 150,000  
    
 
 
 
The Company made elections to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On December 31, 2021, there were borrowings of $150,000 on the 2022 Unsecured Notes.
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
 
26

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2022 is summarized in the table below:
 
 
  
Asset or
Liability
  
Fair Value at
September 30, 2022
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
1,320,263
32,240
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
7.6% – 17.8% (10.9%)
0.1x-21.4x(12.0x)
Equipment Financing
   Asset    $
$
117,733
120,820
 
 
   Income Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
  
8.5% – 9.7% (9.7%)
1.0x-1.28x
(1.14x)
Preferred Equity
   Asset    $ 4,176      Income Approach   Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
147,629
411,880
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
  
7.0x – 9.3x (8.1x)
6.3% – 37.7% (9.7%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using a transaction multiple.
(3)
Includes $624 of investments valued using a Black-Scholes model and $147,005 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below:
 
 
  
Asset or
Liability
  
Fair Value at
December 31, 2021
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
931,769
7,921
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
4.0% – 19.6% (8.7%)
2.0x-3.0x(2.5x)/2.0x-3.0x(2.5x)
Equipment Financing
   Asset    $
$
144,693
 129,102
 
 
   Income Approach
Market Approach
  Market Yield
Return on Equity
  
7.1% – 20.3% (9.8%)
4.6%-4.6%
(4.6%)
Preferred Equity
   Asset    $ 5,630      Income Approach   Market Yield    3.5% – 8.0% (4.4%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
151,615
298,766
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
  
5.8x – 10.5x (9.5x)
6.1% – 18.5% (8.6%)
2022 Unsecured Notes
   Liability    $ 150,000      Income Approach   Market Yield    2.2% – 4.6% (4.5%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected EBITDA multiples
(2x-3x)
for certain segments of the business and expected revenue multiples
(2x-3x)
for certain segments of the business.
(2)
Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple.
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments.
 
27

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Note 7. Debt
Our debt obligations consisted of the following as of September 30, 2022 and December 31, 2021:
 
    
September 30, 2022
   
December 31, 2021
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 460,000      $  454,868
(1)
 
  $  322,500      $  318,015
(1)
 
SPV Credit Facility
     130,200        129,236
(2)
 
                  
2022 Unsecured Notes
                        150,000        150,000  
2022 Tranche C Notes
     21,000        20,991
(3)
 
    21,000        20,964
(3)
 
2023 Unsecured Notes
     75,000        74,881
(4)
 
    75,000        74,592
(4)
 
2024 Unsecured Notes
     125,000        124,350
(5)
 
    125,000        124,143
(5)
 
2025 Unsecured Notes
     85,000        84,572
(6)
 
                  
2026 Unsecured Notes
     75,000        74,468
(7)
 
    75,000        74,384
(7)
 
2027 Unsecured Notes
     50,000        49,950
(8)
 
    50,000        49,940
(8)
 
2027 Series F Unsecured Notes
     135,000        134,975
(9)
 
                  
    
 
 
    
 
 
   
 
 
    
 
 
 
     $  1,156,200      $  1,148,291     $  818,500      $  812,038  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $5,132 and $4,485 as of September 30, 2022 and December 31, 2021, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $964 as of September 30, 2022.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $9 and $36 as of September 30, 2022 and December 31, 2021, respectively.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $119 and $408 as of September 30, 2022 and December 31, 2021, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $650 and $857 as of September 30, 2022 and December 31, 2021, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized market discount of $428 as of September 30, 2022.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $532 and $616 as of September 30, 2022 and December 31, 2021, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $50 and $60 as of September 30, 2022 and December 31, 2021, respectively.
(9)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $25 as of September 30, 2022.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
28

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2017, the Company closed a private offering of $21,000 of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023.
On February 15, 2017, the Company closed a private offering of $100,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 8, 2016, the Company closed a private offering of $50,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of
May 8, 2022
. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity.
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2022, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $130,200.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, the Credit Facility is composed of $600,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At September 30, 2022, outstanding USD equivalent borrowings under the Credit Facility totaled $460,000, composed of $360,000 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
 
29

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
The average annualized interest cost for all borrowings for the nine months ended September 30, 2022 and the year ended December 31, 2021 was 3.81% and 3.64%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2022 Unsecured Notes, the 2022 Tranche C Notes, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the nine months ended September 30, 2022 and the year ended December 31, 2021 were $1,157,100 and $902,550, respectively.
Note 8. Financial Highlights
The following is a schedule of financial highlights for the nine months ended September 30, 2022 and 2021:
 
    
Nine months ended
September 30, 2022
   
Nine months ended
September 30, 2021
 
Per Share Data: (a)
                
Net asset value, beginning of year
   $ 19.93     $ 20.16  
    
 
 
   
 
 
 
Net investment income
     1.06       1.09  
Net realized and unrealized gain (loss)
     (1.08 )*      0.18  
    
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     (0.02     1.27  
Issuance of common stock in connection with the Merger
     (0.31         
Distributions to stockholders:
                
From net investment income
     (1.06     (1.23
From return of capital
 
 
(0.17
)
 
 
 
 
    
 
 
   
 
 
 
Net asset value, end of period
   $ 18.37     $ 20.20  
    
 
 
   
 
 
 
Per share market value, end of period
   $ 12.32     $ 19.13  
Total Return (b)(c)
     (27.75 %)      16.46
Net assets, end of period
   $ 1,006,225     $ 853,490  
Shares outstanding, end of period
     54,772,651       42,260,826  
Ratios to average net assets (c):
                
Net investment income
     5.51     5.38
    
 
 
   
 
 
 
Operating expenses
     3.90 %**      4.23
Interest and other credit facility expenses
     3.22     2.51
    
 
 
   
 
 
 
Total expenses
     7.12 %**      6.74
    
 
 
   
 
 
 
Average debt outstanding
   $ 951,995     $ 672,962  
Portfolio turnover ratio
     13.8     20.8
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per Share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2021 and December 31, 2020 was $18.43 and $17.51, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a permanent incentive fee waiver (see note 3).
For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the incentive fee waiver.
 
30

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Note 9. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of September 30, 2022, total commitments to the revolving credit facility are $250,000.
As of September 30, 2022 SLR Credit had 27 funded commitments to 21 different issuers with total funded loans of approximately $354,853 on total assets of $375,603. As of December 31, 2021 SLR Credit had 22 funded commitments to 19 different issuers with total funded loans of approximately $287,375 on total assets of $347,821. As of September 30, 2022 and December 31, 2021, the largest loan outstanding totaled $34,178 and $35,000, respectively. For the same periods, the average exposure per issuer was $16,898 and $15,125, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $139,497 and $100,742 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Credit had net income of $3,897 and $5,445, respectively, on gross income of $8,596 and $9,508, respectively. For the nine months ended September 30, 2022 and 2021, SLR Credit had net income of $8,557 and $12,497 respectively, on gross income of $22,171 and $27,239, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
 
31

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Note 10. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of September 30, 2022 and December 31, 2021 is $310,204 and $226,733, respectively, comprised of the following:
 
    
September

30, 2022
    
December

31, 2021
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Apeel Technology, Inc.
     32,786            
World Insurance Associates, LLC
     25,554            
CC SAG Holdings Corp. (Spectrum Automotive)
     24,346        18,827  
Human Interest, Inc.
     20,104            
Glooko, Inc.
     17,868        25,091  
Spectrum Pharmaceuticals, Inc.
     12,279            
iCIMS, Inc.
     11,577            
BridgeBio Pharma, Inc.
     9,016        23,049  
BDG Media, Inc.
     8,573            
RSC Acquisition, Inc.
     8,553            
Arcutis Biotherapeutics, Inc.
     8,356        43,470  
Atria Wealth Solutions, Inc.
     8,215        3,746  
Ardelyx, Inc.
     7,752            
Luxury Asset Capital, LLC
     7,500            
OIS Management Services, LLC
     5,205            
Vessco Midco Holdings, LLC
     4,098            
One Touch Direct, LLC
     4,013        7,226  
Kaseya, Inc.
     3,936            
Maurices, Incorporated
     3,922        5,649  
Foundation Consumer Brands, LLC
     3,009        2,269  
Inszone Mid, LLC
     2,790        12,465  
Kid Distro Holdings, LLC
     2,650        2,650  
Plastics Management, LLC
     2,424            
Pediatric Home Respiratory Services, LLC
     2,380            
Southern Orthodontic Partners Management, LLC
     2,292            
Basic Fun, Inc.
     2,150        1,935  
Copper River Seafoods, Inc.
     2,043            
Peter C. Foy & Associates Insurance Services, LLC
     1,969            
Orthopedic Care Partners Management, LLC
     1,896            
MMIT Holdings, LLC
     1,894        2,009  
SPAR Marketing Force, Inc.
     1,613            
Ivy Fertility Services, LLC
     1,571        4,532  
NAC Holdings Corporation
     1,479        4,765  
SLR Healthcare ABL*
     1,400            
RxSense Holdings LLC
     1,250            
Erie Construction
Mid-west,
LLC
     1,247            
Composite Technology Acquisition Corp.
     1,139            
Enverus Holdings, Inc.
     1,004            
SLR Equipment Finance
     1,000        5,000  
American Teleconferencing Services, Ltd.
     914        573  
SunMed Group Holdings, LLC
     843        828  
All State Ag Parts, LLC
     730            
Ultimate Baked Goods Midco LLC
     551        801  
BayMark Health Services, Inc.
     391            
Pinnacle Treatment Centers, Inc.
     387        1,414  
GSM Acquisition Corp.
     365            
High Street Buyer, Inc.
     327            
Tilley Distribution, Inc.
     293            
TAUC Management, LLC
     287            
RQM+ Corp.
               3,818  
Rezolute, Inc.
               5,675  
SOC Telemed, Inc.
               4,448  
Neuronetics, Inc.
               2,230  
    
 
 
    
 
 
 
Total Commitments
   $  310,204      $  226,733  
    
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
 
32

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.​​​​​​​
Note 11. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies is doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023.
As of September 30, 2022, SLR Equipment had 129 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $189,254 on total assets of $241,189. As of December 31, 2021, SLR Equipment had 135 funded equipment-backed leases and loans to 61 different customers with a total net investment in leases and loans of approximately $210,986 on total assets of $264,007. As of September 30, 2022 and December 31, 2021, the largest position outstanding totaled $19,272 and $19,207, respectively. For the same periods, the average exposure per customer was $3,208 and $3,459, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $110,997 and $118,002 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and September 30, 2021, SLR Equipment had net income (loss) of $1,034 and ($306), respectively, on gross income of $6,486 and $5,809, respectively. For the nine months ended September 30, 2022 and September 30, 2021, SLR Equipment had net loss of $125 and $2,301, respectively, on gross income of $15,704 and $16,443, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
 
33

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Note 12. Capital Share Transactions
As of September 30, 2022 and September 30, 2021, 200,000,000 shares of $0.01 par value capital stock were authorized.
Transactions in capital stock were as follows:
 
                                                                                                                                                     
    
Shares
    
Amount
 
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2021
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2021
 
Shares issued in connection with the Mergers
  
 
  
 
  
 
  
 
  
$
  
 
  
$
  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
  
 
  
 
  
 
  
 
  
$
  
 
  
$
  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
                                                                                                                                                     
    
Shares
    
Amount
 
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2021
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2021
 
Shares issued in connection with the Mergers
  
 
12,511,825
 
  
 
  
 
  
$
226,839
 
  
$
  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
  
 
12,511,825
 
  
 
  
 
  
$
226,839
 
  
$
  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Note 13. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired an 87.5% equity interest in Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a newly formed Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continue to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of September 30, 2022 and December 31, 2021, KBHT had total assets of $774,619 and $738,425, respectively. For the same periods, debt recourse to KBHT totaled $246,210 and $216,881, respectively, and
non-recourse
debt totaled $316,840 and $323,844, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2022 and 2021, KBHT had net income of $3,327 and $3,163, respectively, on gross income of $71,332 and $60,510, respectively. For the nine months ended September 30, 2022 and 2021, KBHT had net income of $10,393 and $10,314, respectively, on gross income of $215,074 and $180,079, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
Note 14. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2022, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Merger on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100,000 credit facility with
non-affiliates,
which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023.
 
34

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2022, the portfolio totaled approximat
e
ly $179,633
of commitments with a total net investment in loans of $81,360 on total assets of $93,010. As of December 31, 2021, the portfolio totaled approximately $183,501 of commitments with a total net investment in loans of $81,604 on total assets of $91,275. At September 30, 2022, the portfolio consisted of 37 issuers with an average balance of approximately $2,199 versus 36 issuers with an average balance of approximately $2,267 at December 31, 2021. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $62,000 and $60,000 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Healthcare had net income (loss) of $822 and ($40), respectively, on gross income of $3,020 and $2,631, respectively. For the nine months ended September 30, 2022 and 2021, SLR Healthcare had net income of $2,543 and $494, respectively, on gross income of $7,898 and $7,035, respectively. Due to timing and
non-cash
items, there
may
be material differences between GAAP net income and cash available for distributions.
Note 15. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Merger on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of
September 30, 2022, the portfolio totaled approximately $554,171 of commitments, of which $295,973 were funded, on total assets of $346,278. As of
December 31, 2021, the portfolio totaled approximately $513,869 of commitments, of which $248,652 were funded, on total assets of $290,794. At
September 30, 2022, the portfolio consisted of 109 issuers with an average balance of approximately $2,715 versus 125 issuers with an average balance
of approximately $1,989 at December 31, 2021. NMC has a senior credit facility with a bank lending group for $240,000 which expires on
November 13, 2025
. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had
approximately $237,510 and $183,252 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months
ended September 30, 2022 and 2021, SLR Business Credit had net income of $1,977 and $2,577, respectively, on gross income of $7,607 and $6,857,
respectively. For the nine months ended September 30, 2022 and 2021, SLR Business Credit had net income of $5,703 and $4,737, respectively, on
gross income of $20,378 and $16,674, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income
and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and
the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
 
35

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Note 16. Merger with SUNS
On December 1, 2021, we entered into the Merger Agreement, which provides that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into SUNS, with SUNS continuing as the surviving company and as our wholly-owned subsidiary and, immediately thereafter, SUNS will merge with and into us, with us continuing as the surviving company. Both the Board and SUNS’s board of directors, including all of the respective independent directors, in each case, on the recommendation of a special committee comprised solely of the independent directors of us or SUNS, as applicable, have approved the Merger Agreement and the transactions contemplated thereby.
The Merger Agreement contains customary representations and warranties by each of us, SUNS and the Investment Adviser. The Merger Agreement also contains customary covenants, including, among others, covenants relating to the operation of each of our and SUNS’s businesses during the period prior to the closing of the Mergers.
Consummation of the Mergers, which occurred on April 1, 2022, was subject to certain closing conditions as disclosed in the Merger Agreement.
On April 1, 2022, the Company completed its previously announced acquisition of SUNS. Pursuant to the Merger Agreement, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into the Company, with the Company as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of the Company’s common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Mergers, the Company issued an aggregate of 12,511,825 shares of its common stock to former SUNS stockholders.
The Merger is accounted for as an asset acquisition of SLR Senior Investment Corp. by the Company in accordance with the asset acquisition method of accounting as detailed in ASC
805-50,
Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Merger allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Merger. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain
“non-qualifying”
assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Merger. The Merger was considered a
tax-free
reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes. Prior to the Merger, SUNS was also managed by the Investment Adviser.
The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger:
 
Common stock issued by the Company
(1)
   $ 227,602  
    
 
 
 
Assets acquired:
        
Investments, at fair value
   $ 400,105  
Cash
     2,313  
Other assets
     4,662  
    
 
 
 
Total assets acquired
   $ 407,080  
    
 
 
 
Liabilities assumed:
        
Debt, at fair value
   $ 159,816  
Other liabilities
     2,573  
    
 
 
 
Total liabilities assumed
   $ 162,389  
    
 
 
 
Net assets acquired
   $ 244,691  
    
 
 
 
Total purchase discount
   $ (17,089
    
 
 
 
 
(1)
Based on the market price at closing of $18.13, adjusted for transaction costs.
 
36

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (unaudited)(continued)
September 30, 2022
(in thousands, except share amounts)
 
Letter Agreement
On April 1, 2022, in connection with the consummation of the Mergers, the Company entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by the Company to the Investment Adviser pursuant to the Advisory Agreement, resulting in an annual base management fee rate payable by the Company to the Investment Adviser of 1.50% on gross assets up to 200% of the Company’s total net assets. The Company retained the annual base management fee rate payable by the Company to the Investment Adviser of 1.00% on gross assets that exceed 200% of the Company’s total net assets.
Note 17. Stock Repurchase Program
On May 3, 2022, our Board authorized a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases. As of September 30, 2022, no repurchases have taken place.
Note 18. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On October 5, 2022, our Board declared a monthly distribution of $0.136667 per share payable on November 2, 2022 to holders of record as of October 20, 2022.
On October 12, 2022, the Company entered into a joint venture agreement with SunStone Senior Credit L.P. (the “Investor”) to create SLR Senior Lending Program LLC (“SSLP”). The joint venture is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. SSLP intends to seek third party financing to allow the joint venture to utilize leverage. The Company and the Investor expect to begin funding SSLP with investments prior to the end of 2022. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On November 2, 2022, our Board declared a monthly distribution of $0.136667 per share payable on December 1, 2022 to holders of record as of November 17, 2022.
 
37

Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
SLR Investment Corp.:
Results of Review of Interim Financial Information
We have reviewed the consolidated statement of assets and liabilities of SLR Investment Corp. (and subsidiaries) (the Company), including the consolidated schedule of investments, as of September 30, 2022, the related consolidated statements of operations and changes in net assets, for the three-month and nine-month periods ended September 30, 2022 and 2021, the related consolidated statements of cash flows for the nine-month periods ended September 30, 2022 and 2021, and the related notes (collectively, the consolidated interim financial information). Based on our reviews, we are not aware of any material modifications that should be made to the consolidated interim financial information for it to be in conformity with U.S. generally accepted accounting principles.
We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated statement of assets and liabilities, including the consolidated schedule of investments, of the Company as of December 31, 2021, and the related consolidated statements of operations, changes in net assets, and cash flows for the year then ended (not presented herein); and in our report dated March 1, 2022, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated statement of assets and liabilities, including the consolidated schedule of investments, as of December 31, 2021, is fairly stated, in all material respects, in relation to the consolidated statement of assets and liabilities, including the consolidated schedule of investments, from which it has been derived.
Basis for Review Results
This consolidated interim financial information is the responsibility of the Company’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our reviews in accordance with the standards of the PCAOB. A review of consolidated interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.
/s/ KPMG LLP
New York, New York
November 2, 2022
 
38

Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The information contained in this section should be read in conjunction with our consolidated financial statements and notes thereto appearing elsewhere in this report.
Some of the statements in this report constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained herein involve risks and uncertainties, including statements as to:
 
   
our future operating results, including our ability to achieve objectives as a result of the current
COVID-19
pandemic;
 
   
our business prospects and the prospects of our portfolio companies;
 
   
the impact of investments that we expect to make;
 
   
our contractual arrangements and relationships with third parties;
 
   
the dependence of our future success on the general economy and its impact on the industries in which we invest and the impact of the
COVID-19
pandemic thereon;
 
   
the impact of any protracted decline in the liquidity of credit markets on our business and the impact of the
COVID-19
pandemic thereon;
 
   
the ability of our portfolio companies to achieve their objectives, including as a result of the current
COVID-19
pandemic;
 
   
the valuation of our investments in portfolio companies, particularly those having no liquid trading market, and the impact of the
COVID-19
pandemic thereon;
 
   
market conditions and our ability to access alternative debt markets and additional debt and equity capital, and the impact of the
COVID-19
pandemic thereon;
 
   
our expected financings and investments;
 
   
the adequacy of our cash resources and working capital;
 
   
the timing of cash flows, if any, from the operations of our portfolio companies and the impact of the
COVID-19
pandemic thereon; and
 
   
the ability of our investment adviser to locate suitable investments for us and to monitor and administer our investments and the impacts of the
COVID-19
pandemic thereon.
 
   
changes in the political conditions and relations between the United States, Russia, Ukraine and other nations.
These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:
 
   
an economic downturn, including as a result of the current
COVID-19
pandemic, could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies;
 
   
a contraction of available credit and/or an inability to access the equity markets, including as a result of the current
COVID-19
pandemic, could impair our lending and investment activities;
 
   
interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy;
 
   
currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars;
 
   
the ability to realize the anticipated benefits of the Mergers;
 
   
the effects of disruption on our business from the Mergers;
 
   
the combined company’s plans, expectations, objectives and intentions as a result of the Mergers;
 
   
the risks, uncertainties and other factors we identify in Item 1A. — Risk Factors contained in our Annual Report on Form
10-K
for the year ended December 31, 2021, elsewhere in this Quarterly Report on Form
10-Q
and in our other filings with the SEC.
We generally use words such as “anticipates,” “believes,” “expects,” “intends” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements for any reason, including any factors set forth in “Risk Factors” and elsewhere in this report.
We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including any annual reports on Form
10-K,
quarterly reports on Form
10-Q
and current reports on Form
8-K.
 
39

Overview
Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1.2 billion of which 47.04% was funded by affiliated parties.
SLR Investment Corp. (the “Company”, “SLRC”, “we” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S federal income tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, we priced our initial public offering, selling 5.68 million shares of our common stock. Concurrent with our initial public offering, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, and Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, collectively purchased an additional 0.6 million shares of our common stock through a private placement transaction exempt from registration under the Securities Act.
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives. Our investment activities are managed by SLR Capital Partners, LLC (the “Investment Adviser”) and supervised by the board of directors (the “Board)”, a majority of whom are
non-interested,
as such term is defined in the 1940 Act. SLR Capital Management, LLC (the “Administrator”) provides the administrative services necessary for us to operate.
In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States.
Merger Agreement
On December 1, 2021, we entered into an Agreement and Plan of Merger, or the Merger Agreement, with SLR Senior Investment Corp., a Maryland corporation (“SUNS”), Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, the Investment Adviser. The Merger Agreement provides that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger,”) and, immediately thereafter, SUNS will merge with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). Both the Board and SUNS’s board of directors, including all of the respective independent directors, in each case, on the recommendation of a special committee comprised solely of the independent directors of us and SUNS, as applicable, have approved the Merger Agreement and the transactions contemplated thereby.
The Merger Agreement contains customary representations and warranties by each of us, SUNS and the Investment Adviser. The Merger Agreement also contains customary covenants, including, among others, covenants relating to the operation of each of our and SUNS’s businesses during the period prior to the closing of the Mergers.
Consummation of the Mergers, which occurred on April 1, 2022, was subject to certain closing conditions as disclosed in the Merger Agreement.
On April 1, 2022, we completed our previously announced acquisition of SUNS. Pursuant to the Merger Agreement, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into us, with us as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
 
40

The Merger is accounted for as an asset acquisition of SLR Senior Investment Corp. by the Company in accordance with the asset acquisition method of accounting as detailed in ASC
805-50,
Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Merger allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Merger. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain
“non-qualifying”
assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Merger. The Merger was considered a
tax-free
reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes.
Letter Agreement
On April 1, 2022, in connection with the consummation of the Mergers, we entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by us to the Investment Adviser pursuant to the Advisory Agreement, resulting in an annual base management fee rate payable by us to the Investment Adviser of 1.50% on gross assets up to 200% of our total net assets. We retained the annual base management fee rate payable by us to the Investment Adviser of 1.00% on gross assets that exceed 200% of our total net assets.
Recent Developments
On October 5, 2022, our Board declared a monthly distribution of $0.136667 per share payable on November 2, 2022 to holders of record as of October 20, 2022.
On October 12, 2022, the Company entered into a joint venture agreement with SunStone Senior Credit L.P. (the “Investor”) to create SLR Senior Lending Program LLC (“SSLP”). The joint venture is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50 million, resulting in a total equity commitment of $100 million. SSLP intends to seek third party financing to allow the joint venture to utilize leverage. The Company and the Investor expect to begin funding SSLP with investments prior to the end of 2022. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On November 2, 2022, our Board declared a monthly distribution of $0.136667 per share payable on December 1, 2022 to holders of record as of November 17, 2022.
The global outbreak of the
COVID-19
pandemic, and the related effect on the U.S. and global economies, has continued to have adverse consequences for the business operations of some of the Company’s portfolio companies and, as a result, has had adverse effects on the Company’s operations. The ultimate economic fallout from the pandemic, and the long-term impact on economies, markets, industries and individual issuers, including the Company, remain uncertain. The operational and financial performance of the issuers of securities in which the Company invests depends on future developments, including the duration and spread of the outbreak, and such uncertainty may in turn adversely affect the value and liquidity of the Company’s investments and negatively impact the Company’s performance.
Investments
Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive environment for the types of investments we make. As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” The definition of “eligible portfolio company” includes certain public companies that do not have any securities listed on a national securities exchange and companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.
Revenue
We generate revenue primarily in the form of interest and dividend income from the securities we hold and capital gains, if any, on investment securities that we may sell. Our debt investments generally have a stated term of three to seven years and typically bear interest at a floating rate usually determined on the basis of a benchmark London interbank offered rate (“LIBOR”), the Secured Overnight Financing Rate (“SOFR”), commercial paper rate, or the prime rate. Interest on our debt investments is generally payable monthly or quarterly but may be
bi-monthly
or semi-annually. In addition, our investments may provide
payment-in-kind
(“PIK”) income. Such amounts of accrued PIK income are added to the cost of the investment on the respective capitalization dates and generally become due at maturity of the investment or upon the investment being called by the issuer. We may also generate revenue in the form of commitment, origination, structuring fees, fees for providing managerial assistance and, if applicable, consulting fees, etc.
 
41

Expenses
All investment professionals of the investment adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Investment Adviser. We bear all other costs and expenses of our operations and
transactions, including (without limitation):
 
 
the cost of our organization and public offerings;
 
 
the cost of calculating our net asset value, including the cost of any third-party valuation services;
 
 
the cost of effecting sales and repurchases of our shares and other securities;
 
 
interest payable on debt, if any, to finance our investments;
 
 
fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;
 
 
transfer agent and custodial fees;
 
 
fees and expenses associated with marketing efforts;
 
 
federal and state registration fees, any stock exchange listing fees;
 
 
federal, state and local taxes;
 
 
independent directors’ fees and expenses;
 
 
brokerage commissions;
 
 
fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;
 
 
direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;
 
 
fees and expenses associated with independent audits and outside legal costs;
 
 
costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and
 
 
all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs.
We expect our general and administrative operating expenses related to our ongoing operations to increase moderately in dollar terms. During periods of asset growth, we generally expect our general and administrative operating expenses to decline as a percentage of our total assets and increase during periods of asset declines. Incentive fees, interest expense and costs relating to future offerings of securities, among others, may also increase or reduce overall operating expenses based on portfolio performance, interest rate benchmarks, and offerings of our securities relative to comparative periods, among other factors.
Portfolio and Investment Activity
During the three months ended September 30, 2022, we invested approximately $245.4 million across 44 portfolio companies. This compares to investing approximately $230.7 million in 23 portfolio companies for the three months ended September 30, 2021. Investments sold, prepaid or repaid during the three months ended September 30, 2022 totaled approximately $81.1 million versus approximately $105.9 million for the three months ended September 30, 2021.
At September 30, 2022, our portfolio consisted of 135 portfolio companies and was invested 30.2% in cash flow senior secured loans, 31.9% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 21.6% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 16.3% in life science senior secured loans, in each case, measured at fair value, versus 106 portfolio companies and was invested 28.4% in cash flow senior secured loans, 26.5% in asset-based senior secured loans / SLR Credit, 30.4% in equipment senior secured financings / SLR Equipment / KBH, and 14.7% in life science senior secured loans, in each case, measured at fair value, at September 30, 2021.
 
42

At September 30, 2022, 79.7% or $1.71 billion of our income producing investment portfolio
*
is floating rate and 20.3% or $434.9 million is fixed rate, measured at fair value. At September 30, 2021, 74.1% or $1.20 billion of our income producing investment portfolio
*
is floating rate and 25.9% or $418.4 million is fixed rate, measured at fair value. As of September 30, 2022 and 2021, we had three and one issuers, respectively, on
non-accrual
status.
 
*
 
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275 million in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400 million at November 30, 2012 and a $275 million committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5.7 million. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of September 30, 2022, total commitments to the revolving credit facility are $250 million.
As of September 30, 2022, SLR Credit had 27 funded commitments to 21 different issuers with total funded loans of approximately $354.9 million on total assets of $375.6 million. As of December 31, 2021, SLR Credit had 22 funded commitments to 19 different issuers with total funded loans of approximately $287.4 million on total assets of $347.8 million. As of September 30, 2022 and December 31, 2021, the largest loan outstanding totaled $34.2 million and $35.0 million, respectively. For the same periods, the average exposure per issuer was $16.9 million and $15.1 million, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $139.5 million and $100.7 million of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Credit had net income of $3.9 million and $5.4 million, respectively, on gross income of $8.6 million and $9.5 million, respectively. For the nine months ended September 30, 2022 and 2021, SLR Credit had net income of $8.6 million and $12.5 million, respectively, on gross income of $22.2 million and $27.2 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us.
SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies is doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209.9 million in cash to effect the transaction, of which $145.0 million was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64.9 million was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150.0 million
non-recourse
facility with an accordion feature to expand up to $250.0 million. In September 2019, SLR Equipment amended the facility, increasing commitments to $214.0 million with an accordion feature to expand up to $314.0 million and extended the maturity date of the facility to July 31, 2023.
As of September 30, 2022, SLR Equipment had 129 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $189.3 million on total assets of $241.2 million. As of December 31, 2021, SLR Equipment had 135 funded equipment-backed leases and loans to 61 different customers with a total net investment in leases and loans of approximately $211.0 million on total assets of $264.0 million. As of September 30, 2022 and December 31, 2021, the largest position outstanding totaled $19.3 million and $19.2 million, respectively. For the same periods, the average exposure per customer was $3.2 million and $3.5 million, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $111.0 million and $118.0 million of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Equipment had net income (loss) of $1.0 million and ($0.3) million, respectively, on gross income of $6.5 million and $5.8 million, respectively. For the nine months ended September 30, 2022 and 2021, SLR Equipment had net loss of $0.1 million and $2.3 million, respectively, on gross income of $15.7 million and $16.4 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us.
 
43

Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a newly formed Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million in KBH’s debt. The existing management team of KBH committed to continue to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of September 30, 2022 and December 31, 2021, KBHT had total assets of $774.6 million and $738.4 million, respectively. For the same periods, debt recourse to KBHT totaled $246.2 million and $216.9 million, respectively, and
non-recourse
debt totaled $316.8 million and $323.8 million, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2022 and 2021, KBHT had net income of $3.3 million and $3.2 million, respectively, on gross income of $71.3 million and $60.5 million, respectively. For the nine months ended September 30, 2022 and 2021, KBHT had net income of $10.4 million and $10.3 million, respectively, on gross income of $215.1 million and $180.1 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32.8 million. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2022, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Merger on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100 million credit facility with
non-affiliates,
which was expandable to $150 million under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105 million and again on June 27, 2014 to $110 million. On May 27, 2016, SLR Healthcare entered into a new $125 million credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200 million and had a maturity date of May 27, 2020. On June 28, 2019, this $125 million facility was amended, extending the maturity date to June 28, 2023.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2022, the portfolio totaled approximately $179.6 million of commitments with a total net investment in loans of $81.4 million on total assets of $93.0 million. As of December 31, 2021, the portfolio totaled approximately $183.5 million of commitments with a total net investment in loans of $81.6 million on total assets of $91.3 million. At September 30, 2022, the portfolio consisted of 37 issuers with an average balance of approximately $2.2 million versus 36 issuers with an average balance of approximately $2.3 million at December 31, 2021. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $62 million and $60 million of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Healthcare had net income (loss) of $0.8 million and ($0.04) million, respectively, on gross income of $3.0 million and $2.6 million, respectively. For the nine months ended September 30, 2022 and 2021, SLR Healthcare had net income of $2.5 million and $0.5 million, respectively, on gross income of $7.9 million and $7.0 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51.0 million to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15.5 million transaction
 
44

was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66.7 million was financed with equity from SUNS of $19.0 million and borrowings on NMC’s credit facility of $47.7 million. SLRC acquired SLR Business Credit in connection with the Merger on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2022, the portfolio totaled approximately $554.2 million of commitments, of which $296.0 million were funded, on total assets of $346.3 million. As of December 31, 2021, the portfolio totaled approximately $513.9 million of commitments, of which $248.7 million were funded, on total assets of $290.8 million. At September 30, 2022, the portfolio consisted of 109 issuers with an average balance of approximately $2.7 million versus 125 issuers with an average balance of approximately $2.0 million at December 31, 2021. NMC has a senior credit facility with a bank lending group for $240 million which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $237.5 million and $183.3 million of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Business Credit had net income of $2.0 million and $2.6 million, respectively, on gross income of $7.6 million and $6.9 million, respectively. For the nine months ended September 30, 2022 and 2021, SLR Business Credit had net income of $5.7 million and $4.7 million, respectively, on gross income of $20.4 million and $16.7 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
Stock Repurchase Program
On May 3, 2022, our Board authorized a program for the purpose of repurchasing up to $50 million of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50 million of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases. As of September 30, 2022, no repurchases have taken place.
Critical Accounting Policies
The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.
Valuation of Portfolio Investments
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with GAAP, and the 1940 Act. Our valuation procedures are set forth in more detail in Note 2(b) to the Company’s Consolidated Financial Statements.
Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.
Revenue Recognition
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Investments that are expected to pay regularly scheduled interest and/or dividends in cash are generally placed on
non-accrual
status when principal or interest/dividend cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest/dividend cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest or dividends are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining interest or dividend obligations. Interest or dividend cash payments received on investments may be recognized as income or applied to principal depending upon management’s judgment. Some of our investments may have contractual PIK income. PIK income computed at the contractual rate, as applicable, is accrued and reflected as
 
45

a receivable up to the capitalization date. PIK investments offer issuers the option at each payment date of making payments in cash or in additional securities. When additional securities are received, they typically have the same terms, including maturity dates and interest rates as the original securities issued. On these payment dates, the Company capitalizes the accrued interest or dividends receivable (reflecting such amounts as the basis in the additional securities received). PIK generally becomes due at the maturity of the investment or upon the investment being called by the issuer. At the point the Company believes PIK is not expected to be realized, the PIK investment will be placed on
non-accrual
status. When a PIK investment is placed on
non-accrual
status, the accrued, uncapitalized interest or dividends is reversed from the related receivable through interest or dividend income, respectively. The Company does not reverse previously capitalized PIK income. Upon capitalization, PIK is subject to the fair value estimates associated with their related investments. PIK investments on
non-accrual
status are restored to accrual status if the Company again believes that PIK is expected to be realized. Loan origination fees, original issue discount, and market discounts are capitalized and amortized into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record prepayment premiums on loans and other investments as interest income when we receive such amounts. Capital structuring fees are recorded as other income when earned.
The typically higher yields and interest rates on PIK securities, to the extent we invested, reflects the payment deferral and increased credit risk associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the
loan-to-value
ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on
non-cash
accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the three and nine months ended September 30, 2022, capitalized PIK income totaled $0.7 million and $1.7 million, respectively. For the three and nine months ended September 30, 2021, capitalized PIK income totaled $1.7 million and $5.0 million, respectively.
Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss
We generally measure realized gain or loss by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation previously recognized, but considering unamortized origination or commitment fees and prepayment penalties. The net change in unrealized gain or loss reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded unrealized gain or loss, when gains or losses are realized. Gains or losses on investments are calculated by using the specific identification method.
Income Taxes
SLRC, a U.S. corporation, has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. In order to qualify for U.S. federal income taxation as a RIC, the Company is required, among other things, to timely distribute to its stockholders at least 90% of investment company taxable income, as defined by the Code, for each year. Depending on the level of taxable income earned in a given tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company accrues an estimated excise tax, if any, on estimated excess taxable income.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU
2020-04
is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures.
RESULTS OF OPERATIONS
Results comparisons are for the three and nine months ended September 30, 2022 and September 30, 2021:
Investment Income
For the three and nine months ended September 30, 2022, gross investment income totaled $47.6 million and $123.4 million, respectively. For the three and nine months ended September 30, 2021, gross investment income totaled $32.2 million and $103.6 million, respectively. The increase in gross investment income for the year over year three and nine month periods was primarily due to a larger portfolio size as a result of the Merger coupled with organic growth, as well as due to an increase in LIBOR and SOFR.
 
46

Expenses
Net expenses totaled $27.5 million and $69.5 million, respectively, for the three and nine months ended September 30, 2022, of which $12.9 million and $31.7 million, respectively, were base management fees and gross performance-based incentive fees and $12.8 million and $31.5 million, respectively, were interest and other credit facility expenses. Over the same periods, $0.2 million and $1.6 million, respectively, of performance-based incentive fees were waived. Administrative services and other general and administrative expenses totaled $2.1 million and $7.9 million, respectively, for the three and nine months ended September 30, 2022. Expenses totaled $17.2 million and $57.6 million, respectively, for the three and nine months ended September 30, 2021, of which $7.8 million and $29.3 million, respectively, were base management fees and performance-based incentive fees and $7.1 million and $21.5 million, respectively, were interest and other credit facility expenses. Administrative services and other general and administrative expenses totaled $2.2 million and $6.8 million, respectively, for the three and nine months ended September 30, 2021. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses, and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The increase in expenses for the year over year three and nine month periods was primarily due to higher interest expense associated with an increase in borrowings to fund new investments as well as the increase in LIBOR and SOFR.
Net Investment Income
The Company’s net investment income totaled $20.1 million and $53.8 million, or $0.37 and $1.06, per average share, respectively, for the three and nine months ended September 30, 2022. The Company’s net investment income totaled $15.0 million and $46.0 million, or $0.36 and $1.09, per average share, respectively, for the three and nine months ended September 30, 2021.
Net Realized Gain (Loss)
The Company had investment sales and prepayments totaling approximately $81 million and $261 million, respectively, for the three and nine months ended September 30, 2022. Net realized losses over the same periods were $37.3 million and $37.4 million, respectively. Net realized losses for the three and nine months ended September 30, 2022 were primarily related to the exit of our investment in PhyMed Management, LLC. The Company had investment sales and prepayments totaling approximately $106 million and $320 million, respectively, for the three and nine months ended September 30, 2021. Net realized gains (losses) over the same periods were ($0.1) million and $0.1 million, respectively. Net realized losses for the three months ended September 30, 2021 were generally related to the exit of our warrant position in Scynexis, Inc. Net realized gains for the nine months ended September 30, 2021 were generally related to the exit of our warrant position in PQ Bypass, Inc., partially offset by losses from the sale of our legacy investment in B. Riley Financial, Inc and exit of our warrant position in Scynexis, Inc.
Net Change in Unrealized Gain (Loss)
For the three and nine months ended September 30, 2022, net change in unrealized gain (loss) on the Company’s assets and liabilities totaled $30.8 million and ($17.1) million, respectively. For the three and nine months ended September 30, 2021, net change in unrealized gain (loss) on the Company’s assets and liabilities totaled ($1.5) million and $7.4 million, respectively. Net unrealized gain for the three months ended September 30, 2022 is primarily due to the reversal of previously recognized unrealized depreciation on our investment in PhyMed Management LLC, as well as appreciation in the value of our investments in SLR Business Credit, Alimera Sciences, Inc. and Kingsbridge Holdings, LLC, among others, partially offset by depreciation in the value of our investments in SLR Equipment Finance, PPT Management Holdings, LLC, KBH Topco, LLC, SLR Healthcare ABL and SLR Credit Solutions, among others. Net unrealized loss for the nine months ended September 30, 2022 is primarily due to depreciation in the value of our investments in RD Holdco, Inc., American Teleconferencing Services, Ltd., SLR Credit Solutions and SLR Equipment Finance, among others, partially offset by the reversal of previously recognized unrealized depreciation on our investment in PhyMed Management LLC as well as appreciation on the value of our investments in SLR Business Credit and Alimera Sciences, Inc. in addition to unrealized appreciation on assets acquired in the Merger due to the accounting treatment of the purchase discount. Net unrealized loss for the three months ended September 30, 2021 is primarily due to depreciation in the value of our investments in American Teleconferencing Services, Ltd., PhyMed Management LLC and Rug Doctor, among others, partially offset by appreciation in the value of our investments in KBH Topco, LLC and SLR Credit Solutions, among others. Net unrealized gain for the nine months ended September 30, 2021 was primarily due to appreciation in the value our investments in KBH Topco, LLC, SLR Credit Solutions, and Senseonics Holdings, Inc., among others, partially offset by depreciation in the value of our investments in American Teleconferencing Services, Ltd., Rug Doctor and SOAGG, LLC, among others.
 
47

Net Increase (Decrease) in Net Assets From Operations
For the three and nine months ended September 30, 2022, the Company had a net increase (decrease) in net assets resulting from operations of $13.5 million and ($0.7) million, respectively. For the same periods, earnings (losses) per average share were $0.25 and ($0.01), respectively. For the three and nine months ended September 30, 2021, the Company had a net increase in net assets resulting from operations of $13.4 million and $53.4 million, respectively. For the same periods, earnings per average share were $0.32 and $1.26, respectively.
LIQUIDITY AND CAPITAL RESOURCES
The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2022 Tranche C Notes, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes, through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic
follow-on
equity and/or debt offerings. As of September 30, 2022, we had a total of $334.8 million of unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.
We may from time to time issue equity and/or debt securities in either public or private offerings. The issuance of such securities will depend on future market conditions, funding needs and other factors and there can be no assurance that any such issuance will occur or be successful. The primary uses of existing funds and any funds raised in the future is expected to be for investments in portfolio companies, repayment of indebtedness, cash distributions to our stockholders, or for other general corporate purposes.
On April 1, 2022, we entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225 million; however, the commitment can also be expanded up to $600 million. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature.
On April 1, 2022, we entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to our assumption of $85 million in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, we expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135 million of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, the Credit Facility is composed of $600 million of revolving credit and $100 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year.
On September 14, 2021, the Company closed a private offering of $50 million of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125 million of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
48

On December 18, 2019, the Company closed a private offering of $75 million of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2017, the Company closed a private offering of $21 million of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75 million in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73.8 million. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023.
On February 15, 2017, the Company closed a private offering of $100 million of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 8, 2016, the Company closed a private offering of $50 million of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity.
On January 11, 2013, the Company closed its most recent
follow-on
public equity offering of 6.3 million shares of common stock raising approximately $146.9 million in net proceeds. The primary uses of the funds raised were for investments in portfolio companies, reductions in revolving debt outstanding and for other general corporate purposes.
Cash Equivalents
We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from
time-to-time
we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose is excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held approximately $269 million in cash equivalents as of September 30, 2022.
Debt
Unsecured Notes
On April 1, 2022, we entered into the Note Assumption Agreement, effective as of the closing of the Mergers. The Note Assumption Agreement relates to our assumption of $85 million of the 2025 Unsecured Notes and other obligations of SUNS under the Note Purchase Agreement, among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, we expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135 million of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50 million of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125 million of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75 million of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
49

On December 28, 2017, the Company closed a private offering of $21 million of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75 million in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73.8 million. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023.
On February 15, 2017, the Company closed a private offering of $100 million of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 8, 2016, the Company closed a private offering of $50 million of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity.
Revolving & Term Loan Facilities
On April 1, 2022, we entered into the CF Assumption Agreement, effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the SPV Credit Facility, by and among SUNS SPV, a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225 million; however, the commitment can also be expanded up to $600 million. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2022, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $130.2 million.
On December 28, 2021, the Company closed on Amendment No. 1 to the Credit Facility. Following the amendment, the Credit Facility is composed of $600 million of revolving credit and $100 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At September 30, 2022, outstanding USD equivalent borrowings under the Credit Facility totaled $460.0 million, composed of $360.0 million of revolving credit and $100.0 million of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. At September 30, 2022, the Company was in compliance with all financial and operational covenants required by the Debt Instruments.
Contractual Obligations
A summary of our significant contractual payment obligations is as follows as of September 30, 2022:
Payments Due by Period (in millions)
 
    
Total
    
Less than
1 Year
    
1-3 Years
    
3-5 Years
    
More Than
5 Years
 
Revolving credit facilities (1)
   $ 490.2      $ —      $ —        $ 490.2      $ —  
Unsecured senior notes
     566.0        96.0      210.0      260.0      —    
Term loans
     100.0        —          —          100.0        —    
 
(1)
As of September 30, 2022, we had a total of $334.8 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.
 
50

Under the provisions of the 1940 Act, we are permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss.
We have also entered into two contracts under which we have future commitments: the Advisory Agreement, pursuant to which the Investment Adviser has agreed to serve as our investment adviser, and the Administration Agreement, pursuant to which the Administrator has agreed to furnish us with the facilities and administrative services necessary to conduct our
day-to-day
operations and provide on our behalf managerial assistance to those portfolio companies to which we are required to provide such assistance. Payments under the Advisory Agreement are equal to (1) a percentage of the value of our average gross assets and (2) a
two-part
incentive fee. Payments under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent, technology systems, insurance and our allocable portion of the costs of our chief financial officer and chief compliance officer and their respective staffs. Either party may terminate each of the Advisory Agreement and administration agreement without penalty upon 60 days’ written notice to the other. See note 3 to our Consolidated Financial Statements.
On July 31, 2017, the Company, NEFPASS LLC and NEFCORP LLC entered into a servicing agreement. NEFCORP LLC was engaged to provide NEFPASS LLC with administrative services related to the loans and capital leases held by NEFPASS LLC. NEFPASS LLC may terminate this agreement upon 30 days’ written notice to NEFCORP LLC.
Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2022 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Credit Facility
                                   
Fiscal 2022 (through September 30, 2022)
   $ 360,000      $ 583                  N/A  
Fiscal 2021
     222,500        552                  N/A  
Fiscal 2020
     126,000        421                  N/A  
Fiscal 2019
     42,900        182                  N/A  
Fiscal 2018
     96,400        593                  N/A  
Fiscal 2017
     245,600        1,225                  N/A  
Fiscal 2016
     115,200        990                  N/A  
Fiscal 2015
     207,900        1,459                  N/A  
Fiscal 2014
                                   N/A  
Fiscal 2013
                                   N/A  
Fiscal 2012
     264,452        1,510                  N/A  
SPV Credit Facility
                                   
Fiscal 2022 (through September 30, 2022)
     130,200        211                  N/A  
2022 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
                                   N/A  
Fiscal 2021
     150,000        372                  N/A  
Fiscal 2020
     150,000        501                  N/A  
Fiscal 2019
     150,000        638                  N/A  
Fiscal 2018
     150,000        923                  N/A  
Fiscal 2017
     150,000        748                  N/A  
Fiscal 2016
     50,000        430                  N/A  
2022 Tranche C Notes
                                   
Fiscal 2022 (through September 30, 2022)
     21,000        34                  N/A  
Fiscal 2021
     21,000        52                  N/A  
Fiscal 2020
     21,000        70                  N/A  
Fiscal 2019
     21,000        89                  N/A  
Fiscal 2018
     21,000        129                  N/A  
Fiscal 2017
     21,000        105                  N/A  
2023 Unsecured Notes
                                   
 
51

Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Fiscal 2022 (through September 30, 2022)
     75,000        121                  N/A  
Fiscal 2021
     75,000        186                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
Fiscal 2018
     75,000        461                  N/A  
Fiscal 2017
     75,000        374                  N/A  
2024 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     125,000        202                  N/A  
Fiscal 2021
     125,000        309                  N/A  
Fiscal 2020
     125,000        417                  N/A  
Fiscal 2019
     125,000        531                  N/A  
2025 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     85,000        137                  N/A  
2026 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     75,000        121                  N/A  
Fiscal 2021
     75,000        186                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
2027 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     50,000        81                  N/A  
Fiscal 2021
     50,000        124                  N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     135,000        218                  N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
                                   N/A  
Fiscal 2016
     100,000        859                $ 1,002  
Fiscal 2015
     100,000        702                  982  
Fiscal 2014
     100,000        2,294                  943  
Fiscal 2013
     100,000        2,411                  934  
Fiscal 2012
     100,000        571                  923  
Senior Secured Notes
                                   
Fiscal 2017
                                   N/A  
Fiscal 2016
     75,000        645                  N/A  
Fiscal 2015
     75,000        527                  N/A  
Fiscal 2014
     75,000        1,721                  N/A  
Fiscal 2013
     75,000        1,808                  N/A  
Fiscal 2012
     75,000        428                  N/A  
Term Loans
                                   
Fiscal 2022 (through September 30, 2022)
     100,000        162                  N/A  
Fiscal 2021
     100,000        248                  N/A  
Fiscal 2020
     75,000        250                  N/A  
Fiscal 2019
     75,000        319                  N/A  
Fiscal 2018
     50,000        308                  N/A  
Fiscal 2017
     50,000        250                  N/A  
Fiscal 2016
     50,000        430                  N/A  
Fiscal 2015
     50,000        351                  N/A  
Fiscal 2014
     50,000        1,147                  N/A  
Fiscal 2013
     50,000        1,206                  N/A  
Fiscal 2012
     50,000        285                  N/A  
NEFPASS Facility
                                   
Fiscal 2021
                                   N/A  
Fiscal 2020
     30,000        100                  N/A  
Fiscal 2019
     30,000        128                  N/A  
Fiscal 2018
     30,000        185                  N/A  
SSLP Facility
                                   
Fiscal 2019
                                   N/A  
Fiscal 2018
     53,785        331                  N/A  
 
52

Total Senior Securities
                                   
Fiscal 2022 (through September 30, 2022)
   $ 1,156,200      $ 1,870                  N/A  
Fiscal 2021
     818,500        2,029                  N/A  
Fiscal 2020
     677,000        2,259                  N/A  
Fiscal 2019
     593,900        2,525                  N/A  
Fiscal 2018
     476,185        2,930                  N/A  
Fiscal 2017
     541,600        2,702                  N/A  
Fiscal 2016
     390,200        3,354                  N/A  
Fiscal 2015
     432,900        3,039                  N/A  
Fiscal 2014
     225,000        5,162                  N/A  
Fiscal 2013
     225,000        5,425                  N/A  
Fiscal 2012
     489,452        2,794                  N/A  
 
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2022, asset coverage was 187.0%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014, 2013 and 2012 periods was $100,175, $98,196, $94,301, $93,392, and $92,302, respectively.
Off-Balance
Sheet Arrangements
From
time-to-time
and in the normal course of business, the Company may make unfunded capital commitments to current or prospective portfolio companies. Typically, the Company may agree to provide delayed-draw term loans or, to a lesser extent, revolving loan or equity commitments. These unfunded capital commitments always take into account the Company’s liquidity and cash available for investment, portfolio and issuer diversification, and other considerations. Accordingly, the Company had the following unfunded capital commitments at September 30, 2022 and December 31, 2021, respectively:
 
    
September 30,
2022
    
December 31,
2021
 
(in millions)
 
SLR Credit Solutions*
   $ 44.3      $ 44.3  
Apeel Technology, Inc.
     32.8        —    
World Insurance Associates, LLC
     25.5        —    
CC SAG Holdings Corp. (Spectrum Automotive)
     24.3        18.8  
Human Interest, Inc.
     20.1        —    
Glooko, Inc.
     17.9        25.1  
Spectrum Pharmaceuticals, Inc.
     12.3        —    
iCIMS, Inc.
     11.6        —    
BridgeBio Pharma, Inc.
     9.0        23.0  
BDG Media, Inc.
     8.6        —    
RSC Acquisition, Inc.
     8.5        —    
Arcutis Biotherapeutics, Inc.
     8.4        43.5  
Atria Wealth Solutions, Inc.
     8.2        3.7  
Ardelyx, Inc.
     7.8        —    
Luxury Asset Capital, LLC
     7.5        —    
OIS Management Services, LLC
     5.2        —    
Vessco Midco Holdings, LLC
     4.1        —    
One Touch Direct, LLC
     4.0        7.2  
Kaseya, Inc.
     3.9        —    
Maurices, Incorporated
     3.9        5.7  
Foundation Consumer Brands, LLC
     3.0        2.3  
Inszone Mid, LLC
     2.8        12.5  
Kid Distro Holdings, LLC
     2.7        2.7  
Plastics Management, LLC
     2.4        —    
Pediatric Home Respiratory Services, LLC
     2.4        —    
Southern Orthodontic Partners Management, LLC
     2.3        —    
Basic Fun, Inc.
     2.2        1.9  
 
53

    
September 30,
2022
    
December 31,
2021
 
(in millions)
 
Copper River Seafoods, Inc.
     2.0        —    
Peter C. Foy & Associates Insurance Services, LLC
     2.0        —    
Orthopedic Care Partners Management, LLC
     1.9        —    
MMIT Holdings, LLC
     1.9        2.0  
SPAR Marketing Force, Inc.
     1.6        —    
Ivy Fertility Services, LLC
     1.6        4.5  
NAC Holdings Corporation
     1.5        4.8  
SLR Healthcare ABL*
     1.4        —    
RxSense Holdings LLC
     1.3        —    
Erie Construction
Mid-west,
LLC
     1.2        —    
Composite Technology Acquisition Corp.
     1.1        —    
Enverus Holdings, Inc.
     1.0        —    
SLR Equipment Finance
     1.0        5.0  
American Teleconferencing Services, Ltd.
     0.9        0.6  
SunMed Group Holdings, LLC
     0.8        0.8  
All State Ag Parts, LLC
     0.7        —    
Ultimate Baked Goods Midco LLC
     0.5        0.8  
BayMark Health Services, Inc.
     0.4        —    
Pinnacle Treatment Centers, Inc.
     0.4        1.4  
GSM Acquisition Corp.
     0.4        —    
High Street Buyer, Inc.
     0.3        —    
Tilley Distribution, Inc.
     0.3        —    
TAUC Management, LLC
     0.3        —    
RQM+ Corp.
     —          3.8  
Rezolute, Inc.
     —          5.7  
SOC Telemed, Inc.
     —          4.4  
Neuronetics, Inc.
     —          2.2  
    
 
 
    
 
 
 
Total Commitments
   $ 310.2      $ 226.7  
    
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare commitments and may cancel them at its discretion.
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
In the normal course of its business, we invest or trade in various financial instruments and may enter into various investment activities with
off-balance
sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of
off-balance
sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.
Distributions
The following table reflects the cash distributions per share on our common stock for the two most recent fiscal years and the current fiscal year to date:
 
Date Declared
  
Record Date
  
Payment Date
  
Amount
 
Fiscal 2022
                  
November 2, 2022
   November 17, 2022    December 1, 2022    $ 0.136667  
October 5, 2022
   October 20, 2022    November 2, 2022      0.136667  
September 2, 2022
   September 20, 2022    October 4, 2022      0.136667  
August 2, 2022
   August 18, 2022    September 1, 2022      0.136667  
July 6, 2022
   July 21, 2022    August 2, 2022      0.136667  
June 3, 2022
   June 23, 2022    July 5, 2022      0.136667  
May 3, 2022
   May 19, 2022    June 2, 2022      0.136667  
April 4, 2022
   April 21, 2022    May 3, 2022      0.136667  
 
54

March 1, 2022
     March 18, 2022        April 1, 2022        0.41  
                      
 
 
 
Total 2022
                     $ 1.503336  
                      
 
 
 
Fiscal 2021
                          
November 3, 2021
     December 16, 2021        January 5, 2022      $ 0.41  
August 3, 2021
     September 23, 2021        October 5, 2021        0.41  
May 5, 2021
     June 23, 2021        July 2, 2021        0.41  
February 24, 2021
     March 18, 2021        April 2, 2021        0.41  
                      
 
 
 
Total 2021
                     $ 1.64  
                      
 
 
 
Fiscal 2020
                          
November 5, 2020
     December 17, 2020        January 5, 2021      $ 0.41  
August 4, 2020
     September 17, 2020        October 2, 2020        0.41  
May 7, 2020
     June 18, 2020        July 2, 2020        0.41  
February 20, 2020
     March 19, 2020        April 3, 2020        0.41  
                      
 
 
 
Total 2020
                     $ 1.64  
                      
 
 
 
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future quarterly distributions, if any, will be determined by the Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or
non-taxable
return of capital, if any, as applicable.
We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (
i.e.
, net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, the Credit Facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a regulated investment company. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual
payment-in-kind
income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a regulated investment company.
With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.
Related Parties
We have entered into a number of business relationships with affiliated or related parties, including the following:
 
   
We have entered into the Advisory Agreement with the Investment Adviser. Mr. Gross, our Chairman,
Co-Chief
Executive Officer and President and Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Peteka, our Chief Financial Officer, Treasurer and Secretary serves as the Chief Financial Officer for the Investment Adviser.
 
   
The Administrator provides us with the office facilities and administrative services necessary to conduct
day-to-day
operations pursuant to our Administration Agreement. We reimburse the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and the compensation of our chief compliance officer, our chief financial officer and their respective staffs.
 
   
We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a
non-exclusive,
royalty-free license to use the licensed marks “SOLAR” and “SLR”.
 
55

The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including
non-traditional
asset-based loans and first lien loans and SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry. In addition, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, and Richard L. Peteka, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC and SLR HC BDC LLC. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or its affiliates may determine that we should invest
side-by-side
with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures. On June 13, 2017, the Adviser received an exemptive order that permits the Company to participate in
negotiated co-investment transactions
with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Order”). If the Company is unable to rely on the Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Adviser.
Related party transactions may occur among us, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment. These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
 
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
We are subject to financial market risks, including changes in interest rates. In addition, U.S. and global capital markets and credit markets have experienced a higher level of stress due to the global
COVID-19
pandemic, which has resulted in an increase in the level of volatility across such markets and a general decline in value of the securities that we hold. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In a low interest rate environment, including a reduction of LIBOR and SOFR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such difference could potentially increase thereby increasing our net investment income. During the nine months ended September 30, 2022, certain investments in our comprehensive investment portfolio had floating interest rates. These floating rate investments were primarily based on floating LIBOR or SOFR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have floors. The Company also has revolving credit facilities that are generally based on floating LIBOR or SOFR. Assuming no changes to our balance sheet as of September 30, 2022 and no new defaults by portfolio companies, a hypothetical one percent decrease in LIBOR and SOFR on our comprehensive floating rate assets and liabilities would decrease our net investment income by eleven cents per average share over the next twelve months. Assuming no changes to our balance sheet as of September 30, 2022 and no new defaults by portfolio companies, a hypothetical one percent increase in LIBOR and SOFR on our comprehensive floating rate assets and liabilities would increase our net investment income by approximately twelve cents per average share over the next twelve months. However, we may hedge against interest rate fluctuations from
time-to-time
by using standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with respect to our portfolio of investments. At September 30, 2022, we have no interest rate hedging instruments outstanding on our balance sheet.
 
Increase (Decrease) in LIBOR and SOFR
     (1.00 %)      1.00
Increase (Decrease) in Net Investment Income Per Share Per Year
     (0.11   $ 0.12  
We may also have exposure to foreign currencies through various investments. These investments are converted into U.S. dollars at the balance sheet date, exposing us to movements in foreign exchange rates. In order to reduce our exposure to fluctuations in foreign exchange rates, we may borrow from
time-to-time
in such currencies under our multi-currency revolving credit facility or enter into forward currency or similar contracts.
 
56

Item 4.
Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
As of September 30, 2022 (the end of the period covered by this report), we, including our
Co-Chief
Executive Officers and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule
13a-15(e)
of the 1934 Act). Based on that evaluation, our management, including the
Co-Chief
Executive Officers and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.
(b) Changes in Internal Controls Over Financial Reporting
Management has not identified any change in the Company’s internal control over financial reporting that occurred during the third quarter of 2022 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
 
Item 1.
Legal Proceedings
Other than as described in Part II, Item. 1 - Legal Proceedings section of our Form
10-Q
for the quarter ended March 31, 2022 (which was filed with the SEC on May 3, 2022), to which there have been no material updates as of the date of this report, we, the Administrator, and the Investment Adviser are not currently subject to any material pending legal proceedings threatened against us. From time to time, we may be a party to certain legal proceedings incidental to the normal course of our business including the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our business, financial condition or results of operations beyond what has been disclosed within these financial statements.
 
Item 1A.
Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the March 1, 2022 filing of our Annual Report on
Form 10-K, which
could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended September 30, 2022 to the risk factors discussed in “Risk Factors” in the March 1, 2022 filing of our Annual Report on Form
10-K.
The Russian invasion of Ukraine may have a material adverse impact on us and our portfolio companies.
On February 24, 2022, the Russian military commenced a full-scale invasion of
Russia’s pre-positioned forces
into Ukraine, which could have a negative impact on the economy and business activity globally (including in the countries in which the Company invests), and therefore could adversely affect the performance of the Company’s investments. Following such invasion, the United States and several European nations announced sanctions against Russia. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to the Company and the performance of its investments or operations, and the ability of the Company to achieve its investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict.
 
57

Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
We did not engage in unregistered sales of securities during the quarter ended September 30, 2022.
 
Item 3.
Defaults Upon Senior Securities
None.
 
Item 4.
Mine Safety Disclosures
Not applicable.
 
Item 5.
Other Information
None.
 
Item 6.
Exhibits
The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:
 
Exhibit
Number
  
Description
  2.1
  
  3.1
  
  3.2
  
  4.1
  
  4.2
  
  4.3
  
10.1
  
10.2
  
10.3
  
10.4
  
10.5
  
10.6
  
23.1
  
31.1
  
31.2
  
 
58

Exhibit
Number
  
Description
  31.3
  
  32.1
  
  32.2
  
  32.3
  
101.INS
  
Inline XBRL Instance Document — the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.*
101.SCH
  
Inline XBRL Taxonomy Extension Schema Document.*
101.CAL
  
Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF
  
Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB
  
Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE
  
Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104
  
Cover Page Interactive Data File — The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
(1)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Pre-Effective
Amendment No. 7 (File
No. 333-148734)
filed on January 7, 2010.
(2)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
(File No
333-148734)
filed on February 9, 2010.
(3)
Previously filed in connection with SLR Senior Investment Corp.’s report on Form
8-K
(File
No. 814-00849)
filed on August 31, 2011.
(4)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 6 (File
No. 333-172968)
filed on November 16, 2012.
(5)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 5 (File
No. 333-194870)
filed on November 22, 2017.
(6)
Previously filed in connection with SLR Senior Investment Corp.’s report on Form
10-Q
(File
No. 814-00849)
filed on May 7, 2020.
(7)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on December 1, 2021.
(8)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on April 1, 2022.
(9)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-Q
filed on May 3, 2022.
*
Filed herewith.
 
59

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on November 2, 2022.
 
SLR INVESTMENT CORP.
By:
 
/
S
/ M
ICHAEL
S. G
ROSS
 
Michael S. Gross
Co-Chief Executive Officer
(Principal Executive Officer)
By:
 
/
S
/ B
RUCE
J. S
POHLER
 
Bruce J. Spohler
Co-Chief Executive Officer
(Principal Executive Officer)
By:
 
/
S
/ R
ICHARD
L. P
ETEKA
 
Richard L. Peteka
Chief Financial Officer
(Principal Financial and Accounting Officer)
 
60
EX-23.1 2 d375653dex231.htm EX-23.1 EX-23.1

Exhibit 23.1

November 2, 2022

SLR Investment Corp.

New York, New York

Re: Registration Statement No. 333-255662

With respect to the subject registration statement, we acknowledge our awareness of the use therein of our report dated November 2, 2022 related to our review of interim financial information. Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/ KPMG LLP

New York, New York

EX-31.1 3 d375653dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael S. Gross, Co-Chief Executive Officer of SLR Investment Corp., certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 2nd day of November, 2022

 

/S/ MICHAEL S. GROSS

Michael S. Gross
EX-31.2 4 d375653dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Bruce J. Spohler, Co-Chief Executive Officer of SLR Investment Corp., certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 2nd day of November, 2022

 

/S/ BRUCE J. SPOHLER

Bruce J. Spohler
EX-31.3 5 d375653dex313.htm EX-31.3 EX-31.3

EXHIBIT 31.3

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Richard L. Peteka, Chief Financial Officer of SLR Investment Corp., certify that:

1. I have reviewed this quarterly report on Form 10-Q of SLR Investment Corp.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated this 2nd day of November, 2022

 

/S/ RICHARD L. PETEKA

Richard L. Peteka
EX-32.1 6 d375653dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, MICHAEL S. GROSS, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

/S/ MICHAEL S. GROSS

Name:   Michael S. Gross
Date:   November 2, 2022
EX-32.2 7 d375653dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION OF CO-CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, BRUCE J. SPOHLER, the Co-Chief Executive Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

 

/S/ BRUCE J. SPOHLER

Name:   Bruce J. Spohler
Date:   November 2, 2022
EX-32.3 8 d375653dex323.htm EX-32.3 EX-32.3

EXHIBIT 32.3

CERTIFICATION OF CHIEF FINANCIAL OFFICER

PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (18 U.S.C. 1350)

In connection with the Quarterly Report on Form 10-Q for the period ended September 30, 2022 (the “Report”) of SLR Investment Corp. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, RICHARD L. PETEKA, the Chief Financial Officer of the Registrant, hereby certify, to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.

 

   

/S/ RICHARD L. PETEKA

Name:   Richard L. Peteka
Date:   November 2, 2022
EX-101.SCH 9 slrc-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Consolidated Statements of Assets And Liabilities link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Consolidated Statements of Changes In Net Assets link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Consolidated Schedule of Investments link:presentationLink link:definitionLink link:calculationLink 1009 - Statement - Consolidated Schedule of Investments (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 999001 - Disclosure - Organization link:presentationLink link:definitionLink link:calculationLink 999002 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 999003 - Disclosure - Agreements link:presentationLink link:definitionLink link:calculationLink 999004 - Disclosure - Net Asset Value Per Share link:presentationLink link:definitionLink link:calculationLink 999005 - Disclosure - Earnings Per Share link:presentationLink link:definitionLink link:calculationLink 999006 - Disclosure - Fair Value link:presentationLink link:definitionLink link:calculationLink 999007 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 999008 - Disclosure - Financial Highlights link:presentationLink link:definitionLink link:calculationLink 999009 - Disclosure - SLR Credit Solutions link:presentationLink link:definitionLink link:calculationLink 999010 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 999011 - Disclosure - SLR Equipment Finance link:presentationLink link:definitionLink link:calculationLink 999012 - Disclosure - Capital Share Transactions link:presentationLink link:definitionLink link:calculationLink 999013 - Disclosure - Kingsbridge Holdings, LLC link:presentationLink link:definitionLink link:calculationLink 999014 - Disclosure - SLR Healthcare ABL link:presentationLink link:definitionLink link:calculationLink 999015 - Disclosure - SLR Business Credit link:presentationLink link:definitionLink link:calculationLink 999016 - Disclosure - Merger with SUNS link:presentationLink link:definitionLink link:calculationLink 999017 - Disclosure - Stock Repurchase Program link:presentationLink link:definitionLink link:calculationLink 999018 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 999019 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 999020 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 999021 - Disclosure - Fair Value (Tables) link:presentationLink link:definitionLink link:calculationLink 999022 - Disclosure - Debt (Tables) link:presentationLink link:definitionLink link:calculationLink 999023 - Disclosure - Financial Highlights (Tables) link:presentationLink link:definitionLink link:calculationLink 999024 - Disclosure - Commitments and Contingencies (Tables) link:presentationLink link:definitionLink link:calculationLink 999025 - Disclosure - Capital Share Transactions (Tables) link:presentationLink link:definitionLink link:calculationLink 999026 - Disclosure - Merger with SUNS (Tables) link:presentationLink link:definitionLink link:calculationLink 999027 - Disclosure - Organization - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999028 - Disclosure - Significant Accounting Policies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999029 - Disclosure - Agreements - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999030 - Disclosure - Net Asset Value Per Share - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999031 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail) link:presentationLink link:definitionLink link:calculationLink 999032 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) link:presentationLink link:definitionLink link:calculationLink 999033 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) link:presentationLink link:definitionLink link:calculationLink 999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) link:presentationLink link:definitionLink link:calculationLink 999035 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) link:presentationLink link:definitionLink link:calculationLink 999037 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 999039 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) link:presentationLink link:definitionLink link:calculationLink 999040 - Disclosure - Debt - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details) link:presentationLink link:definitionLink link:calculationLink 999042 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) link:presentationLink link:definitionLink link:calculationLink 999043 - Disclosure - SLR Credit Solutions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999044 - Disclosure - Commitments and Contingencies - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999045 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) link:presentationLink link:definitionLink link:calculationLink 999046 - Disclosure - SLR Equipment Finance - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999047 - Disclosure - Capital Share Transactions - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999048 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details) link:presentationLink link:definitionLink link:calculationLink 999049 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999050 - Disclosure - SLR Healthcare ABL - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999051 - Disclosure - SLR Business Credit - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999052 - Disclosure - Merger with SUNS - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999053 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail) link:presentationLink link:definitionLink link:calculationLink 999054 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail) link:presentationLink link:definitionLink link:calculationLink 999055 - Disclosure - Stock Repurchase Program - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink 999056 - Disclosure - Subsequent Events - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 10 slrc-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 11 slrc-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 12 slrc-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 13 slrc-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 14 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover Page - shares
9 Months Ended
Sep. 30, 2022
Oct. 31, 2022
Document Information [Line Items]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
Entity Registrant Name SLR INVESTMENT CORP.  
Securities Act File Number 814-00754  
Entity Tax Identification Number 26-1381340  
Trading Symbol SLRC  
Entity Central Index Key 0001418076  
Current Fiscal Year End Date --12-31  
Document Quarterly Report true  
Document Transition Report false  
Entity Current Reporting Status Yes  
Entity Filer Category Large Accelerated Filer  
Entity Interactive Data Current Yes  
City Area Code 212  
Local Phone Number 993-1670  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Address, Address Line One 500 Park Avenue  
Entity Shell Company false  
Title of 12(b) Security Common Stock, par value $0.01 per share  
Security Exchange Name NASDAQ  
Entity Address, State or Province NY  
Entity Address, City or Town New York  
Entity Address, Postal Zip Code 10022  
Entity Incorporation, State or Country Code MD  
Entity Common Stock, Shares Outstanding   54,772,651
XML 15 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Assets And Liabilities - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Investments at fair value:    
Cash $ 7,983 $ 2,935
Cash equivalents (cost: $268,931 and $320,000, respectively) 268,931 320,000
Dividends receivable 11,542 9,028
Interest receivable 9,456 6,521
Receivable for investments sold 1,276 1,378
Prepaid expenses and other assets 886 567
Total assets 2,455,435 2,011,011
Liabilities    
Debt ($1,156,200 and $818,500 face amounts, respectively, reported net of unamortized debt issuance costs/market discount of $7,909 and $6,462, respectively. See notes 6 and 7) 1,148,291 812,038
Payable for investments and cash equivalents purchased 268,952 320,041
Distributions payable 7,486 17,327
Management fee payable (see note 3) 7,890 7,435
Performance-based incentive fee payable (see note 3) 4,771 1,864
Interest payable (see note 7) 7,083 4,492
Administrative services payable (see note 3) 1,293 2,689
Other liabilities and accrued expenses 3,444 2,844
Total liabilities 1,449,210 1,168,730
Commitments and contingencies (see note 10)
Net Assets    
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,772,651 and 42,260,826 shares issued and outstanding, respectively 548 423
Paid-in capital in excess of par 1,163,713 936,999
Accumulated distributable net loss (158,036) (95,141)
Total net assets $ 1,006,225 $ 842,281
Net Asset Value Per Share $ 18.37 $ 19.93
Companies less than 5% owned [Member]    
Investments at fair value:    
Investment Owned, at Fair Value $ 1,368,827 $ 964,379
Companies more than 25% owned [Member]    
Investments at fair value:    
Investment Owned, at Fair Value $ 786,534 $ 706,203
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Assets And Liabilities (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Investment owned, at cost $ 2,467,745 $ 2,016,953
Cash equivalents at cost 268,931 320,000
Debt instrument, face amount 1,156,200 818,500
Debt issuance costs $ 7,909 $ 6,462
Common stock, par or stated value per share $ 0.01 $ 0.01
Common Stock, shares authorized 200,000,000 200,000,000
Common stock, shares, issued 54,772,651 42,260,826
Common stock, shares, outstanding 54,772,651 42,260,826
Companies less than 5% owned [Member]    
Investment owned, at cost $ 1,386,014 $ 985,088
Companies more than 25% owned [Member]    
Investment owned, at cost $ 812,800 $ 711,865
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
INVESTMENT INCOME:        
Total investment income $ 47,567 $ 32,163 $ 123,353 $ 103,622
EXPENSES:        
Management fees (see note 3) 7,890 7,142 22,019 20,842
Performance-based incentive fees (see note 3) 4,965 698 9,699 8,444
Interest and other credit facility expenses (see note 7) 12,784 7,127 31,464 21,502
Administrative services expense (see note 3) 1,132 1,435 3,684 4,170
Other general and administrative expenses 935 755 4,212 2,673
Total expenses 27,706 17,157 71,078 57,631
Performance-based incentive fees waived (see note 3) (194) 0 (1,552) 0
Net expenses 27,512 17,157 69,526 57,631
Net investment income 20,055 15,006 53,827 45,991
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:        
Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned) (37,326) (127) (37,401) 68
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents 30,799 (1,508) (17,081) 7,389
Net realized and unrealized gain (loss) on investments and cash equivalents (6,527) (1,635) (54,482) 7,457
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS $ 13,528 $ 13,371 $ (655) $ 53,448
Earnings Per Share, Basic $ 0.25 $ 0.32 $ (0.01) $ 1.26
Earnings Per Share, Diluted $ 0.25 $ 0.32 $ (0.01) $ 1.26
Companies less than 5% owned [Member]        
INVESTMENT INCOME:        
Interest $ 32,933 $ 19,202 $ 82,450 $ 62,517
Dividends 0 0 0 133
Other income 234 1,044 1,222 3,862
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents 28,783 (6,507) 3,521 1,284
Companies more than 25% owned [Member]        
INVESTMENT INCOME:        
Interest 2,431 2,834 6,914 8,605
Dividends 11,969 9,078 32,767 28,485
Other income 0 5 0 20
Net change in unrealized gain (loss) on investments and cash equivalents:        
Net change in unrealized gain (loss) on investments and cash equivalents $ 2,016 $ 4,999 $ (20,602) $ 6,105
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes In Net Assets - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Increase (decrease) in net assets resulting from operations:        
Net investment income $ 20,055 $ 15,006 $ 53,827 $ 45,991
Net realized gain (loss) (37,326) (127) (37,401) 68
Net change in unrealized gain (loss) 30,799 (1,508) (17,081) 7,389
NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS 13,528 13,371 (655) 53,448
Distributions to stockholders:        
From net investment income (20,055) (17,327) (53,827) (51,981)
From return of capital (2,401) 0 (8,413) 0
Net distributions to stockholders (22,456) (17,327) (62,240) (51,981)
Capital transactions (see note 12):        
Issuance of common stock 0 0 226,839 0
Total increase (decrease) in net assets (8,928) (3,956) 163,944 1,467
Net assets at beginning of period 1,015,153 857,446 842,281 852,023
Net assets at end of period $ 1,006,225 $ 853,490 $ 1,006,225 $ 853,490
Capital stock activity (see note 12):        
Issuance of common stock 0 0 12,511,825 0
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows from Operating Activities    
Net increase (decrease) in net assets resulting from operations $ (655) $ 53,448
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by operating activities:    
Net realized (gain) loss on investments and cash equivalents 37,401 (68)
Net change in unrealized (gain) loss on investments 17,081 (7,389)
(Increase) decrease in operating assets:    
Purchase of investments (406,302) (398,349)
Proceeds from disposition of investments 259,784 321,918
Net accretion of discount on investments (7,760) (4,652)
Capitalization of payment-in-kind income (1,753) (5,000)
Collections of payment-in-kind income 1,112 942
Receivable for investments sold 102 51
Interest receivable (2,935) 838
Dividends receivable (2,514) (1,092)
Prepaid expenses and other assets (319) (40)
Cash acquired in merger 2,313 0
Increase (decrease) in operating liabilities:    
Payable for investments and cash equivalents purchased (51,089) 116,760
Management fee payable 455 607
Performance-based incentive fee payable 2,907 (94)
Administrative services expense payable (1,396) 206
Interest payable 2,591 3,175
Other liabilities and accrued expenses 600 62
Deferred financing costs/market discount 1,631 1,169
Net Cash Provided by (Used in) Operating Activities (148,746) 82,492
Cash Flows from Financing Activities:    
Cash distributions paid (72,081) (51,981)
Proceeds from unsecured borrowings 134,914 49,966
Repayment of unsecured borrowings (150,000) 0
Proceeds from secured borrowings 743,892 457,000
Repayment of secured borrowings (554,000) (466,260)
Net Cash Provided by (Used in) Financing Activities 102,725 (11,275)
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (46,021) 71,217
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD 322,935 388,776
CASH AND CASH EQUIVALENTS AT END OF PERIOD 276,914 459,993
Supplemental disclosure of cash flow information:    
Cash paid for interest 28,873 18,327
Issuance of shares in connection with the Merger [1] $ 226,839 $ 0
[1] On April 1, 2022, in connection with the Merger (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. For further details, refer to Note 16 “Merger with SUNS”.
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows (Parenthetical)
$ in Thousands
Apr. 01, 2022
USD ($)
Statement of Cash Flows [Abstract]  
Noncash or part noncash acquisition, value of assets acquired $ 244,691
Stock issued $ 226,839
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Schedule of Investments - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Schedule of Investments [Line Items]    
Cost $ 2,467,745 $ 2,016,953
Total Investments & Cash Equivalents 2,424,292 1,990,582
Liabilities in Excess of Other Assets (1,418,067) (1,148,301)
Total net assets $ 1,006,225 $ 842,281
Percentage of Total Investments (at fair value) 100.00% 100.00%
Senior Secured Loans  0 134.4% [Member]    
Schedule of Investments [Line Items]    
Cost $ 1,373,866  
Fair Value 1,352,503  
Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost 958,828  
Fair Value 936,888  
Senior Secured Loans  0 134.4% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost 58,863  
Fair Value 59,488  
Senior Secured Loans  0 134.4% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost 11,791  
Fair Value $ 6,450  
Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Interest Rate [1] 11.23%  
Cost $ 344,384  
Fair Value 349,677  
Preferred Equity  3 0.4% [Member]    
Schedule of Investments [Line Items]    
Cost 5,254  
Fair Value 4,176  
Total Investments [Member]    
Schedule of Investments [Line Items]    
Cost 2,198,814 $ 1,696,953 [2]
Fair Value $ 2,155,361 1,670,582 [2]
Senior Secured Loans  0 111.5% [Member]    
Schedule of Investments [Line Items]    
Cost   959,162
Fair Value   939,690
Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   579,211
Fair Value   559,571
Senior Secured Loans  0 111.5% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   58,795
Fair Value   58,889
Senior Secured Loans  0 111.5% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   49,576
Fair Value   48,703
Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Cost   271,580
Fair Value   272,527
Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Cost   292,365
Fair Value   273,795
Preferred Equity  3 0.7% [Member]    
Schedule of Investments [Line Items]    
Cost   6,049
Fair Value   5,630
Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Cost   439,377
Fair Value   $ 451,467
Cash Equivalents  0 38.0% [Member] | U.S. Treasury Bill [Member]    
Schedule of Investments [Line Items]    
Industry   Government
Acquisition Date   Dec. 31, 2021
Maturity Date   Jan. 25, 2022
Par Amount   $ 320,000
Cost   320,000
Fair Value   $ 320,000
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC) [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 18.30% 24.80%
Diversified Financial Services (includes SLR Credit Solutions) [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 21.50% 20.70%
Health Care Providers & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 7.10% 9.60%
Pharmaceuticals [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 8.10% 7.80%
Health Care Equipment & Supplies [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 6.10% 5.00%
Software [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 4.30% 5.00%
Biotechnology [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 2.50% 2.40%
Wireless Telecommunication Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 2.20% 2.20%
Capital Markets [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.60% 1.60%
Personal Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.80% 2.00%
Road & Rail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.70% 1.90%
IT Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 2.00% 1.90%
Insurance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 4.80% 1.60%
Diversified Consumer Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 2.40% 1.80%
Commercial Services & Supplies [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90% 1.60%
Auto Parts & Equipment [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.20% 1.50%
Internet & Catalog Retail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.10% 1.50%
Packaged Foods & Meats [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.20% 1.10%
Life Sciences Tools & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.20% 1.00%
Communications Equipment [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.70% 0.90%
Specialty Retail [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50% 0.70%
Auto Components [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.40% 0.60%
Airlines [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.40% 0.60%
Health Care Technology [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.80% 0.50%
Machinery [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.30%
Metals & Mining [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.30%
Aerospace & Defense [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20% 0.30%
Consumer Finance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10% 0.10%
Air Freight & Logistics [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value)   0.10%
Construction & Engineering [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.10%
Hotels, Restaurants & Leisure [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.30% 0.30%
Oil, Gas & Consumable Fuels [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.10%
Containers & Packaging [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.00%
Energy Equipment & Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00% 0.10%
Building Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90%  
Internet Software Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90%  
Trading Companies and Distributors [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90%  
Leisure Equipment and Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50%  
Professional Services [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00%  
Footwear [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.20%  
Water Utilities [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.10%  
Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Cost $ 263,950  
Fair Value 238,553  
Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Cost 555,744  
Fair Value $ 560,129  
Cash Equivalents  0 26.7% | U.S. Treasury Bill [Member]    
Schedule of Investments [Line Items]    
Acquisition Date Sep. 30, 2022  
Maturity Date Nov. 22, 2022  
Par Amount $ 270,000  
Cost 268,931  
Fair Value $ 268,931  
Thrifts Mortgage Finance [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 1.30%  
Media [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.90%  
Food Products [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.50%  
Transportation Infrastructure [Member]    
Schedule of Investments [Line Items]    
Percentage of Total Investments (at fair value) 0.00%  
Aegis Toxicology Sciences Corporation [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] L+550  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.41%  
Acquisition Date [3] May 07, 2018  
Maturity Date [3] May 09, 2025  
Par Amount [3] $ 17,176  
Cost [3] 16,836  
Fair Value [3] $ 17,176  
Aegis Toxicology Sciences Corporation [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+550
Floor   1.00%
Interest Rate [6]   6.50%
Acquisition Date   May 07, 2018
Maturity Date   May 09, 2025
Par Amount   $ 12,402
Cost   12,283
Fair Value   $ 12,402
All State Ag Parts LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Trading Companies & Distributors  
Spread Above Index [3],[4] S+500  
Floor [3] 1.00%  
Interest Rate [1],[3] 7.84%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Sep. 01, 2026  
Par Amount [3] $ 2,681  
Cost [3] 2,591  
Fair Value [3] $ 2,681  
Alteon Health, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+650
Floor   1.00%
Interest Rate [6]   7.50%
Acquisition Date   Sep. 14, 2018
Maturity Date   Sep. 01, 2023
Par Amount   $ 14,117
Cost   14,079
Fair Value   $ 14,117
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7] Communications Equipment  
Spread Above Index [4],[7] L+650  
Floor [7] 1.00%  
Interest Rate [1],[7] 0.00%  
Acquisition Date [7] May 05, 2016  
Maturity Date [7] Sep. 09, 2021  
Par Amount [7] $ 36,135  
Cost [7] 25,926  
Fair Value [7] $ 0  
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7]   Communications Equipment
Spread Above Index [5],[7]   L+650
Floor [7]   1.00%
Interest Rate [6],[7]   7.50%
Acquisition Date [7]   May 05, 2016
Maturity Date [7]   Sep. 09, 2021
Par Amount [7]   $ 24,822
Cost [7]   24,453
Fair Value [7]   $ 3,345
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7] Communications Equipment  
Spread Above Index [4],[7] L+650  
Floor [7] 1.00%  
Interest Rate [1],[7] 0.00%  
Acquisition Date [7] Sep. 17, 2021  
Maturity Date [7] Dec. 16, 2022  
Par Amount [7] $ 6,581  
Cost [7] 6,426  
Fair Value [7] $ 1,287  
American Teleconferencing Services, Ltd. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7]   Communications Equipment
Spread Above Index [5],[7]   L+650
Floor [7]   1.00%
Interest Rate [6],[7]   7.50%
Acquisition Date [7]   Sep. 17, 2021
Maturity Date [7]   Mar. 31, 2022
Par Amount [7]   $ 4,576
Cost [7]   4,508
Fair Value [7]   $ 4,576
AmeriMark Intermediate Holdings, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [8] Internet & Catalog Retail  
Spread Above Index [4],[8] L+600  
Floor [8] 1.00%  
Interest Rate [1],[8] 11.09%  
Acquisition Date [8] Jul. 28, 2021  
Maturity Date [8] Oct. 15, 2026  
Par Amount [8] $ 24,633  
Cost [8] 24,225  
Fair Value [8] $ 24,141  
AmeriMark Intermediate Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [8]   Internet & Catalog Retail
Spread Above Index [5],[7]   L+600
Floor [8]   1.00%
Interest Rate [6],[8]   7.00%
Acquisition Date [8]   Jul. 28, 2021
Maturity Date [8]   Oct. 15, 2026
Par Amount [8]   $ 25,226
Cost [8]   24,739
Fair Value [8]   $ 24,721
Atria Wealth Solutions, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Diversified Financial Services  
Spread Above Index [4] S+600  
Floor 1.00%  
Interest Rate [1] 8.79%  
Acquisition Date Sep. 14, 2018  
Maturity Date Feb. 29, 2024  
Par Amount $ 10,674  
Cost 10,617  
Fair Value $ 10,674  
Atria Wealth Solutions, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Diversified Financial Services
Spread Above Index [5]   L+600
Floor   1.00%
Interest Rate [6]   7.00%
Acquisition Date   Sep. 14, 2018
Maturity Date   Nov. 30, 2022
Par Amount   $ 6,345
Cost   6,329
Fair Value   $ 6,345
Basic Fun, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Specialty Retail  
Spread Above Index [4] L+550  
Floor 1.00%  
Interest Rate [1] 8.59%  
Acquisition Date Oct. 30, 2020  
Maturity Date Oct. 30, 2023  
Par Amount $ 2,687  
Cost 2,675  
Fair Value $ 2,687  
Basic Fun, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Specialty Retail
Spread Above Index [5]   L+550
Floor   1.00%
Interest Rate [6]   6.50%
Acquisition Date   Oct. 30, 2020
Maturity Date   Oct. 30, 2023
Par Amount   $ 2,902
Cost   2,871
Fair Value   $ 2,902
BayMark Health Services Inc [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] L+500  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.12%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Jun. 11, 2027  
Par Amount [3] $ 12,455  
Cost [3] 11,968  
Fair Value [3] $ 12,455  
CC SAG Holdings Corp. (Spectrum Automotive) [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Diversified Consumer Services  
Spread Above Index [3],[4] L+575  
Floor [3] 0.75%  
Interest Rate [1],[3] 9.42%  
Acquisition Date [3] Jun. 29, 2021  
Maturity Date [3] Jun. 29, 2028  
Par Amount [3] $ 16,794  
Cost [3] 16,468  
Fair Value [3] $ 16,794  
CC SAG Holdings Corp. (Spectrum Automotive) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Diversified Consumer Services
Spread Above Index [5]   L+575
Floor   0.75%
Interest Rate [6]   6.50%
Acquisition Date   Jun. 29, 2021
Maturity Date   Jun. 29, 2028
Par Amount   $ 12,168
Cost   11,995
Fair Value   $ 12,168
Community Brands ParentCo, LLC (fka Ministry Brands) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Software
Spread Above Index [5]   L+400
Floor   1.00%
Interest Rate [6]   5.00%
Acquisition Date   Jul. 30, 2021
Maturity Date   Dec. 02, 2022
Par Amount   $ 34,901
Cost   34,538
Fair Value   $ 34,901
Enhanced Permanent Capital, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [9] Capital Markets  
Spread Above Index [4],[9] L+700  
Floor [9] 1.00%  
Interest Rate [1],[9] 8.72%  
Acquisition Date [9] Dec. 29, 2020  
Maturity Date [9] Dec. 29, 2025  
Par Amount [9] $ 35,205  
Cost [9] 34,444  
Fair Value [9] $ 35,205  
Enhanced Permanent Capital, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Capital Markets
Spread Above Index [5],[10]   L+700
Floor [10]   1.00%
Interest Rate [6],[10]   8.00%
Acquisition Date [10]   Dec. 29, 2020
Maturity Date [10]   Dec. 29, 2025
Par Amount [10]   $ 26,061
Cost [10]   25,418
Fair Value [10]   $ 26,061
Foundation Consumer Brands, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Personal Products  
Spread Above Index [3],[4] L+550  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.43%  
Acquisition Date [3] Feb. 12, 2021  
Maturity Date [3] Feb. 12, 2027  
Par Amount [3] $ 39,038  
Cost [3] 38,070  
Fair Value [3] $ 39,038  
Foundation Consumer Brands, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Personal Products
Spread Above Index [5]   L+638
Floor   1.00%
Interest Rate [6]   7.38%
Acquisition Date   Feb. 12, 2021
Maturity Date   Feb. 12, 2027
Par Amount   $ 33,367
Cost   32,633
Fair Value   $ 33,367
iCIMS, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Software  
Spread Above Index [4] S+675  
Floor 0.75%  
Interest Rate [1] 9.49%  
Acquisition Date Aug. 18, 2022  
Maturity Date Aug. 18, 2028  
Par Amount $ 32,084  
Cost 31,530  
Fair Value $ 31,522  
iCIMS, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Software
Spread Above Index [5]   L+650
Floor   1.00%
Interest Rate [6]   7.50%
Acquisition Date   Sep. 07, 2018
Maturity Date   Sep. 12, 2024
Par Amount   $ 19,341
Cost   19,120
Fair Value   $ 19,341
Inszone Mid, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Insurance  
Spread Above Index [4] L+575  
Floor 1.00%  
Interest Rate [1] 8.23%  
Acquisition Date Sep. 28, 2021  
Maturity Date Jun. 30, 2026  
Par Amount $ 20,670  
Cost 20,487  
Fair Value $ 20,670  
Inszone Mid, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Insurance
Spread Above Index [5]   L+575
Floor   1.00%
Interest Rate [6]   6.75%
Acquisition Date   Sep. 28, 2021
Maturity Date   Jun. 30, 2026
Par Amount   $ 11,141
Cost   11,035
Fair Value   $ 11,086
Ivy Fertility Services, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] L+625  
Floor 1.00%  
Interest Rate [1] 8.80%  
Acquisition Date Dec. 22, 2021  
Maturity Date Feb. 25, 2026  
Par Amount $ 33,176  
Cost 32,406  
Fair Value $ 33,176  
Ivy Fertility Services, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+625
Floor   1.00%
Interest Rate [6]   7.25%
Acquisition Date   Dec. 22, 2021
Maturity Date   Feb. 25, 2026
Par Amount   $ 21,677
Cost   21,299
Fair Value   $ 21,298
Kid Distro Holdings, LLC (Distro Kid) [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Software  
Spread Above Index [4] L+575  
Floor 1.00%  
Interest Rate [1] 8.63%  
Acquisition Date Sep. 24, 2021  
Maturity Date Oct. 01, 2027  
Par Amount $ 29,519  
Cost 29,010  
Fair Value $ 29,519  
Kid Distro Holdings, LLC (Distro Kid) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Software
Spread Above Index [5]   L+600
Floor   1.00%
Interest Rate [6]   7.00%
Acquisition Date   Sep. 24, 2021
Maturity Date   Oct. 01, 2027
Par Amount   $ 29,743
Cost   29,168
Fair Value   $ 29,148
Kingsbridge Holdings, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [11] Multi-Sector Holdings  
Spread Above Index [4],[11] L+700  
Floor [11] 1.00%  
Interest Rate [1],[11] 9.29%  
Acquisition Date [11] Dec. 21, 2018  
Maturity Date [11] Dec. 21, 2024  
Par Amount [11] $ 80,000  
Cost [11] 79,778  
Fair Value [11] $ 80,000  
Kingsbridge Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [12]   Multi-Sector Holdings
Spread Above Index [5],[12]   L+700
Floor [12]   1.00%
Interest Rate [6],[12]   8.00%
Acquisition Date [12]   Dec. 21, 2018
Maturity Date [12]   Dec. 21, 2024
Par Amount [12]   $ 80,000
Cost [12]   79,713
Fair Value [12]   $ 80,000
KORE Wireless Group, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Wireless Telecommunication Services  
Spread Above Index [3],[4] L+550  
Floor [3] 0.00%  
Interest Rate [1],[3] 9.17%  
Acquisition Date [3] Dec. 21, 2018  
Maturity Date [3] Dec. 21, 2024  
Par Amount [3] $ 47,899  
Cost [3] 47,169  
Fair Value [3] $ 47,899  
KORE Wireless Group, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Wireless Telecommunication Services
Spread Above Index [5],[10]   L+550
Floor [10]   0.00%
Interest Rate [6],[10]   5.72%
Acquisition Date [10]   Dec. 21, 2018
Maturity Date [10]   Dec. 21, 2024
Par Amount [10]   $ 36,470
Cost [10]   36,062
Fair Value [10]   $ 36,470
Logix Holding Company, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Communications Equipment  
Spread Above Index [3],[4] L+575  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.87%  
Acquisition Date [3] Sep. 14, 2018  
Maturity Date [3] Dec. 22, 2024  
Par Amount [3] $ 14,009  
Cost [3] 13,159  
Fair Value [3] $ 13,449  
Logix Holding Company, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Communications Equipment
Spread Above Index [5]   L+575
Floor   1.00%
Interest Rate [6]   6.75%
Acquisition Date   Sep. 14, 2018
Maturity Date   Dec. 22, 2024
Par Amount   $ 7,400
Cost   7,359
Fair Value   $ 7,178
Maurices, Incorporated [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Specialty Retail  
Spread Above Index [3],[4] L+675  
Floor [3] 1.00%  
Interest Rate [1],[3] 9.38%  
Acquisition Date [3] Aug. 27, 2021  
Maturity Date [3] Jun. 01, 2024  
Par Amount [3] $ 8,914  
Cost [3] 8,746  
Fair Value [3] $ 8,914  
Maurices, Incorporated [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Specialty Retail
Spread Above Index [5]   L+675
Floor   1.00%
Interest Rate [6]   7.75%
Acquisition Date   Aug. 27, 2021
Maturity Date   Jun. 01, 2024
Par Amount   $ 5,135
Cost   5,044
Fair Value   $ 5,135
MMIT Holdings, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry IT Services  
Spread Above Index [4] L+625  
Floor 1.00%  
Interest Rate [1] 9.50%  
Acquisition Date Sep. 21, 2021  
Maturity Date Sep. 15, 2027  
Par Amount $ 30,909  
Cost 30,477  
Fair Value $ 30,909  
MMIT Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   IT Services
Spread Above Index [5]   L+625
Floor   1.00%
Interest Rate [6]   7.25%
Acquisition Date   Sep. 21, 2021
Maturity Date   Sep. 15, 2027
Par Amount   $ 31,026
Cost   30,541
Fair Value   $ 31,026
NAC Holdings Corporation (Jaguar) [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] L+525  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.23%  
Acquisition Date [3] Jul. 30, 2021  
Maturity Date [3] Sep. 28, 2024  
Par Amount [3] $ 28,675  
Cost [3] 28,234  
Fair Value [3] $ 28,675  
NAC Holdings Corporation (Jaguar) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Insurance
Spread Above Index [5]   L+525
Floor   1.00%
Interest Rate [6]   6.25%
Acquisition Date   Jul. 30, 2021
Maturity Date   Sep. 28, 2024
Par Amount   $ 15,924
Cost   15,730
Fair Value   $ 15,844
One Touch Direct, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Commercial Services & Supplies  
Spread Above Index [4] P+75  
Floor 0.00%  
Interest Rate [1] 7.00%  
Acquisition Date Apr. 03, 2020  
Maturity Date Mar. 30, 2024  
Par Amount $ 3,487  
Cost 3,487  
Fair Value $ 3,487  
One Touch Direct, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Commercial Services & Supplies
Spread Above Index [5]   P+75
Floor   0.00%
Interest Rate [6]   4.00%
Acquisition Date   Apr. 03, 2020
Maturity Date   Sep. 30, 2022
Par Amount   $ 274
Cost   274
Fair Value   $ 274
PhyNet Dermatology LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4],[13] L+600  
Floor 1.00%  
Interest Rate [1] 8.85%  
Acquisition Date Sep. 05, 2018  
Maturity Date Aug. 16, 2024  
Par Amount $ 14,498  
Cost 14,454  
Fair Value $ 14,498  
PhyNet Dermatology LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5],[13]   L+600
Floor   1.00%
Interest Rate [6]   7.00%
Acquisition Date   Sep. 05, 2018
Maturity Date   Aug. 16, 2024
Par Amount   $ 14,589
Cost   14,529
Fair Value   $ 14,589
Pinnacle Treatment Centers, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] L+575  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.00%  
Acquisition Date [3] Jan. 22, 2020  
Maturity Date [3] Dec. 31, 2022  
Par Amount [3] $ 16,289  
Cost [3] 16,223  
Fair Value [3] $ 16,289  
Pinnacle Treatment Centers, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+575
Floor   1.00%
Interest Rate [6]   6.75%
Acquisition Date   Jan. 22, 2020
Maturity Date   Dec. 31, 2022
Par Amount   $ 11,996
Cost   11,953
Fair Value   $ 11,996
PPT Management Holdings, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4],[14] L+850  
Floor [3] 1.00%  
Interest Rate [1],[3] 10.78%  
Acquisition Date [3] Sep. 14, 2018  
Maturity Date [3] Dec. 16, 2022  
Par Amount [3] $ 30,515  
Cost [3] 30,000  
Fair Value [3] $ 24,503  
PPT Management Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5],[15]   L+800
Floor   1.00%
Interest Rate [6]   9.00%
Acquisition Date   Sep. 14, 2018
Maturity Date   Dec. 16, 2022
Par Amount   $ 21,120
Cost   21,086
Fair Value   $ 18,374
RQM+ Corp. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Life Sciences Tools & Services  
Spread Above Index [3],[4] L+575  
Floor [3] 1.00%  
Interest Rate [1],[3] 9.31%  
Acquisition Date [3] Aug. 20, 2021  
Maturity Date [3] Aug. 12, 2026  
Par Amount [3] $ 26,890  
Cost [3] 26,501  
Fair Value [3] $ 26,890  
RQM+ Corp. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Life Sciences Tools & Services
Spread Above Index [5]   L+575
Floor   1.00%
Interest Rate [6]   6.75%
Acquisition Date   Aug. 20, 2021
Maturity Date   Aug. 12, 2026
Par Amount   $ 16,504
Cost   16,349
Fair Value   $ 16,462
Stryten Energy LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Auto Parts & Equipment
Spread Above Index [5]   L+800
Floor   1.00%
Interest Rate [6]   9.00%
Acquisition Date   Aug. 11, 2021
Maturity Date   Oct. 12, 2026
Par Amount   $ 26,184
Cost   25,676
Fair Value   $ 25,923
SunMed Group Holdings, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Equipment & Supplies  
Spread Above Index [3],[4] L+575  
Floor [3] 0.75%  
Interest Rate [1],[3] 8.82%  
Acquisition Date [3] Jun. 16, 2021  
Maturity Date [3] Jun. 16, 2028  
Par Amount [3] $ 25,014  
Cost [3] 24,487  
Fair Value [3] $ 25,014  
SunMed Group Holdings, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [5]   L+575
Floor   0.75%
Interest Rate [6]   6.50%
Acquisition Date   Jun. 16, 2021
Maturity Date   Jun. 16, 2028
Par Amount   $ 18,536
Cost   18,232
Fair Value   $ 18,351
Ultimate Baked Goods Midco LLC (Rise Baking) [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Packaged Foods & Meats  
Spread Above Index [3],[4] L+650  
Floor [3] 1.00%  
Interest Rate [1],[3] 10.17%  
Acquisition Date [3] Aug. 12, 2021  
Maturity Date [3] Aug. 13, 2027  
Par Amount [3] $ 26,136  
Cost [3] 25,322  
Fair Value [3] $ 25,874  
Ultimate Baked Goods Midco LLC (Rise Baking) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Packaged Foods & Meats
Spread Above Index [5]   L+625
Floor   1.00%
Interest Rate [6]   7.25%
Acquisition Date   Aug. 12, 2021
Maturity Date   Aug. 13, 2027
Par Amount   $ 19,381
Cost   18,920
Fair Value   $ 18,896
USR Parent, Inc. (Staples) [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Specialty Retail
Spread Above Index [5]   L+884
Floor   1.00%
Interest Rate [6]   9.84%
Acquisition Date   Jun. 03, 2020
Maturity Date   Sep. 12, 2022
Par Amount   $ 3,275
Cost   3,275
Fair Value   $ 3,275
ACRES Commercial Mortgage, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Diversified Financial Services  
Spread Above Index [4] S+705  
Floor 1.00%  
Interest Rate [1] 9.82%  
Acquisition Date Dec. 24, 2021  
Maturity Date Aug. 21, 2028  
Par Amount $ 29,925  
Cost 29,380  
Fair Value $ 29,925  
ACRES Commercial Mortgage, LLC [Member] | Senior Secured Loans  0 111.5% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Diversified Financial Services
Spread Above Index [5]   L+705
Floor   1.00%
Interest Rate [6]   8.05%
Acquisition Date   Dec. 24, 2021
Maturity Date   Aug. 21, 2028
Par Amount   $ 29,925
Cost   29,328
Fair Value   $ 29,326
Varilease Finance, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Multi-Sector Holdings  
Spread Above Index [4] L+750  
Floor 1.00%  
Interest Rate [1] 9.79%  
Acquisition Date Aug. 22, 2014  
Maturity Date Nov. 15, 2025  
Par Amount $ 29,563  
Cost 29,483  
Fair Value $ 29,563  
Varilease Finance, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | Second Lien Asset-Based Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Multi-Sector Holdings
Spread Above Index [5]   L+750
Floor   1.00%
Interest Rate [6]   8.50%
Acquisition Date   Aug. 22, 2014
Maturity Date   Nov. 15, 2025
Par Amount   $ 29,563
Cost   29,467
Fair Value   $ 29,563
PhyMed Management LLC [Member] | Senior Secured Loans  0 111.5% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5],[16]   L+1500
Floor   1.00%
Interest Rate [6]   16.00%
Acquisition Date   Dec. 18, 2015
Maturity Date   Sep. 30, 2022
Par Amount   $ 37,819
Cost   37,757
Fair Value   $ 36,874
Rug Doctor LLC [Member] | Senior Secured Loans  0 111.5% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [12]   Diversified Consumer Services
Spread Above Index [5],[12],[14]   L+975
Floor [12]   1.50%
Interest Rate [6],[12]   11.25%
Acquisition Date [12]   Dec. 23, 2013
Maturity Date [12]   May 16, 2023
Par Amount [12]   $ 11,828
Cost [12]   11,819
Fair Value [12]   $ 11,829
Alimera Sciences, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Pharmaceuticals  
Spread Above Index [3],[4] L+765  
Floor [3] 1.78%  
Interest Rate [1],[3] 10.28%  
Acquisition Date [3] Dec. 31, 2019  
Maturity Date [3] Jul. 01, 2024  
Par Amount [3] $ 23,159  
Cost [3] 23,823  
Fair Value [3] $ 26,280  
Alimera Sciences, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+765
Floor   1.78%
Interest Rate [6]   9.43%
Acquisition Date   Dec. 31, 2019
Maturity Date   Jul. 01, 2024
Par Amount   $ 20,074
Cost   20,512
Fair Value   $ 20,475
Arcutis Biotherapeutics, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [9] Pharamceuticals  
Spread Above Index [4],[9] L+745  
Floor [9] 0.10%  
Interest Rate [1],[9] 10.08%  
Acquisition Date [9] Dec. 22, 2021  
Maturity Date [9] Jan. 01, 2027  
Par Amount [9] $ 66,849  
Cost [9] 66,803  
Fair Value [9] $ 67,518  
Arcutis Biotherapeutics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Pharamceuticals
Spread Above Index [5],[10]   L+745
Floor [10]   0.10%
Interest Rate [6],[10]   7.55%
Acquisition Date [10]   Dec. 22, 2021
Maturity Date [10]   Jan. 01, 2027
Par Amount [10]   $ 21,735
Cost [10]   21,645
Fair Value [10]   $ 21,637
Ardelyx, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Pharmaceuticals  
Spread Above Index [4] L+795  
Floor 0.10%  
Interest Rate [1] 10.58%  
Acquisition Date Feb. 23, 2022  
Maturity Date Mar. 01, 2027  
Par Amount $ 9,475  
Cost 9,407  
Fair Value $ 9,475  
Ardelyx, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+745
Floor   0.25%
Interest Rate [6]   7.70%
Acquisition Date   May 10, 2018
Maturity Date   Nov. 01, 2022
Par Amount   $ 14,972
Cost   16,198
Fair Value   $ 16,170
Axcella Health Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Pharmaceuticals  
Spread Above Index [4] L+860  
Floor 0.10%  
Acquisition Date Sep. 02, 2021  
Maturity Date Sep. 01, 2026  
Par Amount $ 7,137  
Cost 7,236  
Fair Value $ 7,262  
Axcella Health Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+860
Floor   0.10%
Interest Rate [6]   8.70%
Acquisition Date   Sep. 02, 2021
Maturity Date   Sep. 01, 2026
Par Amount   $ 9,278
Cost   9,318
Fair Value   $ 9,302
BridgeBio Pharma, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [9] Biotechnology  
Spread Above Index [4],[9] 0  
Floor [9] 0.00%  
Interest Rate [1],[9] 9.00%  
Acquisition Date [9] Nov. 17, 2021  
Maturity Date [9] Nov. 17, 2026  
Par Amount [9] $ 39,530  
Cost [9] 38,954  
Fair Value [9] $ 39,184  
BridgeBio Pharma, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Biotechnology
Spread Above Index [5],[10]   0
Floor [10]   0.00%
Interest Rate [6],[10]   9.00%
Acquisition Date [10]   Nov. 17, 2021
Maturity Date [10]   Nov. 17, 2026
Par Amount [10]   $ 34,574
Cost [10]   34,082
Fair Value [10]   $ 34,055
Centrexion Therapeutics, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Pharmaceuticals  
Spread Above Index [4] L+725  
Floor 2.45%  
Interest Rate [1] 9.88%  
Acquisition Date Jun. 28, 2019  
Maturity Date Jan. 01, 2024  
Par Amount $ 14,578  
Cost 15,043  
Fair Value $ 15,015  
Centrexion Therapeutics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+725
Floor   2.45%
Interest Rate [6]   9.70%
Acquisition Date   Jun. 28, 2019
Maturity Date   Jan. 01, 2024
Par Amount   $ 16,400
Cost   16,693
Fair Value   $ 16,728
Cerapedics, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Equipment & Supplies  
Spread Above Index [3],[4] L+695  
Floor [3] 2.50%  
Interest Rate [1],[3] 9.58%  
Acquisition Date [3] Mar. 22, 2019  
Maturity Date [3] Mar. 01, 2025  
Par Amount [3] $ 30,982  
Cost [3] 32,059  
Fair Value [3] $ 33,151  
Cerapedics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [5]   L+695
Floor   2.50%
Interest Rate [6]   9.45%
Acquisition Date   Mar. 22, 2019
Maturity Date   Mar. 01, 2025
Par Amount   $ 26,861
Cost   27,518
Fair Value   $ 27,465
Delphinus Medical Technologies, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [5]   L+850
Floor   1.00%
Interest Rate [6]   9.50%
Acquisition Date   Aug. 18, 2017
Maturity Date   Jun. 01, 2022
Par Amount   $ 1,089
Cost   1,414
Fair Value   $ 1,405
Delphinus Medical Technologies, Inc. [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Health Care Equipment & Supplies  
Glooko, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Technology  
Spread Above Index [3],[4] L+790  
Floor [3] 0.10%  
Interest Rate [1],[3] 10.53%  
Acquisition Date [3] Sep. 30, 2021  
Maturity Date [3] Oct. 01, 2026  
Par Amount [3] $ 15,883  
Cost [3] 15,830  
Fair Value [3] $ 15,903  
Glooko, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Technology
Spread Above Index [5]   L+790
Floor   0.10%
Interest Rate [6]   8.00%
Acquisition Date   Sep. 30, 2021
Maturity Date   Oct. 01, 2026
Par Amount   $ 8,364
Cost   8,339
Fair Value   $ 8,322
Neuronetics, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Equipment & Supplies  
Spread Above Index [3],[4] L+765  
Floor [3] 1.66%  
Interest Rate [1],[3] 10.28%  
Acquisition Date [3] Mar. 02, 2020  
Maturity Date [3] Feb. 28, 2025  
Par Amount [3] $ 18,012  
Cost [3] 18,387  
Fair Value [3] $ 18,463  
Neuronetics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Equipment & Supplies
Spread Above Index [5]   L+765
Floor   1.66%
Interest Rate [6]   9.31%
Acquisition Date   Mar. 02, 2020
Maturity Date   Feb. 28, 2025
Par Amount   $ 15,613
Cost   15,874
Fair Value   $ 15,878
OmniGuide Holdings, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [18] Health Care Equipment & Supplies  
Spread Above Index [4],[18] L+1405  
Floor 0.10%  
Interest Rate [1],[18] 16.68%  
Acquisition Date [18] Jul. 30, 2018  
Maturity Date [18] Jul. 01, 2023  
Par Amount [18] $ 18,879  
Cost [18] 18,413  
Fair Value [18] $ 19,314  
OmniGuide Holdings, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [18]   Health Care Equipment & Supplies
Spread Above Index [5],[18]   L+1405
Floor [18]   0.10%
Interest Rate [6],[18]   14.15%
Acquisition Date [18]   Jul. 30, 2018
Maturity Date [18]   Jul. 01, 2023
Par Amount [18]   $ 18,879
Cost [18]   17,845
Fair Value [18]   $ 18,958
Rezolute, Inc [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Biotechnology
Spread Above Index [5]   L+875
Floor   0.12%
Interest Rate [6]   8.87%
Acquisition Date   Apr. 14, 2021
Maturity Date   Apr. 01, 2026
Par Amount   $ 5,675
Cost   5,663
Fair Value   $ 5,661
Rubius Therapeutics, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Pharmaceuticals  
Spread Above Index [3],[4] L+550  
Floor [3] 2.10%  
Interest Rate [1],[3] 8.13%  
Acquisition Date [3] Dec. 21, 2018  
Maturity Date [3] Jun. 01, 2026  
Par Amount [3] $ 46,473  
Cost [3] 47,552  
Fair Value [3] $ 46,783  
Rubius Therapeutics, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [10]   Pharmaceuticals
Spread Above Index [5],[10]   L+550
Floor [10]   2.10%
Interest Rate [6],[10]   7.60%
Acquisition Date [10]   Dec. 21, 2018
Maturity Date [10]   Jun. 01, 2026
Par Amount [10]   $ 40,291
Cost [10]   41,103
Fair Value [10]   $ 41,097
scPharmaceuticals, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Pharmaceuticals  
Spread Above Index [3],[4] L+795  
Floor [3] 2.23%  
Interest Rate [1],[3] 10.58%  
Acquisition Date [3] Sep. 17, 2019  
Maturity Date [3] Sep. 17, 2023  
Par Amount [3] $ 2,701  
Cost [3] 2,787  
Fair Value [3] $ 2,848  
scPharmaceuticals, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Pharmaceuticals
Spread Above Index [5]   L+795
Floor   2.23%
Interest Rate [6]   10.18%
Acquisition Date   Sep. 17, 2019
Maturity Date   Sep. 17, 2023
Par Amount   $ 4,098
Cost   4,165
Fair Value   $ 4,160
SOC Telemed, Inc. [Member] | Senior Secured Loans  0 111.5% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry   Health Care Providers & Services
Spread Above Index [5]   L+747
Floor   0.13%
Interest Rate [6]   7.60%
Acquisition Date   Mar. 26, 2021
Maturity Date   Apr. 01, 2026
Par Amount   $ 31,137
Cost   31,211
Fair Value   $ 31,214
Vapotherm, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Equipment & Supplies  
Spread Above Index [4] S+830  
Floor 1.00%  
Interest Rate [1] 10.93%  
Acquisition Date Feb. 18, 2022  
Maturity Date Feb. 01, 2027  
Par Amount $ 34,455  
Cost 34,104  
Fair Value $ 34,455  
Aero Operating LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Acquisition Date [19]   Feb. 12, 2021
Par Amount [19]   $ 3,103
Cost [19]   3,100
Fair Value [19]   $ 3,100
Aero Operating LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.47%
Maturity Date [19]   Dec. 01, 2026
Aero Operating LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.64%
Maturity Date [19]   Mar. 01, 2025
Aero Operating LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Acquisition Date [19] Feb. 12, 2021  
Par Amount [19] $ 2,392  
Cost [19] 2,389  
Fair Value [19] $ 2,389  
Aero Operating LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 9.64%  
Maturity Date [19] Dec. 01, 2026  
Aero Operating LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.47%  
Maturity Date [19] Mar. 01, 2025  
Air Methods Corporation [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Airlines
Acquisition Date [19]   Nov. 03, 2021
Par Amount [19]   $ 4,063
Cost [19]   4,145
Fair Value [19]   $ 4,063
Air Methods Corporation [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   7.08%
Maturity Date [19]   Nov. 23, 2026
Air Methods Corporation [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   7.13%
Maturity Date [19]   Nov. 03, 2026
Air Methods Corporation [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Airlines  
Acquisition Date [19] Nov. 03, 2021  
Par Amount [19] $ 3,719  
Cost [19] 3,784  
Fair Value [19] $ 3,719  
Air Methods Corporation [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 7.13%  
Maturity Date [19] Nov. 23, 2026  
Air Methods Corporation [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 7.08%  
Maturity Date [19] Nov. 03, 2026  
AmeraMex International, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Interest Rate [6],[19]   10.00%
Acquisition Date [19]   Mar. 29, 2019
Maturity Date [19]   Mar. 28, 2022
Par Amount [19]   $ 3,149
Cost [19]   3,148
Fair Value [19]   $ 3,180
AmeraMex International, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Interest Rate [19] 10.00%  
Acquisition Date [19] Mar. 29, 2019  
Maturity Date [19] Apr. 15, 2025  
Par Amount [19] $ 1,551  
Cost [19] 1,551  
Fair Value [19] $ 1,566  
Blackhawk Mining, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Oil, Gas & Consumable Fuels
Acquisition Date [19]   Feb. 16, 2018
Par Amount [19]   $ 1,642
Cost [19]   1,615
Fair Value [19]   $ 1,636
Blackhawk Mining, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   10.97%
Maturity Date [19]   Nov. 01, 2022
Blackhawk Mining, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   11.16%
Maturity Date [19]   Mar. 01, 2022
Blackhawk Mining, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Oil, Gas & Consumable Fuels  
Interest Rate [19] 11.17%  
Acquisition Date [19] Feb. 16, 2018  
Maturity Date [19] Nov. 01, 2022  
Par Amount [19] $ 409  
Cost [19] 409  
Fair Value [19] $ 409  
Boart Longyear Company [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Metals & Mining
Acquisition Date [19]   May 28, 2020
Par Amount [19]   $ 5,374
Cost [19]   5,374
Fair Value [19]   $ 5,374
Boart Longyear Company [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   10.44%
Maturity Date [19]   Jan. 01, 2026
Boart Longyear Company [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.06%
Maturity Date [19]   Jul. 01, 2024
Boart Longyear Company [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Metals & Mining  
Acquisition Date [19] May 28, 2020  
Par Amount [19] $ 4,231  
Cost [19] 4,231  
Fair Value [19] $ 4,231  
Boart Longyear Company [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 10.44%  
Maturity Date [19] Jan. 01, 2026  
Boart Longyear Company [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 9.06%  
Maturity Date [19] Jul. 01, 2024  
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Airlines
Interest Rate [6],[19]   10.00%
Acquisition Date [19]   Apr. 04, 2018
Par Amount [19]   $ 3,102
Cost [19]   3,102
Fair Value [19]   $ 3,053
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19]   Jun. 22, 2026
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19]   Oct. 04, 2023
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Airlines  
Interest Rate [19] 10.00%  
Acquisition Date [19] Apr. 04, 2018  
Par Amount [19] $ 2,464  
Cost [19] 2,464  
Fair Value [19] $ 2,432  
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19] Jun. 22, 2026  
Capital City Jet Center, Inc. [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19] Oct. 04, 2023  
Champion Air, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Airlines
Interest Rate [6],[19]   10.00%
Acquisition Date [19]   Mar. 19, 2018
Maturity Date [19]   Jan. 01, 2023
Par Amount [19]   $ 1,685
Cost [19]   1,685
Fair Value [19]   $ 1,685
Champion Air, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Airlines  
Interest Rate [19] 10.00%  
Acquisition Date [19] Mar. 19, 2018  
Maturity Date [19] Jan. 01, 2023  
Par Amount [19] $ 1,219  
Cost [19] 1,219  
Fair Value [19] $ 1,219  
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Hotels, Restaurants & Leisure
Acquisition Date [19]   May 27, 2021
Par Amount [19]   $ 4,326
Cost [19]   4,326
Fair Value [19]   $ 4,326
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.87%
Maturity Date [19]   Jan. 01, 2027
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.41%
Maturity Date [19]   Jun. 01, 2025
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Hotels, Restaurants & Leisure  
Acquisition Date [19] May 27, 2021  
Par Amount [19] $ 6,027  
Cost [19] 6,027  
Fair Value [19] $ 6,027  
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 13.01%  
Maturity Date [19] Oct. 01, 2027  
Clubcorp Holdings, Inc. [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 9.36%  
Maturity Date [19] Apr. 01, 2025  
Dongwon Autopart Technology Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Auto Components
Interest Rate [6],[19]   7.96%
Acquisition Date [19]   Feb. 02, 2021
Maturity Date [19]   Jan. 01, 2026
Par Amount [19]   $ 2,347
Cost [19]   2,382
Fair Value [19]   $ 2,347
Dongwon Autopart Technology Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Auto Components  
Interest Rate [19] 7.96%  
Acquisition Date [19] Feb. 02, 2021  
Maturity Date [19] Jan. 01, 2026  
Par Amount [19] $ 1,962  
Cost [19] 1,986  
Fair Value [19] $ 1,962  
EasyPak, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Containers & Packaging
Interest Rate [6],[19]   9.01%
Acquisition Date [19]   Jan. 06, 2021
Maturity Date [19]   Jan. 01, 2024
Par Amount [19]   $ 616
Cost [19]   616
Fair Value [19]   $ 616
EasyPak, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Containers & Packaging  
Interest Rate [19] 9.01%  
Acquisition Date [19] Jan. 06, 2021  
Maturity Date [19] Jan. 01, 2024  
Par Amount [19] $ 364  
Cost [19] 364  
Fair Value [19] $ 364  
Environmental Protection & Improvement Company, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Interest Rate [6],[19]   8.25%
Acquisition Date [19]   Sep. 30, 2020
Maturity Date [19]   Oct. 01, 2027
Par Amount [19]   $ 5,921
Cost [19]   5,959
Fair Value [19]   $ 5,921
Environmental Protection & Improvement Company, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Interest Rate [19] 8.25%  
Acquisition Date [19] Sep. 30, 2020  
Maturity Date [19] Oct. 01, 2027  
Par Amount [19] $ 5,438  
Cost [19] 5,469  
Fair Value [19] $ 5,438  
Equipment Operating Leases, LLC [Member]    
Schedule of Investments [Line Items]    
Industry [12],[20]   Multi-Sector Holdings
Equipment Operating Leases, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Acquisition Date [12],[20]   Apr. 27, 2018
Par Amount [12],[20]   $ 19,671
Cost [12],[20]   19,671
Fair Value [12],[20]   $ 18,939
Equipment Operating Leases, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[12],[20]   7.53%
Maturity Date [12],[20]   Apr. 27, 2025
Equipment Operating Leases, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[12],[20]   8.37%
Maturity Date [12],[20]   Aug. 01, 2022
Equipment Operating Leases, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [11],[20] Multi-Sector Holdings  
Interest Rate [11],[20] 8.37%  
Acquisition Date [11],[20] Apr. 27, 2018  
Maturity Date [11],[20] Apr. 27, 2025  
Par Amount [11],[20] $ 3,946  
Cost [11],[20] 3,946  
Fair Value [11],[20] $ 3,847  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Diversified Financial Services
Interest Rate [6],[19]   7.50%
Acquisition Date [19]   Oct. 28, 2021
Maturity Date [19]   Nov. 01, 2026
Par Amount [19]   $ 2,487
Cost [19]   2,492
Fair Value [19]   $ 2,487
First American Commercial Bancorp, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Diversified Financial Services  
Acquisition Date [19] Oct. 28, 2021  
Par Amount [19] $ 3,094  
Cost [19] 3,098  
Fair Value [19] $ 3,094  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 9.02%  
Maturity Date [19] Apr. 01, 2027  
First American Commercial Bancorp, Inc. [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 7.50%  
Maturity Date [19] Nov. 01, 2026  
First National Capital, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Diversified Financial Services
Interest Rate [6],[19]   9.00%
Acquisition Date [19]   Nov. 05, 2021
Maturity Date [19]   Aug. 01, 2026
Par Amount [19]   $ 8,681
Cost [19]   8,681
Fair Value [19]   $ 8,681
First National Capital, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Diversified Financial Services  
Interest Rate [19] 9.00%  
Acquisition Date [19] Nov. 05, 2021  
Maturity Date [19] Aug. 01, 2026  
Par Amount [19] $ 7,533  
Cost [19] 7,533  
Fair Value [19] $ 7,533  
Freightsol LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Acquisition Date [19]   Apr. 09, 2019
Maturity Date [19]   Nov. 01, 2023
Par Amount [19]   $ 1,364
Cost [19]   1,381
Fair Value [19]   $ 1,364
Freightsol LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   12.89%
Freightsol LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   12.51%
Freightsol LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Acquisition Date [19] Apr. 09, 2019  
Maturity Date [19] Nov. 01, 2023  
Par Amount [19] $ 932  
Cost [19] 940  
Fair Value [19] $ 932  
Freightsol LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 12.89%  
Freightsol LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 12.51%  
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Acquisition Date [19]   Mar. 22, 2018
Par Amount [19]   $ 1,245
Cost [19]   1,245
Fair Value [19]   $ 1,242
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.77%
Maturity Date [19]   Oct. 05, 2023
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.30%
Maturity Date [19]   Jun. 05, 2023
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Acquisition Date [19] Mar. 22, 2018  
Par Amount [19] $ 669  
Cost [19] 669  
Fair Value [19] $ 667  
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.77%  
Maturity Date [19] Oct. 05, 2023  
Garda CL Technical Services, Inc. [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.30%  
Maturity Date [19] Jun. 05, 2023  
Georgia Jet, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Airlines
Interest Rate [6],[19]   8.00%
Acquisition Date [19]   Dec. 04, 2017
Maturity Date [19]   Jan. 04, 2024
Par Amount [19]   $ 795
Cost [19]   795
Fair Value [19]   $ 795
Georgia Jet, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Airlines  
Interest Rate [19] 8.00%  
Acquisition Date [19] Dec. 04, 2017  
Maturity Date [19] Jan. 04, 2024  
Par Amount [19] $ 520  
Cost [19] 520  
Fair Value [19] $ 520  
GMT Corporation [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Machinery
Interest Rate [6],[19]   10.71%
Acquisition Date [19]   Oct. 23, 2018
Maturity Date [19]   Oct. 01, 2025
Par Amount [19]   $ 5,476
Cost [19]   5,484
Fair Value [19]   $ 5,476
GMT Corporation [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Machinery  
Interest Rate [19] 10.71%  
Acquisition Date [19] Oct. 23, 2018  
Maturity Date [19] Jan. 01, 2026  
Par Amount [19] $ 5,032  
Cost [19] 5,038  
Fair Value [19] $ 5,032  
Haljoe Coaches USA, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Interest Rate [6],[19]   8.53%
Acquisition Date [19]   Jul. 31, 2017
Maturity Date [19]   Jul. 01, 2024
Par Amount [19]   $ 1,061
Cost [19]   1,061
Fair Value [19]   $ 915
Hawkeye Contracting Company, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Construction & Engineering
Interest Rate [6],[19]   10.50%
Acquisition Date [19]   Oct. 08, 2021
Maturity Date [19]   Nov. 01, 2025
Par Amount [19]   $ 1,252
Cost [19]   1,252
Fair Value [19]   $ 1,252
Hawkeye Contracting Company, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Construction & Engineering  
Interest Rate [19] 10.50%  
Acquisition Date [19] Oct. 08, 2021  
Maturity Date [19] Nov. 01, 2025  
Par Amount [19] $ 1,069  
Cost [19] 1,069  
Fair Value [19] $ 1,069  
HTI Logistics Corporation [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Acquisition Date [19]   Nov. 15, 2018
Par Amount [19]   $ 414
Cost [19]   414
Fair Value [19]   $ 404
HTI Logistics Corporation [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.94%
Maturity Date [19]   Sep. 01, 2025
HTI Logistics Corporation [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.69%
Maturity Date [19]   May 01, 2024
HTI Logistics Corporation [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Acquisition Date [19] Nov. 15, 2018  
Par Amount [19] $ 322  
Cost [19] 322  
Fair Value [19] $ 314  
HTI Logistics Corporation [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 9.94%  
Maturity Date [19] Sep. 01, 2025  
HTI Logistics Corporation [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 9.69%  
Maturity Date [19] May 01, 2024  
International Automotive Components Group, North America, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Auto Components
Interest Rate [6],[19]   7.95%
Acquisition Date [19]   Jun. 23, 2021
Maturity Date [19]   Jun. 23, 2025
Par Amount [19]   $ 8,184
Cost [19]   8,250
Fair Value [19]   $ 8,184
International Automotive Components Group, North America, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Auto Components  
Interest Rate [19] 7.95%  
Acquisition Date [19] Jun. 23, 2021  
Maturity Date [19] Jun. 23, 2025  
Par Amount [19] $ 6,616  
Cost [19] 6,659  
Fair Value [19] $ 6,484  
Kool Pak, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Interest Rate [6],[19]   8.58%
Acquisition Date [19]   Feb. 05, 2018
Maturity Date [19]   Mar. 01, 2024
Par Amount [19]   $ 345
Cost [19]   345
Fair Value [19]   $ 345
Kool Pak, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Interest Rate [19] 8.58%  
Acquisition Date [19] Feb. 05, 2018  
Maturity Date [19] Mar. 01, 2024  
Par Amount [19] $ 233  
Cost [19] 233  
Fair Value [19] $ 233  
Loyer Capital LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [12],[20]   Multi-Sector Holdings
Acquisition Date [12],[20]   May 16, 2019
Par Amount [12],[20]   $ 11,000
Cost [12],[20]   11,000
Fair Value [12],[20]   $ 10,725
Loyer Capital LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [12],[20]   11.52%
Maturity Date [12],[20]   Sep. 25, 2024
Loyer Capital LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [12],[20]   8.73%
Maturity Date [12],[20]   May 16, 2024
Loyer Capital LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [11],[20] Multi-Sector Holdings  
Acquisition Date [11],[20] May 16, 2019  
Par Amount [11],[20] $ 7,500  
Cost [11],[20] 7,500  
Fair Value [11],[20] $ 7,361  
Loyer Capital LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [11],[20] 11.52%  
Maturity Date [11],[20] Sep. 25, 2024  
Loyer Capital LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [11],[20] 8.73%  
Maturity Date [11],[20] May 16, 2024  
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Acquisition Date [19]   Jun. 17, 2021
Par Amount [19]   $ 9,343
Cost [19]   9,343
Fair Value [19]   $ 9,343
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.65%
Maturity Date [19]   Dec. 01, 2025
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.28%
Maturity Date [19]   Dec. 01, 2024
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Acquisition Date [19] Jun. 17, 2021  
Par Amount [19] $ 15,930  
Cost [19] 15,930  
Fair Value [19] $ 15,930  
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 11.12%  
Maturity Date [19] Oct. 01, 2026  
Lux Credit Consultants, LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.28%  
Maturity Date [19] Dec. 01, 2024  
Lux Vending, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Consumer Finance
Acquisition Date [19]   Aug. 20, 2021
Par Amount [19]   $ 2,526
Cost [19]   2,583
Fair Value [19]   $ 2,526
Lux Vending, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   13.26%
Maturity Date [19]   Oct. 01, 2024
Lux Vending, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   12.46%
Maturity Date [19]   Aug. 20, 2024
Lux Vending, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Consumer Finance  
Acquisition Date [19] Aug. 20, 2021  
Par Amount [19] $ 1,870  
Cost [19] 1,902  
Fair Value [19] $ 1,870  
Lux Vending, LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 13.26%  
Maturity Date [19] Oct. 01, 2024  
Lux Vending, LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 12.46%  
Maturity Date [19] Aug. 20, 2024  
Mountain Air Helicopters, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Interest Rate [6],[19]   10.00%
Acquisition Date [19]   Jul. 31, 2017
Maturity Date [19]   Feb. 28, 2025
Par Amount [19]   $ 479
Cost [19]   476
Fair Value [19]   $ 479
Mountain Air Helicopters, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Interest Rate [19] 10.00%  
Acquisition Date [19] Jul. 31, 2017  
Maturity Date [19] Feb. 28, 2025  
Par Amount [19] $ 398  
Cost [19] 396  
Fair Value [19] $ 398  
Rane Light Metal Castings Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Machinery
Interest Rate [6],[19]   10.00%
Acquisition Date [19]   Jun. 01, 2020
Maturity Date [19]   Jul. 01, 2024
Par Amount [19]   $ 253
Cost [19]   253
Fair Value [19]   $ 253
Rane Light Metal Castings Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Machinery  
Interest Rate [19] 10.00%  
Acquisition Date [19] Jun. 01, 2020  
Maturity Date [19] Jul. 01, 2024  
Par Amount [19] $ 184  
Cost [19] 184  
Fair Value [19] $ 184  
Rango, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Acquisition Date [19]   Sep. 24, 2019
Par Amount [19]   $ 3,615
Cost [19]   3,656
Fair Value [19]   $ 3,547
Rango, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.79%
Maturity Date [19]   Nov. 01, 2024
Rango, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.33%
Maturity Date [19]   Apr. 01, 2023
Rango, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Acquisition Date [19] Sep. 24, 2019  
Par Amount [19] $ 2,374  
Cost [19] 2,399  
Fair Value [19] $ 2,329  
Rango, Inc. [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 9.79%  
Maturity Date [19] Nov. 01, 2024  
Rango, Inc. [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 9.33%  
Maturity Date [19] Apr. 01, 2023  
Rossco Crane & Rigging, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Interest Rate [6],[19]   11.53%
Acquisition Date [19]   Aug. 25, 2017
Maturity Date [19]   Sep. 01, 2022
Par Amount [19]   $ 126
Cost [19]   126
Fair Value [19]   $ 126
Royal Coach Lines, Inc.[Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Interest Rate [6],[19]   9.56%
Acquisition Date [19]   Nov. 21, 2019
Maturity Date [19]   Aug. 01, 2025
Par Amount [19]   $ 1,041
Cost [19]   1,041
Fair Value [19]   $ 950
Royal Coach Lines, Inc.[Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Interest Rate [19] 9.56%  
Acquisition Date [19] Nov. 21, 2019  
Maturity Date [19] Aug. 01, 2025  
Par Amount [19] $ 913  
Cost [19] 913  
Fair Value [19] $ 833  
Royal Express Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Interest Rate [6],[19]   9.53%
Acquisition Date [19]   Jan. 17, 2019
Maturity Date [19]   Feb. 01, 2024
Par Amount [19]   $ 683
Cost [19]   690
Fair Value [19]   $ 683
Royal Express Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Interest Rate [19] 9.53%  
Acquisition Date [19] Jan. 17, 2019  
Maturity Date [19] Feb. 01, 2024  
Par Amount [19] $ 494  
Cost [19] 497  
Fair Value [19] $ 494  
Sidelines Tree Service LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Diversified Consumer Services
Interest Rate [6],[19]   10.25%
Acquisition Date [19]   Jul. 31, 2017
Maturity Date [19]   Oct. 01, 2022
Par Amount [19]   $ 46
Cost [19]   46
Fair Value [19]   $ 45
Sidelines Tree Service LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Diversified Consumer Services  
Interest Rate [19] 10.25%  
Acquisition Date [19] Jul. 31, 2017  
Maturity Date [19] Oct. 01, 2022  
Par Amount [19] $ 19  
Cost [19] 19  
Fair Value [19] $ 19  
SLR Equipment Finance [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [11] Multi-Sector Holdings  
Interest Rate [11] 8.50%  
Acquisition Date [11] Jan. 24, 2022  
Maturity Date [19] Jan. 24, 2023  
Par Amount [11] $ 5,000  
Cost [11] 5,000  
Fair Value [11] $ 5,000  
South Texas Oilfield Solutions, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Energy Equipment & Services
Acquisition Date [19]   Mar. 29, 2018
Par Amount [19]   $ 1,363
Cost [19]   1,363
Fair Value [19]   $ 1,338
South Texas Oilfield Solutions, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   13.76%
Maturity Date [19]   Jul. 01, 2023
South Texas Oilfield Solutions, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   12.52%
Maturity Date [19]   Sep. 01, 2022
ST Coaches, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Acquisition Date [19]   Jul. 31, 2017
Par Amount [19]   $ 1,951
Cost [19]   1,951
Fair Value [19]   $ 1,839
ST Coaches, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.58%
Maturity Date [19]   Jan. 25, 2025
ST Coaches, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.22%
Maturity Date [19]   Oct. 01, 2022
ST Coaches, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Acquisition Date [19] Jul. 31, 2017  
Par Amount [19] $ 1,810  
Cost [19] 1,810  
Fair Value [19] $ 1,729  
ST Coaches, LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.58%  
Maturity Date [19] Jan. 25, 2025  
ST Coaches, LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.22%  
Maturity Date [19] Oct. 01, 2022  
Stafford Logistics, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Interest Rate [6],[19]   12.62%
Acquisition Date [19]   Sep. 11, 2019
Maturity Date [19]   Feb. 15, 2026
Par Amount [19]   $ 7,094
Cost [19]   7,094
Fair Value [19]   $ 7,094
Star Coaches Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Interest Rate [6],[19]   8.42%
Acquisition Date [19]   Mar. 09, 2018
Maturity Date [19]   Apr. 01, 2025
Par Amount [19]   $ 3,401
Cost [19]   3,401
Fair Value [19]   $ 2,916
Star Coaches Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Interest Rate [19] 8.42%  
Acquisition Date [19] Mar. 09, 2018  
Maturity Date [19] Apr. 01, 2025  
Par Amount [19] $ 3,019  
Cost [19] 3,019  
Fair Value [19] $ 2,710  
Sturgeon Services International Inc.[Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Energy Equipment & Services
Interest Rate [6],[19]   18.38%
Acquisition Date [19]   Jul. 31, 2017
Maturity Date [19]   Feb. 28, 2022
Par Amount [19]   $ 132
Cost [19]   132
Fair Value [19]   $ 125
Superior Transportation, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Acquisition Date [19]   Jul. 31, 2017
Maturity Date [19]   Jan. 01, 2026
Par Amount [19]   $ 4,578
Cost [19]   4,578
Fair Value [19]   $ 4,578
Superior Transportation, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   10.62%
Superior Transportation, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   10.22%
Superior Transportation, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Acquisition Date [19] Jul. 31, 2017  
Maturity Date [19] Jan. 01, 2026  
Par Amount [19] $ 3,814  
Cost [19] 3,814  
Fair Value [19] $ 3,814  
Superior Transportation, Inc. [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 10.63%  
Superior Transportation, Inc. [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 10.22%  
Tailwinds, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Air Freight & Logistics
Acquisition Date [19]   Jul. 26, 2019
Par Amount [19]   $ 2,267
Cost [19]   2,267
Fair Value [19]   $ 2,267
Tailwinds, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   9.00%
Maturity Date [19]   Oct. 16, 2025
Tailwinds, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.50%
Maturity Date [19]   Aug. 01, 2024
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Acquisition Date [19]   Jul. 31, 2017
Par Amount [19]   $ 3,798
Cost [19]   3,800
Fair Value [19]   $ 3,536
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   15.36%
Maturity Date [19]   Feb. 10, 2024
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   10.21%
Maturity Date [19]   Oct. 29, 2023
The Smedley Company & Smedley Services, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Interest Rate [19] 4.07%  
Acquisition Date [19] Jul. 31, 2017  
Maturity Date [19] Jan. 01, 2028  
Par Amount [19] $ 2,706  
Cost [19] 2,706  
Fair Value [19] $ 2,706  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Acquisition Date [19]   Oct. 08, 2021
Par Amount [19]   $ 777
Cost [19]   777
Fair Value [19]   $ 777
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.75%
Maturity Date [19]   Dec. 01, 2026
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   7.94%
Maturity Date [19]   Nov. 01, 2024
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Acquisition Date [19] Oct. 08, 2021  
Par Amount [19] $ 628  
Cost [19] 628  
Fair Value [19] $ 628  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.75%  
Maturity Date [19] Dec. 01, 2026  
Trinity Equipment Rentals, Inc. [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 7.94%  
Maturity Date [19] Nov. 01, 2024  
Trolleys, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Interest Rate [6],[19]   9.99%
Acquisition Date [19]   Jul. 18, 2018
Maturity Date [19]   Aug. 01, 2022
Par Amount [19]   $ 1,573
Cost [19]   1,573
Fair Value [19]   $ 1,540
Up Trucking Services, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Road & Rail
Interest Rate [6],[19]   11.21%
Acquisition Date [19]   Mar. 23, 2018
Maturity Date [19]   Aug. 01, 2024
Par Amount [19]   $ 696
Cost [19]   705
Fair Value [19]   $ 696
Up Trucking Services, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Interest Rate [19] 11.21%  
Acquisition Date [19] Mar. 23, 2018  
Maturity Date [19] Aug. 01, 2024  
Par Amount [19] $ 510  
Cost [19] 515  
Fair Value [19] $ 510  
Warrior Crane Services, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Commercial Services & Supplies
Interest Rate [6],[19]   8.95%
Acquisition Date [19]   Jul. 11, 2019
Par Amount [19]   $ 2,567
Cost [19]   2,567
Fair Value [19]   $ 2,518
Warrior Crane Services, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19]   Aug. 01, 2026
Warrior Crane Services, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19]   Aug. 01, 2024
Warrior Crane Services, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Interest Rate [19] 8.95%  
Acquisition Date [19] Jul. 11, 2019  
Par Amount [19] $ 2,144  
Cost [19] 2,144  
Fair Value [19] $ 2,104  
Warrior Crane Services, LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19] Aug. 01, 2026  
Warrior Crane Services, LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19] Aug. 01, 2024  
Wind River Environmental, LLC [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Diversified Consumer Services
Acquisition Date [19]   Jul. 31, 2019
Par Amount [19]   $ 870
Cost [19]   873
Fair Value [19]   $ 870
Wind River Environmental, LLC [Member] | Equipment Financing  0 32.5% [Member] | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   10.00%
Maturity Date [19]   Oct. 05, 2025
Wind River Environmental, LLC [Member] | Equipment Financing  0 32.5% [Member] | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [6],[19]   8.43%
Maturity Date [19]   Aug. 01, 2024
Wind River Environmental, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Diversified Consumer Services  
Acquisition Date [19] Jul. 31, 2019  
Par Amount [19] $ 673  
Cost [19] 675  
Fair Value [19] $ 673  
Wind River Environmental, LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 10.00%  
Maturity Date [19] Oct. 05, 2025  
Wind River Environmental, LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.43%  
Maturity Date [19] Aug. 01, 2024  
Womble Company, Inc. [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [19]   Energy Equipment & Services
Interest Rate [6],[19]   9.11%
Acquisition Date [19]   Dec. 27, 2019
Maturity Date [19]   Jan. 01, 2025
Par Amount [19]   $ 547
Cost [19]   547
Fair Value [19]   $ 537
Womble Company, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Energy Equipment & Services  
Interest Rate [19] 9.11%  
Acquisition Date [19] Dec. 27, 2019  
Maturity Date [19] Jan. 01, 2025  
Par Amount [19] $ 428  
Cost [19] 428  
Fair Value [19] $ 411  
SLR Equipment Finance Equity Interests [Member] | Equipment Financing  0 32.5% [Member]    
Schedule of Investments [Line Items]    
Industry [12],[17],[21]   Multi-Sector Holdings
Acquisition Date [12],[17],[21]   Jul. 31, 2017
Shares/Units [12],[17],[21]   200
Cost [12],[17],[21]   $ 145,000
Fair Value [12],[17],[21]   $ 129,102
SLR Equipment Finance Equity Interests [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [11],[17],[21],[22] Multi-Sector Holdings  
Acquisition Date [11],[21],[22] Jul. 31, 2017  
Shares/Units [11],[21],[22] 200  
Cost [11],[21],[22] $ 145,000  
Fair Value [11],[21],[22] $ 120,820  
SOINT, LLC [Member] | Preferred Equity  3 0.4% [Member]    
Schedule of Investments [Line Items]    
Industry [9],[11],[23] Aerospace & Defense  
Interest Rate [9],[11],[23] 5.00%  
Acquisition Date [9],[11],[23] Jun. 08, 2012  
Maturity Date [9],[11],[23] Jun. 30, 2023  
Shares/Units [9],[11],[23] 52,536  
Cost [9],[11],[23] $ 5,254  
Fair Value [9],[11],[23] $ 4,176  
SOINT, LLC [Member] | Preferred Equity  3 0.7% [Member]    
Schedule of Investments [Line Items]    
Industry [10],[12],[24]   Aerospace & Defense
Interest Rate [6],[10],[12],[14],[24]   5.00%
Acquisition Date [10],[12],[24]   Jun. 08, 2012
Maturity Date [10],[12],[24]   Jun. 30, 2023
Shares/Units [10],[12],[24]   56,030
Cost [10],[12],[24]   $ 5,603
Fair Value [10],[12],[24]   $ 4,509
SOAGG LLC [Member] | Preferred Equity  3 0.7% [Member]    
Schedule of Investments [Line Items]    
Industry   Aerospace & Defense
Interest Rate   8.00%
Acquisition Date   Dec. 14, 2010
Maturity Date   Jun. 30, 2023
Shares/Units   446
Cost   $ 446
Fair Value   $ 1,121
aTyr Pharma, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [17]   Pharmaceuticals
Acquisition Date [17]   Nov. 18, 2016
Shares/Units [17]   6,347
Cost [17]   $ 106
Fair Value [17]   $ 0
aTyr Pharma, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Pharmaceuticals  
Acquisition Date [17] Nov. 18, 2016  
Shares/Units [17] 6,347  
Cost [17] $ 106  
Fair Value [17] $ 0  
CardioFocus, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [17]   Health Care Equipment & Supplies
Acquisition Date [17]   Mar. 31, 2017
Shares/Units [17]   90
Cost [17]   $ 51
Fair Value [17]   $ 0
CardioFocus, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Health Care Equipment & Supplies  
Acquisition Date [17] Mar. 31, 2017  
Shares/Units [17] 90  
Cost [17] $ 51  
Fair Value [17] $ 0  
Centrexion Therapeutics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [17]   Pharmaceuticals
Acquisition Date [17]   Jun. 28, 2019
Shares/Units [17]   289,102
Cost [17]   $ 136
Fair Value [17]   $ 65
Centrexion Therapeutics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Pharmaceuticals  
Acquisition Date [17] Jun. 28, 2019  
Shares/Units [17] 289,102  
Cost [17] $ 136  
Fair Value [17] $ 92  
Conventus Orthopaedics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [17]   Health Care Equipment & Supplies
Acquisition Date [17]   Jun. 15, 2016
Shares/Units [17]   157,500
Cost [17]   $ 65
Fair Value [17]   $ 0
Conventus Orthopaedics, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Health Care Equipment & Supplies  
Acquisition Date [17] Jun. 15, 2016  
Shares/Units [17] 157,500  
Cost [17] $ 65  
Fair Value [17] $ 0  
Delphinus Medical Technologies, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [17]   Health Care Equipment & Supplies
Acquisition Date [17]   Aug. 18, 2017
Shares/Units [17]   444,388
Cost [17]   $ 74
Fair Value [17]   $ 80
Delphinus Medical Technologies, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Acquisition Date [17] Aug. 18, 2017  
Shares/Units [17] 444,388  
Cost [17] $ 74  
Fair Value [17] $ 108  
Essence Group Holdings Corporation (Lumeris) Warrants [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [17]   Health Care Technology
Acquisition Date [17]   Mar. 22, 2017
Shares/Units [17]   208,000
Cost [17]   $ 63
Fair Value [17]   $ 258
Essence Group Holdings Corporation (Lumeris) Warrants [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Health Care Technology  
Acquisition Date [17] Mar. 22, 2017  
Shares/Units [17] 260,000  
Cost [17] $ 129  
Fair Value [17] $ 377  
KBH Topco LLC (Kingsbridge) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [12],[25]   Multi-Sector Holdings
Acquisition Date [12],[25]   Nov. 03, 2020
Shares/Units [12],[25]   73,500,000
Cost [12],[25]   $ 136,596
Fair Value [12],[25]   $ 145,996
KBH Topco LLC (Kingsbridge) [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [11],[25],[26] Multi-Sector Holdings  
Acquisition Date [11],[25],[26] Nov. 03, 2020  
Shares/Units [11],[25],[26] 73,500,000  
Cost [11],[25],[26] $ 136,596  
Fair Value [11],[25],[26] $ 147,000  
RD Holdco Inc. (Rug Doctor) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [12],[17]   Diversified Consumer Services
Acquisition Date [12],[17]   Dec. 23, 2013
Shares/Units [12],[17]   231,177
Cost [12],[17]   $ 15,683
Fair Value [12],[17]   $ 0
RD Holdco Inc. (Rug Doctor) [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [11],[17] Diversified Consumer Services  
Acquisition Date [11],[17] Dec. 23, 2013  
Shares/Units [11],[17] 231,177  
Cost [11],[17] $ 15,683  
Fair Value [11],[17] $ 0  
RD Holdco Inc. (Rug Doctor, class B) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [12],[17]   Diversified Consumer Services
Acquisition Date [12],[17]   Dec. 23, 2013
Shares/Units [12],[17]   522
Cost [12],[17]   $ 5,216
Fair Value [12],[17]   $ 5,216
RD Holdco Inc. (Rug Doctor, class B) [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [11],[17] Diversified Consumer Services  
Acquisition Date [11],[17] Dec. 23, 2013  
Shares/Units [11],[17] 522  
Cost [11],[17] $ 5,216  
Fair Value [11],[17] $ 0  
RD Holdco Inc. (Rug Doctor, Warrants) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [12],[17]   Diversified Consumer Services
Acquisition Date [12],[17]   Dec. 23, 2013
Shares/Units [12],[17]   30,370
Cost [12],[17]   $ 381
Fair Value [12],[17]   $ 0
RD Holdco Inc. (Rug Doctor, Warrants) [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [11],[17] Diversified Consumer Services  
Acquisition Date [11],[17] Dec. 23, 2013  
Shares/Units [11],[17] 30,370  
Cost [11],[17] $ 381  
Fair Value [11],[17] $ 0  
Senseonics Holdings, Inc. [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [10],[17],[27]   Health Care Equipment & Supplies
Acquisition Date [10],[17],[27]   Jul. 25, 2019
Shares/Units [10],[17],[27]   406,923
Cost [10],[17],[27]   $ 117
Fair Value [10],[17],[27]   $ 1,086
Senseonics Holdings, Inc. [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [9],[17],[27] Health Care Equipment & Supplies  
Acquisition Date [9],[11],[17],[27] Jul. 25, 2019  
Shares/Units [9],[11],[17],[27] 469,353  
Cost [9],[11],[17],[27] $ 235  
Fair Value [9],[11],[17],[27] $ 620  
SLR Business Credit [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [9],[11],[28] Diversified Financial Services  
Acquisition Date [9],[11],[28] Apr. 01, 2022  
Shares/Units [9],[11],[28] 100  
Cost [9],[11],[28] $ 81,583  
Fair Value [9],[11],[28] $ 89,370  
SLR Credit Solutions [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [10],[12]   Diversified Financial Services
Acquisition Date [10],[12]   Dec. 28, 2012
Shares/Units [10],[12]   280,303
Cost [10],[12]   $ 280,737
Fair Value [10],[12]   $ 298,766
SLR Credit Solutions [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [9],[11],[29] Diversified Financial Services  
Acquisition Date [9],[11],[29] Dec. 28, 2012  
Shares/Units [9],[11],[29] 280,303  
Cost [9],[11],[29] $ 280,737  
Fair Value [9],[11],[29] $ 288,760  
SLR Healthcare ABL [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [9],[11],[30] Diversified Financial Services  
Acquisition Date [9],[11],[30] Apr. 01, 2022  
Shares/Units [9],[11],[30] 32,839  
Cost [9],[11],[30] $ 34,335  
Fair Value [9],[11],[30] $ 33,750  
Spectrum Pharmaceuticals, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Biotechnology  
Acquisition Date [17] Sep. 21, 2022  
Shares/Units [17] 159,470  
Cost [17] $ 50  
Fair Value [17] $ 22  
TwentyEighty Investors LLC [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Professional Services  
Acquisition Date [17] Apr. 01, 2022  
Shares/Units [17] 17,214  
Cost [17] $ 5  
Fair Value [17] $ 5  
Vapotherm, Inc. Warrants [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [9],[17] Health Care Equipment & Supplies  
Acquisition Date [9],[17] Feb. 18, 2022  
Shares/Units [9],[17] 36,996  
Cost [9],[17] $ 210  
Fair Value [9],[17] $ 25  
Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member] | Common Equity/Equity Interests/Warrants  0 53.6% [Member]    
Schedule of Investments [Line Items]    
Industry [17]   Health Care Equipment & Supplies
Acquisition Date [17]   May 10, 2018
Shares/Units [17]   27,352
Cost [17]   $ 152
Fair Value [17]   $ 0
Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member] | Common Equity/Equity Interests/Warrants 055.7%    
Schedule of Investments [Line Items]    
Industry [17] Health Care Equipment & Supplies  
Acquisition Date [17] May 10, 2018  
Shares/Units [17] 33,430  
Cost [17] $ 152  
Fair Value [17] $ 0  
ENS Holdings III Corp. ES Opco USA LLC (Bluefin) [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Trading Companies & Distributors  
Spread Above Index [3],[4] L+475  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.42%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Dec. 31, 2025  
Par Amount [3] $ 6,232  
Cost [3] 5,997  
Fair Value [3] $ 6,232  
Enverus Holdings Inc fka Drilling Info Holdings [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] IT Services  
Spread Above Index [3],[4] L+450  
Floor [3] 0.00%  
Interest Rate [1],[3] 7.62%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Jul. 30, 2025  
Par Amount [3] $ 11,627  
Cost [3] 11,119  
Fair Value [3] $ 11,627  
Erie Construction Midwest LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Building Products  
Spread Above Index [3],[4] L+475  
Floor [3] 1.00%  
Interest Rate [1],[3] 7.56%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Jul. 30, 2027  
Par Amount [3] $ 9,029  
Cost [3] 8,674  
Fair Value [3] $ 9,029  
GSM Acquisition Corp [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Leisure Equipment & Products  
Spread Above Index [3],[4] S+500  
Floor [3] 1.00%  
Interest Rate [1],[3] 7.32%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Nov. 16, 2026  
Par Amount [3] $ 11,468  
Cost [3] 10,977  
Fair Value [3] $ 11,353  
Higginbotham Insurance Agency Inc [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] L+525  
Floor [3] 0.75%  
Interest Rate [1],[3] 8.37%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Nov. 25, 2026  
Par Amount [3] $ 6,239  
Cost [3] 5,997  
Fair Value [3] $ 6,239  
High Street Buyer Inc [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] L+600  
Floor [3] 0.75%  
Interest Rate [1],[3] 8.56%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Apr. 16, 2028  
Par Amount [3] $ 7,701  
Cost [3] 7,257  
Fair Value [3] $ 7,701  
Human Interest Inc [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Internet Software & Services  
Spread Above Index [4] S+785  
Floor 1.00%  
Interest Rate [1] 10.36%  
Acquisition Date Jun. 30, 2022  
Maturity Date Jul. 01, 2027  
Par Amount $ 20,104  
Cost 19,743  
Fair Value $ 19,702  
Kaseya Inc [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Software  
Spread Above Index [4] S+575  
Floor 0.75%  
Interest Rate [1] 8.29%  
Acquisition Date Jun. 22, 2022  
Maturity Date Jun. 23, 2029  
Par Amount $ 32,426  
Cost 31,953  
Fair Value $ 31,939  
National Spine and Pain Centers LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] L+500  
Floor 1.00%  
Interest Rate [1] 7.31%  
Acquisition Date Apr. 01, 2022  
Maturity Date Jun. 02, 2024  
Par Amount $ 2,486  
Cost 2,365  
Fair Value $ 2,362  
OIS Management Services LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+575  
Floor 1.00%  
Interest Rate [1] 9.45%  
Acquisition Date Apr. 11, 2022  
Maturity Date Jul. 09, 2026  
Par Amount $ 6,262  
Cost 6,161  
Fair Value $ 6,262  
Peter C FoyAnd Associates Insurance Services LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Insurance  
Spread Above Index [4] S+600  
Floor 0.75%  
Interest Rate [1] 8.96%  
Acquisition Date Apr. 01, 2022  
Maturity Date Nov. 01, 2028  
Par Amount $ 10,006  
Cost 9,860  
Fair Value $ 10,006  
Plastics Management LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] S+500  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.13%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Aug. 18, 2027  
Par Amount [3] $ 9,515  
Cost [3] 9,169  
Fair Value [3] $ 9,420  
RSC Acquisition Inc [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] S+550  
Floor [3] 0.75%  
Interest Rate [1],[3] 7.76%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Nov. 01, 2026  
Par Amount [3] $ 5,946  
Cost [3] 5,776  
Fair Value [3] $ 5,946  
RxSense Holdings LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Diversified Consumer Services  
Spread Above Index [3],[4] L+500  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.12%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Mar. 13, 2026  
Par Amount [3] $ 11,775  
Cost [3] 11,328  
Fair Value [3] $ 11,775  
SHO Holding I Corporation Shoes for Crews [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Footwear  
Spread Above Index [3],[4] L+523  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.04%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Apr. 27, 2024  
Par Amount [3] $ 5,719  
Cost [3] 5,315  
Fair Value [3] $ 5,434  
Southern Orthodontic Partners Management LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+575  
Floor 1.00%  
Interest Rate [1] 9.19%  
Acquisition Date Jun. 03, 2022  
Maturity Date Jan. 27, 2026  
Par Amount $ 1,028  
Cost 1,019  
Fair Value $ 1,028  
TAUC Management LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Health Care Providers & Services  
Spread Above Index [3],[4] L+525  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.16%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Feb. 12, 2027  
Par Amount [3] $ 6,908  
Cost [3] 6,578  
Fair Value [3] $ 6,874  
Tilley Distribution Inc [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Trading Companies & Distributors  
Spread Above Index [3],[4] L+600  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.78%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Dec. 31, 2026  
Par Amount [3] $ 10,253  
Cost [3] 9,758  
Fair Value [3] $ 10,253  
Vessco Midco Holdings LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Water Utilities  
Spread Above Index [3],[4] L+450  
Floor [3] 1.00%  
Interest Rate [1],[3] 7.34%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Nov. 02, 2026  
Par Amount [3] $ 1,523  
Cost [3] 1,461  
Fair Value [3] $ 1,508  
World Insurance Associates LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Insurance  
Spread Above Index [3],[4] L+575  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.33%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Apr. 01, 2026  
Par Amount [3] $ 23,188  
Cost [3] 22,463  
Fair Value [3] $ 23,188  
Apeel Technology Inc [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Biotechnology  
Spread Above Index [4] S+625  
Floor 1.00%  
Interest Rate [1] 8.75%  
Acquisition Date Jun. 29, 2022  
Maturity Date Jun. 01, 2027  
Par Amount $ 3,643  
Cost 3,613  
Fair Value $ 3,606  
Smiley Lifting Solutions LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Acquisition Date [19] Jun. 30, 2022  
Par Amount [19] $ 2,006  
Cost [19] 2,006  
Fair Value [19] $ 2,006  
Smiley Lifting Solutions LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 7.95%  
Maturity Date [19] Jul. 01, 2029  
Smiley Lifting Solutions LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 7.82%  
Maturity Date [19] Sep. 15, 2026  
Apex Services Partners, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Diversified Consumer Services  
Spread Above Index [3],[4] S+525  
Floor [3] 1.00%  
Interest Rate [1],[3] 8.30%  
Acquisition Date [3] Aug. 31, 2022  
Maturity Date [3] Jul. 31, 2025  
Par Amount [3] $ 14,021  
Cost [3] 13,612  
Fair Value [3] $ 13,601  
Composite Technology Acquisition Corp. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Building Products  
Spread Above Index [3],[4] L+500  
Floor [3] 1.00%  
Interest Rate [1],[3] 6.50%  
Acquisition Date [3] Apr. 01, 2022  
Maturity Date [3] Feb. 01, 2025  
Par Amount [3] $ 10,759  
Cost [3] 10,276  
Fair Value [3] $ 10,759  
Copper River Seafoods, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Food Products  
Spread Above Index [4] P+275  
Floor 0.00%  
Interest Rate [1] 9.00%  
Acquisition Date Aug. 31, 2022  
Maturity Date Apr. 23, 2025  
Par Amount $ 9,957  
Cost 9,957  
Fair Value $ 9,957  
Luxury Asset Capital, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Thrifts & Mortgage Finance  
Spread Above Index [4] S+675  
Floor 1.00%  
Interest Rate [1] 9.38%  
Acquisition Date Jul. 15, 2022  
Maturity Date Jul. 15, 2027  
Par Amount $ 27,500  
Cost 26,968  
Fair Value $ 27,500  
Montefiore Nyack Hospital [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] L+495  
Floor 0.00%  
Interest Rate [1] 8.05%  
Acquisition Date Aug. 09, 2022  
Maturity Date Nov. 15, 2024  
Par Amount $ 5,000  
Cost 5,000  
Fair Value $ 5,000  
Orthopedic Care Partners Management, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+650  
Floor 1.00%  
Interest Rate [1] 9.36%  
Acquisition Date Aug. 17, 2022  
Maturity Date May 16, 2024  
Par Amount $ 2,843  
Cost 2,823  
Fair Value $ 2,822  
Pediatric Home Respiratory Services, LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Health Care Providers & Services  
Spread Above Index [4] S+625  
Floor 1.00%  
Interest Rate [1] 9.43%  
Acquisition Date Aug. 19, 2022  
Maturity Date Dec. 04, 2024  
Par Amount $ 754  
Cost 744  
Fair Value $ 743  
SPAR Marketing Force, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Media  
Spread Above Index [4] P+95  
Floor 0.00%  
Interest Rate [1] 7.20%  
Acquisition Date Jul. 18, 2022  
Maturity Date Oct. 10, 2024  
Par Amount $ 9,787  
Cost 9,787  
Fair Value $ 9,787  
Stryten Resources LLC [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Auto Parts & Equipment  
Spread Above Index [4] S+800  
Floor 1.00%  
Interest Rate [1] 11.15%  
Acquisition Date Aug. 11, 2021  
Maturity Date Oct. 12, 2026  
Par Amount $ 25,988  
Cost 25,548  
Fair Value $ 25,988  
BDG Media, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry Media  
Spread Above Index [4] L+900  
Floor 0.25%  
Interest Rate [1] 11.29%  
Acquisition Date Jul. 18, 2022  
Maturity Date Apr. 27, 2023  
Par Amount $ 9,427  
Cost 9,427  
Fair Value $ 9,427  
RD Holdco, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | Second Lien Bank Debt/Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [7],[11] Diversified Consumer Services  
Spread Above Index [4],[7],[11],[14] S+975  
Floor [7],[11] 1.50%  
Interest Rate [1],[7],[11] 0.00%  
Acquisition Date [7],[11] Dec. 23, 2013  
Maturity Date [7],[11] May 16, 2023  
Par Amount [7],[11] $ 12,900  
Cost [7],[11] 11,791  
Fair Value [7],[11] $ 6,450  
Spectrum Pharmaceuticals, Inc. [Member] | Senior Secured Loans  0 134.4% [Member] | First Lien Life Science Senior Secured Loans [Member]    
Schedule of Investments [Line Items]    
Industry [3] Biotechnology  
Spread Above Index [3],[4] S+570  
Floor [3] 2.30%  
Interest Rate [1],[3] 8.72%  
Acquisition Date [3] Sep. 21, 2022  
Maturity Date [3] Sep. 01, 2027  
Par Amount [3] $ 10,525  
Cost [3] 10,373  
Fair Value [3] $ 10,420  
AFG Dallas III, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Diversified Consumer Services  
Interest Rate [19] 10.00%  
Acquisition Date [19] Aug. 11, 2022  
Par Amount [19] $ 1,093  
Cost [19] 1,093  
Fair Value [19] $ 1,093  
AFG Dallas III, LLC [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19] Aug. 26, 2026  
AFG Dallas III, LLC [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Maturity Date [19] Aug. 11, 2026  
Bowman Energy Solutions, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Commercial Services & Supplies  
Interest Rate [19] 7.42%  
Acquisition Date [19] Jul. 01, 2022  
Maturity Date [19] Aug. 01, 2026  
Par Amount [19] $ 162  
Cost [19] 162  
Fair Value [19] $ 162  
Energy Drilling Services, LLC [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Diversified Consumer Services  
Interest Rate [19] 6.58%  
Acquisition Date [19] Aug. 26, 2022  
Maturity Date [19] Sep. 01, 2027  
Par Amount [19] $ 1,192  
Cost [19] 1,192  
Fair Value [19] $ 1,192  
CKD Holdings, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Road & Rail  
Acquisition Date [19] Sep. 22, 2022  
Par Amount [19] $ 3,887  
Cost [19] 3,887  
Fair Value [19] $ 3,887  
CKD Holdings, Inc. [Member] | Equipment Financing  0 23.7% | Maximum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.60%  
Maturity Date [19] Sep. 22, 2027  
CKD Holdings, Inc. [Member] | Equipment Financing  0 23.7% | Minimum [Member]    
Schedule of Investments [Line Items]    
Interest Rate [19] 8.10%  
Maturity Date [19] Jun. 22, 2026  
Worldwide Flight Services, Inc. [Member] | Equipment Financing  0 23.7%    
Schedule of Investments [Line Items]    
Industry [19] Transportation Infrastructure  
Interest Rate [19] 8.32%  
Acquisition Date [19] Sep. 23, 2022  
Maturity Date [19] Sep. 23, 2027  
Par Amount [19] $ 209  
Cost [19] 211  
Fair Value [19] $ 209  
[1] Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of September 30, 2022.
[2] Aggregate net unrealized appreciation for U.S. federal income tax purposes is $19,495; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $82,598 and $63,103, respectively, based on a tax cost of $1,651,087. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
[3] Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
[4] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
[5] Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor.
[6] Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2021.
[7] Investment is on non-accrual status.
[8] AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers.
[9] Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 22.7% of the total assets of the Company.
[10] Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis, non-qualifying assets in the portfolio represented 23.1% of the total assets of the Company.
[11] Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2022 in these controlled investments are as follows:
[12] Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows:
[13] Spread is 5.50% Cash / 0.50% PIK.
[14] Interest is paid in kind (“PIK”).
[15] Spread is 6.00% Cash / 2.00% PIK.
[16] Spread is 2.50% Cash / 12.50% PIK.
[17] Non-income producing security.
[18] OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.
[19] Indicates an investment that is wholly held by the Company through NEFPASS LLC.
[20] Denotes a subsidiary of SLR Equipment Finance.
[21] SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
[22] See note 11 to the consolidated financial statements.
[23] The Company’s investment in SOINT, LLC include a one dollar investment in common shares.
[24] The Company’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively.
[25] Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
[26] See note 13 to the consolidated financial statements.
[27] Denotes a Level 1 investment.
[28] See note 15 to the consolidated financial statements.
[29] See note 9 to the consolidated financial statements.
[30] See note 14 to the consolidated financial statements.
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Schedule of Investments (Parenthetical) - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Percentage representing senior secured loans in investments owned 134.40% 111.50%
Percentage representing equipment financing in investments owned 23.70% 32.50%
Percentage representing preferred equity in investments owned 0.40% 0.70%
Percentage representing common equity or equity interests or warrants owned 55.70% 53.60%
Percentage representing total investments in investments owned 214.20% 198.30%
Percentage representing cash equivalents in investments owned 26.70% 38.00%
Percentage representing total investments and cash equivalents in investments owned 240.90% 236.30%
Percentage representing liabilities in excess of other assets in investments owned (140.90%) (136.30%)
Percentage representing net assets in investments owned 100.00% 100.00%
Percentage of outstanding voting securities of the investment 25.00% 25.00%
Percentage of non-qualifying assets in the portfolio of total assets 22.70% 23.10%
Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net $ 13,274 $ 19,495
Tax Basis of Investments, Gross, Unrealized Appreciation 159,987 82,598
Tax Basis of Investments, Gross, Unrealized Depreciation 146,713 63,103
Investment Owned tax costs $ 2,142,087 $ 1,651,087
Spread One [Member]    
Percentage spread as cash 5.50% 6.00%
Percentage spread as paid in kind 0.50% 2.00%
Spread Two [Member]    
Percentage spread as cash   2.50%
Percentage spread as paid in kind   12.50%
Spread Three [Member]    
Percentage spread as cash   5.50%
Percentage spread as paid in kind   0.50%
Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance $ 706,203 $ 709,653
Gross Additions 121,806 1,541
Gross Reductions 20,224 14,189
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (20,602) 9,113
Interest/Dividend Income 39,681 48,942
Ending balance 786,534 706,203
AviatorCap SII LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 2,941
Gross Additions   0
Gross Reductions   2,941
Net realized gain (loss)   0
Net change in unrealized gain (loss)   0
Interest/Dividend Income   92
Ending balance   0
Equipment Operating Leases LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 18,939 25,540
Gross Additions 0 0
Gross Reductions 15,725 6,667
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 633 66
Interest/Dividend Income 668 1,950
Ending balance 3,847 18,939
Kingsbridge Holdings, LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 80,000 80,000
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (64) (79)
Interest/Dividend Income 5,182 6,568
Ending balance 80,000 80,000
KBH Topco LLC (Kingsbridge) [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 145,996 136,596
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 1,004 9,400
Interest/Dividend Income 11,288 13,250
Ending balance 147,000 145,996
Loyer Capital LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 10,725 14,456
Gross Additions 0 0
Gross Reductions 3,500 3,731
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 136 0
Interest/Dividend Income 812 1,426
Ending balance 7,361 10,725
RD Holdco Inc Common Equity [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 1,226
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 (1,226)
Interest/Dividend Income 0 0
Ending balance 0 0
RD Holdco Inc Class B [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 5,216 5,216
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (5,216) 0
Interest/Dividend Income 0 0
Ending balance 0 5,216
RD Holdco Inc Warrants [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 0
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Interest/Dividend Income 0 0
Ending balance 0 0
RD Holdco Inc Debt [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 11,829  
Gross Additions 685  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (5,351)  
Interest/Dividend Income (18)  
Ending balance 6,450 11,829
Rug Doctor LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 11,829 10,559
Gross Additions   1,270
Gross Reductions   0
Net realized gain (loss)   0
Net change in unrealized gain (loss)   (6)
Interest/Dividend Income   1,300
Ending balance   11,829
SLR Business Credit [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0  
Gross Additions 81,583  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) 7,787  
Interest/Dividend Income 3,400  
Ending balance 89,370 0
SLR Credit Solutions [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 298,766 296,766
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (10,006) 2,000
Interest/Dividend Income 15,500 22,500
Ending balance 288,760 298,766
SLR Equipment Finance Equity [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 129,102 129,102
Gross Additions 0 0
Gross Reductions 0 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (8,282) 0
Interest/Dividend Income 0 0
Ending balance 120,820 129,102
SLR Equipment Finance Debt [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0 850
Gross Additions 5,000 0
Gross Reductions 0 850
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 0 0
Interest/Dividend Income 270 42
Ending balance 5,000 0
SLR Healthcare ABL [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 0  
Gross Additions 34,335  
Gross Reductions 0  
Net realized gain (loss) 0  
Net change in unrealized gain (loss) (585)  
Interest/Dividend Income 1,730  
Ending balance 33,750 0
SOAGG LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 1,121 2,300
Gross Additions 0 0
Gross Reductions 447 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) (674) (1,179)
Interest/Dividend Income 647 1,543
Ending balance 0 1,121
SOINT LLC [Member] | Companies more than 25% owned [Member]    
Investment Company Change in Net Assets    
Beginning balance 4,509 4,101
Gross Additions 203 271
Gross Reductions 552 0
Net realized gain (loss) 0 0
Net change in unrealized gain (loss) 16 137
Interest/Dividend Income 202 271
Ending balance $ 4,176 $ 4,509
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
N-2 - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Cover [Abstract]                      
Entity Central Index Key 0001418076                    
Amendment Flag false                    
Securities Act File Number 814-00754                    
Document Type 10-Q                    
Entity Registrant Name SLR INVESTMENT CORP.                    
Entity Address, Address Line One 500 Park Avenue                    
Entity Address, City or Town New York                    
Entity Address, State or Province NY                    
Entity Address, Postal Zip Code 10022                    
City Area Code 212                    
Local Phone Number 993-1670                    
Entity Emerging Growth Company false                    
Financial Highlights [Abstract]                      
Senior Securities [Table Text Block]
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2022 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Credit Facility
                                   
Fiscal 2022 (through September 30, 2022)
   $ 360,000      $ 583        —          N/A  
Fiscal 2021
     222,500        552        —          N/A  
Fiscal 2020
     126,000        421        —          N/A  
Fiscal 2019
     42,900        182        —          N/A  
Fiscal 2018
     96,400        593        —          N/A  
Fiscal 2017
     245,600        1,225        —          N/A  
Fiscal 2016
     115,200        990        —          N/A  
Fiscal 2015
     207,900        1,459        —          N/A  
Fiscal 2014
     —          —          —          N/A  
Fiscal 2013
     —          —          —          N/A  
Fiscal 2012
     264,452        1,510        —          N/A  
SPV Credit Facility
                                   
Fiscal 2022 (through September 30, 2022)
     130,200        211        —          N/A  
2022 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     —          —          —          N/A  
Fiscal 2021
     150,000        372        —          N/A  
Fiscal 2020
     150,000        501        —          N/A  
Fiscal 2019
     150,000        638        —          N/A  
Fiscal 2018
     150,000        923        —          N/A  
Fiscal 2017
     150,000        748        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
2022 Tranche C Notes
                                   
Fiscal 2022 (through September 30, 2022)
     21,000        34        —          N/A  
Fiscal 2021
     21,000        52        —          N/A  
Fiscal 2020
     21,000        70        —          N/A  
Fiscal 2019
     21,000        89        —          N/A  
Fiscal 2018
     21,000        129        —          N/A  
Fiscal 2017
     21,000        105        —          N/A  
2023 Unsecured Notes
                                   
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Fiscal 2022 (through September 30, 2022)
     75,000        121        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     75,000        461        —          N/A  
Fiscal 2017
     75,000        374        —          N/A  
2024 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     125,000        202        —          N/A  
Fiscal 2021
     125,000        309        —          N/A  
Fiscal 2020
     125,000        417        —          N/A  
Fiscal 2019
     125,000        531        —          N/A  
2025 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     85,000        137        —          N/A  
2026 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     75,000        121        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
2027 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     50,000        81        —          N/A  
Fiscal 2021
     50,000        124        —          N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     135,000        218        —          N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     100,000        859        —        $ 1,002  
Fiscal 2015
     100,000        702        —          982  
Fiscal 2014
     100,000        2,294        —          943  
Fiscal 2013
     100,000        2,411        —          934  
Fiscal 2012
     100,000        571        —          923  
Senior Secured Notes
                                   
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     75,000        645        —          N/A  
Fiscal 2015
     75,000        527        —          N/A  
Fiscal 2014
     75,000        1,721        —          N/A  
Fiscal 2013
     75,000        1,808        —          N/A  
Fiscal 2012
     75,000        428        —          N/A  
Term Loans
                                   
Fiscal 2022 (through September 30, 2022)
     100,000        162        —          N/A  
Fiscal 2021
     100,000        248        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     50,000        308        —          N/A  
Fiscal 2017
     50,000        250        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
Fiscal 2015
     50,000        351        —          N/A  
Fiscal 2014
     50,000        1,147        —          N/A  
Fiscal 2013
     50,000        1,206        —          N/A  
Fiscal 2012
     50,000        285        —          N/A  
NEFPASS Facility
                                   
Fiscal 2021
     —          —          —          N/A  
Fiscal 2020
     30,000        100        —          N/A  
Fiscal 2019
     30,000        128        —          N/A  
Fiscal 2018
     30,000        185        —          N/A  
SSLP Facility
                                   
Fiscal 2019
     —          —          —          N/A  
Fiscal 2018
     53,785        331        —          N/A  
Total Senior Securities
                                   
Fiscal 2022 (through September 30, 2022)
   $ 1,156,200      $ 1,870        —          N/A  
Fiscal 2021
     818,500        2,029        —          N/A  
Fiscal 2020
     677,000        2,259        —          N/A  
Fiscal 2019
     593,900        2,525        —          N/A  
Fiscal 2018
     476,185        2,930        —          N/A  
Fiscal 2017
     541,600        2,702        —          N/A  
Fiscal 2016
     390,200        3,354        —          N/A  
Fiscal 2015
     432,900        3,039        —          N/A  
Fiscal 2014
     225,000        5,162        —          N/A  
Fiscal 2013
     225,000        5,425        —          N/A  
Fiscal 2012
     489,452        2,794        —          N/A  
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2022, asset coverage was 187.0%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014, 2013 and 2012 periods was $100,175, $98,196, $94,301, $93,392, and $92,302, respectively.
                   
Senior Securities Amount [1] $ 1,156,200 $ 818,500 $ 677,000 $ 593,900 $ 476,185 $ 541,600 $ 390,200 $ 432,900 $ 225,000 $ 225,000 $ 489,452
Senior Securities Coverage per Unit [2] $ 1,870 $ 2,029 $ 2,259 $ 2,525 $ 2,930 $ 2,702 $ 3,354 $ 3,039 $ 5,162 $ 5,425 $ 2,794
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Senior Securities, Note [Text Block]
Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2022 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Credit Facility
                                   
Fiscal 2022 (through September 30, 2022)
   $ 360,000      $ 583        —          N/A  
Fiscal 2021
     222,500        552        —          N/A  
Fiscal 2020
     126,000        421        —          N/A  
Fiscal 2019
     42,900        182        —          N/A  
Fiscal 2018
     96,400        593        —          N/A  
Fiscal 2017
     245,600        1,225        —          N/A  
Fiscal 2016
     115,200        990        —          N/A  
Fiscal 2015
     207,900        1,459        —          N/A  
Fiscal 2014
     —          —          —          N/A  
Fiscal 2013
     —          —          —          N/A  
Fiscal 2012
     264,452        1,510        —          N/A  
SPV Credit Facility
                                   
Fiscal 2022 (through September 30, 2022)
     130,200        211        —          N/A  
2022 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     —          —          —          N/A  
Fiscal 2021
     150,000        372        —          N/A  
Fiscal 2020
     150,000        501        —          N/A  
Fiscal 2019
     150,000        638        —          N/A  
Fiscal 2018
     150,000        923        —          N/A  
Fiscal 2017
     150,000        748        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
2022 Tranche C Notes
                                   
Fiscal 2022 (through September 30, 2022)
     21,000        34        —          N/A  
Fiscal 2021
     21,000        52        —          N/A  
Fiscal 2020
     21,000        70        —          N/A  
Fiscal 2019
     21,000        89        —          N/A  
Fiscal 2018
     21,000        129        —          N/A  
Fiscal 2017
     21,000        105        —          N/A  
2023 Unsecured Notes
                                   
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Fiscal 2022 (through September 30, 2022)
     75,000        121        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     75,000        461        —          N/A  
Fiscal 2017
     75,000        374        —          N/A  
2024 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     125,000        202        —          N/A  
Fiscal 2021
     125,000        309        —          N/A  
Fiscal 2020
     125,000        417        —          N/A  
Fiscal 2019
     125,000        531        —          N/A  
2025 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     85,000        137        —          N/A  
2026 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     75,000        121        —          N/A  
Fiscal 2021
     75,000        186        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
2027 Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     50,000        81        —          N/A  
Fiscal 2021
     50,000        124        —          N/A  
2027 Series F Unsecured Notes
                                   
Fiscal 2022 (through September 30, 2022)
     135,000        218        —          N/A  
2042 Unsecured Notes
                                   
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     100,000        859        —        $ 1,002  
Fiscal 2015
     100,000        702        —          982  
Fiscal 2014
     100,000        2,294        —          943  
Fiscal 2013
     100,000        2,411        —          934  
Fiscal 2012
     100,000        571        —          923  
Senior Secured Notes
                                   
Fiscal 2017
     —          —          —          N/A  
Fiscal 2016
     75,000        645        —          N/A  
Fiscal 2015
     75,000        527        —          N/A  
Fiscal 2014
     75,000        1,721        —          N/A  
Fiscal 2013
     75,000        1,808        —          N/A  
Fiscal 2012
     75,000        428        —          N/A  
Term Loans
                                   
Fiscal 2022 (through September 30, 2022)
     100,000        162        —          N/A  
Fiscal 2021
     100,000        248        —          N/A  
Fiscal 2020
     75,000        250        —          N/A  
Fiscal 2019
     75,000        319        —          N/A  
Fiscal 2018
     50,000        308        —          N/A  
Fiscal 2017
     50,000        250        —          N/A  
Fiscal 2016
     50,000        430        —          N/A  
Fiscal 2015
     50,000        351        —          N/A  
Fiscal 2014
     50,000        1,147        —          N/A  
Fiscal 2013
     50,000        1,206        —          N/A  
Fiscal 2012
     50,000        285        —          N/A  
NEFPASS Facility
                                   
Fiscal 2021
     —          —          —          N/A  
Fiscal 2020
     30,000        100        —          N/A  
Fiscal 2019
     30,000        128        —          N/A  
Fiscal 2018
     30,000        185        —          N/A  
SSLP Facility
                                   
Fiscal 2019
     —          —          —          N/A  
Fiscal 2018
     53,785        331        —          N/A  
Total Senior Securities
                                   
Fiscal 2022 (through September 30, 2022)
   $ 1,156,200      $ 1,870        —          N/A  
Fiscal 2021
     818,500        2,029        —          N/A  
Fiscal 2020
     677,000        2,259        —          N/A  
Fiscal 2019
     593,900        2,525        —          N/A  
Fiscal 2018
     476,185        2,930        —          N/A  
Fiscal 2017
     541,600        2,702        —          N/A  
Fiscal 2016
     390,200        3,354        —          N/A  
Fiscal 2015
     432,900        3,039        —          N/A  
Fiscal 2014
     225,000        5,162        —          N/A  
Fiscal 2013
     225,000        5,425        —          N/A  
Fiscal 2012
     489,452        2,794        —          N/A  
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2022, asset coverage was 187.0%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014, 2013 and 2012 periods was $100,175, $98,196, $94,301, $93,392, and $92,302, respectively.
                   
General Description of Registrant [Abstract]                      
Investment Objectives and Practices [Text Block]
Portfolio and Investment Activity
During the three months ended September 30, 2022, we invested approximately $245.4 million across 44 portfolio companies. This compares to investing approximately $230.7 million in 23 portfolio companies for the three months ended September 30, 2021. Investments sold, prepaid or repaid during the three months ended September 30, 2022 totaled approximately $81.1 million versus approximately $105.9 million for the three months ended September 30, 2021.
At September 30, 2022, our portfolio consisted of 135 portfolio companies and was invested 30.2% in cash flow senior secured loans, 31.9% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 21.6% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 16.3% in life science senior secured loans, in each case, measured at fair value, versus 106 portfolio companies and was invested 28.4% in cash flow senior secured loans, 26.5% in asset-based senior secured loans / SLR Credit, 30.4% in equipment senior secured financings / SLR Equipment / KBH, and 14.7% in life science senior secured loans, in each case, measured at fair value, at September 30, 2021.
At September 30, 2022, 79.7% or $1.71 billion of our income producing investment portfolio
*
is floating rate and 20.3% or $434.9 million is fixed rate, measured at fair value. At September 30, 2021, 74.1% or $1.20 billion of our income producing investment portfolio
*
is floating rate and 25.9% or $418.4 million is fixed rate, measured at fair value. As of September 30, 2022 and 2021, we had three and one issuers, respectively, on
non-accrual
status.
 
*
 
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
                   
Risk Factors [Table Text Block]
Item 1A.
Risk Factors
In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the March 1, 2022 filing of our Annual Report on
Form 10-K, which
could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended September 30, 2022 to the risk factors discussed in “Risk Factors” in the March 1, 2022 filing of our Annual Report on Form
10-K.
The Russian invasion of Ukraine may have a material adverse impact on us and our portfolio companies.
On February 24, 2022, the Russian military commenced a full-scale invasion of
Russia’s pre-positioned forces
into Ukraine, which could have a negative impact on the economy and business activity globally (including in the countries in which the Company invests), and therefore could adversely affect the performance of the Company’s investments. Following such invasion, the United States and several European nations announced sanctions against Russia. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to the Company and the performance of its investments or operations, and the ability of the Company to achieve its investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict.
 
                   
Credit Facility                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 360,000 $ 222,500 $ 126,000 $ 42,900 $ 96,400 $ 245,600 $ 115,200 $ 207,900 $ 0 $ 0 $ 264,452
Senior Securities Coverage per Unit [2] $ 583 $ 552 $ 421 $ 182 $ 593 $ 1,225 $ 990 $ 1,459 $ 0 $ 0 $ 1,510
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
SPV Credit Facility                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 130,200                    
Senior Securities Coverage per Unit [2] $ 211                    
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0                    
2022 Unsecured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 0 $ 150,000 $ 150,000 $ 150,000 $ 150,000 $ 150,000 $ 50,000        
Senior Securities Coverage per Unit [2] $ 0 $ 372 $ 501 $ 638 $ 923 $ 748 $ 430        
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0        
2022 Tranche C Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 21,000 $ 21,000 $ 21,000 $ 21,000 $ 21,000 $ 21,000          
Senior Securities Coverage per Unit [2] $ 34 $ 52 $ 70 $ 89 $ 129 $ 105          
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0          
2023 Unsecured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 75,000 $ 75,000 $ 75,000 $ 75,000 $ 75,000 $ 75,000          
Senior Securities Coverage per Unit [2] $ 121 $ 186 $ 250 $ 319 $ 461 $ 374          
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0          
2024 Unsecured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 125,000 $ 125,000 $ 125,000 $ 125,000              
Senior Securities Coverage per Unit [2] $ 202 $ 309 $ 417 $ 531              
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0 $ 0 $ 0              
2025 Unsecured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 85,000                    
Senior Securities Coverage per Unit [2] $ 137                    
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0                    
2026 Unsecured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 75,000 $ 75,000 $ 75,000 $ 75,000              
Senior Securities Coverage per Unit [2] $ 121 $ 186 $ 250 $ 319              
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0 $ 0 $ 0              
2027 Unsecured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 50,000 $ 50,000                  
Senior Securities Coverage per Unit [2] $ 81 $ 124                  
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0                  
2027 Series F Unsecured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 135,000                    
Senior Securities Coverage per Unit [2] $ 218                    
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0                    
2042 Unsecured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1]           $ 0 $ 100,000 $ 100,000 $ 100,000 $ 100,000 $ 100,000
Senior Securities Coverage per Unit [2]           $ 0 $ 859 $ 702 $ 2,294 $ 2,411 $ 571
Senior Securities Involuntary Liquidating Preference per Unit [3]           $ 0 0 0 0 0 0
Senior Securities Average Market Value per Unit [4]             $ 1,002 $ 982 $ 943 $ 934 $ 923
Senior Secured Notes                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1]           $ 0 $ 75,000 $ 75,000 $ 75,000 $ 75,000 $ 75,000
Senior Securities Coverage per Unit [2]           $ 0 $ 645 $ 527 $ 1,721 $ 1,808 $ 428
Senior Securities Involuntary Liquidating Preference per Unit [3]           $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
Term Loans                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1] $ 100,000 $ 100,000 $ 75,000 $ 75,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000 $ 50,000
Senior Securities Coverage per Unit [2] $ 162 $ 248 $ 250 $ 319 $ 308 $ 250 $ 430 $ 351 $ 1,147 $ 1,206 $ 285
Senior Securities Involuntary Liquidating Preference per Unit [3] $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 $ 0
NEFPASS Facility                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1]   $ 0 $ 30,000 $ 30,000 $ 30,000            
Senior Securities Coverage per Unit [2]   $ 0 $ 100 $ 128 $ 185            
Senior Securities Involuntary Liquidating Preference per Unit [3]   $ 0 $ 0 $ 0 $ 0            
SSLP Facility                      
Financial Highlights [Abstract]                      
Senior Securities Amount [1]       $ 0 $ 53,785            
Senior Securities Coverage per Unit [2]       $ 0 $ 331            
Senior Securities Involuntary Liquidating Preference per Unit [3]       $ 0 $ 0            
[1] Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
[2] The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2022, asset coverage was 187.0%.
[3] The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
[4] Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014, 2013 and 2012 periods was $100,175, $98,196, $94,301, $93,392, and $92,302, respectively.
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization
9 Months Ended
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization
Note 1. Organization
Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1,200,000 of which 47.04% was funded by affiliated parties.
Immediately prior to our initial public offering, through a series of transactions, SLR Investment Corp. (the “Company”, “we”, “us” or “our”), merged with Solar Capital LLC, leaving SLR Investment Corp. as the surviving entity (the
“Pre-IPO
Merger”). SLR Investment Corp. issued an aggregate of approximately 26.65 million shares of common stock and $125,000 in senior unsecured notes to the existing Solar Capital LLC unit holders in connection with the
Pre-IPO
Merger. SLR Investment Corp. had no assets or operations prior to completion of the
Pre-IPO
Merger and as a result, the historical books and records of Solar Capital LLC have become the books and records of the surviving entity. The number of shares used to calculate weighted average shares for use in computations on a per share basis have been decreased retroactively by a factor of approximately 0.4022 for all periods prior to February 9, 2010. This factor represents the effective impact of the reduction in shares resulting from the
Pre-IPO
Merger.
SLR Investment Corp., a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On December 1, 2021, we entered into an Agreement and Plan of Merger (the “Merger Agreement”), with SLR Senior Investment Corp., a Maryland corporation (“SUNS”), Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). The Merger Agreement provided that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger,”) and, immediately thereafter, SUNS will merge with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). The Mergers closed on April 1, 2022. See Note 16 for additional information.
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Significant Accounting Policies
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form
10-Q
and Regulation
S-X,
as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2022.
In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included.
 
The significant accounting policies consistently followed by the Company are:
 
(a)
Investment transactions are accounted for on the trade date;
 
(b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation]. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
 
 
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the nine months ended September 30, 2022, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
(c)
Gains or losses on investments are calculated by using the specific identification method.
 
(d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
(e)
The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
(f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP.
 
(g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
(h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
 
 
(i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
(j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
(k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
(l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.
 
(m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
(n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU
2020-04
is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures.
 
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Agreements
9 Months Ended
Sep. 30, 2022
Agreements [Abstract]  
Agreements
 
Note 3. Agreements
The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser will manage the
day-to-day
operations of, and provide investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and nine months ended September 30, 2022 and 2021.
For the three and nine months ended September 30, 2022, the Company recognized $7,890 and $22,019, respectively, in base management fees and $4,965 and $9,699, respectively, in gross performance-based incentive fees. For the three and nine months ended September 30, 2022, $194 and $1,552 of such performance-based incentive fees were waived. For the three and nine months ended September 30, 2021, the Company recognized $7,142 and $20,842, respectively, in base management fees and $698 and $8,444, respectively, in performance-based incentive fees. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Merger. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser.
The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the three and nine months ended September 30, 2022, the Company recognized expenses under the Administration Agreement of $1,132 and $3,684 respectively. For the three and nine months ended September 30, 2021, the Company recognized expenses under the Administration Agreement of $1,435 and $4,170 respectively. No managerial assistance fees were accrued or collected for the three and nine months ended September 30, 2022 and 2021.
 
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Asset Value Per Share
9 Months Ended
Sep. 30, 2022
Net Asset Value Per Share [Abstract]  
Net Asset Value Per Share
 
Note 4. Net Asset Value Per Share
At September 30, 2022, the Company’s total net assets and net asset value per share were $1,006,225 and $18.37, respectively. This compares to total net assets and net asset value per share at December 31, 2021 of $842,281 and $19.93, respectively.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Earnings Per Share
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and nine months ended September 30, 2022 and 2021:
 
    
Three months ended September 30,
    
Nine months ended September 30,
 
    
2022
    
2021
    
2022
    
2021
 
Earnings (loss) per share (basic & diluted)
                                   
Numerator - net increase (decrease) in net assets resulting from operations:
   $ 13,528      $ 13,371      $ (655    $ 53,448  
Denominator - weighted average shares:
     54,772,651        42,260,826        50,647,874        42,260,826  
Earnings (loss) per share:
   $ 0.25      $ 0.32      ($ 0.01    $ 1.26  
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Fair Value
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of September 30, 2022 and December 31, 2021:
Fair Value Measurements
As of September 30, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $ —        $ —        $ 1,352,503      $ 1,352,503  
Equipment Financing
     —          —          238,553        238,553  
Preferred Equity
     —          —          4,176        4,176  
Common Equity/Equity Interests/Warrants
     620        —          559,509        560,129  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments$
   $ 620      $ —        $  2,154,741      $ 2,155,361  
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $ —        $ —        $ 939,690      $ 939,690  
Equipment Financing
     —          —          273,795        273,795  
Preferred Equity
     —          —          5,630        5,630  
Common Equity/Equity Interests/Warrants
     1,086        —          450,381        451,467  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments$
   $ 1,086      $ —        $  1,669,496      $ 1,670,582  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
                                   
2022 Unsecured Notes
   $ —        $ —        $ 150,000      $ 150,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
The following tables provide a summary of the changes in fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at September 30, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, June
 30, 2022
   $  1,178,247     $  255,978     $  4,405     $ 554,597     $ 1,993,227  
Total gains or losses included in earnings:
                                        
Net realized loss
     (37,231     —         —         —         (37,231
Net change in unrealized gain (loss)
     34,518       (3,849     59       (139     30,589  
Purchase of investment securities
     228,399       15,581       67       5,051       249,098  
Proceeds from dispositions of investment securities
     (51,430     (29,157     (355     —         (80,942
Transfers in/out of Level 3
     —         —         —         —         —    
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, September
 30, 2022
   $ 1,352,503     $ 238,553     $ 4,176     $ 559,509     $ 2,154,741  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized gain (loss)
   $ 781     $ (3,849   $ 59     $ (139   $ (3,148
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $  273,795     $  5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
                                        
Net realized loss
     (37,191     —         —         —         (37,191
Net change in unrealized loss
     (1,890     (6,828     (658     (7,121     (16,497
Purchase of investment securities(1)
     639,306       44,202       202       116,249       799,959  
Proceeds from dispositions of investment securities
     (187,412     (72,616     (998     —         (261,026
Transfers in/out of Level 3
     —         —         —         —         —    
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, September
 30, 2022
   $  1,352,503     $ 238,553     $ 4,176     $ 559,509     $ 2,154,741  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized loss
   $ (2,744   $ (6,828   $   (658)    $ (7,121   $ (17,351
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Merger.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2022:
 
2022 Unsecured Notes
  
For the three months ended
September 30, 2022
 
Beginning fair value
   $  —    
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     —    
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ —    
    
 
 
 
 
2022 Unsecured Notes
  
For the nine months ended
September 30, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     (150,000
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ —    
    
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full.
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2020
   $ 798,052     $  284,846     $ 6,401     $ 440,971     $ 1,530,270  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
     —         (8     —         345       337  
Net change in unrealized gain (loss)
     (13,567     1,394       (1,042     9,857       (3,358
Purchase of investment securities
     533,614       76,700       271       —         610,585  
Proceeds from dispositions of investment securities
     (378,409     (89,137     —         (675     (468,221
Transfers in/out of Level 3
(1)
     —         —         —         (117     (117
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized gain (loss)
   $ (12,837   $ 1,394     $ (1,042   $ 9,597     $ (2,888
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2021
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     —    
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ 150,000  
    
 
 
 
The Company made elections to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On December 31, 2021, there were borrowings of $150,000 on the 2022 Unsecured Notes.
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2022 is summarized in the table below:
 
 
  
Asset or
Liability
  
Fair Value at
September 30, 2022
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
1,320,263
32,240
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
7.6% – 17.8% (10.9%)
0.1x-21.4x(12.0x)
Equipment Financing
   Asset    $
$
117,733
120,820
 
 
   Income Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
  
8.5% – 9.7% (9.7%)
1.0x-1.28x
(1.14x)
Preferred Equity
   Asset    $ 4,176      Income Approach   Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
147,629
411,880
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
  
7.0x – 9.3x (8.1x)
6.3% – 37.7% (9.7%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using a transaction multiple.
(3)
Includes $624 of investments valued using a Black-Scholes model and $147,005 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below:
 
 
  
Asset or
Liability
  
Fair Value at
December 31, 2021
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
931,769
7,921
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
4.0% – 19.6% (8.7%)
2.0x-3.0x(2.5x)/2.0x-3.0x(2.5x)
Equipment Financing
   Asset    $
$
144,693
 129,102
 
 
   Income Approach
Market Approach
  Market Yield
Return on Equity
  
7.1% – 20.3% (9.8%)
4.6%-4.6%
(4.6%)
Preferred Equity
   Asset    $ 5,630      Income Approach   Market Yield    3.5% – 8.0% (4.4%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
151,615
298,766
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
  
5.8x – 10.5x (9.5x)
6.1% – 18.5% (8.6%)
2022 Unsecured Notes
   Liability    $ 150,000      Income Approach   Market Yield    2.2% – 4.6% (4.5%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected EBITDA multiples
(2x-3x)
for certain segments of the business and expected revenue multiples
(2x-3x)
for certain segments of the business.
(2)
Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple.
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments.
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt
9 Months Ended
Sep. 30, 2022
Debt Instruments [Abstract]  
Debt
Note 7. Debt
Our debt obligations consisted of the following as of September 30, 2022 and December 31, 2021:
 
    
September 30, 2022
   
December 31, 2021
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 460,000      $  454,868
(1)
 
  $  322,500      $  318,015
(1)
 
SPV Credit Facility
     130,200        129,236
(2)
 
    —          —    
2022 Unsecured Notes
     —          —         150,000        150,000  
2022 Tranche C Notes
     21,000        20,991
(3)
 
    21,000        20,964
(3)
 
2023 Unsecured Notes
     75,000        74,881
(4)
 
    75,000        74,592
(4)
 
2024 Unsecured Notes
     125,000        124,350
(5)
 
    125,000        124,143
(5)
 
2025 Unsecured Notes
     85,000        84,572
(6)
 
    —          —    
2026 Unsecured Notes
     75,000        74,468
(7)
 
    75,000        74,384
(7)
 
2027 Unsecured Notes
     50,000        49,950
(8)
 
    50,000        49,940
(8)
 
2027 Series F Unsecured Notes
     135,000        134,975
(9)
 
    —          —    
    
 
 
    
 
 
   
 
 
    
 
 
 
     $  1,156,200      $  1,148,291     $  818,500      $  812,038  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $5,132 and $4,485 as of September 30, 2022 and December 31, 2021, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $964 as of September 30, 2022.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $9 and $36 as of September 30, 2022 and December 31, 2021, respectively.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $119 and $408 as of September 30, 2022 and December 31, 2021, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $650 and $857 as of September 30, 2022 and December 31, 2021, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized market discount of $428 as of September 30, 2022.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $532 and $616 as of September 30, 2022 and December 31, 2021, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $50 and $60 as of September 30, 2022 and December 31, 2021, respectively.
(9)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $25 as of September 30, 2022.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2017, the Company closed a private offering of $21,000 of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were issued in a private placement only to qualified institutional buyers.
On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023.
On February 15, 2017, the Company closed a private offering of $100,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On November 8, 2016, the Company closed a private offering of $50,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of
May 8, 2022
. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity.
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is LIBOR plus
2.00%-2.50%
with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2022, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $130,200.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, the Credit Facility is composed of $600,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At September 30, 2022, outstanding USD equivalent borrowings under the Credit Facility totaled $460,000, composed of $360,000 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
 
The average annualized interest cost for all borrowings for the nine months ended September 30, 2022 and the year ended December 31, 2021 was 3.81% and 3.64%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2022 Unsecured Notes, the 2022 Tranche C Notes, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the nine months ended September 30, 2022 and the year ended December 31, 2021 were $1,157,100 and $902,550, respectively.
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Highlights
9 Months Ended
Sep. 30, 2022
Investment Company, Financial Highlights [Abstract]  
Financial Highlights
Note 8. Financial Highlights
The following is a schedule of financial highlights for the nine months ended September 30, 2022 and 2021:
 
    
Nine months ended
September 30, 2022
   
Nine months ended
September 30, 2021
 
Per Share Data: (a)
                
Net asset value, beginning of year
   $ 19.93     $ 20.16  
    
 
 
   
 
 
 
Net investment income
     1.06       1.09  
Net realized and unrealized gain (loss)
     (1.08 )*      0.18  
    
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     (0.02     1.27  
Issuance of common stock in connection with the Merger
     (0.31     —    
Distributions to stockholders:
                
From net investment income
     (1.06     (1.23
From return of capital
 
 
(0.17
)
 
 
 
 
    
 
 
   
 
 
 
Net asset value, end of period
   $ 18.37     $ 20.20  
    
 
 
   
 
 
 
Per share market value, end of period
   $ 12.32     $ 19.13  
Total Return (b)(c)
     (27.75 %)      16.46
Net assets, end of period
   $ 1,006,225     $ 853,490  
Shares outstanding, end of period
     54,772,651       42,260,826  
Ratios to average net assets (c):
                
Net investment income
     5.51     5.38
    
 
 
   
 
 
 
Operating expenses
     3.90 %**      4.23
Interest and other credit facility expenses
     3.22     2.51
    
 
 
   
 
 
 
Total expenses
     7.12 %**      6.74
    
 
 
   
 
 
 
Average debt outstanding
   $ 951,995     $ 672,962  
Portfolio turnover ratio
     13.8     20.8
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per Share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2021 and December 31, 2020 was $18.43 and $17.51, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a permanent incentive fee waiver (see note 3).
For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the incentive fee waiver.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
SLR Credit Solutions
9 Months Ended
Sep. 30, 2022
Line of Credit Facility [Abstract]  
SLR Credit Solution
Note 9. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of September 30, 2022, total commitments to the revolving credit facility are $250,000.
As of September 30, 2022 SLR Credit had 27 funded commitments to 21 different issuers with total funded loans of approximately $354,853 on total assets of $375,603. As of December 31, 2021 SLR Credit had 22 funded commitments to 19 different issuers with total funded loans of approximately $287,375 on total assets of $347,821. As of September 30, 2022 and December 31, 2021, the largest loan outstanding totaled $34,178 and $35,000, respectively. For the same periods, the average exposure per issuer was $16,898 and $15,125, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $139,497 and $100,742 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Credit had net income of $3,897 and $5,445, respectively, on gross income of $8,596 and $9,508, respectively. For the nine months ended September 30, 2022 and 2021, SLR Credit had net income of $8,557 and $12,497 respectively, on gross income of $22,171 and $27,239, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
 
Note 10. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of September 30, 2022 and December 31, 2021 is $310,204 and $226,733, respectively, comprised of the following:
 
    
September

30, 2022
    
December

31, 2021
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Apeel Technology, Inc.
     32,786        —    
World Insurance Associates, LLC
     25,554        —    
CC SAG Holdings Corp. (Spectrum Automotive)
     24,346        18,827  
Human Interest, Inc.
     20,104        —    
Glooko, Inc.
     17,868        25,091  
Spectrum Pharmaceuticals, Inc.
     12,279        —    
iCIMS, Inc.
     11,577        —    
BridgeBio Pharma, Inc.
     9,016        23,049  
BDG Media, Inc.
     8,573        —    
RSC Acquisition, Inc.
     8,553        —    
Arcutis Biotherapeutics, Inc.
     8,356        43,470  
Atria Wealth Solutions, Inc.
     8,215        3,746  
Ardelyx, Inc.
     7,752        —    
Luxury Asset Capital, LLC
     7,500        —    
OIS Management Services, LLC
     5,205        —    
Vessco Midco Holdings, LLC
     4,098        —    
One Touch Direct, LLC
     4,013        7,226  
Kaseya, Inc.
     3,936        —    
Maurices, Incorporated
     3,922        5,649  
Foundation Consumer Brands, LLC
     3,009        2,269  
Inszone Mid, LLC
     2,790        12,465  
Kid Distro Holdings, LLC
     2,650        2,650  
Plastics Management, LLC
     2,424        —    
Pediatric Home Respiratory Services, LLC
     2,380        —    
Southern Orthodontic Partners Management, LLC
     2,292        —    
Basic Fun, Inc.
     2,150        1,935  
Copper River Seafoods, Inc.
     2,043        —    
Peter C. Foy & Associates Insurance Services, LLC
     1,969        —    
Orthopedic Care Partners Management, LLC
     1,896        —    
MMIT Holdings, LLC
     1,894        2,009  
SPAR Marketing Force, Inc.
     1,613        —    
Ivy Fertility Services, LLC
     1,571        4,532  
NAC Holdings Corporation
     1,479        4,765  
SLR Healthcare ABL*
     1,400        —    
RxSense Holdings LLC
     1,250        —    
Erie Construction
Mid-west,
LLC
     1,247        —    
Composite Technology Acquisition Corp.
     1,139        —    
Enverus Holdings, Inc.
     1,004        —    
SLR Equipment Finance
     1,000        5,000  
American Teleconferencing Services, Ltd.
     914        573  
SunMed Group Holdings, LLC
     843        828  
All State Ag Parts, LLC
     730        —    
Ultimate Baked Goods Midco LLC
     551        801  
BayMark Health Services, Inc.
     391        —    
Pinnacle Treatment Centers, Inc.
     387        1,414  
GSM Acquisition Corp.
     365        —    
High Street Buyer, Inc.
     327        —    
Tilley Distribution, Inc.
     293        —    
TAUC Management, LLC
     287        —    
RQM+ Corp.
     —          3,818  
Rezolute, Inc.
     —          5,675  
SOC Telemed, Inc.
     —          4,448  
Neuronetics, Inc.
     —          2,230  
    
 
 
    
 
 
 
Total Commitments
   $  310,204      $  226,733  
    
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
 
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.​​​​​​​
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
SLR Equipment Finance
9 Months Ended
Sep. 30, 2022
Schedule of Equity Method Investments [Line Items]  
SLR Equipment Finance
Note 13. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired an 87.5% equity interest in Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a newly formed Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continue to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of September 30, 2022 and December 31, 2021, KBHT had total assets of $774,619 and $738,425, respectively. For the same periods, debt recourse to KBHT totaled $246,210 and $216,881, respectively, and
non-recourse
debt totaled $316,840 and $323,844, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2022 and 2021, KBHT had net income of $3,327 and $3,163, respectively, on gross income of $71,332 and $60,510, respectively. For the nine months ended September 30, 2022 and 2021, KBHT had net income of $10,393 and $10,314, respectively, on gross income of $215,074 and $180,079, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
SLR Equipment Finance [Member]  
Schedule of Equity Method Investments [Line Items]  
SLR Equipment Finance
Note 11. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies is doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023.
As of September 30, 2022, SLR Equipment had 129 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $189,254 on total assets of $241,189. As of December 31, 2021, SLR Equipment had 135 funded equipment-backed leases and loans to 61 different customers with a total net investment in leases and loans of approximately $210,986 on total assets of $264,007. As of September 30, 2022 and December 31, 2021, the largest position outstanding totaled $19,272 and $19,207, respectively. For the same periods, the average exposure per customer was $3,208 and $3,459, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $110,997 and $118,002 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and September 30, 2021, SLR Equipment had net income (loss) of $1,034 and ($306), respectively, on gross income of $6,486 and $5,809, respectively. For the nine months ended September 30, 2022 and September 30, 2021, SLR Equipment had net loss of $125 and $2,301, respectively, on gross income of $15,704 and $16,443, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions.
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Capital Share Transactions
9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
Capital Share Transactions
Note 12. Capital Share Transactions
As of September 30, 2022 and September 30, 2021, 200,000,000 shares of $0.01 par value capital stock were authorized.
Transactions in capital stock were as follows:
 
                                                                                                                                                     
    
Shares
    
Amount
 
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2021
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2021
 
Shares issued in connection with the Mergers
  
 
—  
 
  
 
—  
 
  
$
—  
 
  
$
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
  
 
—  
 
  
 
—  
 
  
$
—  
 
  
$
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
                                                                                                                                                     
    
Shares
    
Amount
 
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2021
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2021
 
Shares issued in connection with the Mergers
  
 
12,511,825
 
  
 
—  
 
  
$
226,839
 
  
$
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
  
 
12,511,825
 
  
 
—  
 
  
$
226,839
 
  
$
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Kingsbridge Holdings, LLC
9 Months Ended
Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]  
Kingsbridge Holdings, LLC
Note 13. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired an 87.5% equity interest in Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a newly formed Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continue to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of September 30, 2022 and December 31, 2021, KBHT had total assets of $774,619 and $738,425, respectively. For the same periods, debt recourse to KBHT totaled $246,210 and $216,881, respectively, and
non-recourse
debt totaled $316,840 and $323,844, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2022 and 2021, KBHT had net income of $3,327 and $3,163, respectively, on gross income of $71,332 and $60,510, respectively. For the nine months ended September 30, 2022 and 2021, KBHT had net income of $10,393 and $10,314, respectively, on gross income of $215,074 and $180,079, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us.
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
SLR Healthcare ABL
9 Months Ended
Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]  
SLR Healthcare ABL
Note 14. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of September 30, 2022, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Merger on April 1, 2022.
Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year,
non-recourse,
$100,000 credit facility with
non-affiliates,
which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023.
 
 
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2022, the portfolio totaled approximat
e
ly $179,633
of commitments with a total net investment in loans of $81,360 on total assets of $93,010. As of December 31, 2021, the portfolio totaled approximately $183,501 of commitments with a total net investment in loans of $81,604 on total assets of $91,275. At September 30, 2022, the portfolio consisted of 37 issuers with an average balance of approximately $2,199 versus 36 issuers with an average balance of approximately $2,267 at December 31, 2021. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $62,000 and $60,000 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Healthcare had net income (loss) of $822 and ($40), respectively, on gross income of $3,020 and $2,631, respectively. For the nine months ended September 30, 2022 and 2021, SLR Healthcare had net income of $2,543 and $494, respectively, on gross income of $7,898 and $7,035, respectively. Due to timing and
non-cash
items, there
may
be material differences between GAAP net income and cash available for distributions.
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
SLR Business Credit
9 Months Ended
Sep. 30, 2022
Equity Method Investments and Joint Ventures [Abstract]  
SLR Business Credit
Note 15. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Merger on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of
September 30, 2022, the portfolio totaled approximately $554,171 of commitments, of which $295,973 were funded, on total assets of $346,278. As of
December 31, 2021, the portfolio totaled approximately $513,869 of commitments, of which $248,652 were funded, on total assets of $290,794. At
September 30, 2022, the portfolio consisted of 109 issuers with an average balance of approximately $2,715 versus 125 issuers with an average balance
of approximately $1,989 at December 31, 2021. NMC has a senior credit facility with a bank lending group for $240,000 which expires on
November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had
approximately $237,510 and $183,252 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months
ended September 30, 2022 and 2021, SLR Business Credit had net income of $1,977 and $2,577, respectively, on gross income of $7,607 and $6,857,
respectively. For the nine months ended September 30, 2022 and 2021, SLR Business Credit had net income of $5,703 and $4,737, respectively, on
gross income of $20,378 and $16,674, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income
and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and
the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us.
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Merger with SUNS
9 Months Ended
Sep. 30, 2022
Business Combinations [Abstract]  
Merger with SUNS
Note 16. Merger with SUNS
On December 1, 2021, we entered into the Merger Agreement, which provides that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into SUNS, with SUNS continuing as the surviving company and as our wholly-owned subsidiary and, immediately thereafter, SUNS will merge with and into us, with us continuing as the surviving company. Both the Board and SUNS’s board of directors, including all of the respective independent directors, in each case, on the recommendation of a special committee comprised solely of the independent directors of us or SUNS, as applicable, have approved the Merger Agreement and the transactions contemplated thereby.
The Merger Agreement contains customary representations and warranties by each of us, SUNS and the Investment Adviser. The Merger Agreement also contains customary covenants, including, among others, covenants relating to the operation of each of our and SUNS’s businesses during the period prior to the closing of the Mergers.
Consummation of the Mergers, which occurred on April 1, 2022, was subject to certain closing conditions as disclosed in the Merger Agreement.
On April 1, 2022, the Company completed its previously announced acquisition of SUNS. Pursuant to the Merger Agreement, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into the Company, with the Company as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of the Company’s common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Mergers, the Company issued an aggregate of 12,511,825 shares of its common stock to former SUNS stockholders.
The Merger is accounted for as an asset acquisition of SLR Senior Investment Corp. by the Company in accordance with the asset acquisition method of accounting as detailed in ASC
805-50,
Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Merger allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Merger. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain
“non-qualifying”
assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Merger. The Merger was considered a
tax-free
reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes. Prior to the Merger, SUNS was also managed by the Investment Adviser.
The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger:
 
Common stock issued by the Company
(1)
   $ 227,602  
    
 
 
 
Assets acquired:
        
Investments, at fair value
   $ 400,105  
Cash
     2,313  
Other assets
     4,662  
    
 
 
 
Total assets acquired
   $ 407,080  
    
 
 
 
Liabilities assumed:
        
Debt, at fair value
   $ 159,816  
Other liabilities
     2,573  
    
 
 
 
Total liabilities assumed
   $ 162,389  
    
 
 
 
Net assets acquired
   $ 244,691  
    
 
 
 
Total purchase discount
   $ (17,089
    
 
 
 
 
(1)
Based on the market price at closing of $18.13, adjusted for transaction costs.
Letter Agreement
On April 1, 2022, in connection with the consummation of the Mergers, the Company entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by the Company to the Investment Adviser pursuant to the Advisory Agreement, resulting in an annual base management fee rate payable by the Company to the Investment Adviser of 1.50% on gross assets up to 200% of the Company’s total net assets. The Company retained the annual base management fee rate payable by the Company to the Investment Adviser of 1.00% on gross assets that exceed 200% of the Company’s total net assets.
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Repurchase Program
9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
Stock Repurchase Program
Note 17. Stock Repurchase Program
On May 3, 2022, our Board authorized a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases. As of September 30, 2022, no repurchases have taken place.
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events
9 Months Ended
Sep. 30, 2022
Subsequent Events [Abstract]  
Subsequent Events
Note 18. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On October 5, 2022, our Board declared a monthly distribution of $0.136667 per share payable on November 2, 2022 to holders of record as of October 20, 2022.
On October 12, 2022, the Company entered into a joint venture agreement with SunStone Senior Credit L.P. (the “Investor”) to create SLR Senior Lending Program LLC (“SSLP”). The joint venture is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. SSLP intends to seek third party financing to allow the joint venture to utilize leverage. The Company and the Investor expect to begin funding SSLP with investments prior to the end of 2022. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On November 2, 2022, our Board declared a monthly distribution of $0.136667 per share payable on December 1, 2022 to holders of record as of November 17, 2022.
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2022
Accounting Policies [Abstract]  
Recent Accounting Pronouncements
Recent Accounting Pronouncements
In March 2020, the FASB issued Accounting Standards Update
No. 2020-04,
“Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU
2020-04
is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures.
 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share (Tables)
9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Summary of Computation of Basic And Diluted Net
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the three and nine months ended September 30, 2022 and 2021:
 
    
Three months ended September 30,
    
Nine months ended September 30,
 
    
2022
    
2021
    
2022
    
2021
 
Earnings (loss) per share (basic & diluted)
                                   
Numerator - net increase (decrease) in net assets resulting from operations:
   $ 13,528      $ 13,371      $ (655    $ 53,448  
Denominator - weighted average shares:
     54,772,651        42,260,826        50,647,874        42,260,826  
Earnings (loss) per share:
   $ 0.25      $ 0.32      ($ 0.01    $ 1.26  
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value (Tables)
9 Months Ended
Sep. 30, 2022
Fair Value Disclosures [Abstract]  
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of September 30, 2022 and December 31, 2021:
Fair Value Measurements
As of September 30, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $ —        $ —        $ 1,352,503      $ 1,352,503  
Equipment Financing
     —          —          238,553        238,553  
Preferred Equity
     —          —          4,176        4,176  
Common Equity/Equity Interests/Warrants
     620        —          559,509        560,129  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments$
   $ 620      $ —        $  2,154,741      $ 2,155,361  
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2021
 
    
Level 1
    
Level 2
    
Level 3
    
Total
 
Assets:
                                   
Senior Secured Loans
   $ —        $ —        $ 939,690      $ 939,690  
Equipment Financing
     —          —          273,795        273,795  
Preferred Equity
     —          —          5,630        5,630  
Common Equity/Equity Interests/Warrants
     1,086        —          450,381        451,467  
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments$
   $ 1,086      $ —        $  1,669,496      $ 1,670,582  
    
 
 
    
 
 
    
 
 
    
 
 
 
Liabilities:
                                   
2022 Unsecured Notes
   $ —        $ —        $ 150,000      $ 150,000  
    
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Changes in Fair Value of Level 3 Assets and Liabilities
The following tables provide a summary of the changes in fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at September 30, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, June
 30, 2022
   $  1,178,247     $  255,978     $  4,405     $ 554,597     $ 1,993,227  
Total gains or losses included in earnings:
                                        
Net realized loss
     (37,231     —         —         —         (37,231
Net change in unrealized gain (loss)
     34,518       (3,849     59       (139     30,589  
Purchase of investment securities
     228,399       15,581       67       5,051       249,098  
Proceeds from dispositions of investment securities
     (51,430     (29,157     (355     —         (80,942
Transfers in/out of Level 3
     —         —         —         —         —    
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, September
 30, 2022
   $ 1,352,503     $ 238,553     $ 4,176     $ 559,509     $ 2,154,741  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized gain (loss)
   $ 781     $ (3,849   $ 59     $ (139   $ (3,148
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $  273,795     $  5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
                                        
Net realized loss
     (37,191     —         —         —         (37,191
Net change in unrealized loss
     (1,890     (6,828     (658     (7,121     (16,497
Purchase of investment securities(1)
     639,306       44,202       202       116,249       799,959  
Proceeds from dispositions of investment securities
     (187,412     (72,616     (998     —         (261,026
Transfers in/out of Level 3
     —         —         —         —         —    
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, September
 30, 2022
   $  1,352,503     $ 238,553     $ 4,176     $ 559,509     $ 2,154,741  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized loss
   $ (2,744   $ (6,828   $   (658)    $ (7,121   $ (17,351
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Merger.
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2020
   $ 798,052     $  284,846     $ 6,401     $ 440,971     $ 1,530,270  
Total gains or losses included in earnings:
                                        
Net realized gain (loss)
     —         (8     —         345       337  
Net change in unrealized gain (loss)
     (13,567     1,394       (1,042     9,857       (3,358
Purchase of investment securities
     533,614       76,700       271       —         610,585  
Proceeds from dispositions of investment securities
     (378,409     (89,137     —         (675     (468,221
Transfers in/out of Level 3
(1)
     —         —         —         (117     (117
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
                                        
Net change in unrealized gain (loss)
   $ (12,837   $ 1,394     $ (1,042   $ 9,597     $ (2,888
    
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset.
Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3)
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2022:
 
2022 Unsecured Notes
  
For the three months ended
September 30, 2022
 
Beginning fair value
   $  —    
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     —    
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ —    
    
 
 
 
 
2022 Unsecured Notes
  
For the nine months ended
September 30, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     (150,000
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ —    
    
 
 
 
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2021
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
     —    
Net change in unrealized (gain) loss
     —    
Borrowings
     —    
Repayments
     —    
Transfers in/out of Level 3
     —    
    
 
 
 
Ending fair value
   $ 150,000  
    
 
 
 
Summary of Quantitative Information about the Company's Level 3 Asset and Liability
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2022 is summarized in the table below:
 
 
  
Asset or
Liability
  
Fair Value at
September 30, 2022
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
1,320,263
32,240
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
7.6% – 17.8% (10.9%)
0.1x-21.4x(12.0x)
Equipment Financing
   Asset    $
$
117,733
120,820
 
 
   Income Approach
Market Multiple
(2)
  Market Yield
Comparable Multiple
  
8.5% – 9.7% (9.7%)
1.0x-1.28x
(1.14x)
Preferred Equity
   Asset    $ 4,176      Income Approach   Market Yield    5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
147,629
411,880
 
 
   Market Multiple
(3)
Market Approach
  Comparable Multiple
Return on Equity
  
7.0x – 9.3x (8.1x)
6.3% – 37.7% (9.7%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using a transaction multiple.
(3)
Includes $624 of investments valued using a Black-Scholes model and $147,005 of investments valued using an EBITDA multiple.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below:
 
 
  
Asset or
Liability
  
Fair Value at
December 31, 2021
 
  
Principal Valuation
Technique/Methodology
 
Unobservable Input
  
Range (Weighted
Average)
Senior Secured Loans
   Asset    $
$
931,769
7,921
 
 
   Income Approach
Market Multiple
(1)
  Market Yield
Comparable Multiple
  
4.0% – 19.6% (8.7%)
2.0x-3.0x(2.5x)/2.0x-3.0x(2.5x)
Equipment Financing
   Asset    $
$
144,693
 129,102
 
 
   Income Approach
Market Approach
  Market Yield
Return on Equity
  
7.1% – 20.3% (9.8%)
4.6%-4.6%
(4.6%)
Preferred Equity
   Asset    $ 5,630      Income Approach   Market Yield    3.5% – 8.0% (4.4%)
Common Equity/Equity Interests/Warrants
   Asset    $
$
151,615
298,766
 
 
   Market Multiple
(2)
Market Approach
  Comparable Multiple
Return on Equity
  
5.8x – 10.5x (9.5x)
6.1% – 18.5% (8.6%)
2022 Unsecured Notes
   Liability    $ 150,000      Income Approach   Market Yield    2.2% – 4.6% (4.5%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected EBITDA multiples
(2x-3x)
for certain segments of the business and expected revenue multiples
(2x-3x)
for certain segments of the business.
(2)
Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple.
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt (Tables)
9 Months Ended
Sep. 30, 2022
Debt Instruments [Abstract]  
Schedule of Long-term Debt Instruments
Our debt obligations consisted of the following as of September 30, 2022 and December 31, 2021:
 
    
September 30, 2022
   
December 31, 2021
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 460,000      $  454,868
(1)
 
  $  322,500      $  318,015
(1)
 
SPV Credit Facility
     130,200        129,236
(2)
 
    —          —    
2022 Unsecured Notes
     —          —         150,000        150,000  
2022 Tranche C Notes
     21,000        20,991
(3)
 
    21,000        20,964
(3)
 
2023 Unsecured Notes
     75,000        74,881
(4)
 
    75,000        74,592
(4)
 
2024 Unsecured Notes
     125,000        124,350
(5)
 
    125,000        124,143
(5)
 
2025 Unsecured Notes
     85,000        84,572
(6)
 
    —          —    
2026 Unsecured Notes
     75,000        74,468
(7)
 
    75,000        74,384
(7)
 
2027 Unsecured Notes
     50,000        49,950
(8)
 
    50,000        49,940
(8)
 
2027 Series F Unsecured Notes
     135,000        134,975
(9)
 
    —          —    
    
 
 
    
 
 
   
 
 
    
 
 
 
     $  1,156,200      $  1,148,291     $  818,500      $  812,038  
    
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $5,132 and $4,485 as of September 30, 2022 and December 31, 2021, respectively.
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $964 as of September 30, 2022.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $9 and $36 as of September 30, 2022 and December 31, 2021, respectively.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $119 and $408 as of September 30, 2022 and December 31, 2021, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $650 and $857 as of September 30, 2022 and December 31, 2021, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized market discount of $428 as of September 30, 2022.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $532 and $616 as of September 30, 2022 and December 31, 2021, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $50 and $60 as of September 30, 2022 and December 31, 2021, respectively.
(9)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $25 as of September 30, 2022.
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Highlights (Tables)
9 Months Ended
Sep. 30, 2022
Investment Company, Financial Highlights [Abstract]  
Schedule of financial highlights
The following is a schedule of financial highlights for the nine months ended September 30, 2022 and 2021:
 
    
Nine months ended
September 30, 2022
   
Nine months ended
September 30, 2021
 
Per Share Data: (a)
                
Net asset value, beginning of year
   $ 19.93     $ 20.16  
    
 
 
   
 
 
 
Net investment income
     1.06       1.09  
Net realized and unrealized gain (loss)
     (1.08 )*      0.18  
    
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from operations
     (0.02     1.27  
Issuance of common stock in connection with the Merger
     (0.31     —    
Distributions to stockholders:
                
From net investment income
     (1.06     (1.23
From return of capital
 
 
(0.17
)
 
 
 
 
    
 
 
   
 
 
 
Net asset value, end of period
   $ 18.37     $ 20.20  
    
 
 
   
 
 
 
Per share market value, end of period
   $ 12.32     $ 19.13  
Total Return (b)(c)
     (27.75 %)      16.46
Net assets, end of period
   $ 1,006,225     $ 853,490  
Shares outstanding, end of period
     54,772,651       42,260,826  
Ratios to average net assets (c):
                
Net investment income
     5.51     5.38
    
 
 
   
 
 
 
Operating expenses
     3.90 %**      4.23
Interest and other credit facility expenses
     3.22     2.51
    
 
 
   
 
 
 
Total expenses
     7.12 %**      6.74
    
 
 
   
 
 
 
Average debt outstanding
   $ 951,995     $ 672,962  
Portfolio turnover ratio
     13.8     20.8
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per Share for the applicable period.
(b)
Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2021 and December 31, 2020 was $18.43 and $17.51, respectively. Total return does not include a sales load.
(c)
Not annualized for periods less than one year.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a permanent incentive fee waiver (see note 3).
For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the incentive fee waiver.
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Tables)
9 Months Ended
Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Summary of unfunded debt and equity commitments The total amount of these unfunded commitments as of September 30, 2022 and December 31, 2021 is $310,204 and $226,733, respectively, comprised of the following:
    
September

30, 2022
    
December

31, 2021
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Apeel Technology, Inc.
     32,786        —    
World Insurance Associates, LLC
     25,554        —    
CC SAG Holdings Corp. (Spectrum Automotive)
     24,346        18,827  
Human Interest, Inc.
     20,104        —    
Glooko, Inc.
     17,868        25,091  
Spectrum Pharmaceuticals, Inc.
     12,279        —    
iCIMS, Inc.
     11,577        —    
BridgeBio Pharma, Inc.
     9,016        23,049  
BDG Media, Inc.
     8,573        —    
RSC Acquisition, Inc.
     8,553        —    
Arcutis Biotherapeutics, Inc.
     8,356        43,470  
Atria Wealth Solutions, Inc.
     8,215        3,746  
Ardelyx, Inc.
     7,752        —    
Luxury Asset Capital, LLC
     7,500        —    
OIS Management Services, LLC
     5,205        —    
Vessco Midco Holdings, LLC
     4,098        —    
One Touch Direct, LLC
     4,013        7,226  
Kaseya, Inc.
     3,936        —    
Maurices, Incorporated
     3,922        5,649  
Foundation Consumer Brands, LLC
     3,009        2,269  
Inszone Mid, LLC
     2,790        12,465  
Kid Distro Holdings, LLC
     2,650        2,650  
Plastics Management, LLC
     2,424        —    
Pediatric Home Respiratory Services, LLC
     2,380        —    
Southern Orthodontic Partners Management, LLC
     2,292        —    
Basic Fun, Inc.
     2,150        1,935  
Copper River Seafoods, Inc.
     2,043        —    
Peter C. Foy & Associates Insurance Services, LLC
     1,969        —    
Orthopedic Care Partners Management, LLC
     1,896        —    
MMIT Holdings, LLC
     1,894        2,009  
SPAR Marketing Force, Inc.
     1,613        —    
Ivy Fertility Services, LLC
     1,571        4,532  
NAC Holdings Corporation
     1,479        4,765  
SLR Healthcare ABL*
     1,400        —    
RxSense Holdings LLC
     1,250        —    
Erie Construction
Mid-west,
LLC
     1,247        —    
Composite Technology Acquisition Corp.
     1,139        —    
Enverus Holdings, Inc.
     1,004        —    
SLR Equipment Finance
     1,000        5,000  
American Teleconferencing Services, Ltd.
     914        573  
SunMed Group Holdings, LLC
     843        828  
All State Ag Parts, LLC
     730        —    
Ultimate Baked Goods Midco LLC
     551        801  
BayMark Health Services, Inc.
     391        —    
Pinnacle Treatment Centers, Inc.
     387        1,414  
GSM Acquisition Corp.
     365        —    
High Street Buyer, Inc.
     327        —    
Tilley Distribution, Inc.
     293        —    
TAUC Management, LLC
     287        —    
RQM+ Corp.
     —          3,818  
Rezolute, Inc.
     —          5,675  
SOC Telemed, Inc.
     —          4,448  
Neuronetics, Inc.
     —          2,230  
    
 
 
    
 
 
 
Total Commitments
   $  310,204      $  226,733  
    
 
 
    
 
 
 
 
*
The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Capital Share Transactions (Tables)
9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of Stockholders Equity
Transactions in capital stock were as follows:
 
                                                                                                                                                     
    
Shares
    
Amount
 
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2021
    
Three months ended
September 30, 2022
    
Three months ended
September 30, 2021
 
Shares issued in connection with the Mergers
  
 
—  
 
  
 
—  
 
  
$
—  
 
  
$
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
  
 
—  
 
  
 
—  
 
  
$
—  
 
  
$
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
                                                                                                                                                     
    
Shares
    
Amount
 
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2021
    
Nine months ended
September 30, 2022
    
Nine months ended
September 30, 2021
 
Shares issued in connection with the Mergers
  
 
12,511,825
 
  
 
—  
 
  
$
226,839
 
  
$
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Net increase
  
 
12,511,825
 
  
 
—  
 
  
$
226,839
 
  
$
—  
 
    
 
 
    
 
 
    
 
 
    
 
 
 
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Merger with SUNS (Tables)
9 Months Ended
Sep. 30, 2022
Business Combinations [Abstract]  
Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger
The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger:
 
Common stock issued by the Company
(1)
   $ 227,602  
    
 
 
 
Assets acquired:
        
Investments, at fair value
   $ 400,105  
Cash
     2,313  
Other assets
     4,662  
    
 
 
 
Total assets acquired
   $ 407,080  
    
 
 
 
Liabilities assumed:
        
Debt, at fair value
   $ 159,816  
Other liabilities
     2,573  
    
 
 
 
Total liabilities assumed
   $ 162,389  
    
 
 
 
Net assets acquired
   $ 244,691  
    
 
 
 
Total purchase discount
   $ (17,089
    
 
 
 
 
(1)
Based on the market price at closing of $18.13, adjusted for transaction costs.
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Organization - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Feb. 10, 2010
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Date of commencement of business Mar. 13, 2007          
Initial capital of business $ 1,200,000          
Percentage of initial capital funded by affiliated parties 47.04%          
Stock issued during period, shares     0 0 12,511,825 0
Stock issued during period, values     $ 0 $ 0 $ 226,839 $ 0
IPO [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during period, shares   5,680,000        
Over-Allotment Option [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Share price   $ 18.5        
Private Placement [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during period, shares   600,000        
Share price   $ 18.5        
Common Stock [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during period, shares 26,650,000          
Stock issued during period, values $ 125,000          
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Significant Accounting Policies - Additional Information (Details)
9 Months Ended
Sep. 30, 2022
Property, Plant and Equipment [Line Items]  
Percentage of excise tax 4.00%
Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Debt instrument term 60 days
Restricted investment term 90 days
Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Debt instrument term 60 days
Restricted investment term 30 days
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Agreements - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Apr. 01, 2022
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Agreement [Line Items]          
Management fees   $ 7,890 $ 7,142 $ 22,019 $ 20,842
Administrative fees expense   1,132 1,435 3,684 4,170
Performance Based Incentive Fees Waiver   194   $ 1,552  
Advisory Agreement [Member]          
Agreement [Line Items]          
Pre-incentive fee net investment income Quarter hurdle rate       1.75%  
Pre-incentive fee net investment income Annual hurdle rate       7.00%  
Percentage of cumulative realized capital gain loss       20.00%  
Percentage of cumulative net realized gain and unrealized capital appreciation       20.00%  
Management fees   7,890 7,142 $ 22,019 20,842
Performance based incentive fees   4,965 698 9,699 8,444
Administrative fees expense   $ 1,132 $ 1,435 $ 3,684 $ 4,170
Advisory Agreement [Member] | Minimum [Member]          
Agreement [Line Items]          
Percentage of gross assets 1.00%     1.00%  
Percentage of total net assets 200.00%     200.00%  
Percentage of pre-incentive fee net investment income       100.00%  
Advisory Agreement [Member] | Maximum [Member]          
Agreement [Line Items]          
Percentage of gross assets 1.50%     1.50%  
Percentage of total net assets 200.00%     200.00%  
Percentage of pre-incentive fee net investment income       20.00%  
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Net Asset Value Per Share - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Thousands
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Jun. 30, 2021
Dec. 31, 2020
Net Asset Value Per Share [Abstract]            
Net assets $ 1,006,225 $ 1,015,153 $ 842,281 $ 853,490 $ 857,446 $ 852,023
Net asset value per share $ 18.37   $ 19.93 $ 20.2   $ 20.16
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Earnings (loss) per share (basic & diluted)        
Numerator 0net increase (decrease) in net assets resulting from operations $ 13,528 $ 13,371 $ (655) $ 53,448
Denominator 0weighted average shares, Basic 54,772,651 42,260,826 50,647,874 42,260,826
Denominator 0weighted average shares, Diluted 54,772,651 42,260,826 50,647,874 42,260,826
Earnings (loss) per share, Basic $ 0.25 $ 0.32 $ (0.01) $ 1.26
Earnings (loss) per share, Diluted $ 0.25 $ 0.32 $ (0.01) $ 1.26
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Level 3 | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   $ 150,000
Recurring Fair Value    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 2,155,361 1,670,582
Recurring Fair Value | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   150,000
Recurring Fair Value | Senior Secured Loans    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1,352,503 939,690
Recurring Fair Value | Equipment Financing    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 238,553 273,795
Recurring Fair Value | Preferred Equity    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 4,176 5,630
Recurring Fair Value | Common Equity/Equity Interests/Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 560,129 451,467
Recurring Fair Value | Level 1    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 620 1,086
Recurring Fair Value | Level 1 | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   0
Recurring Fair Value | Level 1 | Senior Secured Loans    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 1 | Equipment Financing    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 1 | Preferred Equity    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 1 | Common Equity/Equity Interests/Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 620 1,086
Recurring Fair Value | Level 2    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 2 | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   0
Recurring Fair Value | Level 2 | Senior Secured Loans    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 2 | Equipment Financing    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 2 | Preferred Equity    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 2 | Common Equity/Equity Interests/Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 0 0
Recurring Fair Value | Level 3    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 2,154,741 1,669,496
Recurring Fair Value | Level 3 | 2022 Unsecured Notes    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Liabilities   150,000
Recurring Fair Value | Level 3 | Senior Secured Loans    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 1,352,503 939,690
Recurring Fair Value | Level 3 | Equipment Financing    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 238,553 273,795
Recurring Fair Value | Level 3 | Preferred Equity    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets 4,176 5,630
Recurring Fair Value | Level 3 | Common Equity/Equity Interests/Warrants    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Assets $ 559,509 $ 450,381
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Dec. 31, 2021
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance $ 1,993,227 $ 1,669,496 $ 1,530,270
Net realized gain (loss) (37,231) (37,191) 337
Net change in unrealized gain (loss) 30,589 (16,497) (3,358)
Purchase of investment securities 249,098 799,959 610,585
Proceeds from dispositions of investment securities (80,942) (261,026) (468,221)
Transfers in/out of Level 3 0 0 (117)
Closing balance 2,154,741 2,154,741 1,669,496
Net change in unrealized gain (loss) (3,148) (17,351) (2,888)
Senior Secured Loans      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 1,178,247 939,690 798,052
Net realized gain (loss) (37,231) (37,191) 0
Net change in unrealized gain (loss) 34,518 (1,890) (13,567)
Purchase of investment securities 228,399 639,306 533,614
Proceeds from dispositions of investment securities (51,430) (187,412) (378,409)
Transfers in/out of Level 3 0 0 0
Closing balance 1,352,503 1,352,503 939,690
Net change in unrealized gain (loss) 781 (2,744) (12,837)
Equipment Financing      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 255,978 273,795 284,846
Net realized gain (loss) 0 0 (8)
Net change in unrealized gain (loss) (3,849) (6,828) 1,394
Purchase of investment securities 15,581 44,202 76,700
Proceeds from dispositions of investment securities (29,157) (72,616) (89,137)
Transfers in/out of Level 3 0 0 0
Closing balance 238,553 238,553 273,795
Net change in unrealized gain (loss) (3,849) (6,828) 1,394
Preferred Equity      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 4,405 5,630 6,401
Net realized gain (loss) 0 0 0
Net change in unrealized gain (loss) 59 (658) (1,042)
Purchase of investment securities 67 202 271
Proceeds from dispositions of investment securities (355) (998) 0
Transfers in/out of Level 3 0 0 0
Closing balance 4,176 4,176 5,630
Net change in unrealized gain (loss) 59 (658) (1,042)
Common Equity/Equity Interests/Warrants      
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Opening balance 554,597 450,381 440,971
Net realized gain (loss) 0 0 345
Net change in unrealized gain (loss) (139) (7,121) 9,857
Purchase of investment securities 5,051 116,249 0
Proceeds from dispositions of investment securities 0 0 (675)
Transfers in/out of Level 3 0 0 (117)
Closing balance 559,509 559,509 450,381
Net change in unrealized gain (loss) $ (139) $ (7,121) $ 9,597
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) - 2022 Unsecured Notes - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Dec. 31, 2021
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]      
Beginning fair value $ 0 $ 150,000 $ 150,000
Net realized (gain) loss 0 0 0
Net change in unrealized (gain) loss 0 0 0
Borrowings 0 0 0
Repayments 0 (150,000) 0
Transfers in/out of Level 3 0 0 0
Ending fair value $ 0 $ 0 $ 150,000
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)
$ in Thousands
Dec. 31, 2021
USD ($)
Level 3 | 2022 Unsecured Notes  
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Notes payable fair value disclosure $ 150,000
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) - Level 3 - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2022
Dec. 31, 2021
Senior Secured Loans | Income Approach | Market Yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 1,320,263 $ 931,769
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield  
Senior Secured Loans | Market Multiple | Comparable Multiple    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 32,240 $ 7,921
Principal Valuation Technique/Methodology Market Multiple Market Multiple
Unobservable Input Comparable Multiple  
Equipment Financing | Income Approach | Market Yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 117,733 $ 144,693
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield  
Equipment Financing | Market Multiple | Comparable Multiple    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 120,820  
Principal Valuation Technique/Methodology Market Multiple  
Unobservable Input Comparable Multiple  
Equipment Financing | Market Approach    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets   $ 129,102
Equipment Financing | Market Approach | Return on Equity    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Principal Valuation Technique/Methodology   Market Approach
Unobservable Input Return on Equity  
Preferred Equity | Income Approach | Market Yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 4,176 $ 5,630
Principal Valuation Technique/Methodology Income Approach Income Approach
Unobservable Input Market Yield  
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 147,629 $ 151,615
Principal Valuation Technique/Methodology Market Multiple Market Multiple
Unobservable Input Comparable Multiple  
Common Equity/Equity Interests/Warrants | Market Approach    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Unobservable Input Return on Equity  
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets $ 411,880 $ 298,766
Principal Valuation Technique/Methodology Market Approach Market Approach
Unobservable Input Return on Equity  
2022 Unsecured Notes | Income Approach | Market Yield    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Assets   $ 150,000
Principal Valuation Technique/Methodology   Income Approach
Unobservable Input Market Yield  
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)
$ in Thousands
Sep. 30, 2022
USD ($)
Dec. 31, 2021
USD ($)
Measurement Input, EBITDA Multiple [Member] | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 147,005 $ 151,212
Black Scholes Pricing Model [Member] | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value 624 403
Senior Secured Loans | Income Approach | Market Yield | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 1,320,263 $ 931,769
Senior Secured Loans | Income Approach | Market Yield | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 7.6 4
Senior Secured Loans | Income Approach | Market Yield | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 17.8 19.6
Senior Secured Loans | Income Approach | Market Yield | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 10.9 8.7
Senior Secured Loans | Market Multiple | Comparable Multiple | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 32,240 $ 7,921
Senior Secured Loans | Market Multiple | Comparable Multiple | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 0.1  
Senior Secured Loans | Market Multiple | Comparable Multiple | Minimum [Member] | Measurement Input, EBITDA Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   2
Senior Secured Loans | Market Multiple | Comparable Multiple | Minimum [Member] | Black Scholes Pricing Model [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   2
Senior Secured Loans | Market Multiple | Comparable Multiple | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 21.4  
Senior Secured Loans | Market Multiple | Comparable Multiple | Maximum [Member] | Measurement Input, EBITDA Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   3
Senior Secured Loans | Market Multiple | Comparable Multiple | Maximum [Member] | Black Scholes Pricing Model [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   3
Senior Secured Loans | Market Multiple | Comparable Multiple | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 12  
Senior Secured Loans | Market Multiple | Comparable Multiple | Weighted Average [Member] | Measurement Input, EBITDA Multiple [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   2.5
Senior Secured Loans | Market Multiple | Comparable Multiple | Weighted Average [Member] | Black Scholes Pricing Model [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   2.5
Equipment Financing | Income Approach | Market Yield | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 117,733 $ 144,693
Equipment Financing | Income Approach | Market Yield | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 8.5 7.1
Equipment Financing | Income Approach | Market Yield | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.7 20.3
Equipment Financing | Income Approach | Market Yield | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.7 9.8
Equipment Financing | Market Multiple | Comparable Multiple | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 120,820  
Equipment Financing | Market Multiple | Comparable Multiple | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1  
Equipment Financing | Market Multiple | Comparable Multiple | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.28  
Equipment Financing | Market Multiple | Comparable Multiple | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 1.14  
Equipment Financing | Market Approach | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value   $ 129,102
Equipment Financing | Market Approach | Return on Equity | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   4.6
Equipment Financing | Market Approach | Return on Equity | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   4.6
Equipment Financing | Market Approach | Return on Equity | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input   4.6
Preferred Equity | Income Approach | Market Yield | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 4,176 $ 5,630
Preferred Equity | Income Approach | Market Yield | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 3.5
Preferred Equity | Income Approach | Market Yield | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 8
Preferred Equity | Income Approach | Market Yield | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 5 4.4
2022 Unsecured Notes | Income Approach | Market Yield | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value   $ 150,000
2022 Unsecured Notes | Income Approach | Market Yield | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long-term Debt, Measurement Input   2.2
2022 Unsecured Notes | Income Approach | Market Yield | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long-term Debt, Measurement Input   4.6
2022 Unsecured Notes | Income Approach | Market Yield | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long-term Debt, Measurement Input   4.5
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 147,629 $ 151,615
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 7 5.8
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.3 10.5
Common Equity/Equity Interests/Warrants | Market Multiple | Comparable Multiple | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 8.1 9.5
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity | Level 3    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Investments at fair value $ 411,880 $ 298,766
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 6.3 6.1
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 37.7 18.5
Common Equity/Equity Interests/Warrants | Market Approach | Return on Equity | Weighted Average [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Long Term Investments Measurement Input 9.7 8.6
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Schedule of Long-term Debt Instruments (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Debt Instrument [Line Items]    
Face Amount $ 1,156,200 $ 818,500
Total 1,148,291 812,038
Credit Facility    
Debt Instrument [Line Items]    
Face Amount 460,000 322,500
Credit Facility, Carrying Value 454,868 318,015
SPV Credit Facility    
Debt Instrument [Line Items]    
Face Amount 130,200 0
SPV Credit Facility, Carrying Value 129,236 0
2022 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 0 150,000
Unsecured Debt 0 150,000
2022 Tranche C Notes    
Debt Instrument [Line Items]    
Face Amount 21,000 21,000
Unsecured Debt 20,991 20,964
2023 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 75,000 75,000
Unsecured Debt 74,881 74,592
2024 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 125,000 125,000
Unsecured Debt 124,350 124,143
2025 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 85,000 0
Unsecured Debt 84,572 0
2026 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 75,000 75,000
Unsecured Debt 74,468 74,384
2027 Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 50,000 50,000
Unsecured Debt 49,950 49,940
2027 Series F Unsecured Notes    
Debt Instrument [Line Items]    
Face Amount 135,000 0
Unsecured Debt $ 134,975 $ 0
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Credit Facility    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs $ 5,132 $ 4,485
SPV Credit Facility    
Debt Instrument [Line Items]    
Debt Instrument, Unamortized Discount 964  
2022 Tranche C Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 9 36
2023 Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 119 408
2024 Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 650 857
2025 Unsecured Notes    
Debt Instrument [Line Items]    
Debt Instrument, Unamortized Discount 428  
2026 Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 532 616
2027 Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs 50 $ 60
2027 Series F Unsecured Notes    
Debt Instrument [Line Items]    
Long term debt unamortized debt issuance costs $ 25  
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
Debt - Additional Information (Details) - USD ($)
3 Months Ended 4 Months Ended 6 Months Ended 9 Months Ended 11 Months Ended 12 Months Ended 14 Months Ended 49 Months Ended
Dec. 31, 2021
Dec. 31, 2019
Dec. 31, 2017
Sep. 30, 2022
Dec. 31, 2011
Jun. 30, 2022
Sep. 30, 2022
Dec. 31, 2017
Dec. 31, 2021
Dec. 31, 2017
Dec. 31, 2021
Apr. 01, 2022
Jan. 06, 2022
Dec. 28, 2021
Sep. 14, 2021
Dec. 18, 2019
Dec. 28, 2017
Nov. 22, 2017
Feb. 15, 2017
Nov. 08, 2016
Aug. 26, 2011
Debt Instrument [Line Items]                                          
Debt instrument face value $ 818,500,000     $ 1,156,200,000     $ 1,156,200,000   $ 818,500,000   $ 818,500,000                    
Long term debt weighted average interest over a period of time             3.81%   3.64%                        
Long term debt maximum amount borrowed during the period             $ 1,157,100,000   $ 902,550,000                        
Credit Facility One [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value       $ 85,000,000     $ 85,000,000         $ 85,000,000                  
Long term debt term       5 years     5 years                            
Debt instrument maturity date       Mar. 31, 2025                                  
Debt instrument payment terms             Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30                            
Debt instrument stated interest rate percentage       3.90%     3.90%                            
Line of credit 0     $ 129,236,000     $ 129,236,000   0   0                    
Two Thousand And Twenty Seven Series F Unsecured Notes [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value       $ 135,000,000     $ 135,000,000           $ 135,000,000                
Debt instrument maturity date             Jan. 06, 2027                            
Debt instrument payment terms             Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6                            
Debt instrument stated interest rate percentage       3.33%     3.33%                            
Two Thousand And Twenty Four Unsecured Notes [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value 125,000,000     $ 125,000,000     $ 125,000,000   125,000,000   125,000,000         $ 125,000,000          
Debt instrument maturity date   Dec. 15, 2024                                      
Debt instrument payment terms   Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15                                      
Debt instrument stated interest rate percentage       4.20%     4.20%                            
Two Thousand And Twenty Six Unsecured Notes [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value $ 75,000,000     $ 75,000,000     $ 75,000,000   $ 75,000,000   $ 75,000,000         $ 75,000,000          
Debt instrument stated interest rate percentage 4.375%     4.375%     4.375%   4.375%   4.375%                    
Two Thousand And Twenty Two Tranche C Notes [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value $ 21,000,000     $ 21,000,000     $ 21,000,000   $ 21,000,000   $ 21,000,000           $ 21,000,000        
Debt instrument maturity date   Dec. 15, 2026                                      
Debt instrument payment terms     Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28                                    
Debt instrument stated interest rate percentage 4.50%     4.50%     4.50%   4.50%   4.50%                    
Two Thousand And Twenty Two Tranche C Notes [Member] | Tranche One [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value $ 100,000,000     $ 100,000,000     $ 100,000,000   $ 100,000,000   $ 100,000,000               $ 100,000,000    
Debt instrument maturity date               May 08, 2022                          
Debt instrument payment terms               Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8                          
Debt instrument stated interest rate percentage 4.60%         4.60%     4.60%   4.60%                    
Two Thousand And Twenty Two Tranche C Notes [Member] | Tranche Two [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value $ 50,000,000     50,000,000     50,000,000   $ 50,000,000   $ 50,000,000                 $ 50,000,000  
Debt instrument payment terms                   Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8                      
Debt instrument stated interest rate percentage 4.40%         4.40%     4.40%   4.40%                    
Two Thousand And Twenty Three Unsecured Notes [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value $ 75,000,000     $ 75,000,000     $ 75,000,000   $ 75,000,000   $ 75,000,000             $ 75,000,000      
Debt instrument maturity date                     Jan. 20, 2023                    
Debt instrument payment terms                     semi-annually on January 20 and July 20                    
Debt instrument stated interest rate percentage 4.50%     4.50%     4.50%   4.50%   4.50%                    
Proceeds from net debt                     $ 73,846,000                    
Term Loan And Credit Facility [Member]                                          
Debt Instrument [Line Items]                                          
Line of credit and term loan outstanding $ 318,015,000     $ 454,868,000     $ 454,868,000   $ 318,015,000   $ 318,015,000                    
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument maturity date       Jun. 01, 2026                                  
Line of credit and term loan outstanding       $ 130,200,000     130,200,000                            
Line of credit maximum borrowing capacity and debt instrument face value                           $ 800,000,000              
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member] | Line of Credit [Member]                                          
Debt Instrument [Line Items]                                          
Line of credit facility, maximum borrowing capacity                           600,000,000              
Other long term debt       360,000,000     360,000,000                            
Term Loan And Credit Facility [Member] | SPV LLC [Member] | Citi Bank NA [Member] | Term Loan [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value                           $ 100,000,000              
Line of credit       100,000,000     100,000,000                            
Term Loan And Credit Facility [Member] | Credit Facility [Member] | Citi Bank NA [Member]                                          
Debt Instrument [Line Items]                                          
Line of credit and term loan outstanding       460,000,000     $ 460,000,000                            
Term Loan And Credit Facility [Member] | Maximum [Member] | SPV LLC [Member] | Citi Bank NA [Member]                                          
Debt Instrument [Line Items]                                          
Line of credit facility, maximum borrowing capacity                                         $ 600,000,000
Debt instrument variable interest rate spread (1.00%)         (2.00%)                              
Term Loan And Credit Facility [Member] | Maximum [Member] | London Interbank Offered Rate (LIBOR) [Member] | Citi Bank NA [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument variable interest rate spread         (2.50%)                                
Term Loan And Credit Facility [Member] | Minimum [Member] | SPV LLC [Member] | Citi Bank NA [Member]                                          
Debt Instrument [Line Items]                                          
Line of credit facility, maximum borrowing capacity                                         $ 225,000,000
Debt instrument variable interest rate spread 0.75%           1.75%                            
Term Loan And Credit Facility [Member] | Minimum [Member] | London Interbank Offered Rate (LIBOR) [Member] | Citi Bank NA [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument variable interest rate spread         2.00%                                
Two Thousand And Twenty Seven Unsecured Notes [Member]                                          
Debt Instrument [Line Items]                                          
Debt instrument face value       $ 50,000,000     $ 50,000,000               $ 50,000,000            
Debt instrument stated interest rate percentage 2.95%     2.95%     2.95%   2.95%   2.95%                    
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Highlights - Schedule of Financial Highlights (Details) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Dec. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Per Share Data:            
Net asset value, beginning of year $ 19.93 $ 20.16        
Per share market value, end of period 12.32 19.13   $ 18.43   $ 17.51
Net investment income 1.06 1.09        
Net realized and unrealized gain (loss) (1.08) 0.18        
Net increase (decrease) in net assets resulting from operations (0.02) 1.27        
Issuance of common stock in connection with the Merger (0.31) 0        
From net investment income (1.06) (1.23)        
From return of capital (0.17) 0        
Net asset value, end of period $ 18.37 $ 20.2        
Total Return (b)(c) (27.75%) 16.46%        
Net assets, end of period $ 1,006,225 $ 853,490 $ 1,015,153 $ 842,281 $ 857,446 $ 852,023
Shares outstanding, end of period 54,772,651 42,260,826   42,260,826    
Ratios to average net assets:            
Net investment income 5.51% 5.38%        
Operating expenses 3.90% 4.23%        
Interest and other credit facility expenses 3.22% 2.51%        
Total expenses 7.12% 6.74%        
Average debt outstanding $ 951,995 $ 672,962        
Portfolio turnover ratio 13.80% 20.80%        
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) - $ / shares
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Investment Company, Financial Highlights [Abstract]        
Fair value of common stock per share $ 12.32 $ 19.13 $ 18.43 $ 17.51
Investment company, expense ratio excluding incentive fee 4.06% 7.28%    
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
SLR Credit Solutions - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jul. 28, 2016
USD ($)
Dec. 28, 2012
USD ($)
Nov. 30, 2012
USD ($)
loans
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
issuers
fund
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
issuers
fund
Assets       $ 2,455,435   $ 2,455,435   $ 2,011,011
Non-recourse debt       1,148,291   1,148,291   812,038
Revolving Credit Facility [Member]                
Line of credit facility, maximum borrowing capacity   $ 275,000            
Crystal Financial [Member]                
Line of credit facility, maximum borrowing capacity     $ 400,000          
SLR Business Credit Facility [Member]                
Line of credit facility, maximum borrowing capacity       34,178   $ 34,178   $ 35,000
Business combination, consideration transferred $ 5,737              
Number of funded commitments | fund           27   22
Number of issuers in business credit | issuers           21   19
Long-term line of credit       354,853   $ 354,853   $ 287,375
Assets       375,603   375,603   347,821
Line of credit facility average outstanding amount           16,898   15,125
Net income (loss)        3,897 $ 5,445 8,557 $ 12,497  
Gross income       8,596 $ 9,508 22,171 $ 27,239  
Non-recourse debt       $ 139,497   139,497   $ 100,742
SLR Business Credit Facility [Member] | Revolving Credit Facility [Member]                
Line of credit facility commitments amount           $ 250,000    
SLR Business Credit Facility [Member] | Crystal Financial [Member]                
Payment to acquire business   $ 275,000            
Equity method investment, ownership percentage 2.00% 98.00%            
Number of loans in business credit | loans     23          
SLR Business Credit Facility [Member] | Crystal Capital Financial Holdings LLC [Member]                
Equity method investment, ownership percentage 100.00%              
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies - Additional Information (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Other Commitments [Line Items]    
Other Commitment $ 310,204 $ 226,733
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Other Commitments [Line Items]    
Other Commitment $ 310,204 $ 226,733
Unfunded Debt and Equity Commitments [Member]    
Other Commitments [Line Items]    
Other Commitment 310,204 226,733
Unfunded Debt and Equity Commitments [Member] | SLR Credit Solutions [Member]    
Other Commitments [Line Items]    
Other Commitment [1] 44,263 44,263
Unfunded Debt and Equity Commitments [Member] | Apeel Technology, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 32,786 0
Unfunded Debt and Equity Commitments [Member] | World Insurance Associates, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 25,554 0
Unfunded Debt and Equity Commitments [Member] | CC SAG Holdings Corp. (Spectrum Automotive) [Member]    
Other Commitments [Line Items]    
Other Commitment 24,346 18,827
Unfunded Debt and Equity Commitments [Member] | Glooko, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 17,868 25,091
Unfunded Debt and Equity Commitments [Member] | Spectrum Pharmaceuticals, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 12,279 0
Unfunded Debt and Equity Commitments [Member] | iCIMS, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 11,577 0
Unfunded Debt and Equity Commitments [Member] | BridgeBio Pharma, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 9,016 23,049
Unfunded Debt and Equity Commitments [Member] | BDG Media, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 8,573 0
Unfunded Debt and Equity Commitments [Member] | RSC Acquisition, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 8,553 0
Unfunded Debt and Equity Commitments [Member] | Arcutis Biotherapeutics, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 8,356 43,470
Unfunded Debt and Equity Commitments [Member] | Atria Wealth Solutions, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 8,215 3,746
Unfunded Debt and Equity Commitments [Member] | Human Interest, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 20,104 0
Unfunded Debt and Equity Commitments [Member] | Ardelyx, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 7,752 0
Unfunded Debt and Equity Commitments [Member] | Luxury Asset Capital, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 7,500 0
Unfunded Debt and Equity Commitments [Member] | OIS Management Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 5,205 0
Unfunded Debt and Equity Commitments [Member] | Vessco Midco Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 4,098 0
Unfunded Debt and Equity Commitments [Member] | One Touch Direct, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 4,013 7,226
Unfunded Debt and Equity Commitments [Member] | Kaseya, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 3,936 0
Unfunded Debt and Equity Commitments [Member] | Maurices, Incorporated [Member]    
Other Commitments [Line Items]    
Other Commitment 3,922 5,649
Unfunded Debt and Equity Commitments [Member] | Foundation Consumer Brands, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 3,009 2,269
Unfunded Debt and Equity Commitments [Member] | Inszone Mid, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,790 12,465
Unfunded Debt and Equity Commitments [Member] | Kid Distro Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,650 2,650
Unfunded Debt and Equity Commitments [Member] | Plastics Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,424 0
Unfunded Debt and Equity Commitments [Member] | Pediatric Home Respiratory Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,380 0
Unfunded Debt and Equity Commitments [Member] | Southern Orthodontic Partners Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 2,292 0
Unfunded Debt and Equity Commitments [Member] | Basic Fun, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 2,150 1,935
Unfunded Debt and Equity Commitments [Member] | Copper River Seafoods, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 2,043 0
Unfunded Debt and Equity Commitments [Member] | Peter C. Foy & Associates Insurance Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,969 0
Unfunded Debt and Equity Commitments [Member] | Orthopedic Care Partners Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,896 0
Unfunded Debt and Equity Commitments [Member] | MMIT Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,894 2,009
Unfunded Debt and Equity Commitments [Member] | SPAR Marketing Force, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 1,613 0
Unfunded Debt and Equity Commitments [Member] | Ivy Fertility Services, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,571 4,532
Unfunded Debt and Equity Commitments [Member] | NAC Holdings Corporation [Member]    
Other Commitments [Line Items]    
Other Commitment 1,479 4,765
Unfunded Debt and Equity Commitments [Member] | SLR Healthcare ABL [Member]    
Other Commitments [Line Items]    
Other Commitment 1,400 0
Unfunded Debt and Equity Commitments [Member] | RxSense Holdings LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,250 0
Unfunded Debt and Equity Commitments [Member] | Erie Construction Mid-west, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 1,247 0
Unfunded Debt and Equity Commitments [Member] | Composite Technology Acquisition Corp [Member]    
Other Commitments [Line Items]    
Other Commitment 1,139 0
Unfunded Debt and Equity Commitments [Member] | Enverus Holdings, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 1,004 0
Unfunded Debt and Equity Commitments [Member] | SLR Equipment Finance [Member]    
Other Commitments [Line Items]    
Other Commitment 1,000 5,000
Unfunded Debt and Equity Commitments [Member] | American Teleconferencing Services, Ltd. [Member]    
Other Commitments [Line Items]    
Other Commitment 914 573
Unfunded Debt and Equity Commitments [Member] | SunMed Group Holdings, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 843 828
Unfunded Debt and Equity Commitments [Member] | All State Ag Parts, LLC    
Other Commitments [Line Items]    
Other Commitment 730 0
Unfunded Debt and Equity Commitments [Member] | Ultimate Baked Goods Midco LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 551 801
Unfunded Debt and Equity Commitments [Member] | Pinnacle Treatment Centers, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 387 1,414
Unfunded Debt and Equity Commitments [Member] | BayMark Health Services, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 391 0
Unfunded Debt and Equity Commitments [Member] | GSM Acquisition Corp [Member]    
Other Commitments [Line Items]    
Other Commitment 365 0
Unfunded Debt and Equity Commitments [Member] | High Street Buyer, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 327 0
Unfunded Debt and Equity Commitments [Member] | Tilley Distribution, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 293 0
Unfunded Debt and Equity Commitments [Member] | TAUC Management, LLC [Member]    
Other Commitments [Line Items]    
Other Commitment 287 0
Unfunded Debt and Equity Commitments [Member] | RQM+ Corp. [Member]    
Other Commitments [Line Items]    
Other Commitment 0 3,818
Unfunded Debt and Equity Commitments [Member] | Rezolute, Inc [Member]    
Other Commitments [Line Items]    
Other Commitment 0 5,675
Unfunded Debt and Equity Commitments [Member] | SOC Telemed, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment 0 4,448
Unfunded Debt and Equity Commitments [Member] | Neuronetics, Inc. [Member]    
Other Commitments [Line Items]    
Other Commitment $ 0 $ 2,230
[1] The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion.
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
SLR Equipment Finance - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2019
USD ($)
Sep. 30, 2022
USD ($)
Customers
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
Customers
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
Customers
Jul. 31, 2017
USD ($)
Schedule of Equity Method Investments [Line Items]              
Non-recourse debt   $ 1,148,291   $ 1,148,291   $ 812,038  
SLR Equipment Finance [Member]              
Schedule of Equity Method Investments [Line Items]              
Equity method investment, ownership percentage             100.00%
Equity method investment, aggregate cost             $ 209,866
Equity method investment aggregate equity investment             145,000
Equity method investment aggregate investment in investee leases and loans held             64,866
Line of credit facility, maximum borrowing capacity $ 213,957           150,000
Line of credit facility maximum borrowing capacity with accordion feature $ 313,957           $ 250,000
Number of funded equipment-backed leases and loans   129   129   135  
Number of Customers | Customers   59   59   61  
Net investment in lease   $ 189,254   $ 189,254   $ 210,986  
Assets under lease   241,189   241,189   264,007  
Equipment backed leases and loans largest position outstanding   19,272   19,272   19,207  
Equipment backed leases and loans average exposure per customer   3,208   3,208   3,459  
Non-recourse debt   110,997   110,997   $ 118,002  
Net income   1,034 $ 306 125 $ 2,301    
Gross income   $ 6,486 $ 5,809 $ 15,704 $ 16,443    
Line of credit facility, expiration date Jul. 31, 2023            
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
Capital Share Transactions - Additional Information (Details) - $ / shares
Sep. 30, 2022
Dec. 31, 2021
Sep. 30, 2021
Stockholders' Equity Note [Abstract]      
Shares authorized 200,000,000 200,000,000 200,000,000
Par value $ 0.01 $ 0.01 $ 0.01
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
Capital Share Transactions - Summary of Transactions In Capital Stock (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Shares 0 0 12,511,825 0
Amount $ 0 $ 0 $ 226,839 $ 0
Shares issued in connection with the Mergers [Member]        
Shares 0 0 12,511,825 0
Amount $ 0 $ 0 $ 226,839 $ 0
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
Kingsbridge Holdings, LLC - Additional Information (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 03, 2020
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Proceeds from unsecured borrowings       $ 134,914 $ 49,966  
Total assets   $ 2,455,435   2,455,435   $ 2,011,011
Non-recourse debt   1,148,291   1,148,291   812,038
KBHT [Member]            
Total assets   774,619   774,619   738,425
Kingsbridge Holdings, LLC [Member]            
Equity method investments $ 216,596          
Payments to acquire investments 136,596          
Proceeds from unsecured borrowings $ 80,000          
Recourse debt   246,210   246,210   216,881
Non-recourse debt   316,840   316,840   $ 323,844
Net income (loss)    3,327 $ 3,163 10,393 10,314  
Gross income   $ 71,332 $ 60,510 $ 215,074 $ 180,079  
Maximum [Member] | Kingsbridge Holdings, LLC [Member]            
Equity method investment, ownership percentage 87.50%          
Minimum [Member] | Kingsbridge Holdings, LLC [Member]            
Equity method investment, ownership percentage 12.50%          
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
SLR Healthcare ABL - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 28, 2019
USD ($)
May 27, 2016
USD ($)
Sep. 30, 2013
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Jun. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
issuers
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
issuers
Jun. 27, 2014
USD ($)
Mar. 31, 2014
USD ($)
Commitments and contingencies                
Total assets       2,455,435     2,455,435   2,011,011    
SLR Healthcare ABL Credit [Member]                      
Line of credit facility, maximum borrowing capacity $ 125,000     62,000     62,000   60,000    
Debt instrument term     4 years                
Line of credit facility, expiration date Jun. 28, 2023 May 27, 2020                  
Total assets       93,010     $ 93,010   $ 91,275    
Number of issuers in business credit | issuers             37   36    
Long-term line of credit       2,199     $ 2,199   $ 2,267    
Net income (loss)        822 $ 40   2,543 $ 494      
Gross income       3,020 $ 2,631 $ 2,021 7,898 $ 7,035      
Senior Secured Commitments [Member]                      
Commitments and contingencies       179,633     179,633   183,501    
Senior Secured Commitments [Member] | SLR Healthcare ABL Credit [Member]                      
Commitment funded amount       $ 81,360     $ 81,360   $ 81,604    
Maximum [Member]                      
Debt instrument term             60 days        
Maximum [Member] | SLR Healthcare ABL Credit [Member]                      
Line of credit facility, maximum borrowing capacity   $ 200,000 $ 150,000             $ 110,000  
Minimum [Member]                      
Debt instrument term             60 days        
Minimum [Member] | SLR Healthcare ABL Credit [Member]                      
Line of credit facility, maximum borrowing capacity   $ 125,000 100,000               $ 105,000
SLR Healthcare ABL [Member]                      
Equity method investments     $ 32,839                
SLR Healthcare ABL [Member] | Maximum [Member]                      
Equity method investment, ownership percentage       93.00%     93.00%        
SLR Healthcare ABL [Member] | Minimum [Member]                      
Equity method investment, ownership percentage       7.00%     7.00%        
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
SLR Business Credit - Additional Information (Details)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 03, 2021
USD ($)
Sep. 30, 2022
USD ($)
Sep. 30, 2021
USD ($)
Sep. 30, 2022
USD ($)
issuers
Sep. 30, 2021
USD ($)
Dec. 31, 2021
USD ($)
issuers
Jun. 28, 2019
USD ($)
May 01, 2018
Oct. 20, 2017
USD ($)
SLR Business Credit [Line Items]                  
Commitments and contingencies            
Assets   2,455,435   $ 2,455,435   $ 2,011,011      
SLR Business Credit [Member]                  
SLR Business Credit [Line Items]                  
Number of issuers in business credit | issuers       109   125      
Long-term line of credit   2,715   $ 2,715   $ 1,989      
Net income   1,977 $ 2,577 5,703 $ 4,737        
Gross income   7,607 $ 6,857 20,378 $ 16,674        
Senior Secured Commitments [Member]                  
SLR Business Credit [Line Items]                  
Commitments and contingencies   179,633   179,633   183,501      
Senior Secured Commitments [Member] | SLR Business Credit [Member]                  
SLR Business Credit [Line Items]                  
Commitments and contingencies   554,171   554,171   513,869      
Commitment funded amount   295,973   295,973   248,652      
Assets   346,278   346,278   290,794      
Fast Pay Partners LLC [Member]                  
SLR Business Credit [Line Items]                  
Percentage of voting interests acquired 100.00%                
Business combination, consideration transferred $ 66,671                
NMCs Credit Facility [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity 47,671           $ 15,500    
SUNS [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity $ 19,000                
NMC Senior Credit Facility [Member]                  
SLR Business Credit [Line Items]                  
Line of credit facility, maximum borrowing capacity   240,000   240,000          
Long-term line of credit   $ 237,510   $ 237,510   $ 183,252      
Line of credit facility, expiration date       Nov. 13, 2025          
NM Holdco [Member]                  
SLR Business Credit [Line Items]                  
Percentage of equity interest contributed to another entity             99.00%    
North Mill Capital LLC [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage               99.00% 100.00%
Equity method investments                 $ 51,000
ESP SSC Corporation [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage               1.00% 1.00%
Summit Financial Resources [Member]                  
SLR Business Credit [Line Items]                  
Equity method investment, ownership percentage             100.00%    
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
Merger with SUNS - Additional Information (Details)
3 Months Ended 9 Months Ended
Apr. 01, 2022
basispoints
$ / shares
shares
Sep. 30, 2022
shares
Sep. 30, 2021
shares
Sep. 30, 2022
shares
Sep. 30, 2021
shares
Merger With Suns [Line Items]          
Stock issued during period, shares, acquisitions   0 0 12,511,825 0
Number of basis points | basispoints 25        
Minimum [Member] | Advisory Agreement [Member]          
Merger With Suns [Line Items]          
Percentage of gross assets 1.00%     1.00%  
Percentage of total net assets 200.00%     200.00%  
Maximum [Member] | Advisory Agreement [Member]          
Merger With Suns [Line Items]          
Percentage of gross assets 1.50%     1.50%  
Percentage of total net assets 200.00%     200.00%  
Common Stock [Member] | SUNS Company Merger [Member]          
Merger With Suns [Line Items]          
Shares issued, price per share | $ / shares $ 0.7796        
Stock issued during period, shares, acquisitions 12,511,825        
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2
Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail) - SUNS Company Merger [Member]
$ in Thousands
Sep. 30, 2022
USD ($)
Business Acquisition [Line Items]  
Common stock issued by the Company $ 227,602 [1]
Assets acquired:  
Investments, at fair value 400,105
Cash 2,313
Other assets 4,662
Total assets acquired 407,080
Liabilities assumed:  
Debt, at fair value 159,816
Other liabilities 2,573
Total liabilities assumed 162,389
Net assets acquired 244,691
Total purchase discount $ (17,089)
[1] Based on the market price at closing of $18.13, adjusted for transaction costs.
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.22.2.2
Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail)
Sep. 30, 2022
$ / shares
SUNS Company Merger [Member]  
Business Acquisition [Line Items]  
Business acquisition, share price $ 18.13
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock Repurchase Program - Additional Information (Details) - USD ($)
$ in Thousands
May 23, 2022
Sep. 30, 2022
May 03, 2022
Stockholders' Equity Note [Abstract]      
Stock repurchase program, authorized amount   $ 0 $ 50,000
Stock repurchase program expiration date May 01, 2023    
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events - Additional Information (Details) - Subsequent Event [Member] - USD ($)
$ / shares in Units, $ in Thousands
Nov. 02, 2022
Oct. 12, 2022
Oct. 05, 2022
SLR Senior Lending Program LLC [Member] | Senior Secured Cash Flow Loans [Member]      
Subsequent Event [Line Items]      
Joint venture agreement coventurer equity funding commitment   $ 50,000  
Joint venture agreement aggregate equity funding commitment   $ 100,000  
Board [Member]      
Subsequent Event [Line Items]      
Dividends payable, amount per share $ 0.136667   $ 0.136667
XML 80 d375653d10q_htm.xml IDEA: XBRL DOCUMENT 0001418076 2022-09-30 0001418076 2021-12-31 0001418076 2022-07-01 2022-09-30 0001418076 2021-07-01 2021-09-30 0001418076 2022-01-01 2022-09-30 0001418076 2021-01-01 2021-09-30 0001418076 2022-10-31 0001418076 2022-09-30 2022-09-30 0001418076 2022-04-01 2022-04-01 0001418076 2022-05-03 0001418076 2022-05-23 2022-05-23 0001418076 2021-01-01 2021-12-31 0001418076 2021-09-30 0001418076 2020-12-31 0001418076 2015-01-01 2015-12-31 0001418076 2016-01-01 2016-12-31 0001418076 2017-01-01 2017-12-31 0001418076 2014-01-01 2014-12-31 0001418076 2018-01-01 2018-12-31 0001418076 2019-01-01 2019-12-31 0001418076 2020-01-01 2020-12-31 0001418076 2012-01-01 2012-12-31 0001418076 2013-01-01 2013-12-31 0001418076 2021-06-30 0001418076 2022-06-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SenseonicsHoldingsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:VenusConceptLtdMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:DelphinusMedicalTechnologiesIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:ConventusOrthopaedicsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CentrexionTherapeuticsIncMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CardioFocusIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:AtyrPharmaIncMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AegisToxicologySciencesCorporationMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlteonHealthLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AtriaWealthSolutionsIncMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BasicFunInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CommunityBrandsParentcoLlcFkaMinistryBrandsMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:IvyFertilityServicesLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:InszoneMidLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:IcimsInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FoundationConsumerBrandsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:EnhancedPermanentCapitalLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:LogixHoldingCompanyLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KoreWirelessGroupInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MauricesIncorporatedMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PinnacleTreatmentCentersInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PhynetDermatologyLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OneTouchDirectLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:NacHoldingsCorporationJaguarMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MmitHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PptManagementHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SunmedGroupHoldingsLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:StrytenEnergyLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RqmCorp.Member 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PhymedManagementLlcMember 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:VarileaseFinanceInc.Member 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AcresCommercialMortgageLlcMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UsrParentInc.StaplesMember 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RugDoctorLlcMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BridgebioPharmaInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AxcellaHealthIncMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArdelyxInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArcutisBiotherapeuticsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlimeraSciencesInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OmniguideHoldingsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CentrexionTherapeuticsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:NeuroneticsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:GlookoInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:DelphinusMedicalTechnologiesInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CerapedicsInc.Member 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RezoluteIncMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SocTelemedInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ScpharmaceuticalsInc.Member 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RubiusTherapeuticsInc.Member 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BlackhawkMiningLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AmeraMexInternationalIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ChampionAirLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:CapitalCityJetCenterIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ClubcorpHoldingsIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:DongwonAutopartTechnologyIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EasyPakLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GeorgiaJetIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstNationalCapitalLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstAmericanCommercialBancorpIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GmtCorporationMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HawkeyeContractingCompanyLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HaljoeCoachesUsaLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:KoolPakLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalExpressIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalCoachLinesIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RosscoCraneRiggingIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RaneLightMetalCastingsIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:MountainAirHelicoptersIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StaffordLogisticsIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SidelinesTreeServiceLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StarCoachesIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SturgeonServicesInternationalIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WombleCompanyIncMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:UpTruckingServicesLlcMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrolleysIncMember 2021-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtThirtyEightPointZeroMember 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember 2021-12-31 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember 2021-12-31 0001418076 slrc:TotalInvestmentMember 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel1Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel2Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:WeightedAverageMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MaximumMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 srt:MinimumMember slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2021-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2021-12-31 0001418076 slrc:CreditFacilityOneMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:KbhtMember 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SpectrumPharmaceuticalsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IcimsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BdgMediaInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SocTelemedInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaymarkHealthServicesIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RezoluteIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RqmCorp.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TaucManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RxsenseHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnverusHoldingsIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CompositeTechnologyAcquisitionCorpMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GsmAcquisitionCorpMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ApeelTechnologyIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WorldInsuranceAssociatesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HumanInterestIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RscAcquisitionIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BridgebioPharmaInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OisManagementServicesLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArdelyxIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VesscoMidcoHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KaseyaIncMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PlasticsManagementLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:InszoneMidLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MmitHoldingsLlcMember 2021-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember 2021-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2021-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2021-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2021-12-31 0001418076 slrc:CapitalMarketsMember 2021-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2021-12-31 0001418076 slrc:InsuranceMember 2021-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2021-12-31 0001418076 slrc:ItServicesMember 2021-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2021-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2021-12-31 0001418076 slrc:MetalsAndMiningMember 2021-12-31 0001418076 slrc:AerospaceAndDefenseMember 2021-12-31 0001418076 slrc:MachineryMember 2021-12-31 0001418076 slrc:HealthCareTechnologyMember 2021-12-31 0001418076 slrc:AirlinesMember 2021-12-31 0001418076 slrc:AutoComponentsMember 2021-12-31 0001418076 slrc:SpecialtyRetailMember 2021-12-31 0001418076 slrc:CommunicationsEquipmentMember 2021-12-31 0001418076 slrc:ContainersAndPackagingMember 2021-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2021-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2021-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2021-12-31 0001418076 slrc:AirFreightAndLogisticsMember 2021-12-31 0001418076 slrc:ConsumerFinanceMember 2021-12-31 0001418076 slrc:MultiSectorHoldingsMember 2021-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2021-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2021-12-31 0001418076 slrc:PharmaceuticalsMember 2021-12-31 0001418076 slrc:SoftwareMember 2021-12-31 0001418076 slrc:PersonalProductsMember 2021-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2021-12-31 0001418076 slrc:BiotechnologyMember 2021-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2021-12-31 0001418076 slrc:RoadAndRailMember 2021-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:DelphinusMedicalTechnologiesIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:KbhTopcoLlcKingsbridgeMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:CardioFocusIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:CentrexionTherapeuticsIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:AtyrPharmaIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-09-30 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:ConventusOrthopaedicsIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrCreditSolutionsMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncClassBMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncWarrantsMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrBusinessCreditMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SenseonicsHoldingsIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:VapothermIncMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:TwentyeightyInvestorsLlcMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:VenusConceptLtdMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxVendingLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:MountainAirHelicoptersIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SuperiorTransportationIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:StarCoachesIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:StCoachesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SlrEquipmentFinanceMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SidelinesTreeServiceLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WombleCompanyIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:UpTruckingServicesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WarriorCraneServicesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2022-09-30 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtTwentySixPointSevenMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RaneLightMetalCastingsIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RangoIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RoyalCoachLinesIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RoyalExpressIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:HtiLogisticsCorporationMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:KoolPakLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LoyerCapitalLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GmtCorporationMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FreightsolLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GardaClTechnicalServicesIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GeorgiaJetIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EasyPakLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FirstNationalCapitalLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:DongwonAutopartTechnologyIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BoartLongyearCompanyMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:ChampionAirLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CkdHoldingsInc.Member 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AmeraMexInternationalIncMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AirMethodsCorporationMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BlackhawkMiningLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AfgDallasIiiLlcMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AeroOperatingLlcMember 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VapothermInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CerapedicsInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ScpharmaceuticalsInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GlookoInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NeuroneticsInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OmniguideHoldingsInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RubiusTherapeuticsInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AxcellaHealthIncMember 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BridgebioPharmaInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CentrexionTherapeuticsInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArdelyxInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApeelTechnologyIncMember 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AlimeraSciencesInc.Member 2022-09-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AcresCommercialMortgageLlcMember 2022-09-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VarileaseFinanceInc.Member 2022-09-30 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RdHoldcoInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PlasticsManagementLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VesscoMidcoHoldingsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:WorldInsuranceAssociatesLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SparMarketingForceInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:StrytenResourcesLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SunmedGroupHoldingsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TaucManagementLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TilleyDistributionIncMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RqmCorp.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RscAcquisitionIncMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RxsenseHoldingsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PptManagementHoldingsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KoreWirelessGroupInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PhynetDermatologyLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PinnacleTreatmentCentersInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OneTouchDirectLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MmitHoldingsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MontefioreNyackHospitalMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NacHoldingsCorporationJaguarMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NationalSpineAndPainCentersLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MauricesIncorporatedMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OisManagementServicesLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LogixHoldingCompanyLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LuxuryAssetCapitalLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KingsbridgeHoldingsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IcimsInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:InszoneMidLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IvyFertilityServicesLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KaseyaIncMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HumanInterestIncMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ErieConstructionMidwestLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FoundationConsumerBrandsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GsmAcquisitionCorpMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HighStreetBuyerIncMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CopperRiverSeafoodsInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnhancedPermanentCapitalLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BasicFunInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaymarkHealthServicesIncMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BdgMediaInc.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApexServicesPartnersLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AtriaWealthSolutionsIncMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AllStateAgPartsLlcMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AegisToxicologySciencesCorporationMember 2022-09-30 0001418076 slrc:TotalInvestmentMember 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember 2022-09-30 0001418076 slrc:PreferredEquityzeroPointFourPercentMember 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember 2022-09-30 0001418076 slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-09-30 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-09-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:MinimumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:MaximumMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:WeightedAverageMember slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:WeightedAverageMember slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:MinimumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:MaximumMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:WeightedAverageMember slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-09-30 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-09-30 0001418076 srt:MinimumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-09-30 0001418076 srt:MaximumMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-09-30 0001418076 srt:WeightedAverageMember us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-09-30 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-09-30 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-09-30 0001418076 slrc:CreditFacilityOneMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-09-30 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-09-30 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-09-30 0001418076 slrc:KbhtMember 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2022-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-09-30 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember slrc:CitiBankNaMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SpectrumPharmaceuticalsInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IcimsInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BdgMediaInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:LuxuryAssetCapitalLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CopperRiverSeafoodsInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SparMarketingForceInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PinnacleTreatmentCentersInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RezoluteIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RqmCorp.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TaucManagementLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:TilleyDistributionIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NeuroneticsInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SocTelemedInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BasicFunInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RxsenseHoldingsLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:NacHoldingsCorporationMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ErieConstructionMidwestLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrEquipmentFinanceMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:EnverusHoldingsIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CompositeTechnologyAcquisitionCorpMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AllStateAgPartsLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SunmedGroupHoldingsLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BaymarkHealthServicesIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HighStreetBuyerIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GsmAcquisitionCorpMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SlrCreditSolutionsMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ApeelTechnologyIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:WorldInsuranceAssociatesLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:HumanInterestIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArcutisBiotherapeuticsInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:RscAcquisitionIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:BridgebioPharmaInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:GlookoInc.Member 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:VesscoMidcoHoldingsLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OisManagementServicesLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:ArdelyxIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:AtriaWealthSolutionsIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:FoundationConsumerBrandsLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MauricesIncorporatedMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KaseyaIncMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:OneTouchDirectLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PlasticsManagementLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:InszoneMidLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:IvyFertilityServicesLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:MmitHoldingsLlcMember 2022-09-30 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember 2022-09-30 0001418076 slrc:TransportationInfrastructureMember 2022-09-30 0001418076 slrc:FoodProductsMember 2022-09-30 0001418076 slrc:MediaMember 2022-09-30 0001418076 slrc:ThriftsMortgageFinanceMember 2022-09-30 0001418076 slrc:DiversifiedFinancialServicesMember 2022-09-30 0001418076 slrc:MultiSectorHoldingsMember 2022-09-30 0001418076 slrc:PharmaceuticalsMember 2022-09-30 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-09-30 0001418076 slrc:AutoPartsAndEquipmentMember 2022-09-30 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-09-30 0001418076 slrc:CapitalMarketsMember 2022-09-30 0001418076 slrc:RoadAndRailMember 2022-09-30 0001418076 slrc:PersonalProductsMember 2022-09-30 0001418076 slrc:ItServicesMember 2022-09-30 0001418076 slrc:AirlinesMember 2022-09-30 0001418076 slrc:AutoComponentsMember 2022-09-30 0001418076 slrc:LeisureEquipmentAndProductsMember 2022-09-30 0001418076 slrc:SpecialtyRetailMember 2022-09-30 0001418076 slrc:CommunicationsEquipmentMember 2022-09-30 0001418076 slrc:HealthCareTechnologyMember 2022-09-30 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-09-30 0001418076 slrc:InternetSoftwareServicesMember 2022-09-30 0001418076 slrc:TradingCompaniesAndDistributorsMember 2022-09-30 0001418076 slrc:ConstructionAndEngineeringMember 2022-09-30 0001418076 slrc:WaterUtilitiesMember 2022-09-30 0001418076 slrc:ConsumerFinanceMember 2022-09-30 0001418076 slrc:AerospaceAndDefenseMember 2022-09-30 0001418076 slrc:MetalsAndMiningMember 2022-09-30 0001418076 slrc:MachineryMember 2022-09-30 0001418076 slrc:FootwearMember 2022-09-30 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-09-30 0001418076 slrc:ProfessionalServicesMember 2022-09-30 0001418076 slrc:ContainersAndPackagingMember 2022-09-30 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-09-30 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-09-30 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-09-30 0001418076 slrc:DiversifiedConsumerServicesMember 2022-09-30 0001418076 slrc:BiotechnologyMember 2022-09-30 0001418076 slrc:SoftwareMember 2022-09-30 0001418076 slrc:InsuranceMember 2022-09-30 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-09-30 0001418076 slrc:BuildingProductsMember 2022-09-30 0001418076 slrc:InternetAndCatalogRetailMember 2022-09-30 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-09-30 0001418076 slrc:SunsCompanyMergerMember 2022-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-01-01 2021-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-09-30 0001418076 slrc:AdvisoryAgreementMember 2021-01-01 2021-09-30 0001418076 slrc:SlrBusinessCreditMember 2021-01-01 2021-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2021-01-01 2021-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2021-01-01 2021-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2021-01-01 2021-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-01-01 2021-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-07-01 2021-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-07-01 2021-09-30 0001418076 slrc:AdvisoryAgreementMember 2021-07-01 2021-09-30 0001418076 slrc:SlrBusinessCreditMember 2021-07-01 2021-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2021-07-01 2021-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-07-01 2021-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2021-07-01 2021-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2021-07-01 2021-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-07-01 2021-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApexServicesPartnersLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AtriaWealthSolutionsIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BasicFunInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnhancedPermanentCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CopperRiverSeafoodsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CompositeTechnologyAcquisitionCorp.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnverusHoldingsIncFkaDrillingInfoHoldingsMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ErieConstructionMidwestLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HighStreetBuyerIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HigginbothamInsuranceAgencyIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:FoundationConsumerBrandsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IcimsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KaseyaIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:InszoneMidLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:KoreWirelessGroupInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LogixHoldingCompanyLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MauricesIncorporatedMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MmitHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NacHoldingsCorporationJaguarMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PeterCFoyandAssociatesInsuranceServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ShoHoldingICorporationShoesForCrewsMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RxsenseHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RscAcquisitionIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SparMarketingForceInc.Member 2022-01-01 2022-09-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AcresCommercialMortgageLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:WorldInsuranceAssociatesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VesscoMidcoHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VarileaseFinanceInc.Member 2022-01-01 2022-09-30 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RdHoldcoInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AlimeraSciencesInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ApeelTechnologyIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArcutisBiotherapeuticsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ArdelyxInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CentrexionTherapeuticsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AxcellaHealthIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BridgebioPharmaInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GlookoInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RubiusTherapeuticsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SpectrumPharmaceuticalsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:ScpharmaceuticalsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtTwentySixPointSevenMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OisManagementServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OneTouchDirectLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OrthopedicCarePartnersManagementLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PediatricHomeRespiratoryServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PhynetDermatologyLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PinnacleTreatmentCentersInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PlasticsManagementLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:PptManagementHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:RqmCorp.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SouthernOrthodonticPartnersManagementLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:StrytenResourcesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:SunmedGroupHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TaucManagementLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:TilleyDistributionIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:CerapedicsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NeuroneticsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:OmniguideHoldingsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:VapothermInc.Member 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:VenusConceptLtdMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:VapothermIncMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:TwentyeightyInvestorsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SpectrumPharmaceuticalsInc.WarrantsMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:NationalSpineAndPainCentersLlcMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrHealthcareAblMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SlrBusinessCreditMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:SenseonicsHoldingsIncMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:RdHoldcoIncMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:DelphinusMedicalTechnologiesInc.Member 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:ConventusOrthopaedicsIncMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:CentrexionTherapeuticsIncMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:CardioFocusIncMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:AtyrPharmaIncMember 2022-01-01 2022-09-30 0001418076 slrc:PreferredEquityzeroPointFourPercentMember slrc:SointLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WorldwideFlightServicesInc.Member 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WombleCompanyIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WarriorCraneServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:UpTruckingServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:StarCoachesIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SlrEquipmentFinanceMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SidelinesTreeServiceLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RoyalExpressIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RoyalCoachLinesIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RangoIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RaneLightMetalCastingsIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:MountainAirHelicoptersIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:KoolPakLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:HawkeyeContractingCompanyLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GmtCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GeorgiaJetIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FirstNationalCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EnergyDrillingServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:EasyPakLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:DongwonAutopartTechnologyIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:ChampionAirLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BowmanEnergySolutionsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BlackhawkMiningLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AmeraMexInternationalIncMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BdgMediaInc.Member 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:MontefioreNyackHospitalMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:LuxuryAssetCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:IvyFertilityServicesLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:HumanInterestIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:GsmAcquisitionCorpMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:BaymarkHealthServicesIncMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AllStateAgPartsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember slrc:AegisToxicologySciencesCorporationMember 2022-01-01 2022-09-30 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AeroOperatingLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AirMethodsCorporationMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:BoartLongyearCompanyMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CkdHoldingsInc.Member 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:ClubcorpHoldingsIncMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FirstAmericanCommercialBancorpIncMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:FreightsolLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:GardaClTechnicalServicesIncMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:HtiLogisticsCorporationMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxCreditConsultantsLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:LuxVendingLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RangoIncMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:RangoIncMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SmileyLiftingSolutionsLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:StCoachesLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:SuperiorTransportationIncMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:TrinityEquipmentRentalsIncMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WindRiverEnvironmentalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember slrc:DelphinusMedicalTechnologiesIncMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WarriorCraneServicesLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:WarriorCraneServicesLlcMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:CapitalCityJetCenterIncMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:EquipmentFinancingTwentyThreePointSevenPercentMember slrc:AfgDallasIiiLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember 2022-01-01 2022-09-30 0001418076 srt:MaximumMember slrc:AdvisoryAgreementMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2022-01-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-09-30 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:SpreadOneMember 2022-01-01 2022-09-30 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MarketApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-09-30 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:CreditFacilityOneMember 2022-01-01 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-09-30 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-01-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-09-30 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:CreditFacilityMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-01-01 2022-09-30 0001418076 slrc:CreditFacilityOneMember 2022-01-01 2022-09-30 0001418076 slrc:TermLoansMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-01 2022-09-30 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-07-01 2022-09-30 0001418076 slrc:AdvisoryAgreementMember 2022-07-01 2022-09-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-07-01 2022-09-30 0001418076 slrc:EquipmentFinancingMember 2022-07-01 2022-09-30 0001418076 slrc:PreferredEquityMember 2022-07-01 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember 2022-07-01 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-07-01 2022-09-30 0001418076 slrc:SlrBusinessCreditMember 2022-07-01 2022-09-30 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-07-01 2022-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-07-01 2022-09-30 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-07-01 2022-09-30 0001418076 slrc:CreditFacilityOneMember 2022-07-01 2022-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2022-07-01 2022-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2022-07-01 2022-09-30 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-07-01 2022-09-30 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmericanTeleconferencingServicesLtd.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmericanTeleconferencingServicesLtdOneMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AtriaWealthSolutionsIncMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BasicFunInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CommunityBrandsParentcoLlcFkaMinistryBrandsMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:InszoneMidLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:IcimsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:FoundationConsumerBrandsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:EnhancedPermanentCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KidDistroHoldingsLlcDistroKidMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:NacHoldingsCorporationJaguarMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MmitHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:MauricesIncorporatedMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:LogixHoldingCompanyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:KoreWirelessGroupInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UsrParentInc.StaplesMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArcutisBiotherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlimeraSciencesInc.Member 2021-01-01 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RugDoctorLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:VarileaseFinanceInc.Member 2021-01-01 2021-12-31 0001418076 slrc:SecondLienAssetbasedSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AcresCommercialMortgageLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CentrexionTherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:BridgebioPharmaInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ArdelyxInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AxcellaHealthIncMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RezoluteIncMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:GlookoInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:ScpharmaceuticalsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RubiusTherapeuticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ChampionAirLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:CapitalCityJetCenterIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:DongwonAutopartTechnologyIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GeorgiaJetIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstAmericanCommercialBancorpIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FirstNationalCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GmtCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:InternationalAutomotiveComponentsGroupNorthAmericaIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RaneLightMetalCastingsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SidelinesTreeServiceLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SlrEquipmentFinanceEquityInterestsMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:AtyrPharmaIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CentrexionTherapeuticsIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:EssenceGroupHoldingsCorporationLumerisMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2021-01-01 2021-12-31 0001418076 slrc:U.s.TreasuryBillMember slrc:CashEquivalentsAtThirtyEightPointZeroMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncWarrantsMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncClassBMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SlrCreditSolutionsMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:KbhTopcoLlcKingsbridgeMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:RdHoldcoIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:VenusConceptLtdMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:SenseonicsHoldingsIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:DelphinusMedicalTechnologiesIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:ConventusOrthopaedicsIncMember 2021-01-01 2021-12-31 0001418076 slrc:CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember slrc:CardioFocusIncMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SointLlcMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityZeroPointSevenPercentMember slrc:SoaggLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WombleCompanyIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:UpTruckingServicesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrolleysIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SturgeonServicesInternationalIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StarCoachesIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StaffordLogisticsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalExpressIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RoyalCoachLinesIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RosscoCraneRiggingIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:MountainAirHelicoptersIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:KoolPakLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HawkeyeContractingCompanyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HaljoeCoachesUsaLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EnvironmentalProtectionImprovementCompanyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EasyPakLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ClubcorpHoldingsIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BlackhawkMiningLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AmeraMexInternationalIncMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SocTelemedInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OmniguideHoldingsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:NeuroneticsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:DelphinusMedicalTechnologiesInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienLifeScienceSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:CerapedicsInc.Member 2021-01-01 2021-12-31 0001418076 slrc:SecondLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PhymedManagementLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:UltimateBakedGoodsMidcoLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:SunmedGroupHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:StrytenEnergyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:RqmCorp.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PptManagementHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PinnacleTreatmentCentersInc.Member 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:PhynetDermatologyLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:OneTouchDirectLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:IvyFertilityServicesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AmerimarkIntermediateHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AlteonHealthLlcMember 2021-01-01 2021-12-31 0001418076 slrc:FirstLienBankDebtOrSeniorSecuredLoansMember slrc:SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember slrc:AegisToxicologySciencesCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AeroOperatingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:AirMethodsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BlackhawkMiningLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BlackhawkMiningLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:BoartLongyearCompanyMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ClubcorpHoldingsIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:ClubcorpHoldingsIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:FreightsolLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:GardaClTechnicalServicesIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:HtiLogisticsCorporationMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxCreditConsultantsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:LuxVendingLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:RangoIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SouthTexasOilfieldSolutionsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:StCoachesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:SuperiorTransportationIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TailwindsLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TheSmedleyCompanySmedleyServicesIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:TrinityEquipmentRentalsIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WindRiverEnvironmentalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:WarriorCraneServicesLlcMember 2021-01-01 2021-12-31 0001418076 srt:MaximumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:CapitalCityJetCenterIncMember 2021-01-01 2021-12-31 0001418076 srt:MinimumMember slrc:EquipmentFinancingThirtyTwoPointFivePercentMember slrc:CapitalCityJetCenterIncMember 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadTwoMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadThreeMember 2021-01-01 2021-12-31 0001418076 slrc:SpreadOneMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2021-01-01 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-01-01 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:AviatorcapSiiLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:CreditFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TermLoansMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-01-01 2021-12-31 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 us-gaap:CommonStockMember 2022-09-30 2022-09-30 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-28 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2017-02-15 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2022-06-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2022-06-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2016-11-08 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2011-08-26 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember slrc:CitiBankNaMember 2011-08-26 2011-12-31 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember slrc:CitiBankNaMember 2011-08-26 2011-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember slrc:TermLoanMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember 2021-12-28 0001418076 slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 srt:MinimumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2021-12-28 2021-12-31 0001418076 srt:MaximumMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember slrc:CitiBankNaMember 2022-01-01 2022-06-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-11-30 2012-11-30 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 2012-12-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:CrystalFinancialMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:CrystalCapitalFinancialHoldingsLlcMember slrc:SlrBusinessCreditFacilityMember 2016-07-28 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 srt:MaximumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2013-09-30 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2014-03-31 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2014-06-27 0001418076 srt:MinimumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 srt:MaximumMember slrc:SlrHealthcareAblCreditMember 2016-05-27 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 2022-04-01 0001418076 srt:MaximumMember slrc:AdvisoryAgreementMember 2022-04-01 2022-04-01 0001418076 srt:MinimumMember slrc:AdvisoryAgreementMember 2022-04-01 2022-04-01 0001418076 slrc:SeniorSecuredNotesMember 2012-01-01 2012-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2012-01-01 2012-12-31 0001418076 slrc:CreditFacilityMember 2012-01-01 2012-12-31 0001418076 slrc:TermLoansMember 2012-01-01 2012-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:CreditFacilityMember 2013-01-01 2013-12-31 0001418076 slrc:TermLoansMember 2013-01-01 2013-12-31 0001418076 slrc:CreditFacilityMember 2014-01-01 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TermLoansMember 2014-01-01 2014-12-31 0001418076 slrc:CreditFacilityMember 2015-01-01 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TermLoansMember 2015-01-01 2015-12-31 0001418076 slrc:CreditFacilityMember 2016-01-01 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:TermLoansMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:CreditFacilityMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TermLoansMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-01-01 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-01-01 2017-12-31 0001418076 slrc:CreditFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-01-01 2018-12-31 0001418076 slrc:TermLoansMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-01-01 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-01-01 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-01-01 2018-12-31 0001418076 slrc:CreditFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TermLoansMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-01-01 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-01-01 2019-12-31 0001418076 slrc:CreditFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TermLoansMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-01-01 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-01-01 2020-12-31 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2022-11-02 0001418076 slrc:BoardMember us-gaap:SubsequentEventMember 2022-10-05 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2013-09-30 2013-09-30 0001418076 slrc:SlrHealthcareAblCreditMember 2019-06-28 2019-06-28 0001418076 slrc:SlrHealthcareAblCreditMember 2016-05-27 2016-05-27 0001418076 slrc:SlrHealthcareAblCreditMember 2021-04-01 2021-06-30 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-28 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheTwoMember 2016-11-08 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember slrc:TrancheOneMember 2017-02-15 2017-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:SeniorSecuredCashFlowLoansMember us-gaap:SubsequentEventMember 2022-10-12 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-09-30 0001418076 slrc:PreferredEquityMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember 2022-09-30 0001418076 slrc:EquipmentFinancingMember 2022-09-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-09-30 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-09-30 0001418076 us-gaap:EquitySecuritiesMember 2022-06-30 0001418076 slrc:PreferredEquityMember 2022-06-30 0001418076 slrc:EquipmentFinancingMember 2022-06-30 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-06-30 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-06-30 0001418076 us-gaap:EquitySecuritiesMember 2020-12-31 0001418076 slrc:PreferredEquityMember 2020-12-31 0001418076 slrc:EquipmentFinancingMember 2020-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:AviatorcapSiiLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2020-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RugDoctorLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:AviatorcapSiiLlcMember 2021-12-31 iso4217:USD shares pure utr:Day utr:Year iso4217:USD shares slrc:basispoints slrc:issuers slrc:loans slrc:fund slrc:Customers false Q3 0001418076 --12-31 NY 10-Q true 2022-09-30 2022 false 814-00754 SLR INVESTMENT CORP. MD 26-1381340 500 Park Avenue New York 10022 212 993-1670 Common Stock, par value $0.01 per share SLRC NASDAQ Yes Yes Large Accelerated Filer false false false 54772651 1386014000 985088000 1368827000 964379000 812800000 711865000 786534000 706203000 7983000 2935000 268931000 320000000 268931000 320000000 11542000 9028000 9456000 6521000 1276000 1378000 886000 567000 2455435000 2011011000 1156200000 818500000 7909000 6462000 1148291000 812038000 268952000 320041000 7486000 17327000 7890000 7435000 4771000 1864000 7083000 4492000 1293000 2689000 3444000 2844000 1449210000 1168730000 0.01 0.01 200000000 200000000 54772651 54772651 42260826 42260826 548000 423000 1163713000 936999000 -158036000 -95141000 1006225000 842281000 18.37 19.93 32933000 19202000 82450000 62517000 2431000 2834000 6914000 8605000 0 0 0 133000 11969000 9078000 32767000 28485000 234000 1044000 1222000 3862000 0 5000 0 20000 47567000 32163000 123353000 103622000 7890000 7142000 22019000 20842000 4965000 698000 9699000 8444000 12784000 7127000 31464000 21502000 1132000 1435000 3684000 4170000 935000 755000 4212000 2673000 27706000 17157000 71078000 57631000 -194000 0 -1552000 0 27512000 17157000 69526000 57631000 20055000 15006000 53827000 45991000 -37326000 -127000 -37401000 68000 28783000 -6507000 3521000 1284000 2016000 4999000 -20602000 6105000 30799000 -1508000 -17081000 7389000 -6527000 -1635000 -54482000 7457000 13528000 13371000 -655000 53448000 0.25 0.25 0.32 0.32 -0.01 -0.01 1.26 1.26 20055000 15006000 53827000 45991000 -37326000 -127000 -37401000 68000 30799000 -1508000 -17081000 7389000 13528000 13371000 -655000 53448000 20055000 17327000 53827000 51981000 2401000 0 8413000 0 22456000 17327000 62240000 51981000 0 0 226839000 0 -8928000 -3956000 163944000 1467000 1015153000 857446000 842281000 852023000 1006225000 853490000 1006225000 853490000 0 0 12511825 0 655000 -53448000 -37401000 68000 -17081000 7389000 -406302000 -398349000 259784000 321918000 -7760000 -4652000 -1753000 -5000000 1112000 942000 102000 51000 2935000 -838000 2514000 1092000 319000 40000 -2313000 0 -51089000 116760000 455000 607000 2907000 -94000 -1396000 206000 2591000 3175000 600000 62000 1631000 1169000 -148746000 82492000 72081000 51981000 134914000 49966000 150000000 0 743892000 457000000 554000000 466260000 102725000 -11275000 -46021000 71217000 322935000 388776000 276914000 459993000 28873000 18327000 226839000 0 244691000 226839000 1.344 Health Care Providers & Services L+550 0.01 0.0841 2018-05-07 2025-05-09 17176000 16836000 17176000 Trading Companies & Distributors S+500 0.01 0.0784 2022-04-01 2026-09-01 2681000 2591000 2681000 Communications Equipment L+650 0.01 0 2016-05-05 2021-09-09 36135000 25926000 0 Communications Equipment L+650 0.01 0 2021-09-17 2022-12-16 6581000 6426000 1287000 Internet & Catalog Retail L+600 0.01 0.1109 2021-07-28 2026-10-15 24633000 24225000 24141000 Diversified Consumer Services S+525 0.01 0.083 2022-08-31 2025-07-31 14021000 13612000 13601000 Diversified Financial Services S+600 0.01 0.0879 2018-09-14 2024-02-29 10674000 10617000 10674000 Specialty Retail L+550 0.01 0.0859 2020-10-30 2023-10-30 2687000 2675000 2687000 Health Care Providers & Services L+500 0.01 0.0812 2022-04-01 2027-06-11 12455000 11968000 12455000 Media L+900 0.0025 0.1129 2022-07-18 2023-04-27 9427000 9427000 9427000 Diversified Consumer Services L+575 0.0075 0.0942 2021-06-29 2028-06-29 16794000 16468000 16794000 Building Products L+500 0.01 0.065 2022-04-01 2025-02-01 10759000 10276000 10759000 Food Products P+275 0 0.09 2022-08-31 2025-04-23 9957000 9957000 9957000 Capital Markets L+700 0.01 0.0872 2020-12-29 2025-12-29 35205000 34444000 35205000 Trading Companies & Distributors L+475 0.01 0.0842 2022-04-01 2025-12-31 6232000 5997000 6232000 IT Services L+450 0 0.0762 2022-04-01 2025-07-30 11627000 11119000 11627000 Building Products L+475 0.01 0.0756 2022-04-01 2027-07-30 9029000 8674000 9029000 Personal Products L+550 0.01 0.0843 2021-02-12 2027-02-12 39038000 38070000 39038000 Leisure Equipment & Products S+500 0.01 0.0732 2022-04-01 2026-11-16 11468000 10977000 11353000 Insurance L+525 0.0075 0.0837 2022-04-01 2026-11-25 6239000 5997000 6239000 Insurance L+600 0.0075 0.0856 2022-04-01 2028-04-16 7701000 7257000 7701000 Internet Software & Services S+785 0.01 0.1036 2022-06-30 2027-07-01 20104000 19743000 19702000 Software S+675 0.0075 0.0949 2022-08-18 2028-08-18 32084000 31530000 31522000 Insurance L+575 0.01 0.0823 2021-09-28 2026-06-30 20670000 20487000 20670000 Health Care Providers & Services L+625 0.01 0.088 2021-12-22 2026-02-25 33176000 32406000 33176000 Software S+575 0.0075 0.0829 2022-06-22 2029-06-23 32426000 31953000 31939000 Software L+575 0.01 0.0863 2021-09-24 2027-10-01 29519000 29010000 29519000 Multi-Sector Holdings L+700 0.01 0.0929 2018-12-21 2024-12-21 80000000 79778000 80000000 Wireless Telecommunication Services L+550 0 0.0917 2018-12-21 2024-12-21 47899000 47169000 47899000 Communications Equipment L+575 0.01 0.0887 2018-09-14 2024-12-22 14009000 13159000 13449000 Thrifts & Mortgage Finance S+675 0.01 0.0938 2022-07-15 2027-07-15 27500000 26968000 27500000 Specialty Retail L+675 0.01 0.0938 2021-08-27 2024-06-01 8914000 8746000 8914000 IT Services L+625 0.01 0.095 2021-09-21 2027-09-15 30909000 30477000 30909000 Health Care Providers & Services L+495 0 0.0805 2022-08-09 2024-11-15 5000000 5000000 5000000 Insurance L+525 0.01 0.0823 2021-07-30 2024-09-28 28675000 28234000 28675000 Health Care Providers & Services L+500 0.01 0.0731 2022-04-01 2024-06-02 2486000 2365000 2362000 Health Care Providers & Services S+575 0.01 0.0945 2022-04-11 2026-07-09 6262000 6161000 6262000 Commercial Services & Supplies P+75 0 0.07 2020-04-03 2024-03-30 3487000 3487000 3487000 Health Care Providers & Services S+650 0.01 0.0936 2022-08-17 2024-05-16 2843000 2823000 2822000 Health Care Providers & Services S+625 0.01 0.0943 2022-08-19 2024-12-04 754000 744000 743000 Insurance S+600 0.0075 0.0896 2022-04-01 2028-11-01 10006000 9860000 10006000 Health Care Providers & Services L+600 0.01 0.0885 2018-09-05 2024-08-16 14498000 14454000 14498000 Health Care Providers & Services L+575 0.01 0.08 2020-01-22 2022-12-31 16289000 16223000 16289000 Health Care Providers & Services S+500 0.01 0.0813 2022-04-01 2027-08-18 9515000 9169000 9420000 Health Care Providers & Services L+850 0.01 0.1078 2018-09-14 2022-12-16 30515000 30000000 24503000 Life Sciences Tools & Services L+575 0.01 0.0931 2021-08-20 2026-08-12 26890000 26501000 26890000 Insurance S+550 0.0075 0.0776 2022-04-01 2026-11-01 5946000 5776000 5946000 Diversified Consumer Services L+500 0.01 0.0812 2022-04-01 2026-03-13 11775000 11328000 11775000 Footwear L+523 0.01 0.0804 2022-04-01 2024-04-27 5719000 5315000 5434000 Health Care Providers & Services S+575 0.01 0.0919 2022-06-03 2026-01-27 1028000 1019000 1028000 Media P+95 0 0.072 2022-07-18 2024-10-10 9787000 9787000 9787000 Auto Parts & Equipment S+800 0.01 0.1115 2021-08-11 2026-10-12 25988000 25548000 25988000 Health Care Equipment & Supplies L+575 0.0075 0.0882 2021-06-16 2028-06-16 25014000 24487000 25014000 Health Care Providers & Services L+525 0.01 0.0816 2022-04-01 2027-02-12 6908000 6578000 6874000 Trading Companies & Distributors L+600 0.01 0.0878 2022-04-01 2026-12-31 10253000 9758000 10253000 Packaged Foods & Meats L+650 0.01 0.1017 2021-08-12 2027-08-13 26136000 25322000 25874000 Water Utilities L+450 0.01 0.0734 2022-04-01 2026-11-02 1523000 1461000 1508000 Insurance L+575 0.01 0.0833 2022-04-01 2026-04-01 23188000 22463000 23188000 958828000 936888000 Diversified Financial Services S+705 0.01 0.0982 2021-12-24 2028-08-21 29925000 29380000 29925000 Multi-Sector Holdings L+750 0.01 0.0979 2014-08-22 2025-11-15 29563000 29483000 29563000 58863000 59488000 Diversified Consumer Services S+975 0.015 0 2013-12-23 2023-05-16 12900000 11791000 6450000 11791000 6450000 Pharmaceuticals L+765 0.0178 0.1028 2019-12-31 2024-07-01 23159000 23823000 26280000 Biotechnology S+625 0.01 0.0875 2022-06-29 2027-06-01 3643000 3613000 3606000 Pharamceuticals L+745 0.001 0.1008 2021-12-22 2027-01-01 66849000 66803000 67518000 Pharmaceuticals L+795 0.001 0.1058 2022-02-23 2027-03-01 9475000 9407000 9475000 Pharmaceuticals L+860 0.001 0.1123 2021-09-02 2026-09-01 7137000 7236000 7262000 Biotechnology 0 0 0.09 2021-11-17 2026-11-17 39530000 38954000 39184000 Pharmaceuticals L+725 0.0245 0.0988 2019-06-28 2024-01-01 14578000 15043000 15015000 Health Care Equipment & Supplies L+695 0.025 0.0958 2019-03-22 2025-03-01 30982000 32059000 33151000 Health Care Technology L+790 0.001 0.1053 2021-09-30 2026-10-01 15883000 15830000 15903000 Health Care Equipment & Supplies L+765 0.0166 0.1028 2020-03-02 2025-02-28 18012000 18387000 18463000 Health Care Equipment & Supplies L+1405 0.001 0.1668 2018-07-30 2023-07-01 18879000 18413000 19314000 Pharmaceuticals L+550 0.021 0.0813 2018-12-21 2026-06-01 46473000 47552000 46783000 Pharmaceuticals L+795 0.0223 0.1058 2019-09-17 2023-09-17 2701000 2787000 2848000 Biotechnology S+570 0.023 0.0872 2022-09-21 2027-09-01 10525000 10373000 10420000 Health Care Equipment & Supplies S+830 0.01 0.1093 2022-02-18 2027-02-01 34455000 34104000 34455000 344384000 349677000 1373866000 1352503000 0.237 Commercial Services & Supplies 0.0847 0.0964 2021-02-12 2025-03-01 2026-12-01 2392000 2389000 2389000 Diversified Consumer Services 0.10 2022-08-11 2026-08-11 2026-08-26 1093000 1093000 1093000 Airlines 0.0708 0.0713 2021-11-03 2026-11-03 2026-11-23 3719000 3784000 3719000 Commercial Services & Supplies 0.10 2019-03-29 2025-04-15 1551000 1551000 1566000 Oil, Gas & Consumable Fuels 0.1117 2018-02-16 2022-11-01 409000 409000 409000 Metals & Mining 0.0906 0.1044 2020-05-28 2024-07-01 2026-01-01 4231000 4231000 4231000 Commercial Services & Supplies 0.0742 2022-07-01 2026-08-01 162000 162000 162000 Airlines 0.10 2018-04-04 2023-10-04 2026-06-22 2464000 2464000 2432000 Airlines 0.10 2018-03-19 2023-01-01 1219000 1219000 1219000 Road & Rail 0.081 0.086 2022-09-22 2026-06-22 2027-09-22 3887000 3887000 3887000 Hotels, Restaurants & Leisure 0.0936 0.1301 2021-05-27 2025-04-01 2027-10-01 6027000 6027000 6027000 Auto Components 0.0796 2021-02-02 2026-01-01 1962000 1986000 1962000 Containers & Packaging 0.0901 2021-01-06 2024-01-01 364000 364000 364000 Diversified Consumer Services 0.0658 2022-08-26 2027-09-01 1192000 1192000 1192000 Road & Rail 0.0825 2020-09-30 2027-10-01 5438000 5469000 5438000 Multi-Sector Holdings 0.0837 2018-04-27 2025-04-27 3946000 3946000 3847000 Diversified Financial Services 0.075 0.0902 2021-10-28 2026-11-01 2027-04-01 3094000 3098000 3094000 Diversified Financial Services 0.09 2021-11-05 2026-08-01 7533000 7533000 7533000 Road & Rail 0.1251 0.1289 2019-04-09 2023-11-01 932000 940000 932000 Commercial Services & Supplies 0.083 0.0877 2018-03-22 2023-06-05 2023-10-05 669000 669000 667000 Airlines 0.08 2017-12-04 2024-01-04 520000 520000 520000 Machinery 0.1071 2018-10-23 2026-01-01 5032000 5038000 5032000 Construction & Engineering 0.105 2021-10-08 2025-11-01 1069000 1069000 1069000 Commercial Services & Supplies 0.0969 0.0994 2018-11-15 2024-05-01 2025-09-01 322000 322000 314000 Auto Components 0.0795 2021-06-23 2025-06-23 6616000 6659000 6484000 Road & Rail 0.0858 2018-02-05 2024-03-01 233000 233000 233000 Multi-Sector Holdings 0.0873 0.1152 2019-05-16 2024-05-16 2024-09-25 7500000 7500000 7361000 Road & Rail 0.0828 0.1112 2021-06-17 2024-12-01 2026-10-01 15930000 15930000 15930000 Consumer Finance 0.1246 0.1326 2021-08-20 2024-08-20 2024-10-01 1870000 1902000 1870000 Commercial Services & Supplies 0.10 2017-07-31 2025-02-28 398000 396000 398000 Machinery 0.10 2020-06-01 2024-07-01 184000 184000 184000 Commercial Services & Supplies 0.0933 0.0979 2019-09-24 2023-04-01 2024-11-01 2374000 2399000 2329000 Road & Rail 0.0956 2019-11-21 2025-08-01 913000 913000 833000 Road & Rail 0.0953 2019-01-17 2024-02-01 494000 497000 494000 Diversified Consumer Services 0.1025 2017-07-31 2022-10-01 19000 19000 19000 Multi-Sector Holdings 0.085 2022-01-24 2023-01-24 5000000 5000000 5000000 Commercial Services & Supplies 0.0782 0.0795 2022-06-30 2026-09-15 2029-07-01 2006000 2006000 2006000 Road & Rail 0.0822 0.0858 2017-07-31 2022-10-01 2025-01-25 1810000 1810000 1729000 Road & Rail 0.0842 2018-03-09 2025-04-01 3019000 3019000 2710000 Road & Rail 0.1022 0.1063 2017-07-31 2026-01-01 3814000 3814000 3814000 Commercial Services & Supplies 0.0407 2017-07-31 2028-01-01 2706000 2706000 2706000 Commercial Services & Supplies 0.0794 0.0875 2021-10-08 2024-11-01 2026-12-01 628000 628000 628000 Road & Rail 0.1121 2018-03-23 2024-08-01 510000 515000 510000 Commercial Services & Supplies 0.0895 2019-07-11 2024-08-01 2026-08-01 2144000 2144000 2104000 Diversified Consumer Services 0.0843 0.10 2019-07-31 2024-08-01 2025-10-05 673000 675000 673000 Energy Equipment & Services 0.0911 2019-12-27 2025-01-01 428000 428000 411000 Transportation Infrastructure 0.0832 2022-09-23 2027-09-23 209000 211000 209000 Multi-Sector Holdings 2017-07-31 200 145000000 120820000 263950000 238553000 0.004 Aerospace & Defense 0.05 2012-06-08 2023-06-30 52536 5254000 4176000 5254000 4176000 0.557 Pharmaceuticals 2016-11-18 6347 106000 0 Health Care Equipment & Supplies 2017-03-31 90 51000 0 Pharmaceuticals 2019-06-28 289102 136000 92000 Health Care Equipment & Supplies 2016-06-15 157500 65000 0 Health Care Equipment & Supplies 2017-08-18 444388 74000 108000 Health Care Technology 2017-03-22 260000 129000 377000 Multi-Sector Holdings 2020-11-03 73500000 136596000 147000000 Diversified Consumer Services 2013-12-23 231177 15683000 0 Diversified Consumer Services 2013-12-23 522 5216000 0 Diversified Consumer Services 2013-12-23 30370 381000 0 Health Care Equipment & Supplies 2019-07-25 469353 235000 620000 Diversified Financial Services 2022-04-01 100 81583000 89370000 Diversified Financial Services 2012-12-28 280303 280737000 288760000 Diversified Financial Services 2022-04-01 32839 34335000 33750000 Biotechnology 2022-09-21 159470 50000 22000 Professional Services 2022-04-01 17214 5000 5000 Health Care Equipment & Supplies 2022-02-18 36996 210000 25000 Health Care Equipment & Supplies 2018-05-10 33430 152000 0 555744000 560129000 2.142 2198814000 2155361000 0.267 2022-09-30 2022-11-22 270000000 268931000 268931000 2.409 2467745000 2424292000 -1.409 1418067000 1 1006225000 0.25 18939000 0 -15725000 0 -633000 -668000 3847000 80000000 0 0 0 64000 -5182000 80000000 145996000 0 0 0 -1004000 -11288000 147000000 10725000 0 -3500000 0 -136000 -812000 7361000 0 0 0 0 0 0 0 5216000 0 0 0 5216000 0 0 0 0 0 0 0 0 0 11829000 685000 0 0 5351000 18000 6450000 0 81583000 0 0 -7787000 -3400000 89370000 298766000 0 0 0 10006000 -15500000 288760000 129102000 0 0 0 8282000 0 120820000 0 5000000 0 0 0 -270000 5000000 0 34335000 0 0 585000 -1730000 33750000 1121000 0 -447000 0 674000 -647000 0 4509000 203000 -552000 0 -16000 -202000 4176000 706203000 121806000 -20224000 0 20602000 -39681000 786534000 0.227 13274000 159987000 146713000 2142087000 0.055 0.005 0.215 0.183 0.081 0.071 0.061 0.048 0.043 0.025 0.024 0.022 0.02 0.018 0.017 0.016 0.013 0.012 0.012 0.012 0.011 0.009 0.009 0.009 0.009 0.009 0.008 0.007 0.005 0.005 0.005 0.004 0.004 0.003 0.002 0.002 0.002 0.002 0.001 0.001 0 0 0 0 0 0 1 1.115 Health Care Providers & Services L+550 0.01 0.065 2018-05-07 2025-05-09 12402000 12283000 12402000 Health Care Providers & Services L+650 0.01 0.075 2018-09-14 2023-09-01 14117000 14079000 14117000 Communications Equipment L+650 0.01 0.075 2016-05-05 2021-09-09 24822000 24453000 3345000 Communications Equipment L+650 0.01 0.075 2021-09-17 2022-03-31 4576000 4508000 4576000 Internet & Catalog Retail L+600 0.01 0.07 2021-07-28 2026-10-15 25226000 24739000 24721000 Diversified Financial Services L+600 0.01 0.07 2018-09-14 2022-11-30 6345000 6329000 6345000 Specialty Retail L+550 0.01 0.065 2020-10-30 2023-10-30 2902000 2871000 2902000 Diversified Consumer Services L+575 0.0075 0.065 2021-06-29 2028-06-29 12168000 11995000 12168000 Software L+400 0.01 0.05 2021-07-30 2022-12-02 34901000 34538000 34901000 Capital Markets L+700 0.01 0.08 2020-12-29 2025-12-29 26061000 25418000 26061000 Personal Products L+638 0.01 0.0738 2021-02-12 2027-02-12 33367000 32633000 33367000 Software L+650 0.01 0.075 2018-09-07 2024-09-12 19341000 19120000 19341000 Insurance L+575 0.01 0.0675 2021-09-28 2026-06-30 11141000 11035000 11086000 Health Care Providers & Services L+625 0.01 0.0725 2021-12-22 2026-02-25 21677000 21299000 21298000 Software L+600 0.01 0.07 2021-09-24 2027-10-01 29743000 29168000 29148000 Multi-Sector Holdings L+700 0.01 0.08 2018-12-21 2024-12-21 80000000 79713000 80000000 Wireless Telecommunication Services L+550 0 0.0572 2018-12-21 2024-12-21 36470000 36062000 36470000 Communications Equipment L+575 0.01 0.0675 2018-09-14 2024-12-22 7400000 7359000 7178000 Specialty Retail L+675 0.01 0.0775 2021-08-27 2024-06-01 5135000 5044000 5135000 IT Services L+625 0.01 0.0725 2021-09-21 2027-09-15 31026000 30541000 31026000 Insurance L+525 0.01 0.0625 2021-07-30 2024-09-28 15924000 15730000 15844000 Commercial Services & Supplies P+75 0 0.04 2020-04-03 2022-09-30 274000 274000 274000 Health Care Providers & Services L+600 0.01 0.07 2018-09-05 2024-08-16 14589000 14529000 14589000 Health Care Providers & Services L+575 0.01 0.0675 2020-01-22 2022-12-31 11996000 11953000 11996000 Health Care Providers & Services L+800 0.01 0.09 2018-09-14 2022-12-16 21120000 21086000 18374000 Life Sciences Tools & Services L+575 0.01 0.0675 2021-08-20 2026-08-12 16504000 16349000 16462000 Auto Parts & Equipment L+800 0.01 0.09 2021-08-11 2026-10-12 26184000 25676000 25923000 Health Care Equipment & Supplies L+575 0.0075 0.065 2021-06-16 2028-06-16 18536000 18232000 18351000 Packaged Foods & Meats L+625 0.01 0.0725 2021-08-12 2027-08-13 19381000 18920000 18896000 Specialty Retail L+884 0.01 0.0984 2020-06-03 2022-09-12 3275000 3275000 3275000 579211000 559571000 Diversified Financial Services L+705 0.01 0.0805 2021-12-24 2028-08-21 29925000 29328000 29326000 Multi-Sector Holdings L+750 0.01 0.085 2014-08-22 2025-11-15 29563000 29467000 29563000 58795000 58889000 Health Care Providers & Services L+1500 0.01 0.16 2015-12-18 2022-09-30 37819000 37757000 36874000 Diversified Consumer Services L+975 0.015 0.1125 2013-12-23 2023-05-16 11828000 11819000 11829000 49576000 48703000 Pharmaceuticals L+765 0.0178 0.0943 2019-12-31 2024-07-01 20074000 20512000 20475000 Pharamceuticals L+745 0.001 0.0755 2021-12-22 2027-01-01 21735000 21645000 21637000 Pharmaceuticals L+745 0.0025 0.077 2018-05-10 2022-11-01 14972000 16198000 16170000 Pharmaceuticals L+860 0.001 0.087 2021-09-02 2026-09-01 9278000 9318000 9302000 Biotechnology 0 0 0.09 2021-11-17 2026-11-17 34574000 34082000 34055000 Pharmaceuticals L+725 0.0245 0.097 2019-06-28 2024-01-01 16400000 16693000 16728000 Health Care Equipment & Supplies L+695 0.025 0.0945 2019-03-22 2025-03-01 26861000 27518000 27465000 Health Care Equipment & Supplies L+850 0.01 0.095 2017-08-18 2022-06-01 1089000 1414000 1405000 Health Care Technology L+790 0.001 0.08 2021-09-30 2026-10-01 8364000 8339000 8322000 Health Care Equipment & Supplies L+765 0.0166 0.0931 2020-03-02 2025-02-28 15613000 15874000 15878000 Health Care Equipment & Supplies L+1405 0.001 0.1415 2018-07-30 2023-07-01 18879000 17845000 18958000 Biotechnology L+875 0.0012 0.0887 2021-04-14 2026-04-01 5675000 5663000 5661000 Pharmaceuticals L+550 0.021 0.076 2018-12-21 2026-06-01 40291000 41103000 41097000 Pharmaceuticals L+795 0.0223 0.1018 2019-09-17 2023-09-17 4098000 4165000 4160000 Health Care Providers & Services L+747 0.0013 0.076 2021-03-26 2026-04-01 31137000 31211000 31214000 271580000 272527000 959162000 939690000 0.325 Commercial Services & Supplies 0.0847 0.0964 2021-02-12 2025-03-01 2026-12-01 3103000 3100000 3100000 Airlines 0.0708 0.0713 2021-11-03 2026-11-03 2026-11-23 4063000 4145000 4063000 Commercial Services & Supplies 0.10 2019-03-29 2022-03-28 3149000 3148000 3180000 Oil, Gas & Consumable Fuels 0.1097 0.1116 2018-02-16 2022-03-01 2022-11-01 1642000 1615000 1636000 Metals & Mining 0.0906 0.1044 2020-05-28 2024-07-01 2026-01-01 5374000 5374000 5374000 Airlines 0.10 2018-04-04 2023-10-04 2026-06-22 3102000 3102000 3053000 Airlines 0.10 2018-03-19 2023-01-01 1685000 1685000 1685000 Hotels, Restaurants & Leisure 0.0887 0.0941 2021-05-27 2025-06-01 2027-01-01 4326000 4326000 4326000 Auto Components 0.0796 2021-02-02 2026-01-01 2347000 2382000 2347000 Containers & Packaging 0.0901 2021-01-06 2024-01-01 616000 616000 616000 Road & Rail 0.0825 2020-09-30 2027-10-01 5921000 5959000 5921000 Multi-Sector Holdings 0.0753 0.0837 2018-04-27 2022-08-01 2025-04-27 19671000 19671000 18939000 Diversified Financial Services 0.075 2021-10-28 2026-11-01 2487000 2492000 2487000 Diversified Financial Services 0.09 2021-11-05 2026-08-01 8681000 8681000 8681000 Road & Rail 0.1251 0.1289 2019-04-09 2023-11-01 1364000 1381000 1364000 Commercial Services & Supplies 0.083 0.0877 2018-03-22 2023-06-05 2023-10-05 1245000 1245000 1242000 Airlines 0.08 2017-12-04 2024-01-04 795000 795000 795000 Machinery 0.1071 2018-10-23 2025-10-01 5476000 5484000 5476000 Road & Rail 0.0853 2017-07-31 2024-07-01 1061000 1061000 915000 Construction & Engineering 0.105 2021-10-08 2025-11-01 1252000 1252000 1252000 Commercial Services & Supplies 0.0969 0.0994 2018-11-15 2024-05-01 2025-09-01 414000 414000 404000 Auto Components 0.0795 2021-06-23 2025-06-23 8184000 8250000 8184000 Road & Rail 0.0858 2018-02-05 2024-03-01 345000 345000 345000 Multi-Sector Holdings 0.0873 0.1152 2019-05-16 2024-05-16 2024-09-25 11000000 11000000 10725000 Road & Rail 0.0828 0.0965 2021-06-17 2024-12-01 2025-12-01 9343000 9343000 9343000 Consumer Finance 0.1246 0.1326 2021-08-20 2024-08-20 2024-10-01 2526000 2583000 2526000 Commercial Services & Supplies 0.10 2017-07-31 2025-02-28 479000 476000 479000 Machinery 0.10 2020-06-01 2024-07-01 253000 253000 253000 Commercial Services & Supplies 0.0933 0.0979 2019-09-24 2023-04-01 2024-11-01 3615000 3656000 3547000 Commercial Services & Supplies 0.1153 2017-08-25 2022-09-01 126000 126000 126000 Road & Rail 0.0956 2019-11-21 2025-08-01 1041000 1041000 950000 Road & Rail 0.0953 2019-01-17 2024-02-01 683000 690000 683000 Diversified Consumer Services 0.1025 2017-07-31 2022-10-01 46000 46000 45000 Energy Equipment & Services 0.1252 0.1376 2018-03-29 2022-09-01 2023-07-01 1363000 1363000 1338000 Road & Rail 0.0822 0.0858 2017-07-31 2022-10-01 2025-01-25 1951000 1951000 1839000 Commercial Services & Supplies 0.1262 2019-09-11 2026-02-15 7094000 7094000 7094000 Road & Rail 0.0842 2018-03-09 2025-04-01 3401000 3401000 2916000 Energy Equipment & Services 0.1838 2017-07-31 2022-02-28 132000 132000 125000 Road & Rail 0.1022 0.1062 2017-07-31 2026-01-01 4578000 4578000 4578000 Air Freight & Logistics 0.085 0.09 2019-07-26 2024-08-01 2025-10-16 2267000 2267000 2267000 Commercial Services & Supplies 0.1021 0.1536 2017-07-31 2023-10-29 2024-02-10 3798000 3800000 3536000 Commercial Services & Supplies 0.0794 0.0875 2021-10-08 2024-11-01 2026-12-01 777000 777000 777000 Road & Rail 0.0999 2018-07-18 2022-08-01 1573000 1573000 1540000 Road & Rail 0.1121 2018-03-23 2024-08-01 696000 705000 696000 Commercial Services & Supplies 0.0895 2019-07-11 2024-08-01 2026-08-01 2567000 2567000 2518000 Diversified Consumer Services 0.0843 0.10 2019-07-31 2024-08-01 2025-10-05 870000 873000 870000 Energy Equipment & Services 0.0911 2019-12-27 2025-01-01 547000 547000 537000 Multi-Sector Holdings 2017-07-31 200 145000000 129102000 292365000 273795000 0.007 Aerospace & Defense 0.08 2010-12-14 2023-06-30 446 446000 1121000 Aerospace & Defense 0.05 2012-06-08 2023-06-30 56030 5603000 4509000 6049000 5630000 0.536 Pharmaceuticals 2016-11-18 6347 106000 0 Health Care Equipment & Supplies 2017-03-31 90 51000 0 Pharmaceuticals 2019-06-28 289102 136000 65000 Health Care Equipment & Supplies 2016-06-15 157500 65000 0 Health Care Equipment & Supplies 2017-08-18 444388 74000 80000 Health Care Technology 2017-03-22 208000 63000 258000 Multi-Sector Holdings 2020-11-03 73500000 136596000 145996000 Diversified Consumer Services 2013-12-23 231177 15683000 0 Diversified Consumer Services 2013-12-23 522 5216000 5216000 Diversified Consumer Services 2013-12-23 30370 381000 0 Health Care Equipment & Supplies 2019-07-25 406923 117000 1086000 Diversified Financial Services 2012-12-28 280303 280737000 298766000 Health Care Equipment & Supplies 2018-05-10 27352 152000 0 439377000 451467000 1.983 1696953000 1670582000 0.38 Government 2021-12-31 2022-01-25 320000000 320000000 320000000 2.363 2016953000 1990582000 -1.363 1148301000 1 842281000 0.25 2941000 0 -2941000 0 0 -92000 0 25540000 0 -6667000 0 -66000 -1950000 18939000 80000000 0 0 0 79000 -6568000 80000000 136596000 0 0 0 -9400000 -13250000 145996000 14456000 0 -3731000 0 0 -1426000 10725000 1226000 0 0 0 1226000 0 0 5216000 0 0 0 0 0 5216000 0 0 0 0 0 0 0 10559000 1270000 0 0 6000 -1300000 11829000 296766000 0 0 0 -2000000 -22500000 298766000 129102000 0 0 0 0 0 129102000 850000 0 -850000 0 0 -42000 0 2300000 0 0 0 1179000 -1543000 1121000 4101000 271000 0 0 -137000 -271000 4509000 709653000 1541000 -14189000 0 -9113000 -48942000 706203000 0.231 19495000 82598000 63103000 1651087000 0.06 0.02 0.025 0.125 0.055 0.005 0.248 0.207 0.096 0.078 0.05 0.05 0.024 0.022 0.02 0.019 0.019 0.018 0.016 0.016 0.016 0.015 0.015 0.011 0.01 0.009 0.007 0.006 0.006 0.005 0.003 0.003 0.003 0.003 0.001 0.001 0.001 0.001 0.001 0 1 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1. Organization </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Solar Capital LLC, a Maryland limited liability company, was formed in February 2007 and commenced operations on March 13, 2007 with initial capital of $1,200,000 of which 47.04% was funded by affiliated parties. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Immediately prior to our initial public offering, through a series of transactions, SLR Investment Corp. (the “Company”, “we”, “us” or “our”), merged with Solar Capital LLC, leaving SLR Investment Corp. as the surviving entity (the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“Pre-IPO</div> Merger”). SLR Investment Corp. issued an aggregate of approximately 26.65 million shares of common stock and $125,000 in senior unsecured notes to the existing Solar Capital LLC unit holders in connection with the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-IPO</div> Merger. SLR Investment Corp. had no assets or operations prior to completion of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-IPO</div> Merger and as a result, the historical books and records of Solar Capital LLC have become the books and records of the surviving entity. The number of shares used to calculate weighted average shares for use in computations on a per share basis have been decreased retroactively by a factor of approximately 0.4022 for all periods prior to February 9, 2010. This factor represents the effective impact of the reduction in shares resulting from the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-IPO</div> Merger. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">SLR Investment Corp., a Maryland corporation formed in November 2007, is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">closed-end,</div> externally managed, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-diversified</div> management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”). </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 1, 2021, we entered into an Agreement and Plan of Merger (the “Merger Agreement”), with SLR Senior Investment Corp., a Maryland corporation (“SUNS”), Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). The Merger Agreement provided that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger,”) and, immediately thereafter, SUNS will merge with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). The Mergers closed on April 1, 2022. See Note 16 for additional information. </div></div> 2007-03-13 1200000000 0.4704 26650000 125000000 5680000 18.5 600000 18.5 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2. Significant Accounting Policies </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Interim consolidated financial statements are prepared in accordance with GAAP for interim financial information and pursuant to the requirements for reporting on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-Q</div> and Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X,</div> as appropriate. Accordingly, they may not include all of the information and notes required by GAAP for annual consolidated financial statements. GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the fiscal year ending on December 31, 2022. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The significant accounting policies consistently followed by the Company are: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investment transactions are accounted for on the trade date; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation]. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-market</div> pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value, the Board has approved a multi-step valuation process each quarter, as described below: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"> </td> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"> </td> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"> </td> <td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"> </td> <td style="width: 4%; vertical-align: top;;text-align:left;">(4)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 9%;"> </td> <td style="width: 4%; vertical-align: top;;text-align:left;">(5)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 4%;">Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">820-10,</div> certain investments that qualify as investment companies in accordance with ASC 946, may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&amp;A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the nine months ended September 30, 2022, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy: </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 1</div>: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 2</div>: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 9%;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Level</div><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;"> 3</div>: Unobservable inputs for the asset or liability. </div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience. </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(c)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gains or losses on investments are calculated by using the specific identification method. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(d)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recurring</div> fee income as well as management fee and other fee income for services rendered, if any, are recorded as other income when earned. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(e)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company intends to comply with the applicable provisions of the Code pertaining to regulated investment companies to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(f)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts annually. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(g)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(h)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">In accordance with Regulation <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">S-X</div> and ASC Topic 810—<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Consolidation</div></div>, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(i)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(j)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">In accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">835-30,</div> the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(k)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">marked-to-market</div></div> by recognizing the difference between the contract exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(l)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">946-20-25.</div></div> </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(m)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Investments that are expected to pay regularly scheduled interest in cash are generally placed on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment. </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(n)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents. </div></div></td></tr></table><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Pronouncements </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In March 2020, the FASB issued Accounting Standards Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> P60D P60D 0.04 P30D P90D <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Pronouncements </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">In March 2020, the FASB issued Accounting Standards Update <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">No. 2020-04,</div> “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The guidance provides optional expedients and exceptions for applying GAAP to contract modifications, hedging relationships and other transactions, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued because of the reference rate reform. ASU <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2020-04</div> is effective for all entities as of March 12, 2020 through December 31, 2022. The Company has determined that the adoption of this guidance has not had a material impact on the Company’s consolidated financial statements and disclosures. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 3. Agreements </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company has an investment advisory and management agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser will manage the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">day-to-day</div></div> operations of, and provide investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. The base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income for the immediately preceding calendar quarter. For this purpose, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee). <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-incentive</div> fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Pre-incentive</div> fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income with respect to that portion of such <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pre-incentive</div> fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">pro-rated</div> for any period of less than three months. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">investment-by-investment</div></div> basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the three and nine months ended September 30, 2022 and 2021. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three and nine months ended September 30, 2022, the Company recognized $7,890 and $22,019, respectively, in base management fees and $4,965 and $9,699, respectively, in gross performance-based incentive fees. For the three and nine months ended September 30, 2022, $194 and $1,552 of such performance-based incentive fees were waived. For the three and nine months ended September 30, 2021, the Company recognized $7,142 and $20,842, respectively, in base management fees and $698 and $8,444, respectively, in performance-based incentive fees. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Merger. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the three and nine months ended September 30, 2022, the Company recognized expenses under the Administration Agreement of $1,132 and $3,684 respectively. For the three and nine months ended September 30, 2021, the Company recognized expenses under the Administration Agreement of $1,435 and $4,170 respectively. No managerial assistance fees were accrued or collected for the three and nine months ended September 30, 2022 and 2021. </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> 0.015 2 0.01 2 0.0175 0.07 1 0.20 0.20 0.20 7890000 22019000 4965000 9699000 194000 1552000 7142000 20842000 698000 8444000 1132000 3684000 1435000 4170000 <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 4. Net Asset Value Per Share </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At September 30, 2022, the Company’s total net assets and net asset value per share were $1,006,225 and $18.37, respectively. This compares to total net assets and net asset value per share at December 31, 2021 of $842,281 and $19.93, respectively. </div></div> 1006225000 18.37 842281000 19.93 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 5. Earnings Per Share </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">260-10,</div> for the three and nine months ended September 30, 2022 and 2021: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 86%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Earnings (loss) per share (basic &amp; diluted)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator - net increase (decrease) in net assets resulting from operations:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,528</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,371</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(655</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53,448</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator - weighted average shares:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,772,651</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,260,826</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,647,874</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,260,826</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Earnings (loss) per share:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.25</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.32</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">($</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.01</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.26</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">260-10,</div> for the three and nine months ended September 30, 2022 and 2021: </div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 86%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended September 30,</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Earnings (loss) per share (basic &amp; diluted)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator - net increase (decrease) in net assets resulting from operations:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,528</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,371</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(655</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53,448</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator - weighted average shares:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">54,772,651</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,260,826</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,647,874</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,260,826</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Earnings (loss) per share:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.25</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.32</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">($</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.01</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.26</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> 13528000 13371000 -655000 53448000 54772651 54772651 42260826 42260826 50647874 50647874 42260826 42260826 0.25 0.25 0.32 0.32 -0.01 -0.01 1.26 1.26 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 6. Fair Value </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows: </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 1.</div></div> Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 2.</div></div> Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following: </div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quoted prices for similar assets or liabilities in active markets; </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Quoted prices for identical or similar assets or liabilities in <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-active</div> markets; </div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">c)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pricing models whose inputs are observable for substantially the full term of the asset or liability; and </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"> </td> <td style="width: 5%; vertical-align: top;;text-align:left;">d)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 3. </div></div>Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3). </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3). </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of September 30, 2022 and December 31, 2021: </div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022 </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,352,503</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,352,503</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipment Financing</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">238,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">238,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Equity/Equity Interests/Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">620</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">559,509</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">560,129</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Investments$</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">620</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 2,154,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,155,361</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021 </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">939,690</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">939,690</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipment Financing</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">273,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">273,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Equity/Equity Interests/Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,086</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450,381</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">451,467</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Investments$</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,086</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,669,496</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,670,582</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables provide a summary of the changes in fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at September 30, 2022: </div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, June</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,178,247</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 255,978</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 4,405</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">554,597</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,993,227</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gains or losses included in earnings:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,518</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,849</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(139</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,589</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">228,399</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,581</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">67</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,051</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">249,098</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds from dispositions of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(51,430</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(29,157</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(355</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(80,942</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, September</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,352,503</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">238,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">559,509</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,154,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">781</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,849</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(139</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,148</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">939,690</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 273,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450,381</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,669,496</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gains or losses included in earnings:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,191</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,191</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,890</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,828</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(658</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,121</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(16,497</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of investment securities(1)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">639,306</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,202</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">202</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">116,249</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">799,959</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds from dispositions of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(187,412</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(72,616</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(998</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(261,026</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, September</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,352,503</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">238,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">559,509</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,154,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,744</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,828</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">(658) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,121</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,351</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes positions acquired from SUNS as a result of the Merger. </div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2022: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 24%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> —  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Borrowings</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Repayments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 19%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Borrowings</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Repayments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(150,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10.</div> On May 8, 2022, the borrowings were repaid in full. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2021, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2021: </div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2020</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">798,052</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 284,846</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,401</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">440,971</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,530,270</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gains or losses included in earnings:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">345</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">337</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(13,567</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,394</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,042</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,857</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,358</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">533,614</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">76,700</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">271</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">610,585</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds from dispositions of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(378,409</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(89,137</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(675</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(468,221</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(117</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(117</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">939,690</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">273,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450,381</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,669,496</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,837</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,394</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,042</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,597</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,888</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset. </div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 12%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Borrowings</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Repayments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company made elections to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">825-10.</div> On December 31, 2021, there were borrowings of $150,000 on the 2022 Unsecured Notes. </div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative Information about Level 3 Fair Value Measurements </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2022 is summarized in the table below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 87%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/>Liability</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/>September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/>Technique/Methodology</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Range (Weighted<br/>Average)</div></div></div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,320,263 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">32,240</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Market Yield <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Comparable Multiple</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7.6% – 17.8% (10.9%)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.1x-21.4x(12.0x)</div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipment Financing</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">117,733 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">120,820</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Market Yield <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Comparable Multiple</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8.5% – 9.7% (9.7%)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.0x-1.28x</div> (1.14x)</div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5.0% – 5.0% (5.0%)</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Equity/Equity Interests/Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">147,629 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">411,880</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(3)</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Approach</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Comparable Multiple <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Return on Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7.0x – 9.3x (8.1x)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6.3% – 37.7% (9.7%)</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes $120,820 of investments valued using a transaction multiple. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes $624 of investments valued using a Black-Scholes model and $147,005 of investments valued using an EBITDA multiple. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 87%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/>Liability</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/>Technique/Methodology</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Range (Weighted<br/>Average)</div></div></div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">931,769 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7,921</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Market Yield <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Comparable Multiple</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4.0% – 19.6% (8.7%)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2.0x-3.0x(2.5x)/2.0x-3.0x(2.5x)</div></div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipment Financing</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">144,693 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> 129,102</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Approach</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Market Yield <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Return on Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7.1% – 20.3% (9.8%)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.6%-4.6%</div> (4.6%)</div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3.5% – 8.0% (4.4%)</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Equity/Equity Interests/Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">151,615 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">298,766</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Approach</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Comparable Multiple <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Return on Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5.8x – 10.5x (9.5x)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6.1% – 18.5% (8.6%)</div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Liability</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">2.2% – 4.6% (4.5%)</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected EBITDA multiples <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(2x-3x)</div> for certain segments of the business and expected revenue multiples <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(2x-3x)</div> for certain segments of the business. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple. </div></div> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">bid-ask</div> spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s investments. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of September 30, 2022 and December 31, 2021: </div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022 </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 66%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,352,503</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,352,503</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipment Financing</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">238,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">238,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Equity/Equity Interests/Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">620</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">559,509</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">560,129</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Investments$</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">620</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 2,154,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,155,361</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements </div></div></div><div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="text-decoration: underline; letter-spacing: 0px; top: 0px;;display:inline;">As of December 31, 2021 </div></div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 65%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 1</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 2</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Level 3</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">939,690</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">939,690</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipment Financing</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">273,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">273,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Equity/Equity Interests/Warrants</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,086</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450,381</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">451,467</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Investments$</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,086</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,669,496</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,670,582</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities:</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 0 0 1352503000 1352503000 0 0 238553000 238553000 0 0 4176000 4176000 620000 0 559509000 560129000 620000 0 2154741000 2155361000 0 0 939690000 939690000 0 0 273795000 273795000 0 0 5630000 5630000 1086000 0 450381000 451467000 1086000 0 1669496000 1670582000 0 0 150000000 150000000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following tables provide a summary of the changes in fair value of Level 3 assets and liabilities for the three and nine months ended September 30, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets and liabilities still held at September 30, 2022: </div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, June</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,178,247</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 255,978</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 4,405</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">554,597</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,993,227</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gains or losses included in earnings:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,231</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34,518</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,849</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(139</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,589</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">228,399</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">15,581</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">67</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,051</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">249,098</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds from dispositions of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(51,430</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(29,157</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(355</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(80,942</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, September</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,352,503</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">238,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">559,509</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,154,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">781</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,849</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">59</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(139</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,148</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">939,690</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 273,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450,381</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,669,496</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gains or losses included in earnings:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,191</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(37,191</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,890</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,828</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(658</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,121</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(16,497</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of investment securities(1)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">639,306</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,202</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">202</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">116,249</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">799,959</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds from dispositions of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(187,412</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(72,616</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(998</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(261,026</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, September</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 30, 2022</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,352,503</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">238,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">559,509</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,154,741</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,744</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(6,828</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">(658) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(7,121</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,351</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes positions acquired from SUNS as a result of the Merger. </div></div> </td> </tr> </table> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 24pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value Measurements Using Level 3 Inputs </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Senior Secured<br/> Loans</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Equipment</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Financing</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Preferred Equity</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Common Equity/<br/> Equity<br/> Interests/<br/> Warrants</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2020</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">798,052</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 284,846</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,401</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">440,971</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,530,270</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total gains or losses included in earnings:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(8</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">345</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">337</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(13,567</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,394</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,042</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,857</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(3,358</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Purchase of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">533,614</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">76,700</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">271</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">610,585</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Proceeds from dispositions of investment securities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(378,409</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(89,137</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(675</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(468,221</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(117</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(117</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair value, December</div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"> 31, 2021</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">939,690</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">273,795</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">450,381</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,669,496</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized gain (loss)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(12,837</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,394</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1,042</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,597</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(2,888</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 17, 2021, the Company exercised its warrants in Senseonics Holdings, Inc., receiving shares in the common stock of Senseonics Holdings, Inc. The common stock of Senseonics Holdings, Inc. is publicly traded, so this position is considered to be a Level 1 asset. </div></div> </td> </tr> </table> 1178247000 255978000 4405000 554597000 1993227000 -37231000 0 0 0 -37231000 34518000 -3849000 59000 -139000 30589000 228399000 15581000 67000 5051000 249098000 -51430000 -29157000 -355000 0 -80942000 0 0 0 0 0 1352503000 238553000 4176000 559509000 2154741000 781000 -3849000 59000 -139000 -3148000 939690000 273795000 5630000 450381000 1669496000 -37191000 0 0 0 -37191000 -1890000 -6828000 -658000 -7121000 -16497000 639306000 44202000 202000 116249000 799959000 -187412000 -72616000 -998000 0 -261026000 0 0 0 0 0 1352503000 238553000 4176000 559509000 2154741000 -2744000 -6828000 -658000 -7121000 -17351000 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the three and nine months ended September 30, 2022: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 72%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 24%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the three months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> —  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Borrowings</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Repayments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 73%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 19%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Borrowings</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Repayments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(150,000</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2021: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 12%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"> <div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">For the year ended<br/> December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Beginning fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net change in unrealized (gain) loss</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Borrowings</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Repayments</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transfers in/out of Level 3</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ending fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> 0 0 0 0 0 0 0 150000000 0 0 0 -150000000 0 0 798052000 284846000 6401000 440971000 1530270000 0 -8000 0 345000 337000 -13567000 1394000 -1042000 9857000 -3358000 533614000 76700000 271000 0 610585000 -378409000 -89137000 0 -675000 -468221000 0 0 0 -117000 -117000 939690000 273795000 5630000 450381000 1669496000 -12837000 1394000 -1042000 9597000 -2888000 150000000 0 0 0 0 0 150000000 150000000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of September 30, 2022 is summarized in the table below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 87%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/>Liability</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/>September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/>Technique/Methodology</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Range (Weighted<br/>Average)</div></div></div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,320,263 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">32,240</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Market Yield <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Comparable Multiple</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7.6% – 17.8% (10.9%)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.1x-21.4x(12.0x)</div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipment Financing</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">117,733 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">120,820</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Market Yield <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Comparable Multiple</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">8.5% – 9.7% (9.7%)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.0x-1.28x</div> (1.14x)</div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,176</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">5.0% – 5.0% (5.0%)</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Equity/Equity Interests/Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;;text-align:center;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">147,629 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">411,880</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(3)</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Approach</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Comparable Multiple <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Return on Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7.0x – 9.3x (8.1x)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6.3% – 37.7% (9.7%)</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes $120,820 of investments valued using a transaction multiple. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes $624 of investments valued using a Black-Scholes model and $147,005 of investments valued using an EBITDA multiple. </div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2021 is summarized in the table below: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;"> <tr style="font-size: 0px;"> <td style="width: 87%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset or<br/>Liability</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Fair Value at<br/>December 31, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Principal Valuation<br/>Technique/Methodology</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable Input</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Range (Weighted<br/>Average)</div></div></div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Loans</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">931,769 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7,921</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Market Yield <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Comparable Multiple</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">4.0% – 19.6% (8.7%)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2.0x-3.0x(2.5x)/2.0x-3.0x(2.5x)</div></div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Equipment Financing</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">144,693 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> 129,102</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Approach</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Market Yield <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Return on Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">7.1% – 20.3% (9.8%)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">4.6%-4.6%</div> (4.6%)</div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Preferred Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,630</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">3.5% – 8.0% (4.4%)</td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common Equity/Equity Interests/Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Asset</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$ <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">$</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">151,615 <div style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">298,766</div></div> </td> <td style="vertical-align: bottom; white-space: nowrap;">  <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Market Multiple<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Market Approach</div></div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">Comparable Multiple <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">Return on Equity</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;"> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">5.8x – 10.5x (9.5x)</div></div> <div style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 1pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">6.1% – 18.5% (8.6%)</div></div> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: top; white-space: nowrap;">Liability</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">Income Approach</td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;;text-align:center;">Market Yield</td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:center;">2.2% – 4.6% (4.5%)</td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">Investments are valued using a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">sum-of-the</div></div> parts analysis, using expected EBITDA multiples <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(2x-3x)</div> for certain segments of the business and expected revenue multiples <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(2x-3x)</div> for certain segments of the business. </div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Includes $403 of investments valued using a Black-Scholes model and $151,212 of investments valued using an EBITDA multiple. </div></div> </td> </tr> </table> 1320263000 32240000 Income Approach Market Multiple Market Yield Comparable Multiple 7.6 17.8 10.9 0.1 21.4 12 117733000 120820000 Income Approach Market Multiple Market Yield Comparable Multiple 8.5 9.7 9.7 1 1.28 1.14 4176000 Income Approach Market Yield 5 5 5 147629000 411880000 Market Multiple Market Approach Comparable Multiple Return on Equity 7 9.3 8.1 6.3 37.7 9.7 120820000 624000 147005000 931769000 7921000 Income Approach Market Multiple Market Yield Comparable Multiple 4 19.6 8.7 2 3 2.5 2 3 2.5 144693000 129102000 Income Approach Market Approach Market Yield Return on Equity 7.1 20.3 9.8 4.6 4.6 4.6 5630000 Income Approach Market Yield 3.5 8 4.4 151615000 298766000 Market Multiple Market Approach Comparable Multiple Return on Equity 5.8 10.5 9.5 6.1 18.5 8.6 150000000 Income Approach Market Yield 2.2 4.6 4.5 403000 151212000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 7. Debt </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our debt obligations consisted of the following as of September 30, 2022 and December 31, 2021: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 84%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Facility</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Credit Facility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">460,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 454,868</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 322,500</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 318,015</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV Credit Facility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">129,236</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Tranche C Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,991</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(3)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,964</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(3)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,881</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,592</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(4)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,350</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,143</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(5)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">84,572</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,468</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(7)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,384</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(7)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,950</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(8)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,940</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(8)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027 Series F Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">135,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">134,975</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(9)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,156,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,148,291</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 818,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 812,038</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $5,132 and $4,485 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized market discount of $964 as of September 30, 2022. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $9 and $36 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(4)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $119 and $408 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(5)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $650 and $857 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(6)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized market discount of $428 as of September 30, 2022. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(7)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $532 and $616 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(8)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $50 and $60 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(9)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $25 as of September 30, 2022. </div></div></td></tr></table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Unsecured Notes </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 28, 2017, the Company closed a private offering of $21,000 of the 2022 Tranche C Notes with a fixed interest rate of 4.50% and a maturity date of December 28, 2022. Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28. The 2022 Tranche C Notes were issued in a private placement only to qualified institutional buyers. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November 22, 2017, we issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes is paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes mature on January 20, 2023. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On February 15, 2017, the Company closed a private offering of $100,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.60% and a maturity date of May 8, 2022. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November 8, 2016, the Company closed a private offering of $50,000 of the 2022 Unsecured Notes with a fixed interest rate of 4.40% and a maturity date of <div style="display:inline;">May 8, 2022</div>. Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8. The 2022 Unsecured Notes were issued in a private placement only to qualified institutional buyers. The 2022 Unsecured Notes were repaid in full at maturity. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Revolving and Term Loan Facilities </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, the commitment under the SPV Credit Facility is $225,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is LIBOR plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">2.00%-2.50%</div> with no LIBOR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At September 30, 2022, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $130,200. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, the Credit Facility is composed of $600,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">1.75%-2.00%</div> or the alternate base rate plus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">0.75%-1.00%.</div> The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, requires the Company to maintain a minimum shareholder’s equity and a minimum asset coverage ratio. At September 30, 2022, outstanding USD equivalent borrowings under the Credit Facility totaled $460,000, composed of $360,000 of revolving credit and $100,000 of term loans. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The average annualized interest cost for all borrowings for the nine months ended September 30, 2022 and the year ended December 31, 2021 was 3.81% and 3.64%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2022 Unsecured Notes, the 2022 Tranche C Notes, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the nine months ended September 30, 2022 and the year ended December 31, 2021 were $1,157,100 and $902,550, respectively. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Our debt obligations consisted of the following as of September 30, 2022 and December 31, 2021: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 84%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December 31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Facility</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Face Amount</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Carrying Value</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Credit Facility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">460,000</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 454,868</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 322,500</td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 318,015</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV Credit Facility</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">129,236</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(2)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Tranche C Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,991</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(3)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,964</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(3)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2023 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,881</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(4)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,592</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(4)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2024 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,350</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(5)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124,143</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(5)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2025 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">84,572</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(6)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2026 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,468</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(7)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">74,384</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(7)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027 Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,950</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(8)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">49,940</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(8)</div> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">2027 Series F Unsecured Notes</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">135,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">134,975</td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(9)</div> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,156,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 1,148,291</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 818,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 812,038</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $5,132 and $4,485 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized market discount of $964 as of September 30, 2022. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $9 and $36 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(4)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $119 and $408 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(5)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $650 and $857 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(6)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized market discount of $428 as of September 30, 2022. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(7)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $532 and $616 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(8)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $50 and $60 as of September 30, 2022 and December 31, 2021, respectively. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(9)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Carrying Value equals the Face Amount net of unamortized debt issuance costs of $25 as of September 30, 2022. </div></div></td></tr></table> 460000000 454868000 322500000 318015000 130200000 129236000 0 0 0 0 150000000 150000000 21000000 20991000 21000000 20964000 75000000 74881000 75000000 74592000 125000000 124350000 125000000 124143000 85000000 84572000 0 0 75000000 74468000 75000000 74384000 50000000 49950000 50000000 49940000 135000000 134975000 0 0 1156200000 1148291000 818500000 812038000 5132000 4485000 964000 9000 36000 119000 408000 650000 857000 428000 532000 616000 50000 60000 25000 85000000 85000000 P5Y 0.039 2025-03-31 Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30 135000000 135000000 0.0333 2027-01-06 Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6 50000000 50000000 0.0295 0.0295 125000000 125000000 125000000 0.042 0.042 2024-12-15 Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15 75000000 75000000 75000000 0.04375 0.04375 2026-12-15 21000000 21000000 21000000 0.045 0.045 Interest on the 2022 Tranche C Notes is due semi-annually on June 28 and December 28 75000000 75000000 75000000 73846000 semi-annually on January 20 and July 20 0.045 0.045 2023-01-20 100000000 100000000 100000000 0.046 0.046 2022-05-08 Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8 50000000 50000000 50000000 0.044 0.044 Interest on the 2022 Unsecured Notes is due semi-annually on May 8 and November 8 225000000 600000000 0.02 -0.025 2026-06-01 130200000 600000000 100000000 0.0175 -0.02 0.0075 -0.01 800000000 460000000 360000000 100000000 0.0381 0.0364 1157100000 902550000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 8. Financial Highlights </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following is a schedule of financial highlights for the nine months ended September 30, 2022 and 2021: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 92%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Per Share Data: (a)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net asset value, beginning of year</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19.93</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20.16</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net investment income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.06</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.09</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized and unrealized gain (loss)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.08</td> <td style="vertical-align: bottom; white-space: nowrap;">)* </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.18</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net increase (decrease) in net assets resulting from operations</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.02</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.27</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock in connection with the Merger</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.31</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions to stockholders:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From net investment income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.06</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.23</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="display:inline;">From return of capital<br/></div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right;"><div style="null;text-indent: 0px;;display:inline;">(0.17</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"><div style="display:inline;">)</div> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; width: 12%; padding: 0pt 5pt 0pt 0pt; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right;"><div style="text-indent: 0px; white-space: nowrap;;display:inline;">—</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net asset value, end of period</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">18.37</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">20.20</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Per share market value, end of period</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">12.32</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">19.13</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Return (b)(c)</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">(27.75</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">%) </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">16.46</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net assets, end of period</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">1,006,225</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">853,490</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares outstanding, end of period</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">54,772,651</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">42,260,826</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ratios to average net assets (c):</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net investment income</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">5.51</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">5.38</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating expenses</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">3.90</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">%** </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">4.23</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">% </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest and other credit facility expenses</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">3.22</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">2.51</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total expenses</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">7.12</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">%** </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">6.74</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">% </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Average debt outstanding</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">951,995</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">672,962</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio turnover ratio</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">13.8</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">% </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">20.8</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">% </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per Share for the applicable period. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2021 and December 31, 2020 was $18.43 and $17.51, respectively. Total return does not include a sales load. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(c)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Not annualized for periods less than one year. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">*</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">**</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a permanent incentive fee waiver (see note 3). </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the incentive fee waiver. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following is a schedule of financial highlights for the nine months ended September 30, 2022 and 2021: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 92%;"/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 1%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Per Share Data: (a)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net asset value, beginning of year</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">19.93</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20.16</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net investment income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.06</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.09</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net realized and unrealized gain (loss)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.08</td> <td style="vertical-align: bottom; white-space: nowrap;">)* </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">0.18</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net increase (decrease) in net assets resulting from operations</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.02</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1.27</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Issuance of common stock in connection with the Merger</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(0.31</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Distributions to stockholders:</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">From net investment income</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.06</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(1.23</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td></tr> <tr> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="display:inline;">From return of capital<br/></div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right;"><div style="null;text-indent: 0px;;display:inline;">(0.17</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"><div style="display:inline;">)</div> </div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; width: 12%; padding: 0pt 5pt 0pt 0pt; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px; text-align: right;"><div style="text-indent: 0px; white-space: nowrap;;display:inline;">—</div></div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"><div style="margin-bottom: 0px; margin-top: 0px;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net asset value, end of period</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">18.37</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">20.20</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Per share market value, end of period</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">12.32</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">19.13</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Return (b)(c)</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">(27.75</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">%) </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">16.46</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net assets, end of period</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">1,006,225</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">853,490</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares outstanding, end of period</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">54,772,651</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">42,260,826</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ratios to average net assets (c):</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net investment income</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">5.51</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">5.38</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Operating expenses</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">3.90</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">%** </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">4.23</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">% </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest and other credit facility expenses</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">3.22</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">2.51</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">% </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgb(204, 238, 255);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total expenses</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">7.12</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">%** </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">6.74</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">% </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; background-color: rgba(255, 255, 255, 0);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Average debt outstanding</div></div></td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">951,995</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; background-color: rgba(255, 255, 255, 0);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);;text-align:right;">672,962</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgba(255, 255, 255, 0);"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; background-color: rgb(204, 238, 255);"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio turnover ratio</div></div></td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">13.8</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">% </td> <td style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">20.8</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">% </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="width: 11%; line-height: 8pt; margin-top: 0pt; margin-bottom: 2pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(a)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Merger, which reflects the actual amount per Share for the applicable period. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(b)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total return is based on the change in market price per share during the period and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. The market price per share as of December 31, 2021 and December 31, 2020 was $18.43 and $17.51, respectively. Total return does not include a sales load. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(c)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Not annualized for periods less than one year. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">*</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Merger. </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">**</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a permanent incentive fee waiver (see note 3). </div></div></td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">For the nine months ended September 30, 2022, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.06% and 7.28%, respectively, without the incentive fee waiver. </div></div> 19.93 20.16 1.06 1.09 -1.08 0.18 -0.02 1.27 -0.31 0 1.06 1.23 -0.17 0 18.37 20.2 12.32 19.13 -0.2775 0.1646 1006225000 853490000 54772651 42260826 0.0551 0.0538 0.039 0.0423 0.0322 0.0251 0.0712 0.0674 951995000 672962000 0.138 0.208 18.43 17.51 0.0406 0.0728 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 9. SLR Credit Solutions </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of September 30, 2022, total commitments to the revolving credit facility are $250,000. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of September 30, 2022 SLR Credit had 27 funded commitments to 21 different issuers with total funded loans of approximately $354,853 on total assets of $375,603. As of December 31, 2021 SLR Credit had 22 funded commitments to 19 different issuers with total funded loans of approximately $287,375 on total assets of $347,821. As of September 30, 2022 and December 31, 2021, the largest loan outstanding totaled $34,178 and $35,000, respectively. For the same periods, the average exposure per issuer was $16,898 and $15,125, respectively. SLR Credit’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to the Company, had approximately $139,497 and $100,742 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Credit had net income of $3,897 and $5,445, respectively, on gross income of $8,596 and $9,508, respectively. For the nine months ended September 30, 2022 and 2021, SLR Credit had net income of $8,557 and $12,497 respectively, on gross income of $22,171 and $27,239, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. </div> 275000000 0.98 23 400000000 275000000 0.02 5737000 1 250000000 27 21 354853000 375603000 22 19 287375000 347821000 34178000 35000000 16898000 15125000 139497000 100742000 3897000 5445000 8596000 9508000 8557000 12497000 22171000 27239000 <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 10. Commitments and Contingencies </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Off-Balance</div> Sheet Arrangements </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of September 30, 2022 and December 31, 2021 is $310,204 and $226,733, respectively, comprised of the following: </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 7pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SLR Credit Solutions*</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,263</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,263</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Apeel Technology, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,786</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">World Insurance Associates, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,554</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">CC SAG Holdings Corp. (Spectrum Automotive)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,346</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,827</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Human Interest, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,104</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Glooko, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,868</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,091</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Spectrum Pharmaceuticals, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,279</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">iCIMS, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,577</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">BridgeBio Pharma, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,016</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,049</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">BDG Media, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,573</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">RSC Acquisition, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Arcutis Biotherapeutics, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,356</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,470</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Atria Wealth Solutions, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,215</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,746</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Ardelyx, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,752</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Luxury Asset Capital, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">OIS Management Services, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,205</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Vessco Midco Holdings, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,098</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">One Touch Direct, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,013</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,226</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Kaseya, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,936</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Maurices, Incorporated</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,922</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,649</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Foundation Consumer Brands, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,009</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,269</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Inszone Mid, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,790</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,465</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Kid Distro Holdings, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,650</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,650</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Plastics Management, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,424</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Pediatric Home Respiratory Services, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,380</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Southern Orthodontic Partners Management, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,292</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic Fun, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,150</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,935</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Copper River Seafoods, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,043</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Peter C. Foy &amp; Associates Insurance Services, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,969</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Orthopedic Care Partners Management, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,896</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">MMIT Holdings, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,894</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,009</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SPAR Marketing Force, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,613</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Ivy Fertility Services, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,571</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,532</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">NAC Holdings Corporation</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,479</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,765</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SLR Healthcare ABL*</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">RxSense Holdings LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Erie Construction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Mid-west,</div> LLC</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,247</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Composite Technology Acquisition Corp.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,139</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Enverus Holdings, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,004</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SLR Equipment Finance</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">American Teleconferencing Services, Ltd.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">914</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">573</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SunMed Group Holdings, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">843</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">828</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">All State Ag Parts, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">730</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Ultimate Baked Goods Midco LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">801</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">BayMark Health Services, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">391</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Pinnacle Treatment Centers, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">387</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,414</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">GSM Acquisition Corp.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">365</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">High Street Buyer, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">327</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Tilley Distribution, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">293</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">TAUC Management, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">287</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">RQM+ Corp.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,818</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Rezolute, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,675</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SOC Telemed, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,448</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Neuronetics, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,230</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Commitments</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 310,204</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 226,733</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">*</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion. </div></div></td></tr></table> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of September 30, 2022 and December 31, 2021, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.​​​​​​​ </div></div> The total amount of these unfunded commitments as of September 30, 2022 and December 31, 2021 is $310,204 and $226,733, respectively, comprised of the following: <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 76%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 80%;"/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 7pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">September</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">30, 2022</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">December</div></div><br/> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">31, 2021</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SLR Credit Solutions*</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,263</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">44,263</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Apeel Technology, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">32,786</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">World Insurance Associates, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,554</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">CC SAG Holdings Corp. (Spectrum Automotive)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">24,346</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">18,827</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Human Interest, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">20,104</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Glooko, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,868</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">25,091</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Spectrum Pharmaceuticals, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,279</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">iCIMS, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">11,577</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">BridgeBio Pharma, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,016</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">23,049</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">BDG Media, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,573</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">RSC Acquisition, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,553</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Arcutis Biotherapeutics, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,356</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">43,470</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Atria Wealth Solutions, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,215</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,746</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Ardelyx, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,752</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Luxury Asset Capital, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">OIS Management Services, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,205</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Vessco Midco Holdings, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,098</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">One Touch Direct, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,013</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,226</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Kaseya, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,936</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Maurices, Incorporated</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,922</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,649</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Foundation Consumer Brands, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,009</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,269</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Inszone Mid, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,790</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">12,465</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Kid Distro Holdings, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,650</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,650</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Plastics Management, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,424</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Pediatric Home Respiratory Services, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,380</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Southern Orthodontic Partners Management, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,292</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic Fun, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,150</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,935</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Copper River Seafoods, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,043</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Peter C. Foy &amp; Associates Insurance Services, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,969</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Orthopedic Care Partners Management, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,896</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">MMIT Holdings, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,894</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,009</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SPAR Marketing Force, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,613</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Ivy Fertility Services, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,571</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,532</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">NAC Holdings Corporation</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,479</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,765</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SLR Healthcare ABL*</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">RxSense Holdings LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;">Erie Construction <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Mid-west,</div> LLC</div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,247</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Composite Technology Acquisition Corp.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,139</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Enverus Holdings, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,004</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SLR Equipment Finance</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">American Teleconferencing Services, Ltd.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">914</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">573</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SunMed Group Holdings, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">843</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">828</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">All State Ag Parts, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">730</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Ultimate Baked Goods Midco LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">551</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">801</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">BayMark Health Services, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">391</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Pinnacle Treatment Centers, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">387</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,414</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">GSM Acquisition Corp.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">365</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">High Street Buyer, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">327</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Tilley Distribution, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">293</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">TAUC Management, LLC</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">287</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">RQM+ Corp.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,818</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Rezolute, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,675</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">SOC Telemed, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,448</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Neuronetics, Inc.</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,230</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Commitments</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 310,204</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 226,733</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">*</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion. </div></div></td></tr></table> 310204000 226733000 44263000 44263000 32786000 0 25554000 0 24346000 18827000 20104000 0 17868000 25091000 12279000 0 11577000 0 9016000 23049000 8573000 0 8553000 0 8356000 43470000 8215000 3746000 7752000 0 7500000 0 5205000 0 4098000 0 4013000 7226000 3936000 0 3922000 5649000 3009000 2269000 2790000 12465000 2650000 2650000 2424000 0 2380000 0 2292000 0 2150000 1935000 2043000 0 1969000 0 1896000 0 1894000 2009000 1613000 0 1571000 4532000 1479000 4765000 1400000 0 1250000 0 1247000 0 1139000 0 1004000 0 1000000 5000000 914000 573000 843000 828000 730000 0 551000 801000 391000 0 387000 1414000 365000 0 327000 0 293000 0 287000 0 0 3818000 0 5675000 0 4448000 0 2230000 310204000 226733000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 11. SLR Equipment Finance </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies is doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000 <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of September 30, 2022, SLR Equipment had 129 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $189,254 on total assets of $241,189. As of December 31, 2021, SLR Equipment had 135 funded equipment-backed leases and loans to 61 different customers with a total net investment in leases and loans of approximately $210,986 on total assets of $264,007. As of September 30, 2022 and December 31, 2021, the largest position outstanding totaled $19,272 and $19,207, respectively. For the same periods, the average exposure per customer was $3,208 and $3,459, respectively. SLR Equipment’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to the Company, had approximately $110,997 and $118,002 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and September 30, 2021, SLR Equipment had net income (loss) of $1,034 and ($306), respectively, on gross income of $6,486 and $5,809, respectively. For the nine months ended September 30, 2022 and September 30, 2021, SLR Equipment had net loss of $125 and $2,301, respectively, on gross income of $15,704 and $16,443, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. </div> 1 209866000 145000000 64866000 150000000 250000000 213957000 313957000 2023-07-31 129 59 189254000 241189000 135 61 210986000 264007000 19272000 19207000 3208000 3459000 110997000 118002000 1034000 306000 6486000 5809000 125000 2301000 15704000 16443000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 12. Capital Share Transactions </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of September 30, 2022 and September 30, 2021, 200,000,000 shares of $0.01 par value capital stock were authorized. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transactions in capital stock were as follows: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 90%; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares issued in connection with the Mergers</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net increase</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 90%; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares issued in connection with the Mergers</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12,511,825</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">226,839</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net increase</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12,511,825</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">226,839</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 200000000 200000000 0.01 0.01 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Transactions in capital stock were as follows: </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 90%; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three months ended<br/> September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares issued in connection with the Mergers</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net increase</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table><div style="clear:both;max-height:0pt;"/><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-size: 8pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 90%; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="font-size: 10pt; white-space: nowrap;">                              </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Shares</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="6" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Amount</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2022</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Nine months ended<br/> September 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Shares issued in connection with the Mergers</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12,511,825</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">226,839</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net increase</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">12,511,825</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">226,839</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">—  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td> <td> </td></tr></table> 0 0 0 0 0 0 0 0 12511825 0 226839000 0 12511825 0 226839000 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 13. Kingsbridge Holdings, LLC </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On November 3, 2020, the Company acquired an 87.5% equity interest in Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a newly formed Delaware corporation. KBH is a residual focused independent <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-ticket</div> lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continue to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of September 30, 2022 and December 31, 2021, KBHT had total assets of $774,619 and $738,425, respectively. For the same periods, debt recourse to KBHT totaled $246,210 and $216,881, respectively, and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> debt totaled $316,840 and $323,844, respectively. None of the debt is recourse to the Company. For the three months ended September 30, 2022 and 2021, KBHT had net income of $3,327 and $3,163, respectively, on gross income of $71,332 and $60,510, respectively. For the nine months ended September 30, 2022 and 2021, KBHT had net income of $10,393 and $10,314, respectively, on gross income of $215,074 and $180,079, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. </div> 0.875 216596000 136596000 0.875 80000000 0.875 0.125 774619000 738425000 246210000 216881000 316840000 323844000 3327000 3163000 71332000 60510000 10393000 10314000 215074000 180079000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 14. SLR Healthcare ABL </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">mid-sized</div> companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">co-invested</div> in the transaction and continues to lead SLR Healthcare. As of September 30, 2022, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Merger on April 1, 2022. </div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Concurrent with the closing of the transaction, SLR Healthcare entered into a new, four-year, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse,</div> $100,000 credit facility with <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-affiliates,</div> which was expandable to $150,000 under its accordion feature. Effective March 31, 2014, the credit facility was expanded to $105,000 and again on June 27, 2014 to $110,000. On May 27, 2016, SLR Healthcare entered into a new $125,000 credit facility which replaced the previously existing facility. The new facility has similar terms as compared to the previous facility and includes an accordion feature increase to $200,000 and had a maturity date of May 27, 2020. On June 28, 2019, this $125,000 facility was amended, extending the maturity date to June 28, 2023. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of September 30, 2022, the portfolio totaled approximat<div style="display:inline;">e</div>ly $179,633 </div></div>of commitments with a total net investment in loans of $81,360 on total assets of $93,010. As of December 31, 2021, the portfolio totaled approximately $183,501 of commitments with a total net investment in loans of $81,604 on total assets of $91,275. At September 30, 2022, the portfolio consisted of 37 issuers with an average balance of approximately $2,199 versus 36 issuers with an average balance of approximately $2,267 at December 31, 2021. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured, <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">cash-pay</div> loans. SLR Healthcare’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to us, had approximately $62,000 and $60,000 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months ended September 30, 2022 and 2021, SLR Healthcare had net income (loss) of $822 and ($40), respectively, on gross income of $3,020 and $2,631, respectively. For the nine months ended September 30, 2022 and 2021, SLR Healthcare had net income of $2,543 and $494, respectively, on gross income of $7,898 and $7,035, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there <div style="letter-spacing: 0px; top: 0px;;display:inline;">may</div> be material differences between GAAP net income and cash available for distributions. </div> 32839000 0.07 0.93 P4Y 100000000 150000000 105000000 110000000 125000000 200000000 2020-05-27 125000000 2023-06-28 179633000 81360000 93010000 183501000 81604000 91275000 37 2199000 36 2267000 62000000 60000000 2021000 822000 40000 3020000 2631000 2543000 494000 7898000 7035000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 15. SLR Business Credit </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">small-to-medium-sized</div></div></div> businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">medium-sized</div> businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671. SLRC acquired SLR Business Credit in connection with the Merger on April 1, 2022. </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of <br/>September 30, 2022, the portfolio totaled approximately $554,171 of commitments, of which $295,973 were funded, on total assets of $346,278. As of <br/>December 31, 2021, the portfolio totaled approximately $513,869 of commitments, of which $248,652 were funded, on total assets of $290,794. At <br/>September 30, 2022, the portfolio consisted of 109 issuers with an average balance of approximately $2,715 versus 125 issuers with an average balance <br/>of approximately $1,989 at December 31, 2021. NMC has a senior credit facility with a bank lending group for $240,000 which expires on <br/>November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-recourse</div> to us, had <br/>approximately $237,510 and $183,252 of borrowings outstanding at September 30, 2022 and December 31, 2021, respectively. For the three months <br/>ended September 30, 2022 and 2021, SLR Business Credit had net income of $1,977 and $2,577, respectively, on gross income of $7,607 and $6,857, <br/>respectively. For the nine months ended September 30, 2022 and 2021, SLR Business Credit had net income of $5,703 and $4,737, respectively, on <br/>gross income of $20,378 and $16,674, respectively. Due to timing and <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-cash</div> items, there may be material differences between GAAP net income <br/>and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and <br/>the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. </div> 1 51000000 0.01 0.99 0.01 1 0.99 15500000 1 66671000 19000000 47671000 554171000 295973000 346278000 513869000 248652000 290794000 109 2715000 125 1989000 240000000 2025-11-13 237510000 183252000 1977000 2577000 7607000 6857000 5703000 4737000 20378000 16674000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 16. Merger with SUNS </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 1, 2021, we entered into the Merger Agreement, which provides that, subject to the conditions set forth in the Merger Agreement, Merger Sub will merge with and into SUNS, with SUNS continuing as the surviving company and as our wholly-owned subsidiary and, immediately thereafter, SUNS will merge with and into us, with us continuing as the surviving company. Both the Board and SUNS’s board of directors, including all of the respective independent directors, in each case, on the recommendation of a special committee comprised solely of the independent directors of us or SUNS, as applicable, have approved the Merger Agreement and the transactions contemplated thereby. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Merger Agreement contains customary representations and warranties by each of us, SUNS and the Investment Adviser. The Merger Agreement also contains customary covenants, including, among others, covenants relating to the operation of each of our and SUNS’s businesses during the period prior to the closing of the Mergers. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Consummation of the Mergers, which occurred on April 1, 2022, was subject to certain closing conditions as disclosed in the Merger Agreement. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On April 1, 2022, the Company completed its previously announced acquisition of SUNS. Pursuant to the Merger Agreement, Merger Sub was first merged with and into SUNS, with SUNS as the surviving corporation, and, immediately following the Merger, SUNS was then merged with and into the Company, with the Company as the surviving company. In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of the Company’s common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of the Company’s common stock). As a result of the Mergers, the Company issued an aggregate of 12,511,825 shares of its common stock to former SUNS stockholders. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Merger is accounted for as an asset acquisition of SLR Senior Investment Corp. by the Company in accordance with the asset acquisition method of accounting as detailed in ASC <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">805-50,</div> Business Combinations – Related Issues, with the fair value of total consideration paid in conjunction with the Merger allocated to the assets acquired and liabilities assumed based on their relative fair values as of the date of the Merger. Generally, under asset acquisition accounting, acquiring assets in groups not only requires ascertaining the cost of the asset (or net assets), but also allocating that cost to the individual assets (or individual assets and liabilities) that make up the group. The cost of the group of assets acquired in an asset acquisition is allocated to the individual assets acquired or liabilities assumed based on their relative fair values of net identifiable assets acquired other than certain <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“non-qualifying”</div> assets (for example cash) and does not give rise to goodwill. The Company is the accounting survivor of the Merger. The Merger was considered a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">tax-free</div> reorganization and the historical cost basis of the acquired SUNS investments are carried forward for tax purposes. Prior to the Merger, SUNS was also managed by the Investment Adviser. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 87%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock issued by the Company<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">227,602</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets acquired:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments, at fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,105</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,313</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,662</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets acquired</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">407,080</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities assumed:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Debt, at fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">159,816</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,573</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities assumed</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">162,389</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net assets acquired</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">244,691</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total purchase discount</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,089</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Based on the market price at closing of $18.13, adjusted for transaction costs. </div></div> </td> </tr> </table> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Letter Agreement </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On April 1, 2022, in connection with the consummation of the Mergers, the Company entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by the Company to the Investment Adviser pursuant to the Advisory Agreement, resulting in an annual base management fee rate payable by the Company to the Investment Adviser of 1.50% on gross assets up to 200% of the Company’s total net assets. The Company retained the annual base management fee rate payable by the Company to the Investment Adviser of 1.00% on gross assets that exceed 200% of the Company’s total net assets. </div></div> 0.7796 12511825 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger: </div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 68%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 87%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 5%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Common stock issued by the Company<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">(1)</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">227,602</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Assets acquired:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Investments, at fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">400,105</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,313</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other assets</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">4,662</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total assets acquired</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">407,080</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Liabilities assumed:</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Debt, at fair value</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">159,816</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Other liabilities</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,573</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total liabilities assumed</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">162,389</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net assets acquired</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">244,691</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total purchase discount</div></div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">(17,089</td> <td style="vertical-align: bottom; white-space: nowrap;">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Based on the market price at closing of $18.13, adjusted for transaction costs. </div></div> </td> </tr> </table> 227602000 400105000 2313000 4662000 407080000 159816000 2573000 162389000 244691000 -17089000 18.13 25 0.015 2 0.01 2 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 17. Stock Repurchase Program </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On May 3, 2022, our Board authorized a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10b-18</div> of the Exchange Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 1, 2023 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases. As of September 30, 2022, no repurchases have taken place. </div> 50000000 2023-05-01 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 18. Subsequent Events </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October 5, 2022, our Board declared a monthly distribution of $0.136667 per share payable on November 2, 2022 to holders of record as of October 20, 2022.</div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On October 12, 2022, the Company entered into a joint venture agreement with SunStone Senior Credit L.P. (the “Investor”) to create SLR Senior Lending Program LLC (“SSLP”). The joint venture is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. SSLP intends to seek third party financing to allow the joint venture to utilize leverage. The Company and the Investor expect to begin funding SSLP with investments prior to the end of 2022. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On November 2, 2022, our Board declared a monthly distribution of $0.136667 per share payable on December 1, 2022 to holders of record as of November 17, 2022. </div></div> 0.136667 50000000 100000000 0.136667 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Portfolio and Investment Activity </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">During the three months ended September 30, 2022, we invested approximately $245.4 million across 44 portfolio companies. This compares to investing approximately $230.7 million in 23 portfolio companies for the three months ended September 30, 2021. Investments sold, prepaid or repaid during the three months ended September 30, 2022 totaled approximately $81.1 million versus approximately $105.9 million for the three months ended September 30, 2021. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At September 30, 2022, our portfolio consisted of 135 portfolio companies and was invested 30.2% in cash flow senior secured loans, 31.9% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 21.6% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 16.3% in life science senior secured loans, in each case, measured at fair value, versus 106 portfolio companies and was invested 28.4% in cash flow senior secured loans, 26.5% in asset-based senior secured loans / SLR Credit, 30.4% in equipment senior secured financings / SLR Equipment / KBH, and 14.7% in life science senior secured loans, in each case, measured at fair value, at September 30, 2021. </div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display:inline;">At September 30, 2022, 79.7% or $1.71 billion of our income producing investment portfolio<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">*</div> is floating rate and 20.3% or $434.9 million is fixed rate, measured at fair value. At September 30, 2021, 74.1% or $1.20 billion of our income producing investment portfolio<div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">*</div> is floating rate and 25.9% or $418.4 million is fixed rate, measured at fair value. As of September 30, 2022 and 2021, we had three and one issuers, respectively, on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">non-accrual</div> status. </div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;"><div style="font-size: 75%; vertical-align: top;;display:inline;;font-size:8.3px">*</div> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio. </div></div></td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 2%;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Senior Securities </div></div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2022 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Class and Year</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/> Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/> Coverage<br/> Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/> Liquidating<br/> Preference<br/> Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Market Value<br/> Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Credit Facility</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">360,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">583</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">222,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">552</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">126,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">421</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,900</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">182</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">96,400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">593</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">245,600</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,225</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">115,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">990</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">207,900</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,459</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">264,452</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,510</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV Credit Facility</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">211</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">501</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">638</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">923</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">748</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">430</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Tranche C Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">52</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">70</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">89</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">129</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">105</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2023 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Class and Year</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/> Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/> Coverage<br/> Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/> Liquidating<br/> Preference<br/> Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Market Value<br/> Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">186</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">319</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">461</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">374</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2024 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">202</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">309</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">417</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">531</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2025 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">137</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2026 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">186</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">319</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2027 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">81</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2027 Series F Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">135,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">218</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2042 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">859</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,002</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">702</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">982</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,294</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">943</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,411</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">934</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">571</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">923</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">645</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">527</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,721</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,808</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">428</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Term Loans</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">162</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">248</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">319</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">308</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">430</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">351</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,147</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,206</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">285</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">NEFPASS Facility</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">128</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">185</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Facility</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53,785</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">331</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Senior Securities</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,156,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,870</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">818,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">677,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,259</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">593,900</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,525</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">476,185</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,930</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">541,600</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,702</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">390,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,354</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">432,900</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,039</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">225,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,162</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">225,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,425</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">489,452</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,794</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2022, asset coverage was 187.0%. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(4)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014, 2013 and 2012 periods was $100,175, $98,196, $94,301, $93,392, and $92,302, respectively. </div></div></td></tr></table> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Information about our senior securities is shown in the following table (in thousands) as of the quarter ended September 30, 2022 and each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities. </div></div><div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 8%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Class and Year</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/> Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/> Coverage<br/> Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/> Liquidating<br/> Preference<br/> Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Market Value<br/> Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Credit Facility</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">360,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">583</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">222,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">552</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">126,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">421</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">42,900</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">182</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">96,400</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">593</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">245,600</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,225</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">115,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">990</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">207,900</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,459</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">264,452</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,510</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">SPV Credit Facility</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">130,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">211</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">372</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">501</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">638</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">923</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">150,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">748</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">430</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2022 Tranche C Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">34</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">52</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">70</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">89</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">129</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">21,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">105</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2023 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 55%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 7%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; white-space: nowrap; padding-bottom: 0.5pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1pt solid rgb(0, 0, 0); display: table-cell; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;">Class and Year</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Total Amount<br/> Outstanding(1)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Asset<br/> Coverage<br/> Per Unit(2)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Involuntary<br/> Liquidating<br/> Preference<br/> Per Unit(3)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Average<br/> Market Value<br/> Per Unit(4)</div></div></td> <td style="vertical-align: bottom; padding-bottom: 0.5pt;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">186</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">319</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">461</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">374</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2024 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">202</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">309</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">417</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">125,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">531</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2025 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">85,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">137</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2026 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">121</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">186</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">319</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2027 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">81</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">124</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2027 Series F Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">135,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">218</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">2042 Unsecured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">859</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,002</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">702</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">982</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,294</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">943</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,411</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">934</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">571</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">923</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Senior Secured Notes</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">645</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">527</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,721</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,808</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">428</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Term Loans</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">162</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">248</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">75,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">319</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">308</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">250</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">430</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">351</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,147</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,206</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">50,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">285</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">NEFPASS Facility</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">100</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">128</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">30,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">185</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">SSLP Facility</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">53,785</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">331</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; width: 92%; font-family: &quot;Times New Roman&quot;; font-size: 9pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="font-size: 0px;"> <td style="width: 77%; font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="width: 2%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/> <td style="font-family: &quot;Times New Roman&quot;;"/></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Total Senior Securities</div></div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; font-size: 0px;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2022 (through September 30, 2022)</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,156,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">1,870</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2021</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">818,500</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,029</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2020</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">677,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,259</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2019</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">593,900</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,525</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2018</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">476,185</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,930</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2017</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">541,600</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,702</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2016</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">390,200</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,354</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2015</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">432,900</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">3,039</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2014</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">225,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,162</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2013</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">225,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">5,425</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 9pt; page-break-inside: avoid;"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 9pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 9pt; letter-spacing: 0px; top: 0px;;display:inline;">Fiscal 2012</div></div></td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">489,452</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">2,794</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">N/A</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td></tr></table> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(1)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(2)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2022, asset coverage was 187.0%. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(3)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. </div></div></td></tr></table><div style="clear:both;max-height:0pt;"/> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%; vertical-align: top;;text-align:left;">(4)</td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014, 2013 and 2012 periods was $100,175, $98,196, $94,301, $93,392, and $92,302, respectively. </div></div></td></tr></table> 360000000 583 0 222500000 552 0 126000000 421 0 42900000 182 0 96400000 593 0 245600000 1225 0 115200000 990 0 207900000 1459 0 0 0 0 0 0 0 264452000 1510 0 130200000 211 0 0 0 0 150000000 372 0 150000000 501 0 150000000 638 0 150000000 923 0 150000000 748 0 50000000 430 0 21000000 34 0 21000000 52 0 21000000 70 0 21000000 89 0 21000000 129 0 21000000 105 0 75000000 121 0 75000000 186 0 75000000 250 0 75000000 319 0 75000000 461 0 75000000 374 0 125000000 202 0 125000000 309 0 125000000 417 0 125000000 531 0 85000000 137 0 75000000 121 0 75000000 186 0 75000000 250 0 75000000 319 0 50000000 81 0 50000000 124 0 135000000 218 0 0 0 0 100000000 859 0 1002 100000000 702 0 982 100000000 2294 0 943 100000000 2411 0 934 100000000 571 0 923 0 0 0 75000000 645 0 75000000 527 0 75000000 1721 0 75000000 1808 0 75000000 428 0 100000000 162 0 100000000 248 0 75000000 250 0 75000000 319 0 50000000 308 0 50000000 250 0 50000000 430 0 50000000 351 0 50000000 1147 0 50000000 1206 0 50000000 285 0 0 0 0 30000000 100 0 30000000 128 0 30000000 185 0 0 0 0 53785000 331 0 1156200000 1870 0 818500000 2029 0 677000000 2259 0 593900000 2525 0 476185000 2930 0 541600000 2702 0 390200000 3354 0 432900000 3039 0 225000000 5162 0 225000000 5425 0 489452000 2794 0 <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; width: 100%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;"> <tr style="page-break-inside: avoid;"> <td id="tx375653_16" style="width: 9%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Item 1A.</div></div></td> <td style="vertical-align: top;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk Factors </div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"/> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">In addition to the other information set forth in this report, you should carefully consider the factors discussed in “Risk Factors” in the March 1, 2022 filing of our Annual Report on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-K, which</div> could materially affect our business, financial condition and/or operating results. The risks described in our Annual Report are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially and adversely affect our business, financial condition and/or operating results. Other than the risk factors set forth below, there have been no material changes during the period ended September 30, 2022 to the risk factors discussed in “Risk Factors” in the March 1, 2022 filing of our Annual Report on Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">10-K.</div> </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">The Russian invasion of Ukraine may have a material adverse impact on us and our portfolio companies. </div></div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On February 24, 2022, the Russian military commenced a full-scale invasion of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Russia’s pre-positioned forces</div> into Ukraine, which could have a negative impact on the economy and business activity globally (including in the countries in which the Company invests), and therefore could adversely affect the performance of the Company’s investments. Following such invasion, the United States and several European nations announced sanctions against Russia. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to the Company and the performance of its investments or operations, and the ability of the Company to achieve its investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they may have adverse consequences related to the ongoing conflict. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> Investment is on non-accrual status. Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company. Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of September 30, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 22.7% of the total assets of the Company. Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the nine months ended September 30, 2022 in these controlled investments are as follows: Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2021, on a fair value basis, non-qualifying assets in the portfolio represented 23.1% of the total assets of the Company. Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2021 in these controlled investments are as follows: Indicates an investment that is wholly held by the Company through NEFPASS LLC. Denotes a subsidiary of SLR Equipment Finance. SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary. Non-income producing security. OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or PRIME rate. These instruments are often subject to a LIBOR or PRIME rate floor. Interest is paid in kind (“PIK”). Spread is 5.50% Cash / 0.50% PIK. AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation. See note 14 to the consolidated financial statements. See note 9 to the consolidated financial statements. See note 15 to the consolidated financial statements. Denotes a Level 1 investment. See note 13 to the consolidated financial statements. The Company’s investment in SOINT, LLC include a one dollar investment in common shares. See note 11 to the consolidated financial statements. The Company’s investments in SOAGG, LLC and SOINT, LLC include a two and one dollar investment in common shares, respectively. Spread is 6.00% Cash / 2.00% PIK. Spread is 2.50% Cash / 12.50% PIK. Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of September 30, 2022. Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2021. On April 1, 2022, in connection with the Merger (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839. For further details, refer to Note 16 “Merger with SUNS”. Aggregate net unrealized appreciation for U.S. federal income tax purposes is $19,495; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $82,598 and $63,103, respectively, based on a tax cost of $1,651,087. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated. The Company controls the funding of the SLR Credit Solutions and SLR Healthcare ABL commitments and may cancel them at its discretion. The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it. The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of September 30, 2022, asset coverage was 187.0%. Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented. Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014, 2013 and 2012 periods was $100,175, $98,196, $94,301, $93,392, and $92,302, respectively. Based on the market price at closing of $18.13, adjusted for transaction costs. EXCEL 81 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 82 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 83 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 84 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 1334 306 1 true 321 0 false 11 false false R1.htm 1001 - Document - Cover Page Sheet http://www.slrinvestments.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Consolidated Statements of Assets And Liabilities Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities Consolidated Statements of Assets And Liabilities Statements 2 false false R3.htm 1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical Consolidated Statements of Assets And Liabilities (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Consolidated Statements of Operations Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Consolidated Statements of Changes In Net Assets Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets Consolidated Statements of Changes In Net Assets Statements 5 false false R6.htm 1006 - Statement - Consolidated Statements of Cash Flows Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 7 false false R8.htm 1008 - Statement - Consolidated Schedule of Investments Sheet http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments Consolidated Schedule of Investments Statements 8 false false R9.htm 1009 - Statement - Consolidated Schedule of Investments (Parenthetical) Sheet http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical Consolidated Schedule of Investments (Parenthetical) Statements 9 false false R10.htm 995470 - Disclosure - N-2 Sheet http://xbrl.sec.gov/cef/role/N2 N-2 Notes 10 false false R11.htm 999001 - Disclosure - Organization Sheet http://www.slrinvestments.com/role/Organization Organization Notes 11 false false R12.htm 999002 - Disclosure - Significant Accounting Policies Sheet http://www.slrinvestments.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 12 false false R13.htm 999003 - Disclosure - Agreements Sheet http://www.slrinvestments.com/role/Agreements Agreements Notes 13 false false R14.htm 999004 - Disclosure - Net Asset Value Per Share Sheet http://www.slrinvestments.com/role/NetAssetValuePerShare Net Asset Value Per Share Notes 14 false false R15.htm 999005 - Disclosure - Earnings Per Share Sheet http://www.slrinvestments.com/role/EarningsPerShare Earnings Per Share Notes 15 false false R16.htm 999006 - Disclosure - Fair Value Sheet http://www.slrinvestments.com/role/FairValue Fair Value Notes 16 false false R17.htm 999007 - Disclosure - Debt Sheet http://www.slrinvestments.com/role/Debt Debt Notes 17 false false R18.htm 999008 - Disclosure - Financial Highlights Sheet http://www.slrinvestments.com/role/FinancialHighlights Financial Highlights Notes 18 false false R19.htm 999009 - Disclosure - SLR Credit Solutions Sheet http://www.slrinvestments.com/role/SlrCreditSolutions SLR Credit Solutions Notes 19 false false R20.htm 999010 - Disclosure - Commitments and Contingencies Sheet http://www.slrinvestments.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 20 false false R21.htm 999011 - Disclosure - SLR Equipment Finance Sheet http://www.slrinvestments.com/role/SlrEquipmentFinance SLR Equipment Finance Notes 21 false false R22.htm 999012 - Disclosure - Capital Share Transactions Sheet http://www.slrinvestments.com/role/CapitalShareTransactions Capital Share Transactions Notes 22 false false R23.htm 999013 - Disclosure - Kingsbridge Holdings, LLC Sheet http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc Kingsbridge Holdings, LLC Notes 23 false false R24.htm 999014 - Disclosure - SLR Healthcare ABL Sheet http://www.slrinvestments.com/role/SlrHealthcareAbl SLR Healthcare ABL Notes 24 false false R25.htm 999015 - Disclosure - SLR Business Credit Sheet http://www.slrinvestments.com/role/SlrBusinessCredit SLR Business Credit Notes 25 false false R26.htm 999016 - Disclosure - Merger with SUNS Sheet http://www.slrinvestments.com/role/MergerWithSuns Merger with SUNS Notes 26 false false R27.htm 999017 - Disclosure - Stock Repurchase Program Sheet http://www.slrinvestments.com/role/StockRepurchaseProgram Stock Repurchase Program Notes 27 false false R28.htm 999018 - Disclosure - Subsequent Events Sheet http://www.slrinvestments.com/role/SubsequentEvents Subsequent Events Notes 28 false false R29.htm 999019 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.slrinvestments.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.slrinvestments.com/role/SignificantAccountingPolicies 29 false false R30.htm 999020 - Disclosure - Earnings Per Share (Tables) Sheet http://www.slrinvestments.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.slrinvestments.com/role/EarningsPerShare 30 false false R31.htm 999021 - Disclosure - Fair Value (Tables) Sheet http://www.slrinvestments.com/role/FairValueTables Fair Value (Tables) Tables http://www.slrinvestments.com/role/FairValue 31 false false R32.htm 999022 - Disclosure - Debt (Tables) Sheet http://www.slrinvestments.com/role/DebtTables Debt (Tables) Tables http://www.slrinvestments.com/role/Debt 32 false false R33.htm 999023 - Disclosure - Financial Highlights (Tables) Sheet http://www.slrinvestments.com/role/FinancialHighlightsTables Financial Highlights (Tables) Tables http://www.slrinvestments.com/role/FinancialHighlights 33 false false R34.htm 999024 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.slrinvestments.com/role/CommitmentsAndContingencies 34 false false R35.htm 999025 - Disclosure - Capital Share Transactions (Tables) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsTables Capital Share Transactions (Tables) Tables http://www.slrinvestments.com/role/CapitalShareTransactions 35 false false R36.htm 999026 - Disclosure - Merger with SUNS (Tables) Sheet http://www.slrinvestments.com/role/MergerWithSunsTables Merger with SUNS (Tables) Tables http://www.slrinvestments.com/role/MergerWithSuns 36 false false R37.htm 999027 - Disclosure - Organization - Additional Information (Details) Sheet http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails Organization - Additional Information (Details) Details 37 false false R38.htm 999028 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 38 false false R39.htm 999029 - Disclosure - Agreements - Additional Information (Details) Sheet http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails Agreements - Additional Information (Details) Details 39 false false R40.htm 999030 - Disclosure - Net Asset Value Per Share - Additional Information (Details) Sheet http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails Net Asset Value Per Share - Additional Information (Details) Details 40 false false R41.htm 999031 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail) Sheet http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail) Details 41 false false R42.htm 999032 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details) Details 42 false false R43.htm 999033 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details) Details 43 false false R44.htm 999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details) Details 44 false false R45.htm 999035 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details) Details 45 false false R46.htm 999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details) Details 46 false false R47.htm 999037 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details) Details 47 false false R48.htm 999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details) Sheet http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails Debt - Schedule of Long-term Debt Instruments (Details) Details 48 false false R49.htm 999039 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) Sheet http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details) Details 49 false false R50.htm 999040 - Disclosure - Debt - Additional Information (Details) Sheet http://www.slrinvestments.com/role/DebtAdditionalInformationDetails Debt - Additional Information (Details) Details 50 false false R51.htm 999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details) Sheet http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails Financial Highlights - Schedule of Financial Highlights (Details) Details 51 false false R52.htm 999042 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) Sheet http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details) Details 52 false false R53.htm 999043 - Disclosure - SLR Credit Solutions - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails SLR Credit Solutions - Additional Information (Details) Details 53 false false R54.htm 999044 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 54 false false R55.htm 999045 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) Sheet http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details) Details 55 false false R56.htm 999046 - Disclosure - SLR Equipment Finance - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails SLR Equipment Finance - Additional Information (Details) Details 56 false false R57.htm 999047 - Disclosure - Capital Share Transactions - Additional Information (Details) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails Capital Share Transactions - Additional Information (Details) Details 57 false false R58.htm 999048 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details) Sheet http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails Capital Share Transactions - Summary of Transactions In Capital Stock (Details) Details 58 false false R59.htm 999049 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details) Sheet http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails Kingsbridge Holdings, LLC - Additional Information (Details) Details 59 false false R60.htm 999050 - Disclosure - SLR Healthcare ABL - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails SLR Healthcare ABL - Additional Information (Details) Details 60 false false R61.htm 999051 - Disclosure - SLR Business Credit - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails SLR Business Credit - Additional Information (Details) Details 61 false false R62.htm 999052 - Disclosure - Merger with SUNS - Additional Information (Details) Sheet http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails Merger with SUNS - Additional Information (Details) Details 62 false false R63.htm 999053 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail) Sheet http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail) Details 63 false false R64.htm 999054 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail) Sheet http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail) Details 64 false false R65.htm 999055 - Disclosure - Stock Repurchase Program - Additional Information (Details) Sheet http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails Stock Repurchase Program - Additional Information (Details) Details 65 false false R66.htm 999056 - Disclosure - Subsequent Events - Additional Information (Details) Sheet http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails Subsequent Events - Additional Information (Details) Details 66 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince - d375653d10q.htm 7 d375653d10q.htm d375653dex231.htm d375653dex311.htm d375653dex312.htm d375653dex313.htm d375653dex321.htm d375653dex322.htm d375653dex323.htm slrc-20220930.xsd slrc-20220930_cal.xml slrc-20220930_def.xml slrc-20220930_lab.xml slrc-20220930_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/cef/2022 http://xbrl.sec.gov/dei/2022 true true JSON 87 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d375653d10q.htm": { "axisCustom": 7, "axisStandard": 23, "contextCount": 1334, "dts": { "calculationLink": { "local": [ "slrc-20220930_cal.xml" ] }, "definitionLink": { "local": [ "slrc-20220930_def.xml" ] }, "inline": { "local": [ "d375653d10q.htm" ] }, "labelLink": { "local": [ "slrc-20220930_lab.xml" ] }, "presentationLink": { "local": [ "slrc-20220930_pre.xml" ] }, "schema": { "local": [ "slrc-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/2006/xbrldi-2006.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/cef/2022/cef-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022_lab.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 918, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 5, "total": 5 }, "keyCustom": 104, "keyStandard": 202, "memberCustom": 286, "memberStandard": 19, "nsprefix": "slrc", "nsuri": "http://www.slrinvestments.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.slrinvestments.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "lang": "en-US", "name": "dei:DocumentPeriodEndDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityFileNumber", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "995470 - Disclosure - N-2", "role": "http://xbrl.sec.gov/cef/role/N2", "shortName": "N-2", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "cef:SeniorSecuritiesNoteTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "lang": "en-US", "name": "cef:SeniorSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999001 - Disclosure - Organization", "role": "http://www.slrinvestments.com/role/Organization", "shortName": "Organization", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999002 - Disclosure - Significant Accounting Policies", "role": "http://www.slrinvestments.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:AgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999003 - Disclosure - Agreements", "role": "http://www.slrinvestments.com/role/Agreements", "shortName": "Agreements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:AgreementsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:NetAssetValuePerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999004 - Disclosure - Net Asset Value Per Share", "role": "http://www.slrinvestments.com/role/NetAssetValuePerShare", "shortName": "Net Asset Value Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:NetAssetValuePerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999005 - Disclosure - Earnings Per Share", "role": "http://www.slrinvestments.com/role/EarningsPerShare", "shortName": "Earnings Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999006 - Disclosure - Fair Value", "role": "http://www.slrinvestments.com/role/FairValue", "shortName": "Fair Value", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999007 - Disclosure - Debt", "role": "http://www.slrinvestments.com/role/Debt", "shortName": "Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999008 - Disclosure - Financial Highlights", "role": "http://www.slrinvestments.com/role/FinancialHighlights", "shortName": "Financial Highlights", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrCreditSolutionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999009 - Disclosure - SLR Credit Solutions", "role": "http://www.slrinvestments.com/role/SlrCreditSolutions", "shortName": "SLR Credit Solutions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrCreditSolutionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Consolidated Statements of Assets And Liabilities", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "shortName": "Consolidated Statements of Assets And Liabilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999010 - Disclosure - Commitments and Contingencies", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999011 - Disclosure - SLR Equipment Finance", "role": "http://www.slrinvestments.com/role/SlrEquipmentFinance", "shortName": "SLR Equipment Finance", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022_SlrEquipmentFinanceMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": null, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:CapitalShareTransactionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999012 - Disclosure - Capital Share Transactions", "role": "http://www.slrinvestments.com/role/CapitalShareTransactions", "shortName": "Capital Share Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:CapitalShareTransactionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999013 - Disclosure - Kingsbridge Holdings, LLC", "role": "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc", "shortName": "Kingsbridge Holdings, LLC", "subGroupType": "", "uniqueAnchor": null }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrHealthcareAblTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999014 - Disclosure - SLR Healthcare ABL", "role": "http://www.slrinvestments.com/role/SlrHealthcareAbl", "shortName": "SLR Healthcare ABL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrHealthcareAblTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrBusinessCreditDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999015 - Disclosure - SLR Business Credit", "role": "http://www.slrinvestments.com/role/SlrBusinessCredit", "shortName": "SLR Business Credit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:SlrBusinessCreditDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:BusinessMergerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999016 - Disclosure - Merger with SUNS", "role": "http://www.slrinvestments.com/role/MergerWithSuns", "shortName": "Merger with SUNS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:BusinessMergerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999017 - Disclosure - Stock Repurchase Program", "role": "http://www.slrinvestments.com/role/StockRepurchaseProgram", "shortName": "Stock Repurchase Program", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999018 - Disclosure - Subsequent Events", "role": "http://www.slrinvestments.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999019 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://www.slrinvestments.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Consolidated Statements of Assets And Liabilities (Parenthetical)", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "shortName": "Consolidated Statements of Assets And Liabilities (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "lang": null, "name": "slrc:CashEquivalentsAtCost", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999020 - Disclosure - Earnings Per Share (Tables)", "role": "http://www.slrinvestments.com/role/EarningsPerShareTables", "shortName": "Earnings Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999021 - Disclosure - Fair Value (Tables)", "role": "http://www.slrinvestments.com/role/FairValueTables", "shortName": "Fair Value (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999022 - Disclosure - Debt (Tables)", "role": "http://www.slrinvestments.com/role/DebtTables", "shortName": "Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999023 - Disclosure - Financial Highlights (Tables)", "role": "http://www.slrinvestments.com/role/FinancialHighlightsTables", "shortName": "Financial Highlights (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999024 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCommitmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999025 - Disclosure - Capital Share Transactions (Tables)", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsTables", "shortName": "Capital Share Transactions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "slrc:BusinessMergerTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999026 - Disclosure - Merger with SUNS (Tables)", "role": "http://www.slrinvestments.com/role/MergerWithSunsTables", "shortName": "Merger with SUNS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "slrc:BusinessMergerTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P09_30_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:DateOfCommencementOfBusiness", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999027 - Disclosure - Organization - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails", "shortName": "Organization - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P09_30_2022To09_30_2022", "decimals": null, "first": true, "lang": "en-US", "name": "slrc:DateOfCommencementOfBusiness", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "2", "first": true, "lang": null, "name": "slrc:PercentageOfExciseTax", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999028 - Disclosure - Significant Accounting Policies - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "Significant Accounting Policies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "2", "first": true, "lang": null, "name": "slrc:PercentageOfExciseTax", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ManagementFeeExpense", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999029 - Disclosure - Agreements - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "shortName": "Agreements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "slrc:AgreementsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "lang": null, "name": "slrc:PerformanceBasedIncentiveFeesWaiver", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GrossInvestmentIncomeOperating", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Consolidated Statements of Operations", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GrossInvestmentIncomeOperating", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsNet", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999030 - Disclosure - Net Asset Value Per Share - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails", "shortName": "Net Asset Value Per Share - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "slrc:IncreaseDecreaseInNetAssetsFromOperation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999031 - Disclosure - Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail)", "role": "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail", "shortName": "Earnings Per Share - Summary of Computation of Basic and Diluted Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "slrc:IncreaseDecreaseInNetAssetsFromOperation", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesPayableFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999032 - Disclosure - Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "shortName": "Fair Value - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999033 - Disclosure - Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details)", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "shortName": "Fair Value - Summary of Changes in Fair Value of Level 3 Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn06_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn06_30_2022_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999034 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details)", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "shortName": "Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn06_30_2022_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn12_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_TwoThousandAndTwentyTwoUnsecuredNotesMemberusgaapFairValueByLiabilityClassAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NotesPayableFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999035 - Disclosure - Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "shortName": "Fair Value - Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3) (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_IncomeApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_InvestmentInSeniorSecuredLoansMemberusgaapFairValueByAssetClassAxis_MeasurementInputMarketYieldMemberusgaapMeasurementInputTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999036 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details)", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "shortName": "Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_IncomeApproachValuationTechniqueMemberusgaapValuationTechniqueAxis_InvestmentInSeniorSecuredLoansMemberusgaapFairValueByAssetClassAxis_MeasurementInputMarketYieldMemberusgaapMeasurementInputTypeAxis", "decimals": null, "lang": "en-US", "name": "slrc:DescriptionOfFairValueMeasurementValuationProcess", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputEbitdaMultipleMemberSLRCMeasurementInputTypeOneAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999037 - Disclosure - Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)", "role": "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "shortName": "Fair Value - Summary of Quantitative Information about the Company's Level 3 Asset and Liability (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputEbitdaMultipleMemberSLRCMeasurementInputTypeOneAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999038 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Details)", "role": "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "shortName": "Debt - Schedule of Long-term Debt Instruments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999039 - Disclosure - Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details)", "role": "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "shortName": "Debt - Schedule of Long-term Debt Instruments (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_TermLoanAndCreditFacilityMemberusgaapLongtermDebtTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Consolidated Statements of Changes In Net Assets", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "shortName": "Consolidated Statements of Changes In Net Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentIncomeNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn12_31_2021", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999040 - Disclosure - Debt - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "shortName": "Debt - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "4", "lang": null, "name": "us-gaap:LongTermDebtWeightedAverageInterestRateOverTime", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "div", "div", "slrc:NetAssetValuePerShareTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn12_31_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NetAssetValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999041 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Details)", "role": "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "shortName": "Financial Highlights - Schedule of Financial Highlights (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "2", "lang": null, "name": "us-gaap:InvestmentCompanyInvestmentIncomeLossPerShare", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "2", "first": true, "lang": null, "name": "slrc:FairValueOfCommonStockPerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999042 - Disclosure - Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)", "role": "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails", "shortName": "Financial Highlights - Schedule of Financial Highlights (Parentheticals) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock", "us-gaap:InvestmentCompanyFinancialHighlightsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "4", "lang": null, "name": "us-gaap:InvestmentCompanyExpenseRatioExcludingIncentiveFee", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999043 - Disclosure - SLR Credit Solutions - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "shortName": "SLR Credit Solutions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "slrc:SlrCreditSolutionTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn12_28_2012_RevolvingCreditFacilityMemberusgaapCreditFacilityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999044 - Disclosure - Commitments and Contingencies - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "Commitments and Contingencies - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R55": { "firstAnchor": { "ancestors": [ "us-gaap:OtherCommitmentsTableTextBlock", "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999045 - Disclosure - Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details)", "role": "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "shortName": "Commitments and Contingencies - Summary of Unfunded Debt and Equity Commitments (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "ix:continuation", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_UnfundedDebtAndEquityCommitmentsMemberusgaapOtherCommitmentsAxis", "decimals": "-3", "lang": null, "name": "us-gaap:OtherCommitment", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LongTermDebt", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999046 - Disclosure - SLR Equipment Finance - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "shortName": "SLR Equipment Finance - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn07_31_2017_SlrEquipmentFinanceMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "decimals": "2", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999047 - Disclosure - Capital Share Transactions - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "shortName": "Capital Share Transactions - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "div", "div", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2021", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999048 - Disclosure - Capital Share Transactions - Summary of Transactions In Capital Stock (Details)", "role": "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "shortName": "Capital Share Transactions - Summary of Transactions In Capital Stock (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "-3", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueAcquisitions", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfUnsecuredDebt", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999049 - Disclosure - Kingsbridge Holdings, LLC - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "shortName": "Kingsbridge Holdings, LLC - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:EquityMethodInvestmentsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn12_31_2021_KbhtMemberdeiLegalEntityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "slrc:NetIncreaseInNetAssetsResultingFromoperations", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "slrc:NetIncreaseInNetAssetsResultingFromoperations", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": null, "first": true, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "999050 - Disclosure - SLR Healthcare ABL - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "shortName": "SLR Healthcare ABL - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:SlrHealthcareAblTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn06_28_2019_SlrHealthcareAblCreditMemberusgaapLineOfCreditFacilityAxis", "decimals": "-3", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": null, "first": true, "lang": null, "name": "us-gaap:CommitmentsAndContingencies", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "true" }, "groupType": "disclosure", "isDefault": "false", "longName": "999051 - Disclosure - SLR Business Credit - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "shortName": "SLR Business Credit - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "slrc:SlrBusinessCreditDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022_SlrBusinessCreditMemberusgaapLineOfCreditFacilityAxis", "decimals": "INF", "lang": null, "name": "slrc:NumberOfIssuerInBusinessCredit", "reportCount": 1, "unique": true, "unitRef": "Unit_issuers", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityTableTextBlock", "slrc:CapitalShareTransactionsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P07_01_2022To09_30_2022", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999052 - Disclosure - Merger with SUNS - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "shortName": "Merger with SUNS - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": "0", "lang": null, "name": "slrc:NumberOfBasisPoints", "reportCount": 1, "unique": true, "unitRef": "Unit_basispoints", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "slrc:BusinessMergerTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_SunsCompanyMergerMemberusgaapBusinessAcquisitionAxis", "decimals": "-3", "first": true, "lang": null, "name": "slrc:BusinessCombinationCommonStockIssuedByTheCompany", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999053 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail)", "role": "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "shortName": "Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "slrc:BusinessMergerTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_SunsCompanyMergerMemberusgaapBusinessAcquisitionAxis", "decimals": "-3", "first": true, "lang": null, "name": "slrc:BusinessCombinationCommonStockIssuedByTheCompany", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "slrc:BusinessMergerTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_SunsCompanyMergerMemberusgaapBusinessAcquisitionAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999054 - Disclosure - Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail)", "role": "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail", "shortName": "Merger with SUNS - Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger (Parenthetical) (Detail)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "slrc:BusinessMergerTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022_SunsCompanyMergerMemberusgaapBusinessAcquisitionAxis", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionSharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999055 - Disclosure - Stock Repurchase Program - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails", "shortName": "Stock Repurchase Program - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn10_12_2022_SeniorSecuredCashFlowLoansMemberusgaapInvestmentTypeAxis_SlrSeniorLendingProgramLlcMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "slrc:JointVentureAgreementCoventurerEquityFundingCommitment", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "999056 - Disclosure - Subsequent Events - Additional Information (Details)", "role": "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails", "shortName": "Subsequent Events - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:SubsequentEventsTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn10_12_2022_SeniorSecuredCashFlowLoansMemberusgaapInvestmentTypeAxis_SlrSeniorLendingProgramLlcMembersrtScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_SubsequentEventMemberusgaapSubsequentEventTypeAxis", "decimals": "-3", "first": true, "lang": null, "name": "slrc:JointVentureAgreementCoventurerEquityFundingCommitment", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1007 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "role": "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1008 - Statement - Consolidated Schedule of Investments", "role": "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "shortName": "Consolidated Schedule of Investments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "PAsOn09_30_2022", "decimals": "-3", "lang": null, "name": "us-gaap:CashCashEquivalentsAndShortTermInvestments", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "3", "first": true, "lang": null, "name": "slrc:PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1009 - Statement - Consolidated Schedule of Investments (Parenthetical)", "role": "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "shortName": "Consolidated Schedule of Investments (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d375653d10q.htm", "contextRef": "P01_01_2022To09_30_2022", "decimals": "3", "first": true, "lang": null, "name": "slrc:PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } } }, "segmentCount": 321, "tag": { "cef_AcquiredFundFeesAndExpensesNoteTextBlock": { "auth_ref": [ "r429" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses, Note [Text Block]" } } }, "localname": "AcquiredFundFeesAndExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundFeesAndExpensesPercent": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees and Expenses [Percent]" } } }, "localname": "AcquiredFundFeesAndExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AcquiredFundFeesEstimatedNoteTextBlock": { "auth_ref": [ "r431" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Fees Estimated, Note [Text Block]" } } }, "localname": "AcquiredFundFeesEstimatedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundIncentiveAllocationNoteTextBlock": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Incentive Allocation, Note [Text Block]" } } }, "localname": "AcquiredFundIncentiveAllocationNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AcquiredFundTotalAnnualExpensesNoteTextBlock": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "label": "Acquired Fund Total Annual Expenses, Note [Text Block]" } } }, "localname": "AcquiredFundTotalAnnualExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AllRisksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "All Risks:" } } }, "localname": "AllRisksMember", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "cef_AllSecuritiesMember": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "All Securities:" } } }, "localname": "AllSecuritiesMember", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "cef_AnnualCoverageReturnRatePercent": { "auth_ref": [ "r459" ], "lang": { "en-us": { "role": { "label": "Annual Coverage Return Rate [Percent]" } } }, "localname": "AnnualCoverageReturnRatePercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualDividendPayment": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment" } } }, "localname": "AnnualDividendPayment", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualDividendPaymentCurrent": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Current" } } }, "localname": "AnnualDividendPaymentCurrent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualDividendPaymentInitial": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "label": "Annual Dividend Payment, Initial" } } }, "localname": "AnnualDividendPaymentInitial", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_AnnualExpensesTableTextBlock": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "label": "Annual Expenses [Table Text Block]" } } }, "localname": "AnnualExpensesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_AnnualInterestRateCurrentPercent": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Current [Percent]" } } }, "localname": "AnnualInterestRateCurrentPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualInterestRateInitialPercent": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate, Initial [Percent]" } } }, "localname": "AnnualInterestRateInitialPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_AnnualInterestRatePercent": { "auth_ref": [ "r458" ], "lang": { "en-us": { "role": { "label": "Annual Interest Rate [Percent]" } } }, "localname": "AnnualInterestRatePercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_BasisOfTransactionFeesNoteTextBlock": { "auth_ref": [ "r435" ], "lang": { "en-us": { "role": { "label": "Basis of Transaction Fees, Note [Text Block]" } } }, "localname": "BasisOfTransactionFeesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_BdcFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "BDC File Number" } } }, "localname": "BdcFileNumber", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "cef_BusinessDevelopmentCompanyFlag": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Business Development Company [Flag]" } } }, "localname": "BusinessDevelopmentCompanyFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_CapitalStockLongTermDebtAndOtherSecuritiesAbstract": { "auth_ref": [ "r403" ], "lang": { "en-us": { "role": { "label": "Capital Stock, Long-Term Debt, and Other Securities [Abstract]" } } }, "localname": "CapitalStockLongTermDebtAndOtherSecuritiesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_CapitalStockTableTextBlock": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "label": "Capital Stock [Table Text Block]" } } }, "localname": "CapitalStockTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_DistributionServicingFeesPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Distribution/Servicing Fees [Percent]" } } }, "localname": "DistributionServicingFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DistributionsMayReducePrincipalTextBlock": { "auth_ref": [ "r411" ], "lang": { "en-us": { "role": { "label": "Distributions May Reduce Principal [Text Block]" } } }, "localname": "DistributionsMayReducePrincipalTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_DividendAndInterestExpensesOnShortSalesPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Dividend and Interest Expenses on Short Sales [Percent]" } } }, "localname": "DividendAndInterestExpensesOnShortSalesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DividendExpenseOnPreferredSharesPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Dividend Expenses on Preferred Shares [Percent]" } } }, "localname": "DividendExpenseOnPreferredSharesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_DividendReinvestmentAndCashPurchaseFees": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "label": "Dividend Reinvestment and Cash Purchase Fees" } } }, "localname": "DividendReinvestmentAndCashPurchaseFees", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_EffectsOfLeveragePurposeTextBlock": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage, Purpose [Text Block]" } } }, "localname": "EffectsOfLeveragePurposeTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_EffectsOfLeverageTableTextBlock": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Table Text Block]" } } }, "localname": "EffectsOfLeverageTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_EffectsOfLeverageTextBlock": { "auth_ref": [ "r457" ], "lang": { "en-us": { "role": { "label": "Effects of Leverage [Text Block]" } } }, "localname": "EffectsOfLeverageTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ExpenseExampleTableTextBlock": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "label": "Expense Example [Table Text Block]" } } }, "localname": "ExpenseExampleTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ExpenseExampleYear01": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "label": "Expense Example, Year 01" } } }, "localname": "ExpenseExampleYear01", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to10": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 10" } } }, "localname": "ExpenseExampleYears1to10", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to3": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 3" } } }, "localname": "ExpenseExampleYears1to3", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_ExpenseExampleYears1to5": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "label": "Expense Example, Years 1 to 5" } } }, "localname": "ExpenseExampleYears1to5", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_FeeTableAbstract": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "label": "Fee Table [Abstract]" } } }, "localname": "FeeTableAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_FinancialHighlightsAbstract": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "label": "Financial Highlights [Abstract]" } } }, "localname": "FinancialHighlightsAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_GeneralDescriptionOfRegistrantAbstract": { "auth_ref": [ "r454" ], "lang": { "en-us": { "role": { "label": "General Description of Registrant [Abstract]" } } }, "localname": "GeneralDescriptionOfRegistrantAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_HighestPriceOrBid": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid" } } }, "localname": "HighestPriceOrBid", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_HighestPriceOrBidNav": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, NAV" } } }, "localname": "HighestPriceOrBidNav", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_HighestPriceOrBidPremiumDiscountToNavPercent": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "label": "Highest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "localname": "HighestPriceOrBidPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationMaximumPercent": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Maximum [Percent]" } } }, "localname": "IncentiveAllocationMaximumPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationMinimumPercent": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation Minimum [Percent]" } } }, "localname": "IncentiveAllocationMinimumPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveAllocationPercent": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "label": "Incentive Allocation [Percent]" } } }, "localname": "IncentiveAllocationPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IncentiveFeesPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Incentive Fees [Percent]" } } }, "localname": "IncentiveFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_InterestExpensesOnBorrowingsPercent": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "label": "Interest Expenses on Borrowings [Percent]" } } }, "localname": "InterestExpensesOnBorrowingsPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_IntervalFundFlag": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Interval Fund [Flag]" } } }, "localname": "IntervalFundFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_InvestmentObjectivesAndPracticesTextBlock": { "auth_ref": [ "r455" ], "lang": { "en-us": { "role": { "label": "Investment Objectives and Practices [Text Block]" } } }, "localname": "InvestmentObjectivesAndPracticesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LatestNav": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "label": "Latest NAV" } } }, "localname": "LatestNav", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LatestPremiumDiscountToNavPercent": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "label": "Latest Premium (Discount) to NAV [Percent]" } } }, "localname": "LatestPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_LatestSharePrice": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "label": "Latest Share Price" } } }, "localname": "LatestSharePrice", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LoanServicingFeesPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Loan Servicing Fees [Percent]" } } }, "localname": "LoanServicingFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_LongTermDebtDividendsAndCovenantsTextBlock": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Dividends and Covenants [Text Block]" } } }, "localname": "LongTermDebtDividendsAndCovenantsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtIssuanceAndSubstitutionTextBlock": { "auth_ref": [ "r419" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Issuance and Substitution [Text Block]" } } }, "localname": "LongTermDebtIssuanceAndSubstitutionTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtPrincipal": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Principal" } } }, "localname": "LongTermDebtPrincipal", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_LongTermDebtRightsLimitedByOtherSecuritiesTextBlock": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Rights Limited by Other Securities [Text Block]" } } }, "localname": "LongTermDebtRightsLimitedByOtherSecuritiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtStructuringTextBlock": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Structuring [Text Block]" } } }, "localname": "LongTermDebtStructuringTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtTableTextBlock": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "label": "Long Term Debt [Table Text Block]" } } }, "localname": "LongTermDebtTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LongTermDebtTitleTextBlock": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "label": "Long Term Debt, Title [Text Block]" } } }, "localname": "LongTermDebtTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_LowestPriceOrBid": { "auth_ref": [ "r461" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid" } } }, "localname": "LowestPriceOrBid", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LowestPriceOrBidNav": { "auth_ref": [ "r465" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, NAV" } } }, "localname": "LowestPriceOrBidNav", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_LowestPriceOrBidPremiumDiscountToNavPercent": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "label": "Lowest Price or Bid, Premium (Discount) to NAV [Percent]" } } }, "localname": "LowestPriceOrBidPremiumDiscountToNavPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ManagementFeeNotBasedOnNetAssetsNoteTextBlock": { "auth_ref": [ "r439" ], "lang": { "en-us": { "role": { "label": "Management Fee not based on Net Assets, Note [Text Block]" } } }, "localname": "ManagementFeeNotBasedOnNetAssetsNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ManagementFeesPercent": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "label": "Management Fees [Percent]" } } }, "localname": "ManagementFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_NetExpenseOverAssetsPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Net Expense over Assets [Percent]" } } }, "localname": "NetExpenseOverAssetsPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_NewCefOrBdcRegistrantFlag": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "New CEF or BDC Registrant [Flag]" } } }, "localname": "NewCefOrBdcRegistrantFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_NoPublicTradingTextBlock": { "auth_ref": [ "r464" ], "lang": { "en-us": { "role": { "label": "No Public Trading [Text Block]" } } }, "localname": "NoPublicTradingTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_NoTradingHistoryTextBlock": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "label": "No Trading History [Text Block]" } } }, "localname": "NoTradingHistoryTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherAnnualExpense1Percent": { "auth_ref": [ "r441" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 1.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 1 [Percent]" } } }, "localname": "OtherAnnualExpense1Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpense2Percent": { "auth_ref": [ "r441" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 2.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 2 [Percent]" } } }, "localname": "OtherAnnualExpense2Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpense3Percent": { "auth_ref": [ "r441" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": 3.0, "parentTag": "cef_OtherAnnualExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Annual Expense 3 [Percent]" } } }, "localname": "OtherAnnualExpense3Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherAnnualExpensesAbstract": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Abstract]" } } }, "localname": "OtherAnnualExpensesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_OtherAnnualExpensesPercent": { "auth_ref": [ "r441" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Ae": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Other Annual Expenses [Percent]" } } }, "localname": "OtherAnnualExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherExpensesNoteTextBlock": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "label": "Other Expenses, Note [Text Block]" } } }, "localname": "OtherExpensesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherFeederFundExpensesPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Other Feeder Fund Expenses [Percent]" } } }, "localname": "OtherFeederFundExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherMasterFundExpensesPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Other Master Fund Expenses [Percent]" } } }, "localname": "OtherMasterFundExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherSecuritiesTableTextBlock": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "label": "Other Securities [Table Text Block]" } } }, "localname": "OtherSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherSecurityDescriptionTextBlock": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "label": "Other Security, Description [Text Block]" } } }, "localname": "OtherSecurityDescriptionTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherSecurityTitleTextBlock": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "label": "Other Security, Title [Text Block]" } } }, "localname": "OtherSecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherTransactionExpense1Percent": { "auth_ref": [ "r436" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 1.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 1 [Percent]" } } }, "localname": "OtherTransactionExpense1Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpense2Percent": { "auth_ref": [ "r436" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 2.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 2 [Percent]" } } }, "localname": "OtherTransactionExpense2Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpense3Percent": { "auth_ref": [ "r436" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": 3.0, "parentTag": "cef_OtherTransactionExpensesPercent", "weight": 1.0 } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expense 3 [Percent]" } } }, "localname": "OtherTransactionExpense3Percent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionExpensesAbstract": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Abstract]" } } }, "localname": "OtherTransactionExpensesAbstract", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_OtherTransactionExpensesPercent": { "auth_ref": [ "r436" ], "calculation": { "http://xbrl.sec.gov/cef/role/Item3Te": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "label": "Other Transaction Expenses [Percent]" } } }, "localname": "OtherTransactionExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionFeesBasisMaximum": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum" } } }, "localname": "OtherTransactionFeesBasisMaximum", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_OtherTransactionFeesBasisMaximumPercent": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Maximum [Percent]" } } }, "localname": "OtherTransactionFeesBasisMaximumPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_OtherTransactionFeesBasisNoteTextBlock": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees Basis, Note [Text Block]" } } }, "localname": "OtherTransactionFeesBasisNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OtherTransactionFeesNoteTextBlock": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fees, Note [Text Block]" } } }, "localname": "OtherTransactionFeesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OutstandingSecuritiesTableTextBlock": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "label": "Outstanding Securities [Table Text Block]" } } }, "localname": "OutstandingSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_OutstandingSecurityAuthorizedShares": { "auth_ref": [ "r424" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Authorized [Shares]" } } }, "localname": "OutstandingSecurityAuthorizedShares", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityHeldShares": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Held [Shares]" } } }, "localname": "OutstandingSecurityHeldShares", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityNotHeldShares": { "auth_ref": [ "r426" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Not Held [Shares]" } } }, "localname": "OutstandingSecurityNotHeldShares", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sharesItemType" }, "cef_OutstandingSecurityTitleTextBlock": { "auth_ref": [ "r423" ], "lang": { "en-us": { "role": { "label": "Outstanding Security, Title [Text Block]" } } }, "localname": "OutstandingSecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PreferredStockRestrictionsArrearageTextBlock": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Arrearage [Text Block]" } } }, "localname": "PreferredStockRestrictionsArrearageTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PreferredStockRestrictionsOtherTextBlock": { "auth_ref": [ "r413" ], "lang": { "en-us": { "role": { "label": "Preferred Stock Restrictions, Other [Text Block]" } } }, "localname": "PreferredStockRestrictionsOtherTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_PrimaryShelfFlag": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Primary Shelf [Flag]" } } }, "localname": "PrimaryShelfFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_PrimaryShelfQualifiedFlag": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Primary Shelf Qualified [Flag]" } } }, "localname": "PrimaryShelfQualifiedFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_ProspectusLineItems": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Prospectus [Line Items]" } } }, "localname": "ProspectusLineItems", "nsuri": "http://xbrl.sec.gov/cef/2022", "xbrltype": "stringItemType" }, "cef_ProspectusTable": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Prospectus:" } } }, "localname": "ProspectusTable", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_PurposeOfFeeTableNoteTextBlock": { "auth_ref": [ "r428" ], "lang": { "en-us": { "role": { "label": "Purpose of Fee Table , Note [Text Block]" } } }, "localname": "PurposeOfFeeTableNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RegisteredClosedEndFundFlag": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Registered Closed-End Fund [Flag]" } } }, "localname": "RegisteredClosedEndFundFlag", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "cef_ReturnAtMinusFivePercent": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "label": "Return at Minus Five [Percent]" } } }, "localname": "ReturnAtMinusFivePercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtMinusTenPercent": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "label": "Return at Minus Ten [Percent]" } } }, "localname": "ReturnAtMinusTenPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtPlusFivePercent": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "label": "Return at Plus Five [Percent]" } } }, "localname": "ReturnAtPlusFivePercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtPlusTenPercent": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "label": "Return at Plus Ten [Percent]" } } }, "localname": "ReturnAtPlusTenPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_ReturnAtZeroPercent": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "label": "Return at Zero [Percent]" } } }, "localname": "ReturnAtZeroPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_RightsLimitedByOtherSecuritiesTextBlock": { "auth_ref": [ "r415" ], "lang": { "en-us": { "role": { "label": "Rights Limited by Other Securities [Text Block]" } } }, "localname": "RightsLimitedByOtherSecuritiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RightsSubjectToOtherThanMajorityVoteTextBlock": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "label": "Rights Subject to Other than Majority Vote [Text Block]" } } }, "localname": "RightsSubjectToOtherThanMajorityVoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RiskAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Axis]" } } }, "localname": "RiskAxis", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_RiskFactorsTableTextBlock": { "auth_ref": [ "r456" ], "lang": { "en-us": { "role": { "label": "Risk Factors [Table Text Block]" } } }, "localname": "RiskFactorsTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_RiskTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risk [Text Block]" } } }, "localname": "RiskTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SalesLoadPercent": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "label": "Sales Load [Percent]" } } }, "localname": "SalesLoadPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_SecurityAxis": { "auth_ref": [ "r402" ], "lang": { "en-us": { "role": { "label": "Security [Axis]" } } }, "localname": "SecurityAxis", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "cef_SecurityDividendsTextBlock": { "auth_ref": [ "r405" ], "lang": { "en-us": { "role": { "label": "Security Dividends [Text Block]" } } }, "localname": "SecurityDividendsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityLiabilitiesTextBlock": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "label": "Security Liabilities [Text Block]" } } }, "localname": "SecurityLiabilitiesTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityLiquidationRightsTextBlock": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "label": "Security Liquidation Rights [Text Block]" } } }, "localname": "SecurityLiquidationRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityObligationsOfOwnershipTextBlock": { "auth_ref": [ "r410" ], "lang": { "en-us": { "role": { "label": "Security Obligations of Ownership [Text Block]" } } }, "localname": "SecurityObligationsOfOwnershipTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityPreemptiveAndOtherRightsTextBlock": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "label": "Security Preemptive and Other Rights [Text Block]" } } }, "localname": "SecurityPreemptiveAndOtherRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityTitleTextBlock": { "auth_ref": [ "r404" ], "lang": { "en-us": { "role": { "label": "Security Title [Text Block]" } } }, "localname": "SecurityTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SecurityVotingRightsTextBlock": { "auth_ref": [ "r406" ], "lang": { "en-us": { "role": { "label": "Security Voting Rights [Text Block]" } } }, "localname": "SecurityVotingRightsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesAmount": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "label": "Senior Securities Amount" } } }, "localname": "SeniorSecuritiesAmount", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_SeniorSecuritiesAverageMarketValuePerUnit": { "auth_ref": [ "r450" ], "lang": { "en-us": { "role": { "label": "Senior Securities Average Market Value per Unit" } } }, "localname": "SeniorSecuritiesAverageMarketValuePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesAveragingMethodNoteTextBlock": { "auth_ref": [ "r452" ], "lang": { "en-us": { "role": { "label": "Senior Securities Averaging Method, Note [Text Block]" } } }, "localname": "SeniorSecuritiesAveragingMethodNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesCoveragePerUnit": { "auth_ref": [ "r448" ], "lang": { "en-us": { "role": { "label": "Senior Securities Coverage per Unit" } } }, "localname": "SeniorSecuritiesCoveragePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesHeadingsNoteTextBlock": { "auth_ref": [ "r453" ], "lang": { "en-us": { "role": { "label": "Senior Securities Headings, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHeadingsNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesHighlightsAnnualizedNoteTextBlock": { "auth_ref": [ "r444", "r451" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Annualized, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHighlightsAnnualizedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesHighlightsAuditedNoteTextBlock": { "auth_ref": [ "r445", "r451" ], "lang": { "en-us": { "role": { "label": "Senior Securities Highlights Audited, Note [Text Block]" } } }, "localname": "SeniorSecuritiesHighlightsAuditedNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit": { "auth_ref": [ "r449" ], "lang": { "en-us": { "role": { "label": "Senior Securities Involuntary Liquidating Preference per Unit" } } }, "localname": "SeniorSecuritiesInvoluntaryLiquidatingPreferencePerUnit", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "cef_SeniorSecuritiesNoteTextBlock": { "auth_ref": [ "r443", "r451" ], "lang": { "en-us": { "role": { "label": "Senior Securities, Note [Text Block]" } } }, "localname": "SeniorSecuritiesNoteTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SeniorSecuritiesTableTextBlock": { "auth_ref": [ "r446" ], "lang": { "en-us": { "role": { "label": "Senior Securities [Table Text Block]" } } }, "localname": "SeniorSecuritiesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SharePriceTableTextBlock": { "auth_ref": [ "r462" ], "lang": { "en-us": { "role": { "label": "Share Price [Table Text Block]" } } }, "localname": "SharePriceTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_SharePricesNotActualTransactionsTextBlock": { "auth_ref": [ "r463" ], "lang": { "en-us": { "role": { "label": "Share Prices Not Actual Transactions [Text Block]" } } }, "localname": "SharePricesNotActualTransactionsTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_ShareholderTransactionExpensesTableTextBlock": { "auth_ref": [ "r427" ], "lang": { "en-us": { "role": { "label": "Shareholder Transaction Expenses [Table Text Block]" } } }, "localname": "ShareholderTransactionExpensesTableTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_TotalAnnualExpensesPercent": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "label": "Total Annual Expenses [Percent]" } } }, "localname": "TotalAnnualExpensesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_UnderwritersCompensationPercent": { "auth_ref": [ "r436" ], "lang": { "en-us": { "role": { "label": "Underwriters Compensation [Percent]" } } }, "localname": "UnderwritersCompensationPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_WaiversAndReimbursementsOfFeesPercent": { "auth_ref": [ "r441" ], "lang": { "en-us": { "role": { "label": "Waivers and Reimbursements of Fees [Percent]" } } }, "localname": "WaiversAndReimbursementsOfFeesPercent", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "percentItemType" }, "cef_WarrantsOrRightsCalledAmount": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Amount" } } }, "localname": "WarrantsOrRightsCalledAmount", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "monetaryItemType" }, "cef_WarrantsOrRightsCalledPeriodDate": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Period [Date]" } } }, "localname": "WarrantsOrRightsCalledPeriodDate", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "cef_WarrantsOrRightsCalledTitleTextBlock": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Called Title" } } }, "localname": "WarrantsOrRightsCalledTitleTextBlock", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "textBlockItemType" }, "cef_WarrantsOrRightsExercisePrice": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "label": "Warrants or Rights, Exercise Price" } } }, "localname": "WarrantsOrRightsExercisePrice", "nsuri": "http://xbrl.sec.gov/cef/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "perShareItemType" }, "dei_AdditionalSecurities462b": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "label": "Additional Securities. 462(b)" } } }, "localname": "AdditionalSecurities462b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_AdditionalSecurities462bFileNumber": { "auth_ref": [ "r481" ], "lang": { "en-us": { "role": { "label": "Additional Securities, 462(b), File Number" } } }, "localname": "AdditionalSecurities462bFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_AdditionalSecuritiesEffective413b": { "auth_ref": [ "r480" ], "lang": { "en-us": { "role": { "label": "Additional Securities Effective, 413(b)" } } }, "localname": "AdditionalSecuritiesEffective413b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_AddressTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.", "label": "Address Type [Domain]" } } }, "localname": "AddressTypeDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings.", "label": "Approximate Date of Commencement of Proposed Sale to Public" } } }, "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateOrAsapItemType" }, "dei_BusinessContactMember": { "auth_ref": [ "r399", "r400" ], "lang": { "en-us": { "role": { "documentation": "Business contact for the entity", "label": "Business Contact [Member]" } } }, "localname": "BusinessContactMember", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_ContactPersonnelName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of contact personnel", "label": "Contact Personnel Name" } } }, "localname": "ContactPersonnelName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DelayedOrContinuousOffering": { "auth_ref": [ "r401", "r402", "r472" ], "lang": { "en-us": { "role": { "label": "Delayed or Continuous Offering" } } }, "localname": "DelayedOrContinuousOffering", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DividendOrInterestReinvestmentPlanOnly": { "auth_ref": [ "r401", "r402", "r472" ], "lang": { "en-us": { "role": { "label": "Dividend or Interest Reinvestment Plan Only" } } }, "localname": "DividendOrInterestReinvestmentPlanOnly", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r398" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r473" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "submissionTypeItemType" }, "dei_EffectiveAfter60Days486a": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "label": "Effective after 60 Days, 486(a)" } } }, "localname": "EffectiveAfter60Days486a", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveOnDate486a": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(a)" } } }, "localname": "EffectiveOnDate486a", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "dei_EffectiveOnDate486b": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "label": "Effective on Date, 486(b)" } } }, "localname": "EffectiveOnDate486b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "dateItemType" }, "dei_EffectiveOnSetDate486a": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(a)" } } }, "localname": "EffectiveOnSetDate486a", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveOnSetDate486b": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "label": "Effective on Set Date, 486(b)" } } }, "localname": "EffectiveOnSetDate486b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveUponFiling462e": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "label": "Effective Upon Filing, 462(e)" } } }, "localname": "EffectiveUponFiling462e", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveUponFiling486b": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "label": "Effective upon Filing, 486(b)" } } }, "localname": "EffectiveUponFiling486b", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EffectiveWhenDeclaredSection8c": { "auth_ref": [ "r488" ], "lang": { "en-us": { "role": { "label": "Effective when Declared, Section 8(c)" } } }, "localname": "EffectiveWhenDeclaredSection8c", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityAddressesAddressTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Entity Addresses, Address Type [Axis]" } } }, "localname": "EntityAddressesAddressTypeAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "stringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]", "terseLabel": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r487" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Securities Act File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityInvCompanyType": { "auth_ref": [ "r477" ], "lang": { "en-us": { "role": { "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).", "label": "Entity Inv Company Type" } } }, "localname": "EntityInvCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "invCompanyType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r396" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "yesNoItemType" }, "dei_ExhibitsOnly462d": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d)" } } }, "localname": "ExhibitsOnly462d", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_ExhibitsOnly462dFileNumber": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "label": "Exhibits Only, 462(d), File Number" } } }, "localname": "ExhibitsOnly462dFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_InvestmentCompanyActFileNumber": { "auth_ref": [ "r402", "r469", "r470", "r471" ], "lang": { "en-us": { "role": { "label": "Investment Company Act File Number" } } }, "localname": "InvestmentCompanyActFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_InvestmentCompanyActRegistration": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "label": "Investment Company Act Registration" } } }, "localname": "InvestmentCompanyActRegistration", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyRegistrationAmendment": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment" } } }, "localname": "InvestmentCompanyRegistrationAmendment", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_InvestmentCompanyRegistrationAmendmentNumber": { "auth_ref": [ "r474" ], "lang": { "en-us": { "role": { "label": "Investment Company Registration Amendment Number" } } }, "localname": "InvestmentCompanyRegistrationAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]", "terseLabel": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "normalizedStringItemType" }, "dei_NewEffectiveDateForPreviousFiling": { "auth_ref": [ "r402", "r469", "r470", "r471" ], "lang": { "en-us": { "role": { "label": "New Effective Date for Previous Filing" } } }, "localname": "NewEffectiveDateForPreviousFiling", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_NoSubstantiveChanges462c": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c)" } } }, "localname": "NoSubstantiveChanges462c", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_NoSubstantiveChanges462cFileNumber": { "auth_ref": [ "r482" ], "lang": { "en-us": { "role": { "label": "No Substantive Changes, 462(c), File Number" } } }, "localname": "NoSubstantiveChanges462cFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "fileNumberItemType" }, "dei_PostEffectiveAmendment": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "label": "Post-Effective Amendment" } } }, "localname": "PostEffectiveAmendment", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_PostEffectiveAmendmentNumber": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective.", "label": "Post-Effective Amendment Number" } } }, "localname": "PostEffectiveAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_PreEffectiveAmendment": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "label": "Pre-Effective Amendment" } } }, "localname": "PreEffectiveAmendment", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "booleanItemType" }, "dei_PreEffectiveAmendmentNumber": { "auth_ref": [ "r394" ], "lang": { "en-us": { "role": { "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective.", "label": "Pre-Effective Amendment Number" } } }, "localname": "PreEffectiveAmendmentNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "sequenceNumberItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r397" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.slrinvestments.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "slrc_AcresCommercialMortgageLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ACRES Commercial Mortgage, LLC.", "label": "ACRES Commercial Mortgage, LLC [Member]", "terseLabel": "ACRES Commercial Mortgage, LLC [Member]" } } }, "localname": "AcresCommercialMortgageLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AdministrativeServicesPayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 16.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Administrative services payable.", "label": "Administrative Services Payable", "terseLabel": "Administrative services payable (see note 3)" } } }, "localname": "AdministrativeServicesPayable", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_AdvisoryAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advisory Agreement (Member)", "label": "Advisory Agreement [Member]", "terseLabel": "Advisory Agreement [Member]" } } }, "localname": "AdvisoryAgreementMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_AegisToxicologySciencesCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aegis toxicology sciences corporation.", "label": "Aegis Toxicology Sciences Corporation [Member]", "terseLabel": "Aegis Toxicology Sciences Corporation [Member]" } } }, "localname": "AegisToxicologySciencesCorporationMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AeroOperatingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aero operating llc.", "label": "Aero Operating LLC [Member]", "terseLabel": "Aero Operating LLC [Member]" } } }, "localname": "AeroOperatingLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AerospaceAndDefenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aerospace and defense member.", "label": "Aerospace and Defense [Member]", "terseLabel": "Aerospace & Defense [Member]" } } }, "localname": "AerospaceAndDefenseMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AfgDallasIiiLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "AFG dallas III, LLC.", "label": "AFG Dallas III, LLC [Member]" } } }, "localname": "AfgDallasIiiLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AgreementAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement Axis", "label": "Agreement [Axis]" } } }, "localname": "AgreementAxis", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement Domain", "label": "Agreement [Domain]" } } }, "localname": "AgreementDomain", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_AgreementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreement [Line item]", "label": "Agreement [Line Items]" } } }, "localname": "AgreementLineItems", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements Abstract", "label": "Agreements [Abstract]" } } }, "localname": "AgreementsAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "xbrltype": "stringItemType" }, "slrc_AgreementsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements [Table]", "label": "Agreements [Table]" } } }, "localname": "AgreementsTable", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_AgreementsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of Agreements.", "label": "Agreements [Text Block]", "terseLabel": "Agreements" } } }, "localname": "AgreementsTextBlock", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/Agreements" ], "xbrltype": "textBlockItemType" }, "slrc_AirFreightAndLogisticsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Air freight and logistics member.", "label": "Air Freight and Logistics [Member]", "verboseLabel": "Air Freight & Logistics [Member]" } } }, "localname": "AirFreightAndLogisticsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AirMethodsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Air methods corporation.", "label": "Air Methods Corporation [Member]", "terseLabel": "Air Methods Corporation [Member]" } } }, "localname": "AirMethodsCorporationMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AirlinesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Airlines member.", "label": "Airlines [Member]" } } }, "localname": "AirlinesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AlimeraSciencesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alimera sciences, inc.", "label": "Alimera Sciences, Inc. [Member]", "terseLabel": "Alimera Sciences, Inc. [Member]" } } }, "localname": "AlimeraSciencesInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AllStateAgPartsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All State Ag Parts, LLC.", "label": "All State Ag Parts LLC [Member]", "terseLabel": "All State Ag Parts, LLC" } } }, "localname": "AllStateAgPartsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AlteonHealthLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Alteon Health, LLC", "label": "Alteon Health, LLC [Member]", "terseLabel": "Alteon Health, LLC [Member]" } } }, "localname": "AlteonHealthLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmeraMexInternationalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amera mex international inc.", "label": "Amera Mex International Inc [Member]", "terseLabel": "AmeraMex International, Inc. [Member]" } } }, "localname": "AmeraMexInternationalIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmericanTeleconferencingServicesLtd.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "American teleconferencing services, ltd.", "label": "American Teleconferencing Services, Ltd. [Member]", "terseLabel": "American Teleconferencing Services, Ltd. [Member]" } } }, "localname": "AmericanTeleconferencingServicesLtd.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmericanTeleconferencingServicesLtdOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "American Teleconferencing Services, Ltd One [Member]", "terseLabel": "American Teleconferencing Services, Ltd. [Member]" } } }, "localname": "AmericanTeleconferencingServicesLtdOneMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AmerimarkIntermediateHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ameri mark intermediate holdings, llc", "label": "AmeriMark Intermediate Holdings, LLC [Member]", "terseLabel": "AmeriMark Intermediate Holdings, LLC [Member]" } } }, "localname": "AmerimarkIntermediateHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ApeelTechnologyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apeel technology Inc.", "label": "Apeel Technology Inc [Member]", "terseLabel": "Apeel Technology, Inc [Member]" } } }, "localname": "ApeelTechnologyIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ApexServicesPartnersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Apex services partners, LLC.", "label": "Apex Services Partners, LLC [Member]" } } }, "localname": "ApexServicesPartnersLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArcutisBiotherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arcutis Biotherapeutics, Inc.", "label": "Arcutis Biotherapeutics, Inc. [Member]", "terseLabel": "Arcutis Biotherapeutics, Inc. [Member]" } } }, "localname": "ArcutisBiotherapeuticsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArdelyxInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ardelyx, Inc.", "label": "Ardelyx, Inc. [Member]", "terseLabel": "Ardelyx, Inc. [Member]" } } }, "localname": "ArdelyxInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ArdelyxIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ardelyx Inc.", "label": "Ardelyx Inc [Member]", "terseLabel": "Ardelyx, Inc [Member]" } } }, "localname": "ArdelyxIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_AtriaWealthSolutionsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atria wealth solutions, inc.", "label": "Atria Wealth Solutions, Inc [Member]", "terseLabel": "Atria Wealth Solutions, Inc. [Member]" } } }, "localname": "AtriaWealthSolutionsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AtyrPharmaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Atyr pharma inc.", "label": "ATyr Pharma Inc [Member]", "terseLabel": "aTyr Pharma, Inc. Warrants [Member]" } } }, "localname": "AtyrPharmaIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AutoComponentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auto components member.", "label": "Auto Components [Member]" } } }, "localname": "AutoComponentsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AutoPartsAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Auto parts and equipment member.", "label": "Auto Parts and Equipment [Member]", "verboseLabel": "Auto Parts & Equipment [Member]" } } }, "localname": "AutoPartsAndEquipmentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_AviatorcapSiiLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aviatorcap sii, llc.", "label": "AviatorCap SII LLC [Member]" } } }, "localname": "AviatorcapSiiLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_AxcellaHealthIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Axcella health inc.", "label": "Axcella Health Inc [Member]", "terseLabel": "Axcella Health Inc. [Member]" } } }, "localname": "AxcellaHealthIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BasicAndDilutedEarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic And Diluted Earnings Per Share.", "label": "Basic And Diluted Earnings Per Share [Abstract]", "terseLabel": "Earnings (loss) per share (basic\u00a0& diluted)" } } }, "localname": "BasicAndDilutedEarningsPerShareAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "stringItemType" }, "slrc_BasicFunInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Basic fun, Inc.", "label": "Basic Fun, Inc. [Member]", "terseLabel": "Basic Fun, Inc. [Member]" } } }, "localname": "BasicFunInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BaymarkHealthServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BayMark health services, Inc.", "label": "BayMark Health Services Inc [Member]", "terseLabel": "BayMark Health Services, Inc [Member]" } } }, "localname": "BaymarkHealthServicesIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BdgMediaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BDG media, Inc.", "label": "BDG Media, Inc. [Member]" } } }, "localname": "BdgMediaInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BiotechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Biotechnology member.", "label": "Biotechnology [Member]" } } }, "localname": "BiotechnologyMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BlackScholesPricingModelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Black scholes pricing model.", "label": "Black Scholes Pricing Model [Member]" } } }, "localname": "BlackScholesPricingModelMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_BlackhawkMiningLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Blackhawk mining llc.", "label": "Blackhawk Mining LLC [Member]", "terseLabel": "Blackhawk Mining, LLC [Member]" } } }, "localname": "BlackhawkMiningLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board [Member].", "label": "Board [Member]", "terseLabel": "Board [Member]" } } }, "localname": "BoardMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_BoartLongyearCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boart longyear company.", "label": "Boart Longyear Company [Member]", "terseLabel": "Boart Longyear Company [Member]" } } }, "localname": "BoartLongyearCompanyMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BowmanEnergySolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bowman energy solutions, LLC.", "label": "Bowman Energy Solutions, LLC [Member]" } } }, "localname": "BowmanEnergySolutionsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BridgebioPharmaInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridgebio pharma, inc.", "label": "BridgeBio Pharma, Inc. [Member]", "terseLabel": "BridgeBio Pharma, Inc. [Member]" } } }, "localname": "BridgebioPharmaInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BuildingProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Building Products Member.", "label": "Building Products [Member]" } } }, "localname": "BuildingProductsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_BusinessCombinationCommonStockIssuedByTheCompany": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 9.0, "parentTag": "slrc_BusinessCombinationPurchaseDiscount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued by the company.", "label": "Business Combination Common stock issued by the Company", "verboseLabel": "Common stock issued by the Company" } } }, "localname": "BusinessCombinationCommonStockIssuedByTheCompany", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "slrc_BusinessCombinationPurchaseDiscount": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination purchase discount.", "label": "Business Combination Purchase Discount", "totalLabel": "Total purchase discount" } } }, "localname": "BusinessCombinationPurchaseDiscount", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "slrc_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsAtFairValue": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed investments at fair value.", "label": "Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Investments at Fair value", "terseLabel": "Investments, at fair value" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInvestmentsAtFairValue", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "slrc_BusinessMergerTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business merger [Text block].", "label": "Business Merger [Text Block]", "terseLabel": "Merger with SUNS" } } }, "localname": "BusinessMergerTextBlock", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSuns" ], "xbrltype": "textBlockItemType" }, "slrc_CapitalCityJetCenterIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital city jet center inc.", "label": "Capital City Jet Center Inc [Member]", "terseLabel": "Capital City Jet Center, Inc. [Member]" } } }, "localname": "CapitalCityJetCenterIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CapitalMarketsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital markets member.", "label": "Capital Markets [Member]" } } }, "localname": "CapitalMarketsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CapitalShareTransactionsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Capital share transactions.", "label": "Capital Share Transactions [Text Block]", "verboseLabel": "Capital Share Transactions" } } }, "localname": "CapitalShareTransactionsTextBlock", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactions" ], "xbrltype": "textBlockItemType" }, "slrc_CapitalizationOfPaymentInKindIncome": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Capitalization of\u00a0payment-in-kind\u00a0income.", "label": "Capitalization Of Payment In Kind Income", "terseLabel": "Capitalization of payment-in-kind income" } } }, "localname": "CapitalizationOfPaymentInKindIncome", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_CardioFocusIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cardio focus inc.", "label": "Cardio Focus Inc [Member]", "terseLabel": "CardioFocus, Inc. Warrants [Member]" } } }, "localname": "CardioFocusIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CashEquivalentsAtCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash equivalents at cost.", "label": "Cash Equivalents At Cost", "terseLabel": "Cash equivalents at cost" } } }, "localname": "CashEquivalentsAtCost", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_CashEquivalentsAtThirtyEightPointZeroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash equivalents at thirty eight point zero.", "label": "Cash Equivalents at Thirty Eight Point Zero [Member]", "terseLabel": "Cash Equivalents \u00a00 38.0% [Member]" } } }, "localname": "CashEquivalentsAtThirtyEightPointZeroMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CashEquivalentsAtTwentySixPointSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash equivalents at twenty six point seven.", "label": "Cash Equivalents at Twenty Six Point Seven [Member]", "terseLabel": "Cash Equivalents \u00a00 26.7%" } } }, "localname": "CashEquivalentsAtTwentySixPointSevenMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CcSagHoldingsCorp.SpectrumAutomotiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cc sag holdings corp. (spectrum automotive).", "label": "CC SAG Holdings Corp. (Spectrum Automotive) [Member]", "terseLabel": "CC SAG Holdings Corp. (Spectrum Automotive) [Member]" } } }, "localname": "CcSagHoldingsCorp.SpectrumAutomotiveMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CentrexionTherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Centrexion therapeutics, inc.", "label": "Centrexion Therapeutics, Inc. [Member]", "terseLabel": "Centrexion Therapeutics, Inc. [Member]" } } }, "localname": "CentrexionTherapeuticsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CentrexionTherapeuticsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Centrexion therapeutics inc.", "label": "Centrexion Therapeutics Inc [Member]", "terseLabel": "Centrexion Therapeutics, Inc. Warrants [Member]" } } }, "localname": "CentrexionTherapeuticsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CerapedicsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cerapedics, inc.", "label": "Cerapedics, Inc. [Member]", "terseLabel": "Cerapedics, Inc. [Member]" } } }, "localname": "CerapedicsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ChampionAirLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Champion air llc.", "label": "Champion Air LLC [Member]", "terseLabel": "Champion Air, LLC [Member]" } } }, "localname": "ChampionAirLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ChangeInUnrealizedGainLossOnInvestmentsAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Change in unrealized gain loss on investments and cash equivalents.", "label": "Change In Unrealized Gain Loss On Investments And Cash Equivalents [Abstract]", "terseLabel": "Net change in unrealized gain (loss) on investments and cash equivalents:" } } }, "localname": "ChangeInUnrealizedGainLossOnInvestmentsAndCashEquivalentsAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_CitiBankNaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Citi Bank NA.", "label": "Citi Bank NA [Member]" } } }, "localname": "CitiBankNaMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CkdHoldingsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CKD holdings, Inc.", "label": "CKD Holdings, Inc. [Member]" } } }, "localname": "CkdHoldingsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ClubcorpHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Clubcorp holdings inc.", "label": "Clubcorp Holdings Inc [Member]", "terseLabel": "Clubcorp Holdings, Inc. [Member]" } } }, "localname": "ClubcorpHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CollateralAgentAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateral agent.", "label": "Collateral Agent [Axis]" } } }, "localname": "CollateralAgentAxis", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_CollateralAgentDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collateral agent.", "label": "Collateral Agent [Domain]" } } }, "localname": "CollateralAgentDomain", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CollectionsOfPaymentInKindIncome": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Collections of\u00a0payment-in-kind\u00a0income.", "label": "Collections Of Payment In Kind Income", "terseLabel": "Collections of payment-in-kind income" } } }, "localname": "CollectionsOfPaymentInKindIncome", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_CommercialServicesAndSuppliesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commercial services and supplies member.", "label": "Commercial Services and Supplies [Member]", "verboseLabel": "Commercial Services & Supplies [Member]" } } }, "localname": "CommercialServicesAndSuppliesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommitmentFundedAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Commitment funded amount.", "label": "Commitment Funded Amount", "terseLabel": "Commitment funded amount" } } }, "localname": "CommitmentFundedAmount", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common equity or equity interests or warrants at fifty five point seven.", "label": "Common Equity Or Equity Interests Or Warrants At Fifty Five Point Seven [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants\u00a0055.7%" } } }, "localname": "CommonEquityOrEquityInterestsOrWarrantsAtFiftyFivePointSevenMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common equity or equity interests or warrants at fifty three point six.", "label": "Common Equity Or Equity Interests Or Warrants At Fifty Three Point Six [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants \u00a00 53.6% [Member]" } } }, "localname": "CommonEquityOrEquityInterestsOrWarrantsAtFiftyThreePointSixMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommunicationsEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Communications equipment member.", "label": "Communications Equipment [Member]" } } }, "localname": "CommunicationsEquipmentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CommunityBrandsParentcoLlcFkaMinistryBrandsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Community brands parentCo, LLC (f/k/a ministry brands).", "label": "Community Brands ParentCo, LLC (fka Ministry Brands) [Member]", "terseLabel": "Community Brands ParentCo, LLC (fka Ministry Brands) [Member]" } } }, "localname": "CommunityBrandsParentcoLlcFkaMinistryBrandsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CompaniesLessThanFivePercentageOwnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Companies less than five percentage owned.", "label": "Companies Less Than Five Percentage Owned [Member]", "terseLabel": "Companies less than 5% owned [Member]" } } }, "localname": "CompaniesLessThanFivePercentageOwnedMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_CompaniesMoreThanTwentyFivePercentageOwnedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Companies more than twenty five percentage owned.", "label": "Companies More Than Twenty Five Percentage Owned [Member]", "terseLabel": "Companies more than 25% owned [Member]" } } }, "localname": "CompaniesMoreThanTwentyFivePercentageOwnedMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_CompositeTechnologyAcquisitionCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Composite technology acquisition corp.", "label": "Composite Technology Acquisition Corp. [Member]" } } }, "localname": "CompositeTechnologyAcquisitionCorp.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CompositeTechnologyAcquisitionCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Composite technology acquisition corp.", "label": "Composite Technology Acquisition Corp [Member]", "terseLabel": "Composite Technology Acquisition Corp [Member]" } } }, "localname": "CompositeTechnologyAcquisitionCorpMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_ConstructionAndEngineeringMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Construction and engineering member.", "label": "Construction and Engineering [Member]", "verboseLabel": "Construction & Engineering [Member]" } } }, "localname": "ConstructionAndEngineeringMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ConsumerFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consumer finance member.", "label": "Consumer Finance [Member]" } } }, "localname": "ConsumerFinanceMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ContainersAndPackagingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Containers and packaging member.", "label": "Containers and Packaging [Member]", "verboseLabel": "Containers & Packaging [Member]" } } }, "localname": "ContainersAndPackagingMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ConventusOrthopaedicsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conventus orthopaedics inc.", "label": "Conventus Orthopaedics Inc [Member]", "terseLabel": "Conventus Orthopaedics, Inc. Warrants [Member]" } } }, "localname": "ConventusOrthopaedicsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CopperRiverSeafoodsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Copper river seafoods, Inc.", "label": "Copper River Seafoods, Inc. [Member]" } } }, "localname": "CopperRiverSeafoodsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_CreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Facility.", "label": "Credit Facility [Member]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_CreditFacilityOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit facility one.", "label": "Credit Facility One [Member]", "terseLabel": "SPV\u00a0Credit Facility", "verboseLabel": "SPV Credit Facility" } } }, "localname": "CreditFacilityOneMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_CrystalCapitalFinancialHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crystal capital financial holdings LLC.", "label": "Crystal Capital Financial Holdings LLC [Member]" } } }, "localname": "CrystalCapitalFinancialHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_CrystalFinancialMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Crystal Financial(Member)", "label": "Crystal Financial [Member]", "terseLabel": "Crystal Financial [Member]" } } }, "localname": "CrystalFinancialMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_DateOfCommencementOfBusiness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date of commencement of business.", "label": "Date of Commencement of Business", "terseLabel": "Date of commencement of business" } } }, "localname": "DateOfCommencementOfBusiness", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "slrc_DelphinusMedicalTechnologiesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Delphinus medical technologies, inc.", "label": "Delphinus Medical Technologies, Inc. [Member]", "terseLabel": "Delphinus Medical Technologies, Inc. [Member]" } } }, "localname": "DelphinusMedicalTechnologiesInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DelphinusMedicalTechnologiesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Delphinus medical technologies inc.", "label": "Delphinus Medical Technologies Inc [Member]", "terseLabel": "Delphinus Medical Technologies, Inc. Warrants [Member]" } } }, "localname": "DelphinusMedicalTechnologiesIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DescriptionOfFairValueMeasurementValuationProcess": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of fair value measurement valuation process.", "label": "Description Of Fair Value Measurement Valuation Process", "terseLabel": "Principal Valuation Technique/Methodology" } } }, "localname": "DescriptionOfFairValueMeasurementValuationProcess", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "xbrltype": "stringItemType" }, "slrc_DescriptionOfSignificantUnobservableInputUsed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of significant unobservable input used.", "label": "Description of Significant Unobservable Input Used", "terseLabel": "Unobservable Input" } } }, "localname": "DescriptionOfSignificantUnobservableInputUsed", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails" ], "xbrltype": "stringItemType" }, "slrc_DiversifiedConsumerServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diversified consumer services member.", "label": "Diversified Consumer Services [Member]" } } }, "localname": "DiversifiedConsumerServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DiversifiedFinancialServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Diversified financial services member", "label": "Diversified Financial Services [Member]", "verboseLabel": "Diversified Financial Services (includes SLR Credit Solutions) [Member]" } } }, "localname": "DiversifiedFinancialServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_DongwonAutopartTechnologyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dongwon autopart technology inc.", "label": "Dongwon Autopart Technology Inc [Member]", "terseLabel": "Dongwon Autopart Technology Inc. [Member]" } } }, "localname": "DongwonAutopartTechnologyIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EasyPakLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Easy pak llc.", "label": "Easy pak LLC [Member]", "terseLabel": "EasyPak, LLC [Member]" } } }, "localname": "EasyPakLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnergyDrillingServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy drilling services, LLC.", "label": "Energy Drilling Services, LLC [Member]" } } }, "localname": "EnergyDrillingServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnergyEquipmentAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Energy equipment and services member.", "label": "Energy Equipment and Services [Member]", "verboseLabel": "Energy Equipment & Services [Member]" } } }, "localname": "EnergyEquipmentAndServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnhancedPermanentCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enhanced permanent capital, llc.", "label": "Enhanced Permanent Capital, LLC [Member]", "terseLabel": "Enhanced Permanent Capital, LLC [Member]" } } }, "localname": "EnhancedPermanentCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ENC holdings III corp. ES opco USALLC (Bluefin).", "label": "ENS Holdings III Corp. ES Opco USA LLC (Bluefin) [Member]" } } }, "localname": "EnsHoldingsIiiCorp.EsOpcoUsaLlcBluefinMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnverusHoldingsIncFkaDrillingInfoHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enverus Holdings Inc fka Drilling Info Holdings Member.", "label": "Enverus Holdings Inc fka Drilling Info Holdings [Member]" } } }, "localname": "EnverusHoldingsIncFkaDrillingInfoHoldingsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EnverusHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Enverus holdings Inc.", "label": "Enverus Holdings Inc [Member]", "terseLabel": "Enverus Holdings, Inc [Member]" } } }, "localname": "EnverusHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_EnvironmentalProtectionImprovementCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Environmental protection\u00a0& improvement company llc.", "label": "Environmental Protection Improvement Company LLC [Member]", "terseLabel": "Environmental Protection & Improvement Company, LLC [Member]" } } }, "localname": "EnvironmentalProtectionImprovementCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentBackedLeasesAndLoansLargestPositionOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equipment backed leases and loans largest position outstanding.", "label": "Equipment Backed Leases And Loans Largest Position Outstanding", "terseLabel": "Equipment backed leases and loans largest position outstanding" } } }, "localname": "EquipmentBackedLeasesAndLoansLargestPositionOutstanding", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquipmentBackedLeasesAndLoansaverageExposurePerCustomer": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equipment backed leases and loans average exposure per customer.", "label": "Equipment Backed Leases and LoansAverage Exposure Per Customer", "terseLabel": "Equipment backed leases and loans average exposure per customer" } } }, "localname": "EquipmentBackedLeasesAndLoansaverageExposurePerCustomer", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquipmentFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing.", "label": "Equipment Financing [Member]", "terseLabel": "Equipment Financing" } } }, "localname": "EquipmentFinancingMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_EquipmentFinancingThirtyTwoPointFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing thirty two point five percent.", "label": "Equipment Financing Thirty Two Point Five Percent [Member]", "terseLabel": "Equipment Financing \u00a00 32.5% [Member]" } } }, "localname": "EquipmentFinancingThirtyTwoPointFivePercentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentFinancingTwentyThreePointSevenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment financing \u00a00 twenty three point seven percent.", "label": "Equipment Financing Twenty Three Point Seven Percent [Member]", "terseLabel": "Equipment Financing \u00a00 23.7%" } } }, "localname": "EquipmentFinancingTwentyThreePointSevenPercentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EquipmentOperatingLeasesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment operating leases llc,", "label": "Equipment Operating Leases LLC [Member]", "terseLabel": "Equipment Operating Leases, LLC [Member]" } } }, "localname": "EquipmentOperatingLeasesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_EquityMethodInvestmentAggregateEquityInvestment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity method investment aggregate equity investment.", "label": "Equity Method Investment Aggregate Equity Investment", "terseLabel": "Equity method investment aggregate equity investment" } } }, "localname": "EquityMethodInvestmentAggregateEquityInvestment", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_EquityMethodInvestmentAggregateInvestmentInInvesteeLeasesAndLoansHeld": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity method investment aggregate investment in investee leases and loans held.", "label": "Equity Method Investment Aggregate Investment In Investee Leases and Loans held", "terseLabel": "Equity method investment aggregate investment in investee leases and loans held" } } }, "localname": "EquityMethodInvestmentAggregateInvestmentInInvesteeLeasesAndLoansHeld", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_ErieConstructionMidwestLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Erie Construction mid-west LLC.", "label": "Erie Construction Midwest LLC [Member]", "terseLabel": "Erie Construction Mid-west, LLC [Member]" } } }, "localname": "ErieConstructionMidwestLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_EspSscCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ESP SSC Corporation Member", "label": "ESP SSC Corporation [Member]", "terseLabel": "ESP SSC Corporation [Member]" } } }, "localname": "EspSscCorporationMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_EssenceGroupHoldingsCorporationLumerisMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Essence group holdings corporation (lumeris).", "label": "Essence Group Holdings Corporation (Lumeris) [Member]", "terseLabel": "Essence Group Holdings Corporation (Lumeris) Warrants [Member]" } } }, "localname": "EssenceGroupHoldingsCorporationLumerisMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expenses.", "label": "Expenses [Abstract]", "terseLabel": "EXPENSES:" } } }, "localname": "ExpensesAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_FairValueMeasurementWithUnobservableInputsReconciliationBasisRealizedGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation basis realized gain loss included in earnings.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Basis Realized Gain Loss Included In Earnings", "terseLabel": "Net realized gain (loss)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationBasisRealizedGainLossIncludedInEarnings", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "slrc_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability realized gain loss included in earnings.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Realized Gain Loss Included In Earnings", "terseLabel": "Net realized (gain) loss" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityRealizedGainLossIncludedInEarnings", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "slrc_FairValueOfCommonStockPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value of common stock per share.", "label": "Fair Value Of Common Stock Per Share", "terseLabel": "Per share market value, end of period", "verboseLabel": "Fair value of common stock per share" } } }, "localname": "FairValueOfCommonStockPerShare", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "xbrltype": "perShareItemType" }, "slrc_FastPayPartnersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fast Pay Partners LLC [Member].", "label": "Fast Pay Partners LLC [Member]", "terseLabel": "Fast Pay Partners LLC [Member]" } } }, "localname": "FastPayPartnersLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_FirstAmericanCommercialBancorpIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First american commercial bancorp inc.", "label": "First American Commercial Bancorp Inc [Member]", "terseLabel": "First American Commercial Bancorp, Inc. [Member]" } } }, "localname": "FirstAmericanCommercialBancorpIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstLienBankDebtOrSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien bank debt or senior secured loans.", "label": "First Lien Bank Debt Or Senior Secured Loans [Member]", "terseLabel": "First Lien Bank Debt/Senior Secured Loans [Member]" } } }, "localname": "FirstLienBankDebtOrSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstLienLifeScienceSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First lien life science senior secured loans.", "label": "First Lien Life Science Senior Secured Loans [Member]", "terseLabel": "First Lien Life Science Senior Secured Loans [Member]" } } }, "localname": "FirstLienLifeScienceSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FirstNationalCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First national capital llc.", "label": "First National Capital LLC [Member]", "terseLabel": "First National Capital, LLC [Member]" } } }, "localname": "FirstNationalCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FoodProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Food products.", "label": "Food Products [Member]", "terseLabel": "Food Products [Member]" } } }, "localname": "FoodProductsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FootwearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Footwear Member.", "label": "Footwear [Member]" } } }, "localname": "FootwearMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FoundationConsumerBrandsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foundation consumer brands, llc", "label": "Foundation Consumer Brands, LLC [Member]", "terseLabel": "Foundation Consumer Brands, LLC [Member]" } } }, "localname": "FoundationConsumerBrandsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_FreightsolLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Freightsol llc.", "label": "Freightsol LLC [Member]", "terseLabel": "Freightsol LLC [Member]" } } }, "localname": "FreightsolLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GardaClTechnicalServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Garda cl technical services inc.", "label": "Garda CL Technical Services Inc [Member]", "terseLabel": "Garda CL Technical Services, Inc. [Member]" } } }, "localname": "GardaClTechnicalServicesIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GeorgiaJetIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Georgia Jet Inc.", "label": "Georgia Jet Inc [Member]", "terseLabel": "Georgia Jet, Inc. [Member]" } } }, "localname": "GeorgiaJetIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GlookoInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Glooko, inc.", "label": "Glooko, Inc. [Member]", "terseLabel": "Glooko, Inc. [Member]" } } }, "localname": "GlookoInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GmtCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GMT corporation.", "label": "GMT Corporation [Member]", "terseLabel": "GMT Corporation [Member]" } } }, "localname": "GmtCorporationMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_GrossIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gross income.", "label": "Gross Income", "terseLabel": "Gross income" } } }, "localname": "GrossIncome", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_GsmAcquisitionCorpMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GSM acquisition corp.", "label": "GSM Acquisition Corp [Member]", "terseLabel": "GSM Acquisition Corp [Member]" } } }, "localname": "GsmAcquisitionCorpMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HaljoeCoachesUsaLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Haljoe coaches usa llc.", "label": "Haljoe Coaches USA LLC [Member]", "terseLabel": "Haljoe Coaches USA, LLC [Member]" } } }, "localname": "HaljoeCoachesUsaLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HawkeyeContractingCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hawkeye contracting company llc.", "label": "Hawkeye Contracting Company LLC [Member]", "terseLabel": "Hawkeye Contracting Company, LLC [Member]" } } }, "localname": "HawkeyeContractingCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HealthCareEquipmentAndSuppliesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care equipment and supplies member.", "label": "Health Care Equipment and Supplies [Member]", "verboseLabel": "Health Care Equipment & Supplies [Member]" } } }, "localname": "HealthCareEquipmentAndSuppliesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HealthCareProvidersAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care providers and services.", "label": "Health Care Providers and Services [Member]", "verboseLabel": "Health Care Providers & Services [Member]" } } }, "localname": "HealthCareProvidersAndServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HealthCareTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Health care technology member.", "label": "Health Care Technology [Member]" } } }, "localname": "HealthCareTechnologyMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HigginbothamInsuranceAgencyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Higginbotham Insurance Agency Inc Member.", "label": "Higginbotham Insurance Agency Inc [Member]" } } }, "localname": "HigginbothamInsuranceAgencyIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HighStreetBuyerIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "High street buyer, Inc.", "label": "High Street Buyer Inc [Member]", "terseLabel": "High Street Buyer, Inc [Member]" } } }, "localname": "HighStreetBuyerIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HotelsRestaurantsAndLeisureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hotels, restaurants and leisure member.", "label": "Hotels, Restaurants and Leisure [Member]", "verboseLabel": "Hotels, Restaurants & Leisure [Member]" } } }, "localname": "HotelsRestaurantsAndLeisureMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HtiLogisticsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "HTI logistics corporation.", "label": "HTI Logistics Corporation [Member]", "terseLabel": "HTI Logistics Corporation [Member]" } } }, "localname": "HtiLogisticsCorporationMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_HumanInterestIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Human interest Inc.", "label": "Human Interest Inc [Member]", "terseLabel": "Human Interest, Inc [Member]" } } }, "localname": "HumanInterestIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_IcimsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "iCIMS, Inc.", "label": "iCIMS, Inc. [Member]", "terseLabel": "iCIMS, Inc. [Member]" } } }, "localname": "IcimsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_IncreaseDecreaseInAdministrativeServicesExpensePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in administrative services expense payable.", "label": "Increase Decrease In Administrative Services Expense Payable", "terseLabel": "Administrative services expense payable" } } }, "localname": "IncreaseDecreaseInAdministrativeServicesExpensePayable", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInDeferredFinancingCosts": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in deferred financing costs.", "label": "Increase Decrease In Deferred Financing Costs", "terseLabel": "Deferred financing costs/market discount" } } }, "localname": "IncreaseDecreaseInDeferredFinancingCosts", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInInvestmentIncomeAmortizationOfDiscount": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in investment income amortization of discount.", "label": "Increase Decrease In Investment Income Amortization Of Discount", "terseLabel": "Net accretion of discount on investments" } } }, "localname": "IncreaseDecreaseInInvestmentIncomeAmortizationOfDiscount", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInManagementFeePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease In management fee payable.", "label": "Increase Decrease In Management Fee Payable", "terseLabel": "Management fee payable" } } }, "localname": "IncreaseDecreaseInManagementFeePayable", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInNetAssetsFromOperation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in net assets from operation.", "label": "Increase Decrease In Net Assets From Operation", "terseLabel": "Numerator\u00a00net increase (decrease) in net assets resulting from operations" } } }, "localname": "IncreaseDecreaseInNetAssetsFromOperation", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPayableForInvestmentsAndCashEquivalentsPurchased": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in payable for investments and cash equivalents purchased.", "label": "Increase Decrease In Payable For Investments And Cash Equivalents Purchased", "terseLabel": "Payable for investments and cash equivalents purchased" } } }, "localname": "IncreaseDecreaseInPayableForInvestmentsAndCashEquivalentsPurchased", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPaymentsToAcquireInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in payments to acquire investments.", "label": "Increase Decrease In Payments To Acquire Investments", "terseLabel": "Purchase of investments" } } }, "localname": "IncreaseDecreaseInPaymentsToAcquireInvestments", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInPerformanceBasedIncentiveFeePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease In performance-based incentive fee payable.", "label": "Increase Decrease In Performance Based Incentive Fee Payable", "terseLabel": "Performance-based incentive fee payable" } } }, "localname": "IncreaseDecreaseInPerformanceBasedIncentiveFeePayable", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseInProceedsFromSaleMaturityAndCollectionsOfInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease in proceeds from sale maturity and collections of investments.", "label": "Increase Decrease IN Proceeds From Sale Maturity And Collections Of Investments", "terseLabel": "Proceeds from disposition of investments" } } }, "localname": "IncreaseDecreaseInProceedsFromSaleMaturityAndCollectionsOfInvestments", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseOfCashAcquiredInMerger": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease of cash acquired in merger.", "label": "Increase Decrease Of Cash Acquired In Merger", "negatedLabel": "Cash acquired in merger" } } }, "localname": "IncreaseDecreaseOfCashAcquiredInMerger", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_IncreaseDecreaseReceivableForInvestmentsSold": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase decrease receivable for investments sold.", "label": "Increase Decrease Receivable For Investments Sold", "terseLabel": "Receivable for investments sold" } } }, "localname": "IncreaseDecreaseReceivableForInvestmentsSold", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_InitialCapitalOfBusiness": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial capital of business.", "label": "Initial Capital Of Business", "terseLabel": "Initial capital of business" } } }, "localname": "InitialCapitalOfBusiness", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_InsuranceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Insurance member.", "label": "Insurance [Member]" } } }, "localname": "InsuranceMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InszoneMidLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Inszone mid, llc.", "label": "Inszone Mid, LLC [Member]", "terseLabel": "Inszone Mid, LLC [Member]" } } }, "localname": "InszoneMidLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InterestAndOtherCreditFacilityExpenses": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and other credit facility expenses.", "label": "Interest And Other Credit Facility Expenses", "terseLabel": "Interest and other credit facility expenses (see note 7)" } } }, "localname": "InterestAndOtherCreditFacilityExpenses", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InternationalAutomotiveComponentsGroupNorthAmericaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "International automotive components group north america inc", "label": "International Automotive Components Group North America Inc [Member]", "terseLabel": "International Automotive Components Group, North America, Inc. [Member]" } } }, "localname": "InternationalAutomotiveComponentsGroupNorthAmericaIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InternetAndCatalogRetailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internet and catalog retail member.", "label": "Internet and Catalog Retail [Member]", "verboseLabel": "Internet & Catalog Retail [Member]" } } }, "localname": "InternetAndCatalogRetailMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InternetSoftwareServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internet Software & Services Member.", "label": "Internet Software Services [Member]" } } }, "localname": "InternetSoftwareServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_InvestmentCompanyDistributionOrdinaryIncome": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 7.0, "parentTag": "us-gaap_InvestmentCompanyDividendDistribution", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment company distribution ordinary income.", "label": "Investment Company Distribution Ordinary Income", "negatedLabel": "From net investment income" } } }, "localname": "InvestmentCompanyDistributionOrdinaryIncome", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in net assets.", "label": "Investment Company Increase Decrease In Net Assets", "totalLabel": "Total increase (decrease) in net assets" } } }, "localname": "InvestmentCompanyIncreaseDecreaseInNetAssets", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyInterestAndOtherCreditFacilityExpensesRatioAfterIncentiveAllocation": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Investment company interest and other credit facility expenses ratio after incentive allocation.", "label": "Investment Company Interest And Other Credit Facility Expenses Ratio After Incentive Allocation", "terseLabel": "Interest and other credit facility expenses" } } }, "localname": "InvestmentCompanyInterestAndOtherCreditFacilityExpensesRatioAfterIncentiveAllocation", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyNetAssetsFromOperationIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Company Net Assets From Operation Increase Decrease", "label": "Investment Company Net Assets From Operation Increase Decrease [Abstract]", "verboseLabel": "Investment Company Change in Net Assets" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationIncreaseDecreaseAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "stringItemType" }, "slrc_InvestmentCompanyOperatingExpensesRatioAfterIncentiveAllocation": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": 1.0, "parentTag": "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Investment company operating expenses ratio after incentive allocation.", "label": "Investment Company Operating Expenses Ratio After Incentive Allocation", "terseLabel": "Operating expenses" } } }, "localname": "InvestmentCompanyOperatingExpensesRatioAfterIncentiveAllocation", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_InvestmentCompanyPerformanceBasedIncentiveFeesWaived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment company performance based incentive fees waived.", "label": "Investment Company Performance Based Incentive Fees Waived", "terseLabel": "Performance-based incentive fees waived (see note 3)" } } }, "localname": "InvestmentCompanyPerformanceBasedIncentiveFeesWaived", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentCompanyReturnOfCapitalDistribution": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 8.0, "parentTag": "us-gaap_InvestmentCompanyDividendDistribution", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the amount of distributions to stockholders return of capital.", "label": "Investment Company Return Of Capital Distribution", "negatedLabel": "From return of capital" } } }, "localname": "InvestmentCompanyReturnOfCapitalDistribution", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentHoldingsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Holdings.", "label": "Investment Holdings [Axis]" } } }, "localname": "InvestmentHoldingsAxis", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_InvestmentHoldingsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment Holdings.", "label": "Investment Holdings [Domain]" } } }, "localname": "InvestmentHoldingsDomain", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "slrc_InvestmentInSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment in senior secured loans.", "label": "Investment in Senior Secured Loans [Member]", "terseLabel": "Senior Secured Loans" } } }, "localname": "InvestmentInSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_InvestmentIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment income.", "label": "Investment Income [Abstract]", "terseLabel": "INVESTMENT INCOME:" } } }, "localname": "InvestmentIncomeAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "slrc_InvestmentIncomeInvestmentExpensesNet": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 14.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment income investment expenses net.", "label": "Investment Income Investment Expenses Net", "terseLabel": "Net expenses" } } }, "localname": "InvestmentIncomeInvestmentExpensesNet", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedAcquisitionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned acquisition date.", "label": "Investment Owned Acquisition Date", "terseLabel": "Acquisition Date" } } }, "localname": "InvestmentOwnedAcquisitionDate", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "dateItemType" }, "slrc_InvestmentOwnedAtFairValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investment owned at fair value.", "label": "Investment Owned At Fair Value [Abstract]", "terseLabel": "Investments at fair value:" } } }, "localname": "InvestmentOwnedAtFairValueAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "slrc_InvestmentOwnedInterestAndDividendIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, interest and dividend income.", "label": "Investment Owned, Interest And Dividend Income", "negatedLabel": "Interest/Dividend Income" } } }, "localname": "InvestmentOwnedInterestAndDividendIncome", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedRealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized realized gain loss.", "label": "Investment Owned, Unrecognized Realized Gain Loss", "negatedLabel": "Net realized gain (loss)" } } }, "localname": "InvestmentOwnedUnrecognizedRealizedGainLoss", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized additions.", "label": "Investment Owned, Unrecognized Unrealized Additions", "terseLabel": "Gross Additions" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedAdditions", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized gain loss.", "label": "Investment Owned, Unrecognized Unrealized Gain Loss", "negatedLabel": "Net change in unrealized gain (loss)" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedGainLoss", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentOwnedUnrecognizedUnrealizedReductions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Investment owned, unrecognized unrealized reductions.", "label": "Investment Owned, Unrecognized Unrealized Reductions", "negatedLabel": "Gross Reductions" } } }, "localname": "InvestmentOwnedUnrecognizedUnrealizedReductions", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "slrc_InvestmentsOwnedFloorRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned floor rate .", "label": "Investments Owned Floor Rate", "terseLabel": "Floor" } } }, "localname": "InvestmentsOwnedFloorRate", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "slrc_InvestmentsOwnedIndustryName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned industry name.", "label": "Investments Owned Industry Name", "terseLabel": "Industry" } } }, "localname": "InvestmentsOwnedIndustryName", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "slrc_InvestmentsOwnedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned interest rate.", "label": "Investments Owned Interest Rate", "terseLabel": "Interest Rate" } } }, "localname": "InvestmentsOwnedInterestRate", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "slrc_InvestmentsOwnedSpreadAboveIndexRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Investments owned Spread above index rate.", "label": "Investments Owned Spread Above Index Rate", "terseLabel": "Spread Above Index" } } }, "localname": "InvestmentsOwnedSpreadAboveIndexRate", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "slrc_IssuanceOfCommonStockInConnectionWithTheMerger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with the merger.", "label": "Issuance of Common Stock in Connection With the Merger", "terseLabel": "Issuance of common stock in connection with the Merger" } } }, "localname": "IssuanceOfCommonStockInConnectionWithTheMerger", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "slrc_ItServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "IT services member.", "label": "IT Services [Member]" } } }, "localname": "ItServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_IvyFertilityServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ivy fertility services, llc.", "label": "Ivy Fertility Services, LLC [Member]", "terseLabel": "Ivy Fertility Services, LLC [Member]" } } }, "localname": "IvyFertilityServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_JointVentureAgreementAggregateEquityFundingCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Joint venture agreement aggregate equity funding commitment.", "label": "Joint Venture Agreement Aggregate Equity Funding Commitment", "terseLabel": "Joint venture agreement aggregate equity funding commitment" } } }, "localname": "JointVentureAgreementAggregateEquityFundingCommitment", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_JointVentureAgreementCoventurerEquityFundingCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Joint venture agreement coventurer equity funding commitment.", "label": "Joint Venture Agreement Coventurer Equity Funding Commitment", "terseLabel": "Joint venture agreement coventurer equity funding commitment" } } }, "localname": "JointVentureAgreementCoventurerEquityFundingCommitment", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_KaseyaIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kaseya Inc.", "label": "Kaseya Inc [Member]", "terseLabel": "Kaseya, Inc [Member]" } } }, "localname": "KaseyaIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_KbhTopcoLlcKingsbridgeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kbh topco llc (kingsbridge).", "label": "KBH Topco LLC (Kingsbridge) [Member]", "terseLabel": "KBH Topco LLC (Kingsbridge) [Member]" } } }, "localname": "KbhTopcoLlcKingsbridgeMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_KbhtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "KBHT", "label": "KBHT [Member]" } } }, "localname": "KbhtMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_KidDistroHoldingsLlcDistroKidMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kid distro holdings, llc (distro kid).", "label": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "terseLabel": "Kid Distro Holdings, LLC (Distro Kid) [Member]", "verboseLabel": "Kid Distro Holdings, LLC [Member]" } } }, "localname": "KidDistroHoldingsLlcDistroKidMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_KingsbridgeHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kingsbridge Holdings, LLC.", "label": "Kingsbridge Holdings, LLC [Member]", "terseLabel": "Kingsbridge Holdings, LLC [Member]" } } }, "localname": "KingsbridgeHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_KoolPakLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kool pak llc.", "label": "Kool Pak LLC [Member]", "terseLabel": "Kool Pak, LLC [Member]" } } }, "localname": "KoolPakLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_KoreWirelessGroupInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Kore wireless group, inc..", "label": "KORE Wireless Group, Inc. [Member]", "terseLabel": "KORE Wireless Group, Inc. [Member]" } } }, "localname": "KoreWirelessGroupInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LeisureEquipmentAndProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leisure Equipment & Products member.", "label": "Leisure Equipment and Products [Member]" } } }, "localname": "LeisureEquipmentAndProductsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LiabilitiesInExcessOfOtherAssets": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Liabilities in excess of other assets.", "label": "Liabilities in Excess of Other Assets", "negatedLabel": "Liabilities in Excess of Other Assets" } } }, "localname": "LiabilitiesInExcessOfOtherAssets", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "monetaryItemType" }, "slrc_LifeSciencesToolsAndServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Life sciences tools and services member.", "label": "Life Sciences Tools and Services [Member]", "verboseLabel": "Life Sciences Tools & Services [Member]" } } }, "localname": "LifeSciencesToolsAndServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LineOfCreditAndTermLoanOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit and term loan outstanding.", "label": "Line Of Credit And Term Loan Outstanding", "terseLabel": "Credit Facility, Carrying Value", "verboseLabel": "Line of credit and term loan outstanding" } } }, "localname": "LineOfCreditAndTermLoanOutstanding", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditFacilityCommitmentsAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Line Of Credit Facility Commitments Amount", "label": "Line Of Credit Facility Commitments Amount", "terseLabel": "Line of credit facility commitments amount" } } }, "localname": "LineOfCreditFacilityCommitmentsAmount", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditFacilityMaximumBorrowingCapacityWithAccordionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit facility maximum borrowing capacity with accordion feature.", "label": "Line Of Credit Facility Maximum Borrowing Capacity with Accordion Feature", "terseLabel": "Line of credit facility maximum borrowing capacity with accordion feature" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacityWithAccordionFeature", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LineOfCreditMaximumBorrowingCapacityAndDebtInstrumentFaceValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Line of credit maximum borrowing capacity and debt instrument face value.", "label": "Line Of Credit Maximum Borrowing Capacity And Debt Instrument Face Value", "terseLabel": "Line of credit maximum borrowing capacity and debt instrument face value" } } }, "localname": "LineOfCreditMaximumBorrowingCapacityAndDebtInstrumentFaceValue", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LogixHoldingCompanyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Logix holding company, llc.", "label": "Logix Holding Company, LLC [Member]", "terseLabel": "Logix Holding Company, LLC [Member]" } } }, "localname": "LogixHoldingCompanyLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LongTermDebtMaximumAmountBorrowedDuringThePeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long term debt maximum amount borrowed during the period.", "label": "Long Term Debt Maximum Amount Borrowed During The Period", "terseLabel": "Long term debt maximum amount borrowed during the period" } } }, "localname": "LongTermDebtMaximumAmountBorrowedDuringThePeriod", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_LongTermDebtOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term debt one.", "label": "Long Term Debt One [Axis]" } } }, "localname": "LongTermDebtOneAxis", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_LongTermDebtOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term debt one.", "label": "Long Term Debt One [Domain]" } } }, "localname": "LongTermDebtOneDomain", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_LongTermInvestmentsMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term investments measurement input.", "label": "Long Term Investments Measurement Input" } } }, "localname": "LongTermInvestmentsMeasurementInput", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "pureItemType" }, "slrc_LoyerCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loyer capital llc.", "label": "Loyer Capital LLC [Member]", "terseLabel": "Loyer Capital LLC [Member]" } } }, "localname": "LoyerCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_LuxCreditConsultantsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lux credit consultants llc.", "label": "Lux Credit Consultants LLC [Member]", "terseLabel": "Lux Credit Consultants, LLC [Member]" } } }, "localname": "LuxCreditConsultantsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LuxVendingLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lux vending llc.", "label": "Lux Vending LLC [Member]", "terseLabel": "Lux Vending, LLC [Member]" } } }, "localname": "LuxVendingLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_LuxuryAssetCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Luxury asset capital, LLC.", "label": "Luxury Asset Capital, LLC [Member]" } } }, "localname": "LuxuryAssetCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MachineryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Machinery member.", "label": "Machinery [Member]" } } }, "localname": "MachineryMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MauricesIncorporatedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maurices, incorporated.", "label": "Maurices, Incorporated [Member]", "terseLabel": "Maurices, Incorporated [Member]" } } }, "localname": "MauricesIncorporatedMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputComparableMultipleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input comparable multiple.", "label": "Measurement Input Comparable Multiple [Member]", "terseLabel": "Comparable Multiple" } } }, "localname": "MeasurementInputComparableMultipleMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputMarketYieldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input market yield.", "label": "Measurement Input Market Yield [Member]", "terseLabel": "Market Yield" } } }, "localname": "MeasurementInputMarketYieldMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputReturnOnEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input return on equity.", "label": "Measurement Input Return on Equity [Member]", "terseLabel": "Return on Equity" } } }, "localname": "MeasurementInputReturnOnEquityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MeasurementInputTypeOneAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input type one.", "label": "Measurement Input Type One [Axis]" } } }, "localname": "MeasurementInputTypeOneAxis", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "slrc_MeasurementInputTypeOneDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input type one.", "label": "Measurement Input Type One [Domain]" } } }, "localname": "MeasurementInputTypeOneDomain", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_MediaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Media", "label": "Media [Member]", "terseLabel": "Media [Member]" } } }, "localname": "MediaMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MergerWithSunsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger With Suns", "label": "Merger With Suns [Line Items]" } } }, "localname": "MergerWithSunsLineItems", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_MergerWithSunsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Merger with SUNS Table", "label": "Merger with SUNS [Table]" } } }, "localname": "MergerWithSunsTable", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_MetalsAndMiningMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Metals and mining member.", "label": "Metals and Mining [Member]", "terseLabel": "Metals & Mining [Member]" } } }, "localname": "MetalsAndMiningMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MmitHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MMIT Holdings, LLC.", "label": "MMIT Holdings, LLC [Member]", "terseLabel": "MMIT Holdings, LLC [Member]" } } }, "localname": "MmitHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MontefioreNyackHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Montefiore nyack Hospital.", "label": "Montefiore Nyack Hospital [Member]" } } }, "localname": "MontefioreNyackHospitalMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MountainAirHelicoptersIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mountain air helicopters inc.", "label": "Mountain Air Helicopters Inc [Member]", "terseLabel": "Mountain Air Helicopters, Inc. [Member]" } } }, "localname": "MountainAirHelicoptersIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_MultiSectorHoldingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multi-sector holdings member.", "label": "Multi Sector Holdings [Member]", "verboseLabel": "Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC) [Member]" } } }, "localname": "MultiSectorHoldingsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NacHoldingsCorporationJaguarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nac holdings corporation (jaguar).", "label": "NAC Holdings Corporation (Jaguar) [Member]", "terseLabel": "NAC Holdings Corporation (Jaguar) [Member]" } } }, "localname": "NacHoldingsCorporationJaguarMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NacHoldingsCorporationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NAC Holdings Corporation", "label": "NAC Holdings Corporation [Member]", "terseLabel": "NAC Holdings Corporation [Member]" } } }, "localname": "NacHoldingsCorporationMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_NationalSpineAndPainCentersLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "National Spine and Pain Centers LLC Member.", "label": "National Spine and Pain Centers LLC [Member]" } } }, "localname": "NationalSpineAndPainCentersLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NefpassFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NEFPASS Facility [Member]", "verboseLabel": "NEFPASS Facility" } } }, "localname": "NefpassFacilityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_NetAssetValuePerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net asset value per share.", "label": "Net Asset Value Per Share [Abstract]", "terseLabel": "Net Asset Value Per Share [Abstract]" } } }, "localname": "NetAssetValuePerShareAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "xbrltype": "stringItemType" }, "slrc_NetAssetValuePerShareTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net asset value per share.", "label": "Net Asset Value Per Share [Text Block]", "terseLabel": "Net Asset Value Per Share" } } }, "localname": "NetAssetValuePerShareTextBlock", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/NetAssetValuePerShare" ], "xbrltype": "textBlockItemType" }, "slrc_NetChangeInUnrealizedGainLossOnInvestments": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net change in unrealized gain loss on investments.", "label": "Net Change In Unrealized Gain Loss On Investments", "negatedLabel": "Net change in unrealized (gain) loss on investments" } } }, "localname": "NetChangeInUnrealizedGainLossOnInvestments", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NetIncreaseInNetAssetsResultingFromoperations": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net increase in net assets resulting from\u00a0operations.", "label": "Net Increase In Net Assets Resulting From Operations", "negatedLabel": "Net increase (decrease) in net assets resulting from operations" } } }, "localname": "NetIncreaseInNetAssetsResultingFromoperations", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NetRealizedGainLossOnInvestmentsAndCashEquivalents": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net realized (gain) loss on investments and cash equivalents.", "label": "Net Realized Gain Loss On Investments And Cash Equivalents", "negatedLabel": "Net realized (gain) loss on investments and cash equivalents" } } }, "localname": "NetRealizedGainLossOnInvestmentsAndCashEquivalents", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "slrc_NeuroneticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Neuronetics, inc.", "label": "Neuronetics, Inc. [Member]", "terseLabel": "Neuronetics, Inc. [Member]" } } }, "localname": "NeuroneticsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_NmHoldcoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NM Holdco [Member].", "label": "NM Holdco [Member]", "terseLabel": "NM Holdco [Member]" } } }, "localname": "NmHoldcoMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NmcSeniorCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NMC senior credit facility.", "label": "NMC Senior Credit Facility [Member]", "terseLabel": "NMC Senior Credit Facility [Member]" } } }, "localname": "NmcSeniorCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NmcsCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NMC's credit facility [Member].", "label": "NMCs Credit Facility [Member]", "terseLabel": "NMCs Credit Facility [Member]" } } }, "localname": "NmcsCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NorthMillCapitalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "North Mill Capital LLC Member", "label": "North Mill Capital LLC [Member]", "terseLabel": "North Mill Capital LLC [Member]" } } }, "localname": "NorthMillCapitalLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_NumberOfBasisPoints": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of basis points.", "label": "Number of Basis Points", "terseLabel": "Number of basis points" } } }, "localname": "NumberOfBasisPoints", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Customers.", "label": "Number Of Customers", "terseLabel": "Number of Customers" } } }, "localname": "NumberOfCustomers", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfFundedCommitment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of funded commitment.", "label": "Number Of Funded Commitment", "terseLabel": "Number of funded commitments" } } }, "localname": "NumberOfFundedCommitment", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfIssuerInBusinessCredit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of issuer in business credit.", "label": "Number Of Issuer In Business Credit", "terseLabel": "Number of issuers in business credit" } } }, "localname": "NumberOfIssuerInBusinessCredit", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_NumberOfLoanInBusinessCredit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Loan in business credit.", "label": "Number Of Loan In Business Credit", "terseLabel": "Number of loans in business credit" } } }, "localname": "NumberOfLoanInBusinessCredit", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "slrc_OilGasAndConsumableFuelsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Oil, gas and consumable fuels member.", "label": "Oil, Gas and Consumable Fuels [Member]", "verboseLabel": "Oil, Gas & Consumable Fuels [Member]" } } }, "localname": "OilGasAndConsumableFuelsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OisManagementServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OIS Management Services LLC.", "label": "OIS Management Services LLC [Member]", "terseLabel": "OIS Management Services, LLC [Member]" } } }, "localname": "OisManagementServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OmniguideHoldingsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OmniGuide holdings, inc.", "label": "OmniGuide Holdings, Inc. [Member]", "terseLabel": "OmniGuide Holdings, Inc. [Member]" } } }, "localname": "OmniguideHoldingsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OneTouchDirectLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One touch direct, llc.", "label": "One Touch Direct, LLC [Member]", "terseLabel": "One Touch Direct, LLC [Member]" } } }, "localname": "OneTouchDirectLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_OrthopedicCarePartnersManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Orthopedic care partners management, LLC.", "label": "Orthopedic Care Partners Management, LLC [Member]" } } }, "localname": "OrthopedicCarePartnersManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PackagedFoodsAndMeatsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Packaged foods and meats member.", "label": "Packaged Foods and Meats [Member]", "verboseLabel": "Packaged Foods & Meats [Member]" } } }, "localname": "PackagedFoodsAndMeatsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PayableForInvestmentsAndCashEquivalentsPurchased": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 11.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payable for investments and cash equivalents purchased.", "label": "Payable For Investments And Cash Equivalents Purchased", "terseLabel": "Payable for investments and cash equivalents purchased" } } }, "localname": "PayableForInvestmentsAndCashEquivalentsPurchased", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_PediatricHomeRespiratoryServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pediatric home respiratory services, LLC.", "label": "Pediatric Home Respiratory Services, LLC [Member]" } } }, "localname": "PediatricHomeRespiratoryServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PerShareDataAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share data.", "label": "Per Share Data [Abstract]", "terseLabel": "Per Share Data:" } } }, "localname": "PerShareDataAbstract", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "stringItemType" }, "slrc_PercentageOfCumulativeNetRealizedGainAndUnrealizedCapitalAppreciation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Cumulative Net Realized Gain And Unrealized Capital Appreciation", "label": "Percentage Of Cumulative Net Realized Gain And Unrealized Capital Appreciation", "terseLabel": "Percentage of cumulative net realized gain and unrealized capital appreciation" } } }, "localname": "PercentageOfCumulativeNetRealizedGainAndUnrealizedCapitalAppreciation", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfCumulativeRealizedCapitalGainLoss": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage Of Cumulative Realized Capital Gain Loss", "label": "Percentage of Cumulative Realized Capital Gain Loss", "terseLabel": "Percentage of cumulative realized capital gain loss" } } }, "localname": "PercentageOfCumulativeRealizedCapitalGainLoss", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfEquityInterestContributedToAnotherEntity": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of equity interest contributed to another entity.", "label": "Percentage Of Equity Interest Contributed To Another Entity", "terseLabel": "Percentage of equity interest contributed to another entity" } } }, "localname": "PercentageOfEquityInterestContributedToAnotherEntity", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfExciseTax": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of excise tax.", "label": "Percentage Of Excise Tax", "terseLabel": "Percentage of excise tax" } } }, "localname": "PercentageOfExciseTax", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfGrossAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of gross assets.", "label": "Percentage Of Gross Assets", "terseLabel": "Percentage of gross assets" } } }, "localname": "PercentageOfGrossAssets", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfInitialCapitalFundedByAffiliatedParties": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of initial capital funded by affiliated parties.", "label": "Percentage Of Initial Capital Funded By Affiliated Parties", "terseLabel": "Percentage of initial capital funded by affiliated parties" } } }, "localname": "PercentageOfInitialCapitalFundedByAffiliatedParties", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfNonQualifyingAssetsInThePortfolioOfTotalAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of non qualifying\u00a0assets in the portfolio of total assets.", "label": "Percentage of Non Qualifying Assets in the Portfolio of Total Assets", "terseLabel": "Percentage of non-qualifying\u00a0assets in the portfolio of total assets" } } }, "localname": "PercentageOfNonQualifyingAssetsInThePortfolioOfTotalAssets", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfOutstandingVotingSecuritiesOfTheInvestment": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of outstanding voting securities of the investment.", "label": "Percentage of Outstanding Voting Securities of the Investment", "terseLabel": "Percentage of outstanding voting securities of the investment" } } }, "localname": "PercentageOfOutstandingVotingSecuritiesOfTheInvestment", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfPreIncentiveFeeNetInvestmentIncome": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of pre-incentive fee net investment income.", "label": "Percentage of Pre Incentive Fee Net Investment Income", "terseLabel": "Percentage of pre-incentive fee net investment income" } } }, "localname": "PercentageOfPreIncentiveFeeNetInvestmentIncome", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageOfTotalNetAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of total net assets.", "label": "Percentage Of Total Net Assets", "terseLabel": "Percentage of total net assets" } } }, "localname": "PercentageOfTotalNetAssets", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingCashEquivalentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing cash equivalents in investments owned.", "label": "Percentage Representing Cash Equivalents in Investments Owned", "terseLabel": "Percentage representing cash equivalents in investments owned" } } }, "localname": "PercentageRepresentingCashEquivalentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingCommonEquityOrEquityInterestsOrWarrantsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing common equity or equity interests or warrants owned.", "label": "Percentage Representing Common Equity Or Equity Interests Or Warrants Owned", "terseLabel": "Percentage representing common equity or equity interests or warrants owned" } } }, "localname": "PercentageRepresentingCommonEquityOrEquityInterestsOrWarrantsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingEquipmentFinancingInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing equipment financing in investments owned.", "label": "Percentage Representing Equipment Financing in Investments Owned", "terseLabel": "Percentage representing equipment financing in investments owned" } } }, "localname": "PercentageRepresentingEquipmentFinancingInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingLiabilitiesInExcessOfOtherAssetsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing liabilities in excess of other assets in investments owned.", "label": "Percentage Representing Liabilities in Excess of Other Assets in Investments Owned", "terseLabel": "Percentage representing liabilities in excess of other assets in investments owned" } } }, "localname": "PercentageRepresentingLiabilitiesInExcessOfOtherAssetsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingNetAssetsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing net assets in investments owned.", "label": "Percentage Representing Net Assets in Investments Owned", "terseLabel": "Percentage representing net assets in investments owned" } } }, "localname": "PercentageRepresentingNetAssetsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingPreferredEquityInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing preferred equity in investments owned.", "label": "Percentage Representing Preferred Equity in Investments Owned", "terseLabel": "Percentage representing preferred equity in investments owned" } } }, "localname": "PercentageRepresentingPreferredEquityInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing senior secured loans in investments owned.", "label": "Percentage Representing Senior Secured Loans In Investments Owned", "terseLabel": "Percentage representing senior secured loans in investments owned" } } }, "localname": "PercentageRepresentingSeniorSecuredLoansInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingTotalInvestmentsAndCashEquivalentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing total investments and cash equivalents in investments owned.", "label": "Percentage Representing Total Investments and Cash Equivalents in Investments Owned", "terseLabel": "Percentage representing total investments and cash equivalents in investments owned" } } }, "localname": "PercentageRepresentingTotalInvestmentsAndCashEquivalentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageRepresentingTotalInvestmentsInInvestmentsOwned": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage representing total investments in investments owned.", "label": "Percentage Representing Total Investments in Investments Owned", "terseLabel": "Percentage representing total investments in investments owned" } } }, "localname": "PercentageRepresentingTotalInvestmentsInInvestmentsOwned", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageSpreadAsCash": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage spread as cash.", "label": "Percentage Spread as Cash", "terseLabel": "Percentage spread as cash" } } }, "localname": "PercentageSpreadAsCash", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PercentageSpreadAsPaidInKind": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage spread as paid in kind .", "label": "Percentage Spread as Paid in Kind", "terseLabel": "Percentage spread as paid in kind" } } }, "localname": "PercentageSpreadAsPaidInKind", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "percentItemType" }, "slrc_PerformanceBasedIncentiveFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Performance Based Incentive Fees", "label": "Performance Based Incentive Fees", "terseLabel": "Performance based incentive fees" } } }, "localname": "PerformanceBasedIncentiveFees", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_PerformanceBasedIncentiveFeesWaiver": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Performance based incentive fees waiver.", "label": "Performance Based Incentive Fees Waiver" } } }, "localname": "PerformanceBasedIncentiveFeesWaiver", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_PersonalProductsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Personal products member.", "label": "Personal Products [Member]" } } }, "localname": "PersonalProductsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PeterC.FoyAssociatesInsuranceServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Peter C. Foy Associates Insurance Services LLC.", "label": "Peter C. Foy Associates Insurance Services LLC [Member]", "terseLabel": "Peter C. Foy & Associates Insurance Services, LLC [Member]" } } }, "localname": "PeterC.FoyAssociatesInsuranceServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_PeterCFoyandAssociatesInsuranceServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Peter C Foy\u00a0And Associates Insurance Services LLC Member.", "label": "Peter C FoyAnd Associates Insurance Services LLC [Member]" } } }, "localname": "PeterCFoyandAssociatesInsuranceServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PharmaceuticalsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pharmaceuticals member.", "label": "Pharmaceuticals [Member]" } } }, "localname": "PharmaceuticalsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PhymedManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PhyMed Management LLC.", "label": "PhyMed Management LLC [Member]", "terseLabel": "PhyMed Management LLC [Member]" } } }, "localname": "PhymedManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PhynetDermatologyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Phynet dermatology llc.", "label": "PhyNet Dermatology LLC [Member]", "terseLabel": "PhyNet Dermatology LLC [Member]" } } }, "localname": "PhynetDermatologyLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PinnacleTreatmentCentersInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pinnacle treatment centers, inc.", "label": "Pinnacle Treatment Centers, Inc. [Member]", "terseLabel": "Pinnacle Treatment Centers, Inc. [Member]" } } }, "localname": "PinnacleTreatmentCentersInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PlasticsManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Plastics Management LLC.", "label": "Plastics Management LLC [Member]", "terseLabel": "Plastics Management, LLC [Member]" } } }, "localname": "PlasticsManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PortfolioTurnoverRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portfolio turnover ratio.", "label": "Portfolio Turnover Ratio", "terseLabel": "Portfolio turnover ratio" } } }, "localname": "PortfolioTurnoverRatio", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "slrc_PptManagementHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ppt management holdings, llc.", "label": "PPT Management Holdings, LLC [Member]", "terseLabel": "PPT Management Holdings, LLC [Member]" } } }, "localname": "PptManagementHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PreIncentiveFeeNetInvestmentIncomeAnnualHurdleRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-incentive fee net investment income annual hurdle rate.", "label": "Pre Incentive Fee Net Investment Income Annual Hurdle Rate", "terseLabel": "Pre-incentive fee net investment income Annual hurdle rate" } } }, "localname": "PreIncentiveFeeNetInvestmentIncomeAnnualHurdleRate", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PreIncentiveFeeNetInvestmentIncomeQuarterHurdleRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pre-incentive fee net investment income Quarter hurdle rate.", "label": "Pre Incentive Fee Net Investment Income Quarter Hurdle Rate", "terseLabel": "Pre-incentive fee net investment income Quarter hurdle rate" } } }, "localname": "PreIncentiveFeeNetInvestmentIncomeQuarterHurdleRate", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "slrc_PreferredEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred equity.", "label": "Preferred Equity [Member]", "terseLabel": "Preferred Equity" } } }, "localname": "PreferredEquityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_PreferredEquityZeroPointSevenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred equity zero point seven percent.", "label": "Preferred Equity Zero Point Seven Percent [Member]", "terseLabel": "Preferred Equity \u00a03 0.7% [Member]" } } }, "localname": "PreferredEquityZeroPointSevenPercentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_PreferredEquityzeroPointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred EquityZero Point Four Percent Member.", "label": "Preferred EquityZero Point Four Percent [Member]", "terseLabel": "Preferred Equity \u00a03 0.4% [Member]" } } }, "localname": "PreferredEquityzeroPointFourPercentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ProfessionalServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Professional Services Member.", "label": "Professional Services [Member]" } } }, "localname": "ProfessionalServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RaneLightMetalCastingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rane light metal castings inc.", "label": "Rane Light Metal Castings Inc [Member]", "terseLabel": "Rane Light Metal Castings Inc. [Member]" } } }, "localname": "RaneLightMetalCastingsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RangoIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rango inc.", "label": "Rango Inc [Member]", "terseLabel": "Rango, Inc. [Member]" } } }, "localname": "RangoIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD holdco, Inc.", "label": "RD Holdco, Inc. [Member]" } } }, "localname": "RdHoldcoInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD Holdco Inc Class B.", "label": "RD Holdco Inc Class B [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor, class B) [Member]" } } }, "localname": "RdHoldcoIncClassBMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncCommonEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RD Holdco Inc Common Equity.", "label": "RD Holdco Inc Common Equity [Member]" } } }, "localname": "RdHoldcoIncCommonEquityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Debt [Member]" } } }, "localname": "RdHoldcoIncDebtMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rd holdco inc.", "label": "RD Holdco Inc [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor) [Member]" } } }, "localname": "RdHoldcoIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RdHoldcoIncWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "RD Holdco Inc Warrants [Member]", "terseLabel": "RD Holdco Inc. (Rug Doctor, Warrants) [Member]" } } }, "localname": "RdHoldcoIncWarrantsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_ReceivableForInvestmentsSold": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Receivable for investments sold.", "label": "Receivable for Investments Sold", "terseLabel": "Receivable for investments sold" } } }, "localname": "ReceivableForInvestmentsSold", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "slrc_RecourseDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recourse debt.", "label": "Recourse Debt", "terseLabel": "Recourse debt" } } }, "localname": "RecourseDebt", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "slrc_RestrictedInvestmentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investment term.", "label": "Restricted Investment Term", "terseLabel": "Restricted investment term" } } }, "localname": "RestrictedInvestmentTerm", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "slrc_RezoluteIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rezolute, inc.", "label": "Rezolute, Inc [Member]", "terseLabel": "Rezolute, Inc [Member]" } } }, "localname": "RezoluteIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RoadAndRailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Road and rail member.", "label": "Road and Rail [Member]", "verboseLabel": "Road & Rail [Member]" } } }, "localname": "RoadAndRailMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RosscoCraneRiggingIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rossco crane\u00a0& rigging inc.", "label": "Rossco Crane Rigging Inc [Member]", "terseLabel": "Rossco Crane & Rigging, Inc. [Member]" } } }, "localname": "RosscoCraneRiggingIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RoyalCoachLinesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royal coach lines inc.", "label": "Royal Coach Lines Inc [Member]", "terseLabel": "Royal Coach Lines, Inc.[Member]" } } }, "localname": "RoyalCoachLinesIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RoyalExpressIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Royal express inc.", "label": "Royal Express Inc [Member]", "terseLabel": "Royal Express Inc. [Member]" } } }, "localname": "RoyalExpressIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RqmCorp.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RQM Corp.", "label": "RQM Corp. [Member]", "terseLabel": "RQM+ Corp. [Member]" } } }, "localname": "RqmCorp.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RscAcquisitionIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RSC acquisition Inc.", "label": "RSC Acquisition Inc [Member]", "terseLabel": "RSC Acquisition, Inc [Member]" } } }, "localname": "RscAcquisitionIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RubiusTherapeuticsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rubius therapeutics, inc.", "label": "Rubius Therapeutics, Inc. [Member]", "terseLabel": "Rubius Therapeutics, Inc. [Member]" } } }, "localname": "RubiusTherapeuticsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_RugDoctorLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rug Doctor LLC.", "label": "Rug Doctor LLC [Member]", "terseLabel": "Rug Doctor LLC [Member]" } } }, "localname": "RugDoctorLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_RxsenseHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "RxSense holdings LLC.", "label": "RxSense Holdings LLC [Member]", "terseLabel": "RxSense Holdings LLC [Member]" } } }, "localname": "RxsenseHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ScpharmaceuticalsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "scPharmaceuticals, inc.", "label": "scPharmaceuticals, Inc. [Member]", "terseLabel": "scPharmaceuticals, Inc. [Member]" } } }, "localname": "ScpharmaceuticalsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SecondLienAssetbasedSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second lien asset based senior secured loans.", "label": "Second Lien AssetBased Senior Secured Loans [Member]", "terseLabel": "Second Lien Asset-Based Senior Secured Loans [Member]" } } }, "localname": "SecondLienAssetbasedSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SecondLienBankDebtOrSeniorSecuredLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second lien bank debt or senior secured loans.", "label": "Second Lien Bank Debt or Senior Secured Loans [Member]", "terseLabel": "Second Lien Bank Debt/Senior Secured Loans [Member]" } } }, "localname": "SecondLienBankDebtOrSeniorSecuredLoansMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredCashFlowLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior Secured Cash Flow Loans", "label": "Senior Secured Cash Flow Loans [Member]", "terseLabel": "Senior Secured Cash Flow Loans [Member]" } } }, "localname": "SeniorSecuredCashFlowLoansMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredCommitmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior-secured commitments [Member].", "label": "Senior Secured Commitments [Member]", "terseLabel": "Senior Secured Commitments [Member]" } } }, "localname": "SeniorSecuredCommitmentsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans at one hundred and eleven point five percent.", "label": "Senior Secured Loans At One Hundred And Eleven Point Five Percent [Member]", "terseLabel": "Senior Secured Loans \u00a00 111.5% [Member]" } } }, "localname": "SeniorSecuredLoansAtOneHundredAndElevenPointFivePercentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior secured loans at one hundred and thirty four point four percent.", "label": "Senior Secured Loans at One hundred and Thirty Four Point Four Percent [Member]", "terseLabel": "Senior Secured Loans \u00a00 134.4% [Member]" } } }, "localname": "SeniorSecuredLoansAtOneHundredAndThirtyFourPointFourPercentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SeniorSecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Senior Secured Notes [Member]", "verboseLabel": "Senior Secured Notes" } } }, "localname": "SeniorSecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_SenseonicsHoldingsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senseonics holdings inc.", "label": "Senseonics Holdings Inc [Member]", "terseLabel": "Senseonics Holdings, Inc. [Member]" } } }, "localname": "SenseonicsHoldingsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SharesIssuedInConnectionWithTheMergersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued in connection with the mergers.", "label": "Shares Issued In Connection With The Mergers [Member]", "terseLabel": "Shares issued in connection with the Mergers [Member]" } } }, "localname": "SharesIssuedInConnectionWithTheMergersMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "xbrltype": "domainItemType" }, "slrc_ShoHoldingICorporationShoesForCrewsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SHO Holding I Corporation Shoes for Crews Member.", "label": "SHO Holding I Corporation Shoes for Crews [Member]" } } }, "localname": "ShoHoldingICorporationShoesForCrewsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SidelinesTreeServiceLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sidelines tree service llc.", "label": "Sidelines Tree Service LLC [Member]", "terseLabel": "Sidelines Tree Service LLC [Member]" } } }, "localname": "SidelinesTreeServiceLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Disclosure TextBlock", "label": "SLR Business Credit Disclosure [Text Block]", "terseLabel": "SLR Business Credit" } } }, "localname": "SlrBusinessCreditDisclosureTextBlock", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCredit" ], "xbrltype": "textBlockItemType" }, "slrc_SlrBusinessCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Facility", "label": "SLR Business Credit Facility [Member]", "terseLabel": "SLR Business Credit Facility [Member]" } } }, "localname": "SlrBusinessCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit [Line Item]", "label": "SLR Business Credit [Line Items]" } } }, "localname": "SlrBusinessCreditLineItems", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_SlrBusinessCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit [Member].", "label": "SLR Business Credit [Member]", "terseLabel": "SLR Business Credit [Member]" } } }, "localname": "SlrBusinessCreditMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrBusinessCreditTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Business Credit Table", "label": "SLR Business Credit [Table]" } } }, "localname": "SlrBusinessCreditTable", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_SlrCreditSolutionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Credit Solution Text Block", "label": "SLR Credit Solution [Text Block]", "terseLabel": "SLR Credit Solution" } } }, "localname": "SlrCreditSolutionTextBlock", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutions" ], "xbrltype": "textBlockItemType" }, "slrc_SlrCreditSolutionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Slr credit solutions.", "label": "SLR Credit Solutions [Member]", "terseLabel": "SLR Credit Solutions [Member]" } } }, "localname": "SlrCreditSolutionsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Equipment Finance Debt.", "label": "SLR Equipment Finance Debt [Member]" } } }, "localname": "SlrEquipmentFinanceDebtMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceEquityInterestsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Slr equipment finance equity interests.", "label": "SLR Equipment Finance Equity Interests [Member]", "terseLabel": "SLR Equipment Finance Equity Interests [Member]" } } }, "localname": "SlrEquipmentFinanceEquityInterestsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceEquityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Equipment Finance Equity.", "label": "SLR Equipment Finance Equity [Member]" } } }, "localname": "SlrEquipmentFinanceEquityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SlrEquipmentFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR equipment finance.", "label": "SLR Equipment Finance [Member]", "terseLabel": "SLR Equipment Finance [Member]", "verboseLabel": "SLR Equipment Finance [Member]" } } }, "localname": "SlrEquipmentFinanceMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Healthcare ABL Credit.", "label": "SLR Healthcare ABL Credit [Member]", "terseLabel": "SLR Healthcare ABL Credit [Member]" } } }, "localname": "SlrHealthcareAblCreditMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR healthcare ABL.", "label": "SLR Healthcare ABL [Member]", "terseLabel": "SLR Healthcare ABL [Member]", "verboseLabel": "SLR Healthcare ABL [Member]" } } }, "localname": "SlrHealthcareAblMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SlrHealthcareAblTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR healthcare ABL.", "label": "SLR Healthcare ABL [Text Block]", "verboseLabel": "SLR Healthcare ABL" } } }, "localname": "SlrHealthcareAblTextBlock", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAbl" ], "xbrltype": "textBlockItemType" }, "slrc_SlrSeniorLendingProgramLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SLR Senior Lending Program LLC", "label": "SLR Senior Lending Program LLC [Member]", "terseLabel": "SLR Senior Lending Program LLC [Member]" } } }, "localname": "SlrSeniorLendingProgramLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SmileyLiftingSolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Smiley Lifting Solutions LLC Member.", "label": "Smiley Lifting Solutions LLC [Member]" } } }, "localname": "SmileyLiftingSolutionsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SoaggLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Soagg llc.", "label": "SOAGG LLC [Member]" } } }, "localname": "SoaggLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SocTelemedInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SOC telemed, inc.", "label": "SOC Telemed, Inc. [Member]", "terseLabel": "SOC Telemed, Inc. [Member]" } } }, "localname": "SocTelemedInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software member.", "label": "Software [Member]" } } }, "localname": "SoftwareMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SointLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Soint llc.", "label": "SOINT LLC [Member]", "terseLabel": "SOINT, LLC [Member]" } } }, "localname": "SointLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SouthTexasOilfieldSolutionsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "South texas oilfield solutions llc.", "label": "South Texas Oilfield Solutions LLC [Member]", "terseLabel": "South Texas Oilfield Solutions, LLC [Member]" } } }, "localname": "SouthTexasOilfieldSolutionsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SouthernOrthodonticPartnersManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Southern Orthodontic Partners Management LLC.", "label": "Southern Orthodontic Partners Management LLC [Member]", "terseLabel": "Southern Orthodontic Partners Management, LLC [Member]" } } }, "localname": "SouthernOrthodonticPartnersManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SparMarketingForceInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SPAR marketing force, Inc.", "label": "SPAR Marketing Force, Inc. [Member]" } } }, "localname": "SparMarketingForceInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpecialtyRetailMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty retail member.", "label": "Specialty Retail [Member]" } } }, "localname": "SpecialtyRetailMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpectrumPharmaceuticalsInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spectrum pharmaceuticals, Inc.", "label": "Spectrum Pharmaceuticals, Inc. [Member]" } } }, "localname": "SpectrumPharmaceuticalsInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpectrumPharmaceuticalsInc.WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spectrum Pharmaceuticals, Inc. Warrants", "label": "Spectrum Pharmaceuticals, Inc. Warrants [Member]" } } }, "localname": "SpectrumPharmaceuticalsInc.WarrantsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SpreadAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread [Axis]" } } }, "localname": "SpreadAxis", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "stringItemType" }, "slrc_SpreadDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread [Domain]" } } }, "localname": "SpreadDomain", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SpreadOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread One [Member]" } } }, "localname": "SpreadOneMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SpreadThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread Three [Member]" } } }, "localname": "SpreadThreeMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SpreadTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Spread Two [Member]" } } }, "localname": "SpreadTwoMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "domainItemType" }, "slrc_SslpFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SSLP Facility [Member]", "verboseLabel": "SSLP Facility" } } }, "localname": "SslpFacilityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_StCoachesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "St coaches llc.", "label": "ST Coaches LLC [Member]", "terseLabel": "ST Coaches, LLC [Member]" } } }, "localname": "StCoachesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StaffordLogisticsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stafford logistics inc.", "label": "Stafford Logistics Inc [Member]", "terseLabel": "Stafford Logistics, Inc. [Member]" } } }, "localname": "StaffordLogisticsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StarCoachesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Star coaches inc.", "label": "Star Coaches Inc [Member]", "terseLabel": "Star Coaches Inc. [Member]" } } }, "localname": "StarCoachesIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StrytenEnergyLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stryten energy llc.", "label": "Stryten Energy LLC [Member]", "terseLabel": "Stryten Energy LLC [Member]" } } }, "localname": "StrytenEnergyLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_StrytenResourcesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stryten resources LLC.", "label": "Stryten Resources LLC [Member]" } } }, "localname": "StrytenResourcesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SturgeonServicesInternationalIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sturgeon services international inc.", "label": "Sturgeon Services International Inc [Member]", "terseLabel": "Sturgeon Services International Inc.[Member]" } } }, "localname": "SturgeonServicesInternationalIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SummitFinancialResourcesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summit Financial Resources [Member].", "label": "Summit Financial Resources [Member]", "terseLabel": "Summit Financial Resources [Member]" } } }, "localname": "SummitFinancialResourcesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SunmedGroupHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sunmed group holdings, llc.", "label": "SunMed Group Holdings, LLC [Member]", "terseLabel": "SunMed Group Holdings, LLC [Member]" } } }, "localname": "SunmedGroupHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_SunsCompanyMergerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUNS Company Merger [Member]" } } }, "localname": "SunsCompanyMergerMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail" ], "xbrltype": "domainItemType" }, "slrc_SunsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "SUNS [Member].", "label": "SUNS [Member]", "terseLabel": "SUNS [Member]" } } }, "localname": "SunsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SunsSpvLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Suns SPV LLC.", "label": "SPV LLC [Member]" } } }, "localname": "SunsSpvLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_SuperiorTransportationIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Superior transportation inc.", "label": "Superior Transportation Inc [Member]", "terseLabel": "Superior Transportation, Inc. [Member]" } } }, "localname": "SuperiorTransportationIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TailwindsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tailwinds llc.", "label": "Tailwinds LLC [Member]", "terseLabel": "Tailwinds, LLC [Member]" } } }, "localname": "TailwindsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TaucManagementLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TAUC management, LLC.", "label": "TAUC Management LLC [Member]", "terseLabel": "TAUC Management, LLC [Member]" } } }, "localname": "TaucManagementLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TermLoanAndCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan and credit facility.", "label": "Term Loan And Credit Facility [Member]", "terseLabel": "Credit Facility" } } }, "localname": "TermLoanAndCreditFacilityMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_TermLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term loan.", "label": "Term Loan [Member]" } } }, "localname": "TermLoanMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TermLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Term Loans [Member]", "verboseLabel": "Term Loans" } } }, "localname": "TermLoansMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TheSmedleyCompanySmedleyServicesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The smedley company\u00a0& smedley services inc.", "label": "The Smedley Company Smedley Services Inc [Member]", "terseLabel": "The Smedley Company & Smedley Services, Inc. [Member]" } } }, "localname": "TheSmedleyCompanySmedleyServicesIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ThriftsMortgageFinanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thrifts & mortgage finance.", "label": "Thrifts Mortgage Finance [Member]", "terseLabel": "Thrifts Mortgage Finance [Member]" } } }, "localname": "ThriftsMortgageFinanceMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TilleyDistributionIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tilley Distribution, Inc.", "label": "Tilley Distribution Inc [Member]", "terseLabel": "Tilley Distribution, Inc [Member]" } } }, "localname": "TilleyDistributionIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TotalInvestmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Total Investment [Member]", "terseLabel": "Total Investments [Member]" } } }, "localname": "TotalInvestmentMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TradingCompaniesAndDistributorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading Companies & Distributors member.", "label": "Trading Companies and Distributors [Member]" } } }, "localname": "TradingCompaniesAndDistributorsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TrancheAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche.", "label": "Tranche [Axis]" } } }, "localname": "TrancheAxis", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "slrc_TrancheDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche.", "label": "Tranche [Domain]" } } }, "localname": "TrancheDomain", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche one.", "label": "Tranche One [Member]" } } }, "localname": "TrancheOneMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche two.", "label": "Tranche Two [Member]" } } }, "localname": "TrancheTwoMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "slrc_TransportationInfrastructureMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Transportation infrastructure.", "label": "Transportation Infrastructure [Member]", "terseLabel": "Transportation Infrastructure [Member]" } } }, "localname": "TransportationInfrastructureMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TrinityEquipmentRentalsIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trinity equipment rentals inc.", "label": "Trinity Equipment Rentals Inc [Member]", "terseLabel": "Trinity Equipment Rentals, Inc. [Member]" } } }, "localname": "TrinityEquipmentRentalsIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TrolleysIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trolleys inc.", "label": "Trolleys Inc [Member]", "terseLabel": "Trolleys, Inc. [Member]" } } }, "localname": "TrolleysIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TwentyeightyInvestorsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "TwentyEighty Investors LLC Member.", "label": "TwentyEighty Investors LLC [Member]" } } }, "localname": "TwentyeightyInvestorsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndFortyTwoUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand And Forty Two Unsecured Notes [Member]", "verboseLabel": "2042 Unsecured Notes" } } }, "localname": "TwoThousandAndFortyTwoUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyFiveUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty five unsecured notes.", "label": "Two Thousand And Twenty Five Unsecured Notes [Member]", "terseLabel": "2025 Unsecured Notes", "verboseLabel": "2025 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentyFiveUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyFourUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty four unsecured notes.", "label": "Two Thousand And Twenty Four Unsecured Notes [Member]", "terseLabel": "2024 Unsecured Notes", "verboseLabel": "2024 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentyFourUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty seven series F unsecured notes.", "label": "Two Thousand And Twenty Seven Series F Unsecured Notes [Member]", "terseLabel": "2027 Series F Unsecured Notes", "verboseLabel": "2027 Series F Unsecured Notes" } } }, "localname": "TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySevenUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty seven unsecured notes.", "label": "Two Thousand And Twenty Seven Unsecured Notes [Member]", "terseLabel": "2027 Unsecured Notes", "verboseLabel": "2027 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentySevenUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentySixUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty six unsecured notes.", "label": "Two Thousand And Twenty Six Unsecured Notes [Member]", "terseLabel": "2026 Unsecured Notes", "verboseLabel": "2026 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentySixUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyThreeUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty three unsecured notes.", "label": "Two Thousand And Twenty Three Unsecured Notes [Member]", "terseLabel": "2023 Unsecured Notes", "verboseLabel": "2023 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentyThreeUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyTwoTrancheCNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty two tranche C notes.", "label": "Two Thousand And Twenty Two Tranche C Notes [Member]", "terseLabel": "2022 Tranche C Notes", "verboseLabel": "2022 Tranche C Notes" } } }, "localname": "TwoThousandAndTwentyTwoTrancheCNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_TwoThousandAndTwentyTwoUnsecuredNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand and twenty two unsecured notes.", "label": "Two Thousand and Twenty Two Unsecured Notes [Member]", "terseLabel": "2022 Unsecured Notes", "verboseLabel": "2022 Unsecured Notes" } } }, "localname": "TwoThousandAndTwentyTwoUnsecuredNotesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://xbrl.sec.gov/cef/role/N2" ], "xbrltype": "domainItemType" }, "slrc_U.s.TreasuryBillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "U.S. treasury bill.", "label": "U.S. Treasury Bill [Member]", "terseLabel": "U.S. Treasury Bill [Member]" } } }, "localname": "U.s.TreasuryBillMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UltimateBakedGoodsMidcoLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ultimate baked goods midco llc.", "label": "Ultimate Baked Goods Midco LLC [Member]", "terseLabel": "Ultimate Baked Goods Midco LLC (Rise Baking) [Member]", "verboseLabel": "Ultimate Baked Goods Midco LLC [Member]" } } }, "localname": "UltimateBakedGoodsMidcoLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UnfundedDebtAndEquityCommitmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Unfunded Debt and Equity Commitments [Member]", "label": "Unfunded Debt and Equity Commitments [Member]", "terseLabel": "Unfunded Debt and Equity Commitments [Member]" } } }, "localname": "UnfundedDebtAndEquityCommitmentsMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "domainItemType" }, "slrc_UpTruckingServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Up trucking services llc.", "label": "Up Trucking Services LLC [Member]", "terseLabel": "Up Trucking Services, LLC [Member]" } } }, "localname": "UpTruckingServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_UsrParentInc.StaplesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "USR Parent, Inc. (Staples)", "label": "USR Parent, Inc. (Staples) [Member]" } } }, "localname": "UsrParentInc.StaplesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_ValuationApproachMarketMultipleMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Valuation approach market multiple.", "label": "Valuation Approach Market Multiple [Member]", "terseLabel": "Market Multiple" } } }, "localname": "ValuationApproachMarketMultipleMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "slrc_VapothermInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vapotherm, inc.", "label": "Vapotherm, Inc. [Member]", "terseLabel": "Vapotherm, Inc. [Member]" } } }, "localname": "VapothermInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VapothermIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vapotherm inc.", "label": "Vapotherm Inc [Member]", "terseLabel": "Vapotherm, Inc. Warrants [Member]" } } }, "localname": "VapothermIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VarileaseFinanceInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Varilease Finance, Inc.", "label": "Varilease Finance, Inc. [Member]", "terseLabel": "Varilease Finance, Inc. [Member]" } } }, "localname": "VarileaseFinanceInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VenusConceptLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Venus concept ltd.", "label": "Venus Concept Ltd [Member]", "terseLabel": "Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) [Member]" } } }, "localname": "VenusConceptLtdMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_VesscoMidcoHoldingsLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vessco midco holdings LLC.", "label": "Vessco Midco Holdings LLC [Member]", "terseLabel": "Vessco Midco Holdings, LLC [Member]" } } }, "localname": "VesscoMidcoHoldingsLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WarriorCraneServicesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrior crane services llc.", "label": "Warrior Crane Services LLC [Member]", "terseLabel": "Warrior Crane Services, LLC [Member]" } } }, "localname": "WarriorCraneServicesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WaterUtilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Water Utilities Member.", "label": "Water Utilities [Member]" } } }, "localname": "WaterUtilitiesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WindRiverEnvironmentalLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wind river environmental llc.", "label": "Wind River Environmental LLC [Member]", "terseLabel": "Wind River Environmental, LLC [Member]" } } }, "localname": "WindRiverEnvironmentalLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WirelessTelecommunicationServicesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Wireless telecommunication services member.", "label": "Wireless Telecommunication Services [Member]" } } }, "localname": "WirelessTelecommunicationServicesMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WombleCompanyIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Womble company inc.", "label": "Womble Company Inc [Member]", "terseLabel": "Womble Company, Inc. [Member]" } } }, "localname": "WombleCompanyIncMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WorldInsuranceAssociatesLlcMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "World Insurance associates LLC.", "label": "World Insurance Associates LLC [Member]", "terseLabel": "World Insurance Associates, LLC [Member]" } } }, "localname": "WorldInsuranceAssociatesLlcMember", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "slrc_WorldwideFlightServicesInc.Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Worldwide flight services, Inc.", "label": "Worldwide Flight Services, Inc. [Member]" } } }, "localname": "WorldwideFlightServicesInc.Member", "nsuri": "http://www.slrinvestments.com/20220930", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "srt_EquityMethodInvesteeNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment, Name [Domain]" } } }, "localname": "EquityMethodInvesteeNameDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r122", "r123", "r124", "r125", "r142", "r176", "r206", "r208", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r329", "r330", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r122", "r123", "r124", "r125", "r142", "r176", "r206", "r208", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r329", "r330", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r118", "r122", "r123", "r124", "r125", "r142", "r176", "r195", "r206", "r208", "r209", "r210", "r211", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r329", "r330", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]", "terseLabel": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r118", "r122", "r123", "r124", "r125", "r142", "r176", "r195", "r206", "r208", "r209", "r210", "r211", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r329", "r330", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]", "terseLabel": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "label": "Investment, Name [Axis]" } } }, "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r106", "r276" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r287", "r289", "r292", "r392", "r393" ], "lang": { "en-us": { "role": { "label": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]", "terseLabel": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccruedLiabilitiesAndOtherLiabilities": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 17.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other.", "label": "Accrued Liabilities and Other Liabilities", "terseLabel": "Other liabilities and accrued expenses" } } }, "localname": "AccruedLiabilitiesAndOtherLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r14" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "terseLabel": "Paid-in capital in excess of par" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "verboseLabel": "Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdministrativeFeesExpense": { "auth_ref": [ "r275" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for administrative services provided to the limited liability company (LLC) or limited partnership (LP) by the managing member or general partner, affiliate of managing member or general partner, or affiliate of LLC or LP, for example, but not limited to, salaries, rent, or overhead costs.", "label": "Administrative Fees Expense", "terseLabel": "Administrative services expense (see note 3)", "verboseLabel": "Administrative fees expense" } } }, "localname": "AdministrativeFeesExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r6", "r61", "r97", "r100", "r104", "r112", "r128", "r129", "r130", "r131", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r228", "r230", "r255", "r278", "r280", "r307", "r319" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 1.0, "parentTag": "us-gaap_AssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "Total assets", "verboseLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNet": { "auth_ref": [ "r2", "r343", "r361", "r365", "r366" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net assets (liabilities).", "label": "Net Assets", "periodEndLabel": "Net assets at end of period", "periodStartLabel": "Net assets at beginning of period", "terseLabel": "Net assets", "totalLabel": "Total net assets", "verboseLabel": "Net assets, end of period" } } }, "localname": "AssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Assets [Abstract]", "terseLabel": "Net Assets" } } }, "localname": "AssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r205", "r207", "r222" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r205", "r207", "r218", "r219", "r222" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of voting interests acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks paid or offered to be paid in a business combination.", "label": "Business Acquisition, Share Price", "terseLabel": "Business acquisition, share price" } } }, "localname": "BusinessAcquisitionSharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r223", "r224", "r225" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Business combination, consideration transferred" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r221" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]", "terseLabel": "Assets acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r221" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "terseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r221" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-term Debt", "verboseLabel": "Debt, at fair value" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r221" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities assumed" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]", "terseLabel": "Liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r220", "r221" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 1.0, "parentTag": "slrc_BusinessCombinationPurchaseDiscount", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther": { "auth_ref": [ "r221" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other", "terseLabel": "Other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r221" ], "calculation": { "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_Cash": { "auth_ref": [ "r4", "r280", "r357", "r358" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsAndShortTermInvestments": { "auth_ref": [ "r15" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.", "label": "Cash, Cash Equivalents, and Short-term Investments", "terseLabel": "Total Investments\u00a0& Cash Equivalents" } } }, "localname": "CashCashEquivalentsAndShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r45", "r50", "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "CASH AND CASH EQUIVALENTS AT END OF PERIOD", "periodStartLabel": "CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r45", "r256" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r4" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "verboseLabel": "Cash equivalents (cost: $268,931 and $320,000, respectively)" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r10", "r11", "r12", "r58", "r61", "r79", "r80", "r81", "r83", "r85", "r93", "r94", "r95", "r112", "r128", "r132", "r133", "r134", "r137", "r138", "r174", "r175", "r178", "r182", "r188", "r255", "r475" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/CoverPage", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r24", "r311", "r322" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies", "verboseLabel": "Commitments and contingencies (see note 10)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r119", "r120", "r121", "r126", "r391" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r64", "r65", "r236" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par or stated value per share", "verboseLabel": "Par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common Stock, shares authorized", "verboseLabel": "Shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r188" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares, outstanding", "verboseLabel": "Shares outstanding, end of period" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12", "r280" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "verboseLabel": "Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,772,651 and 42,260,826 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r57", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r156", "r163", "r164", "r166", "r173" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/Debt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument, Basis Spread on Variable Rate", "terseLabel": "Debt instrument variable interest rate spread" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r8", "r167", "r309", "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Long-term Debt, Gross", "terseLabel": "Face Amount" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r139", "r169", "r170", "r265", "r267", "r268" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Debt instrument, face amount", "verboseLabel": "Debt instrument face value" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r20", "r140" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Debt instrument stated interest rate percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r21", "r142", "r246" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "verboseLabel": "Debt instrument maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentPaymentTerms": { "auth_ref": [ "r22", "r315" ], "lang": { "en-us": { "role": { "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.", "label": "Debt Instrument, Payment Terms", "verboseLabel": "Debt instrument payment terms" } } }, "localname": "DebtInstrumentPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r23", "r60", "r62", "r139", "r140", "r141", "r142", "r143", "r144", "r146", "r152", "r153", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r162", "r165", "r169", "r170", "r171", "r172", "r189", "r190", "r191", "r192", "r264", "r265", "r267", "r268", "r316" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument term" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r152", "r264", "r268" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument, Unamortized Discount", "terseLabel": "Debt Instrument, Unamortized Discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Instruments [Abstract]" } } }, "localname": "DebtInstrumentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.", "label": "Debt, Long-term and Short-term, Combined Amount", "verboseLabel": "Debt ($1,156,200 and $818,500 face amounts, respectively, reported net of unamortized debt issuance costs/market discount of $7,909 and $6,462, respectively. See notes 6 and 7)" } } }, "localname": "DebtLongtermAndShorttermCombinedAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsGross": { "auth_ref": [ "r266" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Gross", "terseLabel": "Debt issuance costs" } } }, "localname": "DeferredFinanceCostsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r152", "r266" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt Issuance Costs, Net", "terseLabel": "Long term debt unamortized debt issuance costs" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeMaturityDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the derivative contract matures, in YYYY-MM-DD format.", "label": "Derivative, Maturity Date", "terseLabel": "Maturity Date" } } }, "localname": "DerivativeMaturityDates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "dateItemType" }, "us-gaap_DividendsPayableAmountPerShare": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date.", "label": "Dividends Payable, Amount Per Share", "terseLabel": "Dividends payable, amount per share" } } }, "localname": "DividendsPayableAmountPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r7", "r9", "r308", "r320" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 12.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends Payable", "terseLabel": "Distributions payable" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsReceivable": { "auth_ref": [ "r13" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of dividends declared but not received.", "label": "Dividends Receivable", "terseLabel": "Dividends receivable" } } }, "localname": "DividendsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r32", "r69", "r70", "r71", "r72", "r73", "r77", "r79", "r83", "r84", "r85", "r89", "r90", "r237", "r238", "r313", "r326" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Earnings (loss) per share, Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r32", "r69", "r70", "r71", "r72", "r73", "r79", "r83", "r84", "r85", "r89", "r90", "r237", "r238", "r313", "r326" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Earnings (loss) per share, Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r86", "r87", "r88", "r91" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": { "auth_ref": [ "r310", "r323" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 14.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Employee-related Liabilities", "terseLabel": "Performance-based incentive fee payable (see note 3)" } } }, "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r28", "r29", "r30", "r64", "r65", "r66", "r68", "r74", "r76", "r92", "r114", "r188", "r193", "r212", "r213", "r214", "r215", "r216", "r236", "r257", "r258", "r259", "r260", "r261", "r262", "r272", "r331", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentAggregateCost": { "auth_ref": [ "r16" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents the aggregate cost of investments accounted for under the equity method of accounting.", "label": "Equity Method Investment, Aggregate Cost", "terseLabel": "Equity method investment, aggregate cost" } } }, "localname": "EquityMethodInvestmentAggregateCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeAxis": { "auth_ref": [ "r1", "r61", "r112", "r255" ], "lang": { "en-us": { "role": { "documentation": "Information by nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Axis]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentNonconsolidatedInvesteeDomain": { "auth_ref": [ "r1", "r61", "r112", "r255" ], "lang": { "en-us": { "role": { "documentation": "Nonconsolidated equity method investee. Excludes information consolidated by reporting entity.", "label": "Equity Method Investment, Nonconsolidated Investee [Domain]" } } }, "localname": "EquityMethodInvestmentNonconsolidatedInvesteeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r110" ], "lang": { "en-us": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Equity Method Investment, Ownership Percentage", "terseLabel": "Equity method investment, ownership percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityMethodInvestments": { "auth_ref": [ "r5", "r98", "r109" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.", "label": "Equity Method Investments", "terseLabel": "Equity method investments" } } }, "localname": "EquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity Method Investments and Joint Ventures [Abstract]" } } }, "localname": "EquityMethodInvestmentsAndJointVenturesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": { "auth_ref": [ "r113" ], "lang": { "en-us": { "role": { "definitionGuidance": "Kingsbridge Holdings, LLC", "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.", "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]", "terseLabel": "SLR Equipment Finance" } } }, "localname": "EquityMethodInvestmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlc", "http://www.slrinvestments.com/role/SlrEquipmentFinance" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquitySecuritiesMember": { "auth_ref": [ "r108", "r318", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Ownership interest or right to acquire or dispose of ownership interest in corporations and other legal entities for which ownership interest is represented by shares of common or preferred stock, convertible securities, stock rights, or stock warrants.", "label": "Equity Securities [Member]", "terseLabel": "Common Equity/Equity Interests/Warrants" } } }, "localname": "EquitySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r241", "r242", "r253" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r241", "r242", "r243", "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of Quantitative Information about the Company's Level 3 Asset and Liability" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r250" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3) and still held.", "label": "Fair Value, Asset, Recurring Basis, Still Held, Unrealized Gain (Loss)", "terseLabel": "Net change in unrealized gain (loss)" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r247", "r253" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r247", "r253" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Changes in Fair Value of Level 3 Assets and Liabilities" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r241", "r253" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r154", "r169", "r170", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r204", "r242", "r284", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r251", "r253" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Liability Class [Axis]" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r241", "r242", "r245", "r246", "r254" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValue" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r154", "r196", "r197", "r202", "r204", "r242", "r284" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r154", "r169", "r170", "r196", "r197", "r202", "r204", "r242", "r285" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r154", "r169", "r170", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r204", "r242", "r286" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value by Liability Class [Domain]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r247", "r253" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of liabilities using significant unobservable inputs (level 3). Separately presenting changes during the period, attributable to: (1) total gains or losses for the period (realized and unrealized) and location reported in the statement of income (or activities); (2) purchases, sales, issuances, and settlements (net); (3) transfers in and/or out of Level 3.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r247", "r253" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of Fair Valued Liabilities measured using Significant Unobservable Inputs (Level 3)" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "auth_ref": [ "r248" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized gain (loss)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "auth_ref": [ "r249" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Purchases", "terseLabel": "Purchase of investment securities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "auth_ref": [ "r249" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Sales", "terseLabel": "Proceeds from dispositions of investment securities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net", "terseLabel": "Transfers in/out of Level\u00a03" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r247" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodEndLabel": "Closing balance", "periodStartLabel": "Opening balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfChangesInFairValueOfLevel3AssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r248" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings", "terseLabel": "Net change in unrealized (gain) loss" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r249" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Borrowings" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r249" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "terseLabel": "Repayments" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net", "terseLabel": "Transfers in/out of Level\u00a03" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r247" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending fair value", "periodStartLabel": "Beginning fair value" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r154", "r169", "r170", "r196", "r197", "r198", "r199", "r200", "r201", "r202", "r204", "r284", "r285", "r286" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r251", "r254" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Recurring Fair Value" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GrossInvestmentIncomeOperating": { "auth_ref": [ "r327" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_NetInvestmentIncome", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Gross Investment Income, Operating", "totalLabel": "Total investment income" } } }, "localname": "GrossInvestmentIncomeOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeApproachValuationTechniqueMember": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach converting future amounts to single current discounted amount.", "label": "Valuation, Income Approach [Member]", "terseLabel": "Income Approach" } } }, "localname": "IncomeApproachValuationTechniqueMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for interest" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedInterestReceivableNet": { "auth_ref": [ "r47" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due from borrowers for interest payments.", "label": "Increase (Decrease) in Accrued Interest Receivable, Net", "negatedLabel": "Interest receivable" } } }, "localname": "IncreaseDecreaseInAccruedInterestReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": { "auth_ref": [ "r47" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.", "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities", "terseLabel": "Other liabilities and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDividendsReceivable": { "auth_ref": [ "r47" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in cash disbursements due from investments, representing the shareholders' portion of profits.", "label": "Increase (Decrease) in Dividends Receivable", "negatedLabel": "Dividends receivable" } } }, "localname": "IncreaseDecreaseInDividendsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r47" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Interest payable" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Assets [Abstract]", "terseLabel": "(Increase) decrease in operating assets:" } } }, "localname": "IncreaseDecreaseInOperatingAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Liabilities [Abstract]", "terseLabel": "Increase (decrease) in operating liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r47" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrentAndNoncurrent": { "auth_ref": [ "r310", "r323" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 15.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest payable on debt, including, but not limited to, trade payables.", "label": "Interest Payable", "terseLabel": "Interest payable (see note 7)" } } }, "localname": "InterestPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivable": { "auth_ref": [ "r13" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.", "label": "Interest Receivable", "terseLabel": "Interest receivable" } } }, "localname": "InterestReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyCapitalShareTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions [Abstract]", "terseLabel": "Capital transactions (see note 12):" } } }, "localname": "InvestmentCompanyCapitalShareTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyCapitalShareTransactionsStockIssuedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Capital Share Transactions, Stock Issued [Abstract]", "terseLabel": "Capital stock activity (see note 12):" } } }, "localname": "InvestmentCompanyCapitalShareTransactionsStockIssuedAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyDistributableEarnings": { "auth_ref": [ "r338", "r339" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated undistributed tax basis earnings (deficit).", "label": "Investment Company, Distributable Earnings", "terseLabel": "Accumulated distributable net loss" } } }, "localname": "InvestmentCompanyDistributableEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyDistributionToShareholdersAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Distribution to Shareholders [Abstract]", "terseLabel": "Distributions to stockholders:" } } }, "localname": "InvestmentCompanyDistributionToShareholdersAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyDistributionToShareholdersPerShare": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of distribution to shareholders. Includes, but is not limited to, dividend and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Distribution to Shareholders, Per Share", "negatedLabel": "From net investment income" } } }, "localname": "InvestmentCompanyDistributionToShareholdersPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyDividendDistribution": { "auth_ref": [ "r340", "r342" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 6.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend distribution from ordinary income and capital gain. Excludes distribution for tax return of capital.", "label": "Investment Company, Dividend Distribution", "negatedTotalLabel": "Net distributions to stockholders" } } }, "localname": "InvestmentCompanyDividendDistribution", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyExpenseRatioAfterIncentiveAllocation": { "auth_ref": [ "r346" ], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Percentage of expense, after incentive allocation, to average net assets.", "label": "Investment Company, Expense Ratio after Incentive Allocation", "totalLabel": "Total expenses" } } }, "localname": "InvestmentCompanyExpenseRatioAfterIncentiveAllocation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyExpenseRatioExcludingIncentiveFee": { "auth_ref": [ "r346" ], "lang": { "en-us": { "role": { "documentation": "Percentage, after deduction of fee waiver and before deduction of incentive fee, of expense to average net assets.", "label": "Investment Company, Expense Ratio Excluding Incentive Fee", "terseLabel": "Investment company, expense ratio excluding incentive fee" } } }, "localname": "InvestmentCompanyExpenseRatioExcludingIncentiveFee", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsParentheticalsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Highlights [Abstract]" } } }, "localname": "InvestmentCompanyFinancialHighlightsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTableTextBlock": { "auth_ref": [ "r344" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial highlights. Includes, but is not limited to, per share information, income and expense ratios, total return, capital commitment and fee waiver.", "label": "Investment Company, Financial Highlights [Table Text Block]", "terseLabel": "Schedule of financial highlights" } } }, "localname": "InvestmentCompanyFinancialHighlightsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialHighlightsTextBlock": { "auth_ref": [ "r356", "r364" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of financial highlights reported by investment company.", "label": "Investment Company, Financial Highlights [Text Block]", "terseLabel": "Financial Highlights" } } }, "localname": "InvestmentCompanyFinancialHighlightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlights" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentCompanyFinancialRatiosAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Financial Ratios [Abstract]", "verboseLabel": "Ratios to average net assets:" } } }, "localname": "InvestmentCompanyFinancialRatiosAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyGainLossOnInvestmentPerShare": { "auth_ref": [ "r352" ], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": 4.0, "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of realized and unrealized gain (loss) on investment.", "label": "Investment Company, Gain (Loss) on Investment, Per Share", "terseLabel": "Net realized and unrealized gain (loss)" } } }, "localname": "InvestmentCompanyGainLossOnInvestmentPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare": { "auth_ref": [ "r353" ], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of investment income (loss) and realized and unrealized gain (loss) on investment.", "label": "Investment Company, Investment Income (Loss) from Operations, Per Share", "totalLabel": "Net increase (decrease) in net assets resulting from operations" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossPerShare": { "auth_ref": [ "r351" ], "calculation": { "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails": { "order": 3.0, "parentTag": "us-gaap_InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per share or unit amount, after investment expense, of dividend and interest investment income (loss).", "label": "Investment Company, Investment Income (Loss), Per Share", "terseLabel": "Net investment income" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyInvestmentIncomeLossRatio": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "Percentage of investment income (loss) to average net assets.", "label": "Investment Company, Investment Income (Loss) Ratio", "terseLabel": "Net investment income" } } }, "localname": "InvestmentCompanyInvestmentIncomeLossRatio", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease": { "auth_ref": [ "r341", "r363" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 1.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in net assets from operations of investment company.", "label": "Investment Company, Net Assets from Operations, Increase (Decrease)", "totalLabel": "NET INCREASE (DECREASE) IN NET ASSETS RESULTING FROM OPERATIONS" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Net Assets from Operations, Increase (Decrease) [Abstract]", "terseLabel": "Increase (decrease) in net assets resulting from operations:" } } }, "localname": "InvestmentCompanyNetAssetsFromOperationsIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency": { "auth_ref": [ "r362" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment, foreign currency translation and foreign currency denominated asset and liability.", "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency", "totalLabel": "Net realized and unrealized gain (loss) on investments and cash equivalents" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investment Company, Realized and Unrealized Gain (Loss) on Investment and Foreign Currency [Abstract]", "terseLabel": "REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:" } } }, "localname": "InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrencyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentCompanyTaxReturnOfCapitalDistributionPerShare": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit amount of capital distribution in excess of tax basis earnings.", "label": "Investment Company, Tax Return of Capital Distribution, Per Share", "terseLabel": "From return of capital" } } }, "localname": "InvestmentCompanyTaxReturnOfCapitalDistributionPerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_InvestmentCompanyTotalReturn": { "auth_ref": [ "r347", "r348", "r349" ], "lang": { "en-us": { "role": { "documentation": "Percentage increase (decrease) in fund net asset value, assuming reinvestment of dividends and capital gain distributions.", "label": "Investment Company, Total Return", "terseLabel": "Total Return (b)(c)" } } }, "localname": "InvestmentCompanyTotalReturn", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentIncomeDividend": { "auth_ref": [ "r35" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 12.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of dividend income on nonoperating securities.", "label": "Investment Income, Dividend", "terseLabel": "Dividends" } } }, "localname": "InvestmentIncomeDividend", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r37", "r96" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 11.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "verboseLabel": "Interest" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInvestmentExpense": { "auth_ref": [ "r39", "r327" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the generation of investment income.", "label": "Investment Income, Investment Expense", "totalLabel": "Total expenses" } } }, "localname": "InvestmentIncomeInvestmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNet": { "auth_ref": [ "r36", "r38" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 2.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after accretion (amortization) of discount (premium), and investment expense, of interest income and dividend income on nonoperating securities.", "label": "Investment Income, Net", "terseLabel": "Net investment income" } } }, "localname": "InvestmentIncomeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r359" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost of the investment.", "label": "Investment Owned, at Cost", "terseLabel": "Cost", "verboseLabel": "Investment owned, at cost" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedAtFairValue": { "auth_ref": [ "r359", "r378", "r386" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of the investment at close of period. For schedules of investments that are categorized, the value would be aggregated by category. For investment in and advances to affiliates, if operations of any controlled companies are different in character from those of the company, group such affiliates within divisions and by type of activities.", "label": "Investment Owned, at Fair Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Fair Value" } } }, "localname": "InvestmentOwnedAtFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r360", "r373" ], "lang": { "en-us": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment Owned, Balance, Shares", "terseLabel": "Shares/Units" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "sharesItemType" }, "us-gaap_InvestmentOwnedPercentOfNetAssets": { "auth_ref": [ "r359", "r383" ], "lang": { "en-us": { "role": { "documentation": "Percent of net assets at close of period. For schedules of investments that are categorized, each category has a percent of net assets for the aggregated value of the Investments in the category.", "label": "Investment Owned, Percent of Net Assets", "terseLabel": "Percentage of Total Investments (at fair value)" } } }, "localname": "InvestmentOwnedPercentOfNetAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "percentItemType" }, "us-gaap_InvestmentOwnedUnderlyingFaceAmountAtMarketValue": { "auth_ref": [ "r233", "r234" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Nominal or face amount on the investment owned.", "label": "Investment Owned, Face Amount", "terseLabel": "Par Amount" } } }, "localname": "InvestmentOwnedUnderlyingFaceAmountAtMarketValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentSecondaryCategorizationAxis": { "auth_ref": [ "r370", "r375", "r380" ], "lang": { "en-us": { "role": { "documentation": "Information by second categorization of investments, which may include, but is not limited to industry.", "label": "Investment Secondary Categorization [Axis]", "terseLabel": "Investment Secondary Categorization [Axis]" } } }, "localname": "InvestmentSecondaryCategorizationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r369", "r371", "r372", "r374", "r376", "r377", "r379", "r381", "r382", "r384", "r385", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r369", "r371", "r372", "r374", "r376", "r377", "r379", "r381", "r382", "r384", "r385", "r387", "r388", "r389", "r390" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments", "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsBySecondaryCategorizationDomain": { "auth_ref": [ "r368", "r370", "r375", "r380" ], "lang": { "en-us": { "role": { "documentation": "Investments in the \"Investment Holdings [Table]\" and the \"Summary of Investment Holdings [Table]\" are often categorized at two levels. The first categorization is the investment type. The second categorization can vary. The usual secondary categorizations are industry, country or geography.", "label": "Investments by Secondary Categorization [Domain]", "terseLabel": "Investments by Secondary Categorization [Domain]" } } }, "localname": "InvestmentsBySecondaryCategorizationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r241" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Assets", "verboseLabel": "Investments at fair value" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r33" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Labor and Related Expense", "terseLabel": "Performance-based incentive fees (see note 3)" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r19", "r61", "r101", "r112", "r128", "r129", "r130", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r229", "r230", "r231", "r255", "r278", "r279" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 9.0, "parentTag": "us-gaap_AssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r8", "r309", "r317" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Long-term Line of Credit", "presentationGuidance": "Line of credit", "terseLabel": "SPV Credit Facility, Carrying Value", "verboseLabel": "Long-term line of credit" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Line of Credit Facility [Abstract]" } } }, "localname": "LineOfCreditFacilityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityAverageOutstandingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount borrowed under the credit facility during the period.", "label": "Line of Credit Facility, Average Outstanding Amount", "terseLabel": "Line of credit facility average outstanding amount" } } }, "localname": "LineOfCreditFacilityAverageOutstandingAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityAxis": { "auth_ref": [ "r17", "r60" ], "lang": { "en-us": { "role": { "documentation": "Information by name of lender, which may be a single entity (for example, but not limited to, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit.", "label": "Lender Name [Axis]" } } }, "localname": "LineOfCreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Line of Credit Facility, Expiration Date", "terseLabel": "Line of credit facility, expiration date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityLenderDomain": { "auth_ref": [ "r17", "r60" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender, which may be a single entity (for example, a bank, pension fund, venture capital firm) or a group of entities that participate in the line of credit, including a letter of credit facility.", "label": "Line of Credit Facility, Lender [Domain]" } } }, "localname": "LineOfCreditFacilityLenderDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r17" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.", "label": "Line of Credit [Member]" } } }, "localname": "LineOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LondonInterbankOfferedRateLIBORMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.", "label": "London Interbank Offered Rate (LIBOR) [Member]" } } }, "localname": "LondonInterbankOfferedRateLIBORMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r8", "r153", "r168", "r169", "r170", "r309", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.", "label": "Long-Term Debt", "presentationGuidance": "Non-recourse debt", "terseLabel": "Total" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAverageAmountOutstanding": { "auth_ref": [ "r475", "r476" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Average amount outstanding of long-term debt.", "label": "Long-Term Debt, Average Amount Outstanding", "terseLabel": "Average debt outstanding" } } }, "localname": "LongTermDebtAverageAmountOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMeasurementInput": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure long-term debt.", "label": "Long-term Debt, Measurement Input" } } }, "localname": "LongTermDebtMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_LongTermDebtTerm": { "auth_ref": [ "r246" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of long-term debt, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Long-term Debt, Term", "verboseLabel": "Long term debt term" } } }, "localname": "LongTermDebtTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_LongTermDebtWeightedAverageInterestRateOverTime": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average interest rate of long-term debt outstanding calculated over time.", "label": "Long-term Debt, Weighted Average Interest Rate, over Time", "terseLabel": "Long term debt weighted average interest over a period of time" } } }, "localname": "LongTermDebtWeightedAverageInterestRateOverTime", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r23", "r127" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails", "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ManagementFeeExpense": { "auth_ref": [ "r275" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses related to the managing member or general partner for management of the day-to-day business functions of the limited liability company (LLC) or limited partnership (LP).", "label": "Management Fee Expense", "terseLabel": "Management fees (see note 3)", "verboseLabel": "Management fees" } } }, "localname": "ManagementFeeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/AgreementsAdditionalInformationDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ManagementFeePayable": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 13.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of the unpaid portion of the fee payable to the managing member or general partner for management of the fund or trust.", "label": "Management Fee Payable", "terseLabel": "Management fee payable (see note 3)" } } }, "localname": "ManagementFeePayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketApproachValuationTechniqueMember": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach using price and other relevant information generated by market transaction involving identical or comparable asset, liability, or group of assets and liabilities.", "label": "Valuation, Market Approach [Member]", "terseLabel": "Market Approach" } } }, "localname": "MarketApproachValuationTechniqueMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputEbitdaMultipleMember": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using earnings before interest, tax, depreciation and amortization (EBITDA) multiple.", "label": "Measurement Input, EBITDA Multiple [Member]" } } }, "localname": "MeasurementInputEbitdaMultipleMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetAssetValuePerShare": { "auth_ref": [ "r239", "r240", "r254", "r350", "r355" ], "lang": { "en-us": { "role": { "documentation": "Net asset value per share or per unit of investments in certain entities that calculate net asset value per share. Includes, but is not limited to, by unit, membership interest, or other ownership interest. Investment includes, but is not limited to, investment in certain hedge funds, venture capital funds, private equity funds, real estate partnerships or funds. Excludes fair value disclosure.", "label": "Net Asset Value Per Share", "periodEndLabel": "Net asset value, end of period", "periodStartLabel": "Net asset value, beginning of year", "terseLabel": "Net asset value per share", "verboseLabel": "Net Asset Value Per Share" } } }, "localname": "NetAssetValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/FinancialHighlightsScheduleOfFinancialHighlightsDetails", "http://www.slrinvestments.com/role/NetAssetValuePerShareAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r45" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by (Used in) Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r45", "r46", "r49" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash Provided by (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r26", "r27", "r30", "r31", "r49", "r61", "r67", "r69", "r70", "r71", "r72", "r75", "r76", "r82", "r97", "r99", "r102", "r103", "r105", "r112", "r128", "r129", "r130", "r132", "r133", "r134", "r135", "r136", "r137", "r138", "r238", "r255", "r312", "r324" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "verboseLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentInLease": { "auth_ref": [ "r107", "r115", "r116", "r270" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of net investment in sales-type and direct financing leases.", "label": "Net Investment in Lease, before Allowance for Credit Loss", "terseLabel": "Net investment in lease" } } }, "localname": "NetInvestmentInLease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentIncome": { "auth_ref": [ "r325" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments.", "label": "Net Investment Income", "totalLabel": "Net investment income" } } }, "localname": "NetInvestmentIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1": { "auth_ref": [ "r52", "r53", "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of an asset or business acquired in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Noncash or Part Noncash Acquisition, Value of Assets Acquired", "terseLabel": "Noncash or part noncash acquisition, value of assets acquired" } } }, "localname": "NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoninterestIncome": { "auth_ref": [ "r314" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 13.0, "parentTag": "us-gaap_GrossInvestmentIncomeOperating", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of noninterest income which may be derived from: (1) fees and commissions; (2) premiums earned; (3) insurance policy charges; (4) the sale or disposal of assets; and (5) other sources not otherwise specified.", "label": "Noninterest Income", "terseLabel": "Other income" } } }, "localname": "NoninterestIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableFairValueDisclosure": { "auth_ref": [ "r18" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of notes payable.", "label": "Notes Payable, Fair Value Disclosure", "terseLabel": "Liabilities", "verboseLabel": "Notes payable fair value disclosure" } } }, "localname": "NotesPayableFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasisDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfFairValuedLiabilitiesMeasuredUsingSignificantUnobservableInputsLevel3ParentheticalDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r3", "r232" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/Organization" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Other Commitment" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails", "http://www.slrinvestments.com/role/SlrBusinessCreditAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.slrinvestments.com/role/CommitmentsAndContingenciesSummaryOfUnfundedDebtAndEquityCommitmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table Text Block]", "terseLabel": "Summary of unfunded debt and equity commitments" } } }, "localname": "OtherCommitmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherGeneralAndAdministrativeExpense": { "auth_ref": [ "r34" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_InvestmentIncomeInvestmentExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense classified as other.", "label": "Other General and Administrative Expense", "terseLabel": "Other general and administrative expenses" } } }, "localname": "OtherGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r8", "r309", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-term Debt", "terseLabel": "Other long term debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]", "terseLabel": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsOfDistributionsToAffiliates": { "auth_ref": [ "r43" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The distributions of earnings to an entity that is affiliated with the reporting entity by means of direct or indirect ownership.", "label": "Payments of Distributions to Affiliates", "negatedLabel": "Cash distributions paid" } } }, "localname": "PaymentsOfDistributionsToAffiliates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r40", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payment to acquire business" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "terseLabel": "Payments to acquire investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssets": { "auth_ref": [], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets.", "label": "Prepaid Expense and Other Assets", "terseLabel": "Prepaid expenses and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrivatePlacementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A private placement is a direct offering of securities to a limited number of sophisticated investors such as insurance companies, pension funds, mezzanine funds, stock funds and trusts.", "label": "Private Placement [Member]", "terseLabel": "Private Placement [Member]" } } }, "localname": "PrivatePlacementMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r42" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds from Debt, Net of Issuance Costs", "verboseLabel": "Proceeds from net debt" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSecuredDebt": { "auth_ref": [ "r42" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from amounts received from issuance of long-term debt that is wholly or partially secured by collateral. Excludes proceeds from tax exempt secured debt.", "label": "Proceeds from Issuance of Secured Debt", "terseLabel": "Proceeds from secured borrowings" } } }, "localname": "ProceedsFromIssuanceOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfUnsecuredDebt": { "auth_ref": [ "r42" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of long-term debt that is not secured by collateral. Excludes proceeds from tax exempt unsecured debt.", "label": "Proceeds from Issuance of Unsecured Debt", "terseLabel": "Proceeds from unsecured borrowings" } } }, "localname": "ProceedsFromIssuanceOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNet": { "auth_ref": [ "r117", "r269", "r271" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated depreciation, of lessor's underlying asset for which right to use has been conveyed to lessee under operating lease.", "label": "Property, Plant, and Equipment, Lessor Asset under Operating Lease, after Accumulated Depreciation", "terseLabel": "Assets under lease" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits": { "auth_ref": [ "r117", "r271" ], "lang": { "en-us": { "role": { "documentation": "The number of units (items of property) under operating lease arrangements.", "label": "Property Subject to or Available for Operating Lease, Number of Units", "terseLabel": "Number of funded equipment-backed leases and loans" } } }, "localname": "PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r328" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 3.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains (Losses)", "terseLabel": "Net realized gain (loss)", "verboseLabel": "Net realized gain (loss) on investments and cash equivalents (companies less than 5% owned)" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r203", "r273", "r274" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r203", "r273", "r277", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfSecuredDebt": { "auth_ref": [ "r44" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is wholly or partially secured by collateral. Excludes repayments of tax exempt secured debt.", "label": "Repayments of Secured Debt", "negatedLabel": "Repayment of secured borrowings" } } }, "localname": "RepaymentsOfSecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfUnsecuredDebt": { "auth_ref": [ "r44" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to repay long-term debt that is not secured by collateral. Excludes repayments of tax exempt unsecured debt.", "label": "Repayments of Unsecured Debt", "negatedLabel": "Repayment of unsecured borrowings" } } }, "localname": "RepaymentsOfUnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r218", "r219", "r222" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerDetail", "http://www.slrinvestments.com/role/MergerWithSunsSummaryTheAllocationOfThePurchasePriceToTheAssetsAcquiredAndLiabilitiesAssumedAsAResultOfTheMergerParentheticalDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r218", "r219" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Summary the allocation of the purchase price to the assets acquired and liabilities assumed as a result of the Merger" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r23", "r62", "r169", "r171", "r189", "r190", "r191", "r192", "r264", "r265", "r268", "r316" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule of Long-term Debt Instruments [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of Computation of Basic And Diluted Net" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Equity Method Investments [Line Items]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEquityMethodInvestmentsTable": { "auth_ref": [ "r1", "r61", "r111", "r112", "r255" ], "lang": { "en-us": { "role": { "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.", "label": "Schedule of Equity Method Investments [Table]" } } }, "localname": "ScheduleOfEquityMethodInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SlrEquipmentFinance", "http://www.slrinvestments.com/role/SlrEquipmentFinanceAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule of Investments [Abstract]", "terseLabel": "Schedule of Investments [Abstract]" } } }, "localname": "ScheduleOfInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule of Investments [Line Items]", "terseLabel": "Schedule of Investments [Line Items]" } } }, "localname": "ScheduleOfInvestmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfInvestmentsTable": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "A container table for all schedule of investment items. It ties in the \"Legal Entity [Axis]\" to all of its contained line items.", "label": "Schedule of Investments [Table]", "terseLabel": "Schedule of Investments [Table]" } } }, "localname": "ScheduleOfInvestmentsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestments" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]", "terseLabel": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityTableTextBlock": { "auth_ref": [ "r188" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of changes in the separate accounts comprising stockholders' equity (in addition to retained earnings) and of the changes in the number of shares of equity securities during at least the most recent annual fiscal period and any subsequent interim period presented is required to make the financial statements sufficiently informative if both financial position and results of operations are presented.", "label": "Schedule of Stockholders Equity [Table Text Block]", "terseLabel": "Schedule of Stockholders Equity" } } }, "localname": "ScheduleOfStockholdersEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Shares issued, price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r56", "r63" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r10", "r11", "r12", "r58", "r61", "r79", "r80", "r81", "r83", "r85", "r93", "r94", "r95", "r112", "r128", "r132", "r133", "r134", "r137", "r138", "r174", "r175", "r178", "r182", "r188", "r255", "r475" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/CoverPage", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r25", "r28", "r29", "r30", "r64", "r65", "r66", "r68", "r74", "r76", "r92", "r114", "r188", "r193", "r212", "r213", "r214", "r215", "r216", "r236", "r257", "r258", "r259", "r260", "r261", "r262", "r272", "r331", "r332", "r333" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r64", "r65", "r66", "r92", "r294" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilities", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfAssetsAndLiabilitiesParenthetical", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations", "http://www.slrinvestments.com/role/KingsbridgeHoldingsLlcAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrCreditSolutionsAdditionalInformationDetails", "http://www.slrinvestments.com/role/SlrHealthcareAblAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r52", "r53", "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Stock issued", "verboseLabel": "Issuance of shares in connection with the Merger" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r11", "r12", "r193" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Stock issued during period, shares, acquisitions", "verboseLabel": "Shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails", "http://www.slrinvestments.com/role/MergerWithSunsAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r188", "r193" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of common stock", "verboseLabel": "Stock issued during period, shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r25", "r188", "r193" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "verboseLabel": "Amount" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/CapitalShareTransactionsSummaryOfTransactionsInCapitalStockDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r188", "r193" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 5.0, "parentTag": "slrc_InvestmentCompanyIncreaseDecreaseInNetAssets", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of common stock", "verboseLabel": "Stock issued during period, values" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program, Authorized Amount", "terseLabel": "Stock repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the YYYY-MM-DD format.", "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Stock repurchase program expiration date" } } }, "localname": "StockRepurchaseProgramExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgramAdditionalInformationDetails" ], "xbrltype": "dateItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r59", "r175", "r177", "r178", "r179", "r180", "r181", "r182", "r183", "r184", "r185", "r186", "r187", "r193", "r194", "r235" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stock Repurchase Program" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/StockRepurchaseProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r263", "r282" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r263", "r282" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r263", "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r263", "r282" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEventsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r281", "r283" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/OrganizationAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosure of cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxBasisOfInvestmentsCostForIncomeTaxPurposes": { "auth_ref": [ "r337" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of investments for Federal income tax purposes.", "label": "Tax Basis of Investments, Cost for Income Tax Purposes", "terseLabel": "Investment Owned tax costs" } } }, "localname": "TaxBasisOfInvestmentsCostForIncomeTaxPurposes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedAppreciation": { "auth_ref": [ "r334" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate gross unrealized appreciation for all Investments in which there is an excess of value over tax cost.", "label": "Tax Basis of Investments, Gross, Unrealized Appreciation", "terseLabel": "Tax Basis of Investments, Gross, Unrealized Appreciation" } } }, "localname": "TaxBasisOfInvestmentsGrossUnrealizedAppreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsGrossUnrealizedDepreciation": { "auth_ref": [ "r335" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate gross unrealized depreciation for all Investments in which there is an excess of tax cost over value.", "label": "Tax Basis of Investments, Gross, Unrealized Depreciation", "terseLabel": "Tax Basis of Investments, Gross, Unrealized Depreciation" } } }, "localname": "TaxBasisOfInvestmentsGrossUnrealizedDepreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet": { "auth_ref": [ "r336" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The net unrealized appreciation or depreciation.", "label": "Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net", "terseLabel": "Tax Basis of Investments, Unrealized Appreciation (Depreciation), Net" } } }, "localname": "TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedScheduleOfInvestmentsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r48" ], "calculation": { "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets": { "order": 4.0, "parentTag": "us-gaap_InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease", "weight": 1.0 }, "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Unrealized Gain (Loss) on Investments", "presentationGuidance": "Net change in unrealized gain (loss) on investments and cash equivalents", "terseLabel": "Net change in unrealized gain (loss)" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/ConsolidatedStatementsOfChangesInNetAssets", "http://www.slrinvestments.com/role/ConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r8", "r309", "r321" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Unsecured Debt" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtScheduleOfLongTermDebtInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Approach and Technique [Axis]" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique.", "label": "Valuation Approach and Technique [Domain]" } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityDetails", "http://www.slrinvestments.com/role/FairValueSummaryOfQuantitativeInformationAboutTheCompanysLevel3AssetAndLiabilityParentheticalDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/DebtAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r78", "r85" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Denominator\u00a00weighted average shares, Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r77", "r85" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Denominator\u00a00weighted average shares, Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.slrinvestments.com/role/EarningsPerShareSummaryOfComputationOfBasicAndDilutedNetDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 11 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524" }, "r108": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(b)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r113": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "323", "URI": "https://asc.fasb.org/topic&trid=2196965" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r121": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r126": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r173": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20,22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r194": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=77885760&loc=SL35686385-199418" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r232": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "10", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=6431724&loc=d3e32938-113948" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "10", "SubTopic": "20", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=6438156&loc=d3e57880-113973" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "54B", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL7495116-110257" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "59", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126972413&loc=SL6740821-110257" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL7498348-110258" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "https://asc.fasb.org/extlink&oid=123405975&loc=d3e41551-112718" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123420820&loc=SL77919306-209978" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919398-209981" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.13)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(1)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(i))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(ii))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(iii))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.6-03(h)(2)(iv))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=126898976&loc=d3e600178-122990" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9120-115832" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9145-115832" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=66023616&loc=d3e9079-115832" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262037&loc=d3e9915-115836" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10177-115837" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10328-115837" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10342-115837" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10396-115837" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10403-115837" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10411-115837" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(a)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(d)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(e)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "205", "Subparagraph": "(h)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=25866437&loc=d3e10246-115837" }, "r356": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "205", "Topic": "946", "URI": "https://asc.fasb.org/subtopic&trid=2324234" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(a),(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-05(4))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604008-122996" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(c)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874225-224268" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874234-224268" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "220", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124439613&loc=SL124453110-224270" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-09(7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874367-224272" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12.2(ii))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611133-123010" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r394": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r395": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r396": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r397": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r398": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r399": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r400": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r401": { "Name": "Form F-3", "Publisher": "SEC" }, "r402": { "Name": "Form N-2", "Publisher": "SEC" }, "r403": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10" }, "r404": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1" }, "r405": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "1", "Subsection": "1" }, "r406": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "2", "Subsection": "1" }, "r407": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "3", "Subsection": "1" }, "r408": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "4", "Subsection": "1" }, "r409": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "5", "Subsection": "1" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r410": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "6", "Subsection": "1" }, "r411": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "Instruction 2", "Subsection": "1" }, "r412": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "1", "Subsection": "1" }, "r413": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subparagraph": "2", "Subsection": "1" }, "r414": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1" }, "r415": { "Name": "Form N-2", "Paragraph": "d", "Publisher": "SEC", "Section": "Item 10", "Subsection": "1" }, "r416": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2" }, "r417": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2" }, "r418": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2" }, "r419": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r420": { "Name": "Form N-2", "Paragraph": "e", "Publisher": "SEC", "Section": "Item 10", "Subsection": "2" }, "r421": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "3" }, "r422": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5" }, "r423": { "Name": "Form N-2", "Paragraph": "1", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5" }, "r424": { "Name": "Form N-2", "Paragraph": "2", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5" }, "r425": { "Name": "Form N-2", "Paragraph": "3", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5" }, "r426": { "Name": "Form N-2", "Paragraph": "4", "Publisher": "SEC", "Section": "Item 10", "Subsection": "5" }, "r427": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1" }, "r428": { "Name": "Form N-2", "Paragraph": "Instruction 1", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1" }, "r429": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a", "Subsection": "1" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r430": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a, g, h", "Subsection": "1" }, "r431": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "f", "Subsection": "1" }, "r432": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "g", "Subsection": "1" }, "r433": { "Name": "Form N-2", "Paragraph": "Instruction 10", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "i", "Subsection": "1" }, "r434": { "Name": "Form N-2", "Paragraph": "Instruction 11", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1" }, "r435": { "Name": "Form N-2", "Paragraph": "Instruction 4", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1" }, "r436": { "Name": "Form N-2", "Paragraph": "Instruction 5", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1" }, "r437": { "Name": "Form N-2", "Paragraph": "Instruction 6", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1" }, "r438": { "Name": "Form N-2", "Paragraph": "Instruction 7", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "a", "Subsection": "1" }, "r439": { "Name": "Form N-2", "Paragraph": "Instruction 7", "Publisher": "SEC", "Section": "Item 3", "Subparagraph": "b", "Subsection": "1" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r440": { "Name": "Form N-2", "Paragraph": "Instruction 8", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1" }, "r441": { "Name": "Form N-2", "Paragraph": "Instruction 9", "Publisher": "SEC", "Section": "Item 3", "Subsection": "1" }, "r442": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 4" }, "r443": { "Name": "Form N-2", "Paragraph": "Instruction 2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1" }, "r444": { "Name": "Form N-2", "Paragraph": "Instruction 3", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1" }, "r445": { "Name": "Form N-2", "Paragraph": "Instruction 8", "Publisher": "SEC", "Section": "Item 4", "Subsection": "1" }, "r446": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3" }, "r447": { "Name": "Form N-2", "Paragraph": "2", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3" }, "r448": { "Name": "Form N-2", "Paragraph": "3", "Publisher": "SEC", "Section": "Item 4", "Subparagraph": "Instruction 2", "Subsection": "3" }, "r449": { "Name": "Form N-2", "Paragraph": "4", "Publisher": "SEC", "Section": "Item 4", "Subparagraph": "Instruction 3", "Subsection": "3" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r450": { "Name": "Form N-2", "Paragraph": "5", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3" }, "r451": { "Name": "Form N-2", "Paragraph": "Instruction 1", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3" }, "r452": { "Name": "Form N-2", "Paragraph": "Instruction 4", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3" }, "r453": { "Name": "Form N-2", "Paragraph": "Instruction 5", "Publisher": "SEC", "Section": "Item 4", "Subsection": "3" }, "r454": { "Name": "Form N-2", "Publisher": "SEC", "Section": "Item 8" }, "r455": { "Name": "Form N-2", "Paragraph": "b, d", "Publisher": "SEC", "Section": "Item 8", "Subsection": "2" }, "r456": { "Name": "Form N-2", "Paragraph": "a", "Publisher": "SEC", "Section": "Item 8", "Subsection": "3" }, "r457": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subsection": "3" }, "r458": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "1", "Subsection": "3" }, "r459": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "2", "Subsection": "3" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r460": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "3", "Subsection": "3" }, "r461": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5" }, "r462": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "4", "Subsection": "5" }, "r463": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 2", "Subsection": "5" }, "r464": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 3", "Subsection": "5" }, "r465": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instruction 4", "Subsection": "5" }, "r466": { "Name": "Form N-2", "Paragraph": "b", "Publisher": "SEC", "Section": "Item 8", "Subparagraph": "Instructions 4, 5", "Subsection": "5" }, "r467": { "Name": "Form N-2", "Paragraph": "c", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5" }, "r468": { "Name": "Form N-2", "Paragraph": "e", "Publisher": "SEC", "Section": "Item 8", "Subsection": "5" }, "r469": { "Name": "Form N-3", "Publisher": "SEC" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r470": { "Name": "Form N-4", "Publisher": "SEC" }, "r471": { "Name": "Form N-6", "Publisher": "SEC" }, "r472": { "Name": "Form S-3", "Publisher": "SEC" }, "r473": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r474": { "Name": "Investment Company Act", "Number": "270", "Publisher": "SEC" }, "r475": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r476": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r477": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "313" }, "r478": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r479": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r480": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "413", "Subsection": "b" }, "r481": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "b" }, "r482": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "c" }, "r483": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "d" }, "r484": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "462", "Subsection": "e" }, "r485": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "486", "Subsection": "a" }, "r486": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "486", "Subsection": "b" }, "r487": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r488": { "Name": "Securities Act", "Publisher": "SEC", "Section": "8", "Subsection": "c" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(10))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r63": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r91": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" } }, "version": "2.1" } ZIP 88 0001193125-22-275831-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-22-275831-xbrl.zip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ɺ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

K_A)D<^?_"KW0^1.(F% +3XGD;M3".R,Y,1BM0S:]D'PH]$:O"&O M[@\;6.IIUSF>*MA)F[]6FI]7 F!MV'86'$T=V9@: ]KF,>E( MQ$YP-.Z]09R<,A>FU6=4$RX%$Z8KJ>1O(ZJ@)X+A^&B' _,S,YHX-'\#0:N! M?UQ<@69W8ZWB"ZM4SVH8GOU]WC\D!_]+/32H?%;*@NFQ2H 3@T_Q<02R$NUK9&5UIC+0VL3Y-/02],/X-59D]S2VJPELWQE)HC) M!]LN.5+\UK+,SY5Q;U76!Z.A-=FL&(*5_9Z&)9.N^#'=+?Q_'H(TX *?QLE> M[HO#])C.*)&Z\[+[\IK4: DGMNV,!1'@F=9A>M2IY[#4G?D")R6"E@AB%]QNBORY M[SGA>BKP-.>;6,B!33AU+> +"X0"0:8+Y\>';/M G[WT-@C7 0U753%QP&$V MA!?WB!ND3??8D[$1P4=*QEJ=>@?V<&91S*%M'1T8MH[5+6 0>-@^P629,%E< MFJRJV6\\MRT[)!L:1\?WF1D6(Z&7%ZKO.0.Y44, 5*-.QQ>,]>?1:ZPN#-US MZN;&J*Z'QV8DL -&6"R8;+C:J^=UPYF^O^(%X=<@6JG'_CY*U!LL?9)V;BN4 M1"X,X7H2.S0V#X.B>8ME?D3 KK'H(6*J;T>JQWJ#,G3.9Y6DC"<2!C<'1PI^X,SU6@*9YGH>$&-AQGE;G>TWD&%T, M'G9>5-Z-52__!JA1%WQ#$G=6#)RPNGKM@LN-%-TAAY/#I;D"Q<$*;,VIU_%! M#3-&*]5[*7U1EQSMD*'6J>_(V"E++BA<\">HK XYT $F@7J9[8_K#Z]!@Y, M^LA-<4RUW <194O,.R^(\N?0U/LL,%Y,;P)JT^[:DHT(/L(6[81S%H_O.;2% MHF.M!L:MF H$_!E-9GXOY#9(K[W(VXAB1N#]2!47IH FI9(,TM\%A9P&C^Q2X(Z1YFC6-^&KD,DP^'E-\5 M2$\3N@HR!?*'R)&+40[(W%>:L20E.:WM$6@^X3&+2,HPTZX9B0(8:(E( WUO M]#FB/:6AQGO.P_2H9;Z&I>X4NN*DCCW8/$%\A^: *N@T"W!AX0;V6)&N ;+F MX]@F$[U"+^5O.QQ7?.J<+AD+:OJ65/9.%D]!75_<.K!S,ED)A[9, &!J9I A M(@F6+&8"489?>J#)H?YXX,47[RP)0L:ZN8S6'04 ,R2'L*B&@-Z#Q0WRK5W<9]W2I&']J+=_LX M#3)ZG**V2@Z]D0-?HP'4Q_)6CM39T;9?\PT[:\:#O69G MQ(BU!=6<%;).X_V>)OHQ<_FX'%L/%^9+P-LCGY4),K5X5[3A2I'2,25OK$XOV M!"Y.)MKUE&SK=O5+N\:%71MF-;HD"<,ETXTN-GSJ"%B-#-*C+D2&I>[,=L.0 M"%JRV(@EB!.93I,4$%-UN^LF!6J:2R8LR,!62Y-[WJ3[7<=1QGPZ3NC-B^=_ M^12G^R#S0KD/*I@P'5$E?[M+C_1$,)"2PXVA"F2.!KAQ;0%"^ 2;1 V;&$VT M3;)MO*>KP#_U$EIN4VB<%VDT@)I^JZ%7)T>RXB6:,://S5CNJ)%=TXQF*VNL B]+ O]3O*/WE/EKPGE?-$IJ@!O K:4!UZM; M8*'@)9R9U+A=3 S7MF"K:H8M\P'+99@PXY:;,:F9,:V;T6C^'O/9:R_Y0GFV MX$7,ND2]P2;G0K; M(*G;P"20/ZPVUWR,4(?H/DI,Z/9*VNZO#V]&:WU_98*^T&"SS5XNHR>:,D9 MW6\%%VH-<)4&G:K/@N%<,)"*PYUY& V:!?SB8_WSRF-4EJ> MD2H1/TR/6IYN6.I.E;'G)2<]GLX[<,8XI_AX%>H4R&F6J,."#:Q&G7[_;VO] M;W2"NBW3HR]YCQK!]UZDP_,6K>S("\ MG<1338O\"H= M*B[4_325!ITM'\% <@XG'^&#&:6YZ89K$=@&W$C+T-PR:<,R9O.)^0?*&U[@ MXW$E&V[6L$J'[E4WT:W5Q38'S[^!AFDE N-:!9C[.](ZJ](ZLQUKGWY9U>Y+ MJBZ,]!.C7A09D+=S%>%O9]52U:53$VE_-^^#H'0V[!Z(1J=O&YUN$*D_QTFX M^AJLZ$7(=Z2.;S:J4 M@Q$0P1(_N@^\%#\F9:M':'6B##=2 .;YU0)"?9J5U M;J6T826CR4C4SY+#[F[K)3O/IVQFY'NAD.YG+TF\*%-MUL ;P$U3@NO56>07 MO*3%7+A(R>^&KV@;L)7-9,MZP-2FV:UHEQ_?=IZR3!3NCA4/PP&L.;Z'1==L/7[6,OD9^7S#897A^=# M\K)(4YJ=>N)6BG+M+F7!=%VY[.T>S:F)("<%O4/K=8 A&BC'M ((XJ.LX0EK M^#5KF'VX^I!M:1*)&R2K.&*CX8B;4;JMX#Y\K:EA]P7GO %2:Z'OHI0+!^YH MRCH4%L9!N/62N%7\ E\:1\2QT8PS[^!KQ))!/K8.7'X*Q4.0^FARJD;W=H M3DX$O5,IJB;T<&C%4[RE89;RGX2SY(Z29/^X9S+1Q7.0]OE#\^]8L&])U:U-P6R1BLXBU]1C@UN^ M;_@+I[>4%D$XY&94:% MY, , R"V6!Y[3T'N\-."LP6#2(TV])UBH+F?[>YP#0D)1;\>NU=!^"@L>># M8!"I(=BDP81@2[J.%4UJ:2,PF- 5TU/DH,P\!A 084ON&"I@3=DCHU$0)TOJ MLQ7 ZBKVHG21W4;TTR%:L5\LHM5Y2)]H=!<'4781/-$[RBP>9<-3$0.-HNZM M3=2_L[ 2[9&B02):)(N,L#9)T2AAK9*\62+:);QA4K1L^R@(I4-^]]OW/[[[ MZSOR_OW[-W_X5_MS+F.>T-RI=,H-8+N8\U@_+:P?"NM[&8F9.VP+=_"8.]#< M'?;"'=;<'?9YRR;/ _);$?QA@.-K@?) )N/ C%)2R=M]7ERR$4]1U)ZG=,+) MU"9H>!!B_X/<8XP=1/W)V@N3.T%OM#Q ?JTA+U2NN%/:3XM:'*!?VLXU]9RL M*'#OR(U064\WZP)@=#.L+(!>=^^*[C:/TLN(33XBFK%!A,UG/>8+]S3S D61 M9147)G*5&G37)#F#&.(*%I+SV*^^/%Z;WWF[_5]U]$'S3QC&&IZ*##"0STX# MFE\8)LD-8]Z3[SS_B[>AJPO^2B=P6# M?>^=I$?NP&I-T/P6@*CFLTF(<((]E#3.'.L*5CMA#/.^>A6LZ=(/*+-!^A#' M(1>NO!N_C(F47$2PB>ZNJBE8=V1C:N5.#5(,[[(Y&'W- M.^?XT(-=/1]MJ[2T559!L"RU,,>",-[M#E'@"V72\W\>@OU.N6FK8$)=(BKD M[SYI7Z0 ,78Z;Y^\ M?=FA@LZI)9:TMSN)NO-W-3@Y5Z_+9UL\+0Y9S)QC'T=460"NGQ:UT'B_M)V* MUXR,'.G<0*JLIYLEQC&Z&59A7*.[_6-WSX#2(&%$JB5"FPH5F6T).YU4$#@" MQMX.;<)PWMZ$ 1#5M:!P W<#G=H WMP] M"D*>3L_.,RKS*CY\10=<+TE9L,?H8=E[QPY!+E:AL+42RD[(:#WRG0_'5GT M1'4F(5AP L]%-,VQKV UYWKO($'W@:?9*ZT#L.T-)9YW_\0Q!DPR;67%+4T M?J^LG4KE=2HWX"WIY&:E>(0>AI6'']'3,^0/L:EG''GA71*O#KXR=6B &C5K M:$CB3F9'04A*2C> *N_Q9FH-3G?#LFJTNWU?=OL,VY.', N6U&?T944]Q4;E M, /JEJ5$[LX6&ZXI?Y(XVI KZJ5EH3L^DE_%+S0I7WO@O_W.#<=7 M@K:Y$8R&6-B6L+;9T]SL50'+&=947KKE@'CR0K[5L<@>MD&2O9SSI\3$K:C_ M19-8L;;2:0+W9H:.;MT;!.F6U-CY-:^\ 2):*.XZ\C9L[VP95K2\S?C#G]Z\ M<^0RXPB8MNZOV,,H\%K+9!/2)E:S'*M48#6_B/@K:V.>"XAL1O,4K!A0P>FX M,%X[EQ*EVLBN)U:,CB7E&E7-Q<1<'20.W,A$A*'FW/:720.# ;0(2AYFQ@C,W$;( VX#CC64TE81&KHDV^F'GX M&NO571K1$&:(&*-GVT#M_3F^&5?L,K!F'*RG-)?2U:;#]\Y44!J-XT9,L0]B M4( Q:]=U9==B&R)C8)ZW&M(=^R--V'242Y&]\/T2(?A2%'B"A!N=%E!/ZW0T MZQPEE3'\B[-W]T))KHX[-YCFD/G+"S33/F MH[GY^$YE$2_2O)*:^8!Q'M%D\]*83H%V+M1\J),0M1:=,"U8VLL39S8M3&CD MXAXE%&_-V0,VV&"3A=$F:BU"YJL9:Z*B0@N^WX]7I^B0)>.1FA>#<-9PZ>100;RZ''&V11@ M\X^F60O3S)'\':59C9BL$)5QZI2.[$,%4P75B)JK;[XD$*ZKH3H+6O[#%#RGOS M@4?%OEH_,>H6VH"\G8V()IT;2)9V=G.3"*6G8?M!(WO,[EA[&NN4_NA[_8AFY<6&_VW2?FO MJEW^N[)E_E:-:)N(QLN#C^#9]G''[#WSMMTM;ZL^*<]:__##FQ\=.1TQYC"= M>[=N>0OX5NY,V"C.5^*D_%=0>0W[W=<2(1X_I^5>DPFO*4YB@N<9#VQ_+4^, M+EBGCCFOE35@\;A6JI?J'+-V6,O9'3VKG:1B[:CV]XX$(VUDRDYJ$6$YYJ!V M%GA>&Y]0_1PD-*1I^L#^WZ_7XH6=V8+9,0,%7*>V'4I.TF%U[,Q3TVP-/[)E M,Y 7&;!=UK'=C,>A"^:IZ9ZMLQ?1ZHPY<90JUL,2!M1B@!*Y.S7;2EJQ_550 MVQXJQRF0[ZA"5, K *A"4+/\'QI\8,7_1L-H5=A@!I<,DHM$7,]D0EW%FR#- M E]=H5C"@URO6"9]3YU=4M 7!08*#OOG'A,TR=T4I@MF:68EKMJ%FO% !2W; MK&N2=0U<8640\U[[X1"(8@RP8C]#U*CEJ(8D[M1)*@@=*_8C[_%F82J<[H;5 MIAK?[>:73^6#>N66-VS5I.*R\5CEH :#;PA6V_QN+8U@)NE]VQ')'EIO.TZP M2RM9USSZKVGFB<>MKH-(F5DR0(Q:XFI WDZ1($&7/^,H*&TO=C0%+]YM5(N. M5U]*AI1F;2D4F,#J2NG#99?WN?GIT14-TD/SDBILI@1@1'V=$:!'YV6\G*=U ML<*MR138/LT'#-&- WN_T(B1BNRU^2HMLJ;7-$T#7M$1-O&2<> >94DD[QX. M'(D=FVNI+= ZP4'K?N"1S60SF)]47<1Q]I5ZB1S);2I,]'8D;'=52> &2/L[ MM ',F7L3!$9XK\YP"NBQ.>CG+ B#3%E2II\6]7RO7]K.@1 G(Q6=&V"4]73S ME ZCFV%'[MSB-F,;>JUYL1=FK!XN< M3^J40J/YTR F&LXT/R! GJ0%C&2>=V4O,^ >98<.=5>R*V5GO^O!LV=,FZC5T,LOQM)$N[SE$*.EZI:#>LCJ!Y9,CD$9;)ZA*H]( MMM$M\CC*1GYIHQG]X5.X#DA M-:X\E:'84;(^.3*E5)'5 % +KZ(C%'?-Y783)@M -@$M[NU-E8/ZN!I<6T.KR=='EYM'ZD'@\ MA^(TWNV]*!#/V)T%:98$CP?6A&*R!F1&?607J$_G\=J2YLC=4-O&O9 MJ_FZK15C@?S!G-&*_-^ZVEB^PVHI\.T8K]@@F? M5P 5%T.T+F89:!CU^K6!?NC<+19MDJ)1(EKEM^I8NV2;-RP\LZCUF]^><>Z> M%UK/E#=2W__P>V=N@1ESC^;->.=\ W:9?CXDI 42PM)'XI:/%"6$U]PQBAK" MXI\SE 3M%D'^RGZJ7[$%5Q,>UY;E^N40;4$ES$5#S3OW+A4;GE'U,I1]_\.; M/_ZK:_7+P6A6E3#'A_+8*N;3[+KNV#7+H=VX&#]7B6*]0@"B1'NEHVK!/KUE M=PN)#/2$H4HB^7,,M:#V3942&=,WP[5$"J_XPQ]L!SMSKC*A@@B*G\Q00D0/ M$[HU1/(7'XZ1K\T'+E[[R*7@953-:O+U MH_5XI U,Q8.U:*@<^5ZMKMG:S]7FZ$P9.F<*%6P.R,)1>ATGV<;;4-"YAIP' M=4-8+GUG2S$G)R4]Z+0#P=TQU,#;Q 8@JKEWC0DGV);U.'OD^].[TBK%N8[9 M.WNKP),[9X,$]WY>7;;N-2OV5]M^-E5$Q!MW'3NW[MG-9V3@[3IE3YJ]50&\ M,-='B7R[0GW;BA/!;L A^(1AB3$OAD NZ2$ GI!!-C-^X+*<") E.[9P"1D MO(S6B9>_9:!,48-P(J< J#7I.4JN,9$FEVT'1-8(,YD!B+EV)@,VX*!I#)/- M%#2X1CDXUR1EJ@@UUE[Z*'0YI*\WGK=_RSW_+0VSM/R-B 4B#A2_^,=E]$33 MC*N[I,R,*R]Y.?4RNHF3X%(Y2'NB@28_4DS0U:I;=Z/D(Q4C:7*27SBO MA>A@5S>,.#$*DV6T& U(9#=+/[P,"'86[[R@$W!Z^T7=B#6' ^@WC,R4/+Y( MT)FWX(3O65+3CAM",3OLBSJ G;(R#)(TNPIH],&+OIS1Q^PVZ2;E*):,.DV@ MKB6U=.NL)3@WX>R$\Q/> #^Y[V^RP0:/:GIH\(TV> )1FLWR <-@1_:8SNCQ0-[D;:1ZYKQ-AF_"NHP# M5N2WY)T8 09ZM<>8O5TZV9X/7V.(/6MD^/:LRSA@3T;BDCT[O=ICS]XNG6Y/ M?FL49-$ZH06;-N0(@: M]?6^(8D[3ZOEA*?>GBPO+\G5U:D;!I=W>?-Y.YS^ACULI]GOC)"D07!"PM W M.C9K?$57$)A4;:J12ZM")6U?WM7<_RJM$Q=UF)V -M$LSJB$;!;8_ M9-0X,T.?;XEK [_.9!GV#?EA_2I.H%R%?-<>*L#/:(RQ'* MCR\COUX/0 YU!1/J P4*^3LUZ<](SD 8!VE6]W "ZR"#-%\$0+4&['4 SJ>#Y ; G1MZN[X]9&GF1;R4YD]Q MQOY?'$6)5UYNUP];>DS9'8+%V-90WV0;JW'GH;"J(1*O2:TIDK=%CHUQ@FQ+ MR;$]2T=*,RD?UY1_RI5/.\H'4N71_&X:XIOOW+D!=]@;>$Y8WNBSD)4@Q4E. M>N<%J\OH;T&T4@>H/AX[8:A7>DFO%[N'7DHX!^MY!Y//:>LJ^E[-]YN6](J;7;KQ$%^/7XENUX_X2> MD!BSWBK1*],H6K<>3>;IEJ3>+;Y6-;YXJ%LL1*>IWC,0PYQQ'&&P?F%?%LG1Z67$%J5W<9*MXS"( MV1(USKPP_Q-D)TJW15N[4=J:RY?FK#ER;"]/_4^Y*?F2O&J34XI6"P+K,F=DHC.\PX3VAI5Y1)"1B+!3 MB>G!>_[@I4%ZNZX%]M,XS2[BY#)BDU/**.X.R3Y.J:PBDV8[R(5B=+7LE-#R MGHEH@!NMUL0)X8V0-9NBY\T03EDV9*]BS%1]:U6;Q"!/,J:6S_BMQ:U)>&U7 MB!D-5GLN^3&)T_1SE% 66WZEJS,^K_*#WC"GZBUI4RXXIEQ7N&^*=D[(L252 M;\HQ[[2GM'7W!6 ;Y,% 8!O?+;EC+#1)Z*K<%)JV50)HSOX^"41GZ"9)U5:Y M?>S\#LE$[1NKXGVE?;7S]TWLC8!1#]@8P8?\A%T1=.//O]\KEC@U-::&,$A[ M]F,82&MH$,MW.NIAR_DH-E7_!I+SI6S0U/];B&-P[ ,"F07@3XAD%@ P?RSK MUKJ8&LU@+=J/9T#-H1&MMXK+I>M!;7HG-%#=5_;D6XEL.IX B&U6W&!"=+.% MA'DS$?D+;? YGM!I VNE=B+L]F1AM,:-D2%B&A\/^;Z% MF0$ T8 ) 2:<)\P#4(R,OT>SB%:MIUY-[]K OF _;HWLF?$[.UZT(IT'CIT/ M=N:[2;'^Y]WDMQ\4_D8BY!1O&[%/9,75#.X1B[VQ,_MF4PZ> MV;=TG7)\76_*[3-[1*5=.[/OP_:8,_LA8!N?35T%WF,0BKNDE]'YLT]3)M=M MMJ6)F:7>F/;MSZ1&]0IT'E5KG$?NO'EQP9U_X)M9,YKNH\; %S;[B%9]%(L^ M^K96F>-]##"#,W MM4Y$-[Y#R[_^66T]*_6&]M4[,M&H"TM"J/[P==+ HF\JC?ZW0D_@G!LI>A< M7UA?0&IY!V@IJ>T:$R8WQ\^**,8_[<>;B'_\OA#BHQ=$5VQQ.S2AT6H"!.$MV'64_^<*QC1C9?1E72Z,DU/?LQ9>>"&*_,J9)3? M69U]C(!E8\9A$Y.@688Q;,8Y-@]U;#;-R:UI.=TZ #IRH.'OV6_X17L! B_G4 R#%9H*$% ZM1@HHO8OG#2-NO, :6L M1;2(5F?!4["BT2J_RPJ,)1)^BV%$II4Z@I32&>%I+I1 8:J()4G5 MC,E@\O U?MC&AY1->MBTZ>$K$^1%O//W.2JN4MW$&4WECX)H-H(92'3UZ^SP M?XU)V8!8IN1-%$\X5HT0T0Q5LQ'IJK+ /)#6RM+4RLL5="BXBA7 M:\1$NWX&BH@F_"TK_8W_+\O]+1/^=JC,&?%6Y@Z$%ZR/IL;!X39LAT&)=M H MR)OX-H*@AK(,&[]W. ;.H(G5$*AR,F4$1/.PT0%0T]/ZXM^:>QIV^ N>)D\# MA]NP'OZ&M0.'/];$-Q+^X,HR;/S!Y?!G7A.[X4_A9.KPA^5AX\.?GJ?UAC_N M:%&K <^B7[@T,?;^$:"GX:Z#"!_=#G\S:"* MW0"HL.@\#<;@7!)DX"F%T;BH;0M)\*B7%N]Z)BW12Z^ MH3"II[X(,4-:NA8V9U;-?A@%."HLFF)ZZ;2@JN^MP[$U+8V-%F0OXB1[8;\: M'UKE+=@+J K-E&%4\!/^:\=#IZ:BW[_[_?<.!Q,(("4A!(K&"0[4*)@+<)=A M>DSGD$C=1DBKHK4CH)^H@%6(JR#3 #0$+U/B/TUVHLRS(LBWR5 C>4?&3KAF M%$6M=>O(U)'6;J3M-WTSG [;?0+H;NAZ[Z7IA>?SBBLOS@VU M\XN[Q7))2D+[8!PKN55@2N'1@*<2&U,&]C3\2+_*W]'1L-O! "[;WO08U ^GD^7[J-J(X[U51=9I53,5K[XSQ<_.7=3P3@8>CA0"'S[W[[_L=W?W4W-'10+HD.\T%\1( M0'U=0CV.C-8_&)@G3+YOZ-Y)D$HWZ1K#:ZXQ'#\+TE553,[=/30WKXCM5<:T M.X9(OC5EG3'U?B'[O8G#[\FU:F^3C1<%OXHN.(VC- Z#E?B!*7N75]L5/]ZN M+X*(+8P"+URRW]#\G9?'E*V6?%G96D/M(U>P-=4K;3C4VSTAC98%.NIM\QJO M5>ODV#SYI?R A276_P$=A%GKUJAWM&GWD]]2V&HOZ]F<;CCI\@O_&-$?.U;#4_Z'?=-AQF)3QF-. J'0@D^"]^/ M#^+]@#LFNQ]0R!1&QH0<$*3RMQ%Z)"8EM1-SAYF5P'0\-9[:+@0#$XHS+(-- M%*P#WXNRKE20\17: +*3@/7J[ >&4DO[IP8V^92S[8OZ<&Q[5?Z6)RPI[C8 M)%2Y AZDQ-PA[)6T$V,K(@="JZ*#&YM'"+T+VB/2[>62RN V][%U6>0>)K4# M2EFXJJ/2:N =);,C[C,8-]&0H.E LMZM+3/92O3(8_*XZ(9FXLW%G[SP0.]H MLMQZ"55%>043;D:O7/Z^MR<$ Q$->PXK'U*1,37>9576 M,.>SDSE"P?^$%B1BVCFL_R)&-G W9 Q0Z MM/'#R8M94(W!H4 *L4D;45"#6 ,5)*@J^!R E2PN#>'*B0 [7AD7O4$98,%( M0O&',_J874;,&0_0K+Y!#F0?&):\LW?(*$F-U*%XJNC^-G8 ?8^&&KU\K$$. M"ZB!)?D(U#B7W:0GOPOPUL@Q H $!=['E[).X]W>BUZJE*9/P68;LO^!(J5> M,\B.H*FCY#&Q@O^DEA]X;,*A6#O&JFV$CC6I,["%Q&K-=AP$KBPNPI'K1,"? MJFZ?:M^")RH'B]$H1?'%JR"BM^OF34C D"%G0_8TA0YMI'%R?CC?*0K@S @ M,4H;9E"+3"G*%"9Y^\LX//##'.7II8P#M4B33/).#N+5?8F-DMR%\\JI.M@M MX:2$3K.4$QYN0*>3D_%SA(^5TTDV\NR"+%^+1ZO36&2>THCGG1[7,8"PK]D. M\CB@JV7GEO^17]PK:K306&([,U*,,FQ[Z!AM57>P"UDNZ#;D(GIE<0<.7R<6 M#//J^TTXIG+M,!ZR.*?^_SR(RDK9-EX=ESEH0LA74@*0/WF-( M)0"&-H!]SPRJ5V<26S#RA?(P='\1[-9!JF>]SK4L;=.Y 4F^XK_,Z"Z= LM: M(ZY!LZ[?2'B*K1[1AOL8[9A3&Z>]MK0Y$=";G^LTXL;P#YNG:HW\SDW3)ZG. MMT)X WMQC)%O?/=FPTS?QJ'K( KX7LO'0[#BGYE+I[_QK,/')%AM*/D4ARO^ MXPFYNCJU'6'TG1 X2YMMJ9$F62VZL)^.D87]H QXW=]2>N/MZ.(YZ!L3IS>) MM64]7??AP\03PLG8"H,1VKMJ9LBZU::Q0=/.!N&%;/M MM&"TM?T7'VI05YX!<#7E1IM"A;8^C+6KT#BW' M("9I+\:@]I@P?)2?N*;)AB;*$6.0''.0&)9Y$!0YJ0L# 5SX0N:O0;8ER\\W M2ZN!7X&31JS' @DHO(\ RZX.ED9C',GJD@:D+'S>"[10=7,.].HI" ML(."_!OZM59'/HDC]D\_+SDRAT8YM_QL+XK9;3D$P=CYOJW3=!R\-_$6T.@O" M0T97(MT8-(J-;=%>IJ^FYM*TWTX-PQ,BVA-IE46+18:Z&]YLL!\.NYV7O(A; M[/%N?SB^?9;WP*+6 S?4>GF=B="7)$*/Q3UN#3]1V9A?=KD*O$=^,S_@S[%Z M?,VUNHWN^0NK"5.#$=S$45+^R)5)P<%@CH_9JA9HLK\D)0:+)HOQOVI6Q(]Z MPTX%$91.JL67_#.B3VH?*OMN13Q>0:/J4OXB8ZTGQ==L1Y_YW'"P9.(L/H@; ML^22"U$_1S%;"B5/7.++B(U"[,_,)(S+4U4'F?=SMN*6V3X;CEPG_:[(G*_E M>B>D_CTB/DB:7W0SN,W;D[7P=NS49GS;E9W*SR"W0S^.QCN9G)>&Y,TC%AGZDMVIV!XBXV =__!M>?D%Z% M+4G+J07WT*I55=YCW&;&#(MK2L MH_K?TV84; 3!%\="X+R^/<<*5LNQD;?>6X7I]7;9AYFM;:A+])'MG5_%T>8U M<^P=Z;XYX%!4F5%/VUX.A^3P[C<$C^X4](;.+<8TYF)I;]70I5'?VQV/-*)Y MW4/7E<;;;ZOL-V@XG89E%-^]91.CI%9G$.RG*D9DGU3JT4:A8"#U(I(N.9JV M.K69\"%:'Z(579$5'_3XY);FN;K^L3W;/@:#7=N?X)A#GE=V4VM'9'&H&[$V MSP3H)XOR=?8R<=PE;YM34=N>I@_2X1FG#D*1/;"\2++PF5RIJ 26?GBI_:3G MBSK-6?-*+9UEL*UNX=1;.B&/+_5?..JQTSJAY[I 7"HP6B53\-]4-D'T2 M^)1D<4Y7[)SS+X@,"#; AK6C0_9WMB!COV?_)*P##F%6-IC?AW(G(N@[S7!L M&.L]P;^W*C] :X$;.YCUB*,P?[JEF^O M\9(:LW"H^L_Y3#W;>A%I,DG*#V-'H6^VH^P$'M-^.!R6YG!"I'NH7D:/A0OY M!D(<"<'[RUL"^=#OF\JU&"B6>Z235*I$\O$9-<"]/@K 4_?**!!,B&6F*R$& M"V41R)E?8UW3W21 +P M'EH+KQ:UI>U[J(R@U7 EM9+ MK]HX4DUDKZS@^#5=OY<&>I5O=]WIUG9]3C .7Z?UUB^7=677!2%NYNE:-KC08[P: F72=OX.[6@4%TBH2H M9_EM.W>.Z/N,C +!NR1X8JNKN]#+[ZDK\3C$@ S.0;G;."@(247I &YG$AX3 MTG+N*F.34#B!_ M7AU0$S-O;S0[ =^U ^ 3B>U/<$$ /9M%AA?1MR'+RHB9. MQ5!/;[%4?7BD%GY+BT>)%F@EB2%X:M0E1@43J#BQ87.8?%?BDC]AZ87%$S)J M3QVFQ_12B=3=2P^"E)2/Y-Q:=\X1PON%\*[XI HU#7]$@PS(%\WTOJ5"X;SB MV!W/#)1M2=>(L+>>Z_)UMIC%ZU3BKQ93*]02[HTR1[N6/Z9&P]7#T+#\^G5C5A+4M:J5OW<"%G."&" M1>RH5$PNI37C:68G#QF&RN'L8C@DD8X4!\2!;!I#F-&/&@'Z:$+0B;U;"XKA M'E%"<=@]KM0!H:$)]OFS'Z3TP7N&3*%KQ+8FR75YY=/@G)(P4@RDLZ]1&A)V[1T&!U43/F@"?;!D]2&D%@K)U9$7DQ)I1 MT_7PJ-/- :,SB4HV@1=%;EGO?O!2/N?@\_G@B5Y0Z6&0C EY12N5 MOV?!4M(3P4 J#L)9[*UP1ZOQ*-0(*C76 VI@KGC5F&JO?!$!!5T!SPHL0[M. MIX?=(12Y@#&/Q*5Q^](%I$J\]14ORB."1:[/<)]8->O?NV*R8T;FM7 M:TI_R'?!CBWSU_!(V3;AC8NW\H[-5P?&]0\XL'-GJ)SK.S03?:GP1T]=YQ)>P?PVW$JXU'UOJD M^!F-[68,L@]L6"#"-+77,;7)D]5Z3%6K!9GS0%JQ->D!:2B?"P#CD@/S'@/* M[F$8=6;J T?PX-S' GRU)S]XEC4::I12__W@)0SC)F9 /4VY-07JTW7L'*AH MZYN8! 'U!@V-I=[?SC1H$.&:\Z#YX6UH(C2SN>>:"GU,V.(O?[L0,N=ID-N: MW#1EEB]^!6WQ=J\#4Q6PZ&SDV@C1O4'1K4P\>O R.,.8$RS:4XFQ/3^7XSW$ MF1>R. +WO3:'+??K2"[W0$$NQG-GO%!' _X0B=" AVK'G+$?0X/^.#. M%UR MHAD,>^;P"?C/'OM'7]TU.*LS:2*5+KIG^B3GM(U]J)7@*12KX#3I'U5JUD!)ZCXB*VE\ T6G:ZEE5@M.#W=F?]K>+#VIE[&G[%%., ?4 M!JM7]Y-9@=M@1>H:X"Q7HY9U:C_H9NI1/=@!>C8G,0F]U5.0QLE+]8G!BJMR M,CHZMQ+HB#:I&RJ(RH%+1[3+/'\;,@5P>R8K@G7J=WG@E/DA!6\I&0F MC)ODE9Y^*1NPY;[C]:NT><43BKXC>Z94*I1Z]<@;_=UOW__X[J^_\W;[OY)5 MWGH';*A^K@G/AM_;PB8H#LR+4;.E'OV$LM7.&QE56P<7S%BW#$/29&\X M/VXI2+!6W?I^.0LI>=F*O;;/1C@_J1JP5BURM'XW#+T)AT<>#=[E9R6%JJ]6 M18/?L=_5-H6*]X,9# EW81*7'[!=<5(/O*T*E):0"ZQ(.1W!I3%;MFQ:T,X] M[Y]IL-FRZ+9X8F)L* ,EF_G9!)MD%HC)T0T8^]>^51MSV@4[X*H%IN^EOI[A?YB-I-*-,6\ MCCX*P^V;ZJ,!;---BZE)1TA]1QUNR0U7E6@ZT5F+EIUS5PV--1Q6HJT#+JO" M,]!I(6!&<=L++TA^\L(#S2<,;#5Q%7B/01CP"IS7;$IP2.CJ-KJG_B%)F(#Y MNQ!)^2./-8/U+6;X!K*KF^R=MDOPMHEH_(14#8CKB_4F;%?=F TG;4>9!22X M+O3A10$1% X\FZLLN\'82;K>!N1MP?B M.? MH_@QI4?>M9T;.HK8 M/ MN4'R.UV;-7I9,81+'SQA'U._[90 MY3)B'Z$IL^K/'G^ S%[V'PQ$;=]1(VC"EGQ5:_B"K:V8IT4;^8'Y,#WFEKM$ MZCX\Y\6B*UK;9^;3I+>Z":Z"2V/3&PTKH$WN4;V^+FD-7RY;TX0-?[EGRQUN M@!CY@EBOO#UW8W*Z(@#;]K.Q/M[F6 M- KB1 R9='45>]'P/$V#%_=0&:1-]SBN=A&-Y(RDX"2"U;93CE2L3Q7+Q\%P MN+6.@BU@#7@,; !S:6ZHM#!4R%GM'/O6-FK*C< 7S9VU/CY[NVN]6K2M41&Y MNLLV; O)3IO<$+APDN\JP_8QFOK M]WF^[8M6,_8F\/G)?RYN(ZCN+8U-S?. M!MT- V38(T"AB%C_)6SR22/_!3X.#'/;&PTD&K6!7R,E%:U[(X/*1I+Q 6(@ M7,CU202/\S)N6Y"3:@2$G&LQ5FVE0=#!3&0-=&D5L)5'%#!V!V#7HQ,L)\+^ M$<9(=8XJ_/_E?>MOY#B2Y[]"X(#=;L"]L]4+'+"[P )9KJIIWV:5C;*[&XOY M,)"5M%/7F5*VI'25[Z\_/O06'T$]&$S/EYDN)X-B!'\1#)+!B):Q$)5'AS:( M]IB@YMM-:/[SEX3F3"[[URU]8>(%>PK&#O"Y:2_CBC:_A>:G&':(&_.RN 0K\H&G NTD:\"X@#7@W00/>!:H!>EZJ<8>H >_< M-4"!GXMY_K(UE-AE/!+5M+B+GKEUU$-)Q^2(CYD?. &M;)2>E84.R>C' N<@E0D M5YUS0M*2X2U)[OQT<+?*L%]H_IBM,7 Y$2=)0I[X/+R(>=@9Y\&G*0'JR= X M."B)%W5O(XX*-VVW$7I6=BL?^E"K(CA-=V9FQ5S20!V?(W\2E1T=QU9LF$8, M]1JN#A?TGM'Q+?F\KUSDJT7(>_+*B58[S>(C5Z3[&;D;)OT/!?KT? E@K?/ M$?GY^:RQ3]C$SO_21>J?XT9VK@Z&NY5="FGK*"/>=E9U[_=[4NY' R[Z(^ZS M)Y@7W3A>%<_[5 "WR3-E9=+);ES;-_89A0(6 PV\&FNM3 F@C>:9+;03S9-L M=U]&>0D^,UY/?KK,CQQW07 +_7S'^V\(L=BK"$-8%$*RQE M2B[-[-:5O6_2^'#>\:H@=6;==WZ,L7$ EVNBS7+U9+BO9,WU'[8B\74]%/[X MK1Y, %> OF7-LQ;'>_87D0'VG.9UG?IG(2N1)/P-64* @J]H'X':?6E6\XZI MQ#XJ*&@+N>CG+M;-R%$S=5AB-%\KCUKO_"E,D9_/^LR,L[X,#0].NA;J=YB% MJB+*ZB_+O2/_=KMSO,'<.2()E>\70]HC^M3/7CZ@2U-.4"HA)"65\5;'H1MQ M[BII(I4T[ROIHU#2/B Y'GFYHN9XAU:?1\YG-']->\BCM'AB5H%IH1__M?_% MRW5C!Y+SYLTVW[WB]<'>A%MK$67S,].\OV3GDONT(M)?EO\(Y^W:.NJXHD>K MT\60@DVNQ5'R3?IKYV@D-&UU20T.,'5T!?2NJZN5%D19]_II,GFN% MDEJ^=R%G!3:IK7]2T":T73NP=,4P2U>';P8$9[UCQMWECN*3H>W>( M/_"CG!_%I5X_LLS[-O.B-_P::LKV\KFZVQLEVBB;JG97F0 M^1R_;6/7EY]5B=3[]9FR669Q?Z2EZU3)\P89+H84K6R^-"EZB"?,: M0ZOYZF4;,>^QM!TK]K;B::$B_<>(J36JZ,H&+J38VDE)G#F]C#&B\3Y-_F3. MIF-&Q84_>X&9R@TR!-X>51:-9R=O.B-M;\&%SJT(N#4RE4/0YD5C.W,NIOR! M?MT ,E]!GD >'#CA9)10098JF> MZ1QUQH\:WP"&52\>P3^F0/$#<[$EKO3)4<[-*R>;=!L/U.#K['B*!#6CMGO!V21-GX WJ>5Y,U%4D.($WHW/+BP'!CH"S[L][;B'@F\/O#:G M4YY%\5Z<@S5D@1P;F.=AN-NS3P(2>*P'!GH2= !I#POL$ KDV, V'W88(15_ MOTF9ST-KZ8Z'9:T!#.W >TDV(%]:R/'"P+R/%GKXA8$G;0 V[@#B7UZ[5!^ *:X.LH*9;\^E;,!&ZANNQ/:>GX[#M1 MCOM\R$4UY*H3NEF;\_GW-6(0,]9,: >^[W&@?!G6S$J9 EHS)W,U8 5[S71# MW>B6RAEREQSILG6O8;C"I]]&Q,L6E*[&+>IE&V ZFI41Z"G\10F_&>[O!UK$ M>7+B'[E]4L78-6,06>R5:1VG=N33+9["YU ;.GV0VR>B48Y6(ZJ>D-SE)3B^ M8U",DU-T4.GY7S[3EW2W>:%Y]&RX--&W]65U#:,=8J5N1ZJ&QL-.+X;5)NK& MDD+DO&"@&X^)OTUU 2YV$LRPMO[8@<\9& %R> MT'HS!7VM.PJ28+_AD2-^2 M#X]DZ:I1G-68M $X$*( .[Z8D= '#G\!CX?$)BO-!ES@ Z:E 6@OO@;MH^/ M2;F+K%$2;N3([]HT/%GUY8I\?'_S\&$#BY3 ?.UFFC7;NS?;E,VPN.\/4?S' M?;QGG!5W>1(GZ?/G;$ $E*' )'75 MF8U)Y"@PL3XRT!$@0T7K1JO!$LBC K/T;8!9- .']^8J=WMD[3Y)H^XU\RW']P?HQ[,PA:RC;9LBH=GRX#O[WX;NF%7I,;! MFN42&5'M"/SUG.QXIO\98J^$':\G[!>:/V:SQ=WBXV =LM>-D4+U1MLAC=YY ML0V_I@4/U*<[;K$,QF'0SK-U&(YR''I9_2[6.CRC,'^7+/V)U[,[,Y;)+@ M4D'4 M%-:VT#E7=]5@._IZR6WM!HI3K_8,K$.* M=.0UB2<,?]'B?LVBDJ3X0U*S%?,^L-=J"YK&ISA6*"&<7O[:ROA#4L1.1YA*6M1S3#4WEB/Q M*](A(S5=*(>;*[.$=_9I0)[Y -0"NQEN\'5V.$1LCJ+#YIE]R!2WKVSJT]%5 MCW6#T9@CKG7-$8$IS8.90S/ M$"+KC=(V010SDGZ"R)>':5(F[Z/TCR^1.3YFW,XK.,>C' F)-2&\#?FR"2/N M6"?:/AS7EBL,B6[RQ4I#G2<\!/4KTP5K NIA4^^9@T=C':>BDTT(;Q-(V*=. MQ..DP'KY>L<"()_TN#$B'@PYI'N(""2V4R]J$RJ0DD1OLW27I3+KC ]K>O+_]:GW=!:3W?\,$XDIQ.,/H2$-(*DH)L!\$\8_HB^6DN5/< ML+A-W )I6_@>U_)67-D4(RU+?ZSZ-"SB5"*0-^$&.2L3K:PI9*?$*@!AMT>F M"[_Y'HS!O._4-$8$J/']PQ"B(>P\C?(VP11SY^DD]/E0732"T;Z&*QHC1C/J M5^=>)&,XR[!6UJ; M447V/KB$O9D!_.%#N!!#O:\&B2J?+,2PA,5^XL4'#OT ME?*#N-U=E)>O#WF4%E',V2G>OW9_L1Q.N'3BV6XY\3>N*B>:$-$FD ,-]PD; M&KEIL^4=C=9#$%5C1'1I78X!B@(Y!-&+VH2711^VWI_3XO[TLCW$YF5QW,[G MPJ@8I>IIQ'9['<;"J)-J;VE<7:2@Q1$B6M:$5/+%]]2;]Z71]^1X/K[/\CS[ MEJ3/U]&)_5*^ GUX>S>(WCV 1XO?WX9[5GV0IA-2]Q+&,Z<9O [>#E^18\7K M8\-K;. 5:_\#1;!I9^0"7R\J*K+ITUWQB;'.#P"^T/+VJ0X_%#%N!L6$$'M6 M1Q _XWH0DHAP %0O9!DAQVH_$A/ST=L"G*6,IQ!>2&"K^3,\OY6Y$]0(30M_UKC&FE[<.ET1V05I^\#4L/F<)FV> MAD)REM3\YOR6[63D$R^6$X):I60-A&$70O\]1 M>9BI^$"3U-4@#+K MA@Y-"-IP%[V*_)DT=TA4U2="U8;!^*W:4+47M_6H^R=W-CK:<*JX*'5:!D2)BN)]KL"0$HB7-FA:# M@7/+=UON:0[,S:1HZWE-5XUV.!^BS2![/]YQ"'S$A][*CKVH:W$Q7-6-H/#N ME X*S'4/-F_9GQZ2H^D4P[DG1)<6QJG-XQV5$QP<\6?LSX3W%4:VL^E,=WSF M;S7/4<5S<[PHN(WX07^2[;A-+S6<8[G7#O V>=^.V%[H#4.UVLK4N7+-I;L/ MYYRMD0][>B>$KG7'G?O!>OD Y-+R**)VN64WI.Z'R(X(ZXG(KK!<[(4X;K6R M]ILBR?%CS?%.[RF$V']QL*($8<\-())< 5;F1WF#1@C0T@9G-^ *X>6= M4I@J@&&^M -*= 60W::&ZN7J=@A0ZXY2AS;QUC.$8'&=9%6@6T^L+KB#B'?A M!\A5MP_?,A#\.NT0X-<=I4X^K$U0\!M)5@6_]<3J C^(>,MO&=)3A8ZK6NUI MI:MJSJ'M1HYXUF/@R9RC_JHYUZDVDJCYM&>R5K,B'[#CYYV>@C[3J0P$>C.L M.=NEW>^CG'Z(RFCS6)1Y%*L.^PUM?5IUS6A'(?(T)Z(=C]>*V%:I:HI5(''2 ML/\#=2TRX:*W'GD!!6A-!!Q>V+:+]XCU]P95JQ9O7I>R.9)8#BG+3&INN//$IJ_R1[)#[S/'^6[ MF;;;*]+HW3KF@1=>L2U^RXJ#/W1*TCBG4<&XWE'Y7S^ROXGW0E%1T+(@C)GS MH>1G;$(B6=,S]M*Y@'8,5]2%5&/&0OLI2G(1+'#[Q(9PS-+[,HO_,&@UB,KG MXFOE8%SC,:4U3_ Z8N/4_$LZZ ?))5)B80GT54%/M*RW-N MRDMB)L/V.OH\0-P*04$D"=YFV9&1[J#)#X\__A#_&-PBKX"3=1778&G&,ET_ M/.[IZTUZG:4I%8F!?D_*_<.>?J;YL_[LT[47G\NX,X#19VYEVTO MA'14>!K+ZJ M#_3EU?&O49+R M$=VF[4]3U-'<#[8Z6KB$J"/OHCZ)$[GKZR9AZJ,CQUP?/9[ZF/V1B4/OLL&.HF**GD-ZPM17$ M,41GNQV1,B/=KE93VW^77*?TF:>><5;<2?O1*6';_NZHIV@PM$=L+09S#CJ]BK[7QT!\]R[[Z^EWF,OP9"$(CQ M '-1S."RXH.Y#_4+N_8N&BW692HRK1H(@.6<4^KAYZIKZ_3YX_<330M:B,]N MGIBU9;MEUBYYH9N#^(3B1*TY.)S;K==S[-DRL.LA:?HD=:=2'XGHEC3]DK9C MK(/NQ<71\DZK'G!/M9?!?/^8.S# P\Z]UP1^7 $_&TT^$7$Q)!+ 3QK@1TW' M 1^,"X',/16O.L'V*TS\S8J+$YT$Y/.[,'JYY^ ]:$XZ!!_AN^/C8]==9(UE= QP\S^8YKOJMULO(#:<-W MZPL^J?D.9A$UHMQI!;5"'*V&I:6FLYXD@-J4FOQ66YKNF.W\$AVQLX5!!0\I MLXA2B5DU$"E>:UUF.VD "!KP JYH6D$,.UV8ZS1!<*:;HSD5G@_Y^W/!OE44 M@]*AYH+/-C*O]9^M/(QJ%F^_DIID=$AIRKOD82/@D1MOVP,@ROH%L#U##%8/ M>]')0=D\./D8 7@7(+]BA/H@? NX5Q& /]$?@M6'4#='Q8;65QBA(Q#?P"1R M,T*F^0"S,?*5OF2'%UY_!.8K .D\H\;&Q2A*L&X?D*O@EQ>?2@'"V% [P "; MX2I?YZ]%&1V:*$JSAZQK[=,QUHYX;"!%PTZ$+[(3O-+(O3F\9JST_%Q/0 &Y MM]/%_H-L.GI%.%_?JL<"S9=^R0[\M*[8'F*0!@+H$702PI5.Z/43F1;S-379 M;J^#4@#PY*E4PO_,N2C)G!FLGOR0IV8&]YT9Q+E4:O:UV?&1#8M+X#I+BV17 M)9_CN9.+)YJS!=94T=ZM&\^>GR./P^EK]_$M_17I]4 Z7>!YA4OQ&7?YC'M\ MEF8^?7J,4Y [=""GPG:A9A.&%W<8B[2,^:L4Y8)#;555?R!T+I[J!XQXU\3RZ6(G M#[O6=$SK)H#+0 ./X(O!.BM_IQ,TN[(PKT,+4[]F[=0>0+8T

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end

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